,Sentence,ESG BERT Topic 1,ESG BERT Topic 2,ESG BERT Topic 3,Mapped Criteria Topic 1,Mapped Criteria Topic 2,Mapped Criteria Topic 3
Line 1,"THE  POWER  OF  PURPOSE  2019 Integrated  Performance Report Ambar , a Medtronic Diabetes customerT ABLE OF CONTENTS 2A Message from   our CEO Company Overview Sustainability Priorities  and Strategies Adding Value to Society Promoting Environmental  Stewardship Supporting a Global   Workforce Working Responsibly About This Report 2019 ESG Disclosure IndexA MESSAGE  FROM OMAR The Medtronic Mission is one of the greatest gifts our co-founder  Earl Bakken gave to Medtronic.
","('Business_Model_Resilience', 0.5775452256202698)","('Product_Design_And_Lifecycle_Management', 0.085261270403862)","('Supply_Chain_Management', 0.06149018555879593)","(['Codes of Business Conduct'], 0.5775452256202698)","('NON-ESG', 0.085261270403862)","('NON-ESG', 0.06149018555879593)"
Line 2,"It clarifies our purpose and reminds  us that our foremost priority is to contribute to human welfare.
","('Human_Rights_And_Community_Relations', 0.7190102934837341)","('Access_And_Affordability', 0.09157181531190872)","('Employee_Health_And_Safety', 0.03120185248553753)","(['Community Relations'], 0.7190102934837341)","('NON-ESG', 0.09157181531190872)","('NON-ESG', 0.03120185248553753)"
Line 3,"Though it was written nearly 60 years ago, it continues to inspire us,  define our long-term strategy, and guide how we operate as   a company.
","('Business_Model_Resilience', 0.8221443295478821)","('Product_Design_And_Lifecycle_Management', 0.023108765482902527)","('Director_Removal', 0.019848305732011795)","(['Codes of Business Conduct'], 0.8221443295478821)","('NON-ESG', 0.023108765482902527)","('NON-ESG', 0.019848305732011795)"
Line 4,"At its core, the Mission states that we are a technology company  that aims to improve outcomes meaningful to patients.
","('Access_And_Affordability', 0.7489593029022217)","('Employee_Health_And_Safety', 0.03643297776579857)","('Human_Rights_And_Community_Relations', 0.026738787069916725)","(['Health Outcome Contribution'], 0.7489593029022217)","('NON-ESG', 0.03643297776579857)","('NON-ESG', 0.026738787069916725)"
Line 5,"T oday we  are executing on the strongest product pipeline in Medtronic history,  bringing to market a long list of technology innovations that will, in the  words of the Mission, alleviate pain, restore health, and extend life for  millions of people around the world.
","('Product_Design_And_Lifecycle_Management', 0.6763917803764343)","('Employee_Health_And_Safety', 0.0786510482430458)","('Product_Quality_And_Safety', 0.053028304129838943)","(['Product Stewardship'], 0.6763917803764343)","('NON-ESG', 0.0786510482430458)","('NON-ESG', 0.053028304129838943)"
Line 6,"I’m incredibly pleased to share  that together with our physician partners, we served a record   375 million+ patients in FY19 — improving the lives of more than   two people every second.
","('Access_And_Affordability', 0.5616405010223389)","('Employee_Health_And_Safety', 0.08829017728567123)","('Customer_Welfare', 0.05146079137921333)","(['Health Outcome Contribution'], 0.5616405010223389)","('NON-ESG', 0.08829017728567123)","('NON-ESG', 0.05146079137921333)"
Line 7,"Our Mission also provides an ethical framework for our 90,000+  Medtronic employees around the world.
","('Business_Ethics', 0.5845233798027039)","('Labor_Practices', 0.06450460851192474)","('Employee_Health_And_Safety', 0.06196896731853485)","(['Business Ethics'], 0.5845233798027039)","('NON-ESG', 0.06450460851192474)","('NON-ESG', 0.06196896731853485)"
Line 8,"It calls upon us to be a  leader and a partner in finding ways to better serve our communities.
","('Human_Rights_And_Community_Relations', 0.9403061270713806)","('Access_And_Affordability', 0.009541818872094154)","('Employee_Engagement_Inclusion_And_Diversity', 0.005420859903097153)","(['Community Relations'], 0.9403061270713806)","('NON-ESG', 0.009541818872094154)","('NON-ESG', 0.005420859903097153)"
Line 9,"T o help guide our efforts related to the economic, social, and  environmental areas where we can make the greatest contributions,  we have established a Citizenship framework.
","('Human_Rights_And_Community_Relations', 0.9203419089317322)","('Ecological_Impacts', 0.012028123252093792)","('Management_Of_Legal_And_Regulatory_Framework', 0.007046270649880171)","(['Community Relations'], 0.9203419089317322)","('NON-ESG', 0.012028123252093792)","('NON-ESG', 0.007046270649880171)"
Line 10,"In this, our FY19  Integrated Performance Report, we outline our progress within the  four pillars of our Citizenship framework: Adding Value to Society,  Promoting Environmental Stewardship, Supporting a Global  Workforce, and Working Responsibly.
","('Human_Rights_And_Community_Relations', 0.5853525400161743)","('Business_Model_Resilience', 0.10120314359664917)","('Ecological_Impacts', 0.06369846314191818)","(['Community Relations'], 0.5853525400161743)","('NON-ESG', 0.10120314359664917)","('NON-ESG', 0.06369846314191818)"
Line 11,"Before highlighting some of our many notable accomplishments  in FY19, there are three topics I want to address more deeply.
","('Business_Model_Resilience', 0.16531775891780853)","('Director_Removal', 0.1370551586151123)","('Employee_Engagement_Inclusion_And_Diversity', 0.1290447860956192)","('NON-ESG', 0.16531775891780853)","('NON-ESG', 0.1370551586151123)","('NON-ESG', 0.1290447860956192)"
Line 12,"First,  this year’s Integrated Performance Report debuts the Medtronic  contribution to the UN Sustainable Development Goals.
","('Human_Rights_And_Community_Relations', 0.49922794103622437)","('Business_Model_Resilience', 0.10048960894346237)","('Ecological_Impacts', 0.08843338489532471)","('NON-ESG', 0.49922794103622437)","('NON-ESG', 0.10048960894346237)","('NON-ESG', 0.08843338489532471)"
Line 13,"As a global  company, we support the UN’s commitment to achieve “peace  and prosperity for people and the planet,” and are focused on the  specific goals where we can have the greatest impact, including  ones related to good health, well-being, economic opportunity,   and partnerships.
","('Human_Rights_And_Community_Relations', 0.8650909662246704)","('Access_And_Affordability', 0.033917807042598724)","('Employee_Health_And_Safety', 0.012272951193153858)","(['Community Relations'], 0.8650909662246704)","('NON-ESG', 0.033917807042598724)","('NON-ESG', 0.012272951193153858)"
Line 14,"Second, Medtronic values equity, inclusion, and diversity — and aims  to create an enriching work experience for all employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9751801490783691)","('Employee_Health_And_Safety', 0.00220854626968503)","('Human_Rights_And_Community_Relations', 0.0018956686835736036)","(['Human Capital Development'], 0.9751801490783691)","('NON-ESG', 0.00220854626968503)","('NON-ESG', 0.0018956686835736036)"
Line 15,"In FY19,  ethnically diverse talent held 22% of leadership positions in the  United States, surpassing our aspirational goal of 20% or more by  2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9737605452537537)","('Business_Model_Resilience', 0.001919361762702465)","('Customer_Privacy', 0.0018521767342463136)","(['Human Capital Development'], 0.9737605452537537)","('NON-ESG', 0.001919361762702465)","('NON-ESG', 0.0018521767342463136)"
Line 16,"And 38% of our leadership positions were held by women, on  track to meet our 2020 aspirational goal of 40% or more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7074974775314331)","('Director_Removal', 0.08241522312164307)","('Business_Model_Resilience', 0.03954722732305527)","(['Human Capital Development'], 0.7074974775314331)","('NON-ESG', 0.08241522312164307)","('NON-ESG', 0.03954722732305527)"
Line 17,"Third, with this year’s report, Medtronic is joining a handful of  companies who have shared information about pay equity — an  important component of the UN’s goal on economic opportunity  and tightly aligned with T enet 5 of our Mission, which calls on us to  “recognize the personal worth of all employees” — regardless of  gender , race, or ethnicity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9679381847381592)","('Labor_Practices', 0.003670471254736185)","('Customer_Privacy', 0.0026266933418810368)","(['Human Capital Development'], 0.9679381847381592)","('NON-ESG', 0.003670471254736185)","('NON-ESG', 0.0026266933418810368)"
Line 18,"A comprehensive analysis we conducted  in FY19 showed that our global pay equity between genders was  99% — and 100% in certain countries, including the United States.
","('Labor_Practices', 0.9191794395446777)","('Employee_Engagement_Inclusion_And_Diversity', 0.0277600958943367)","('Director_Removal', 0.0058989753015339375)","(['Labor Practice Indicators'], 0.9191794395446777)","('NON-ESG', 0.0277600958943367)","('NON-ESG', 0.0058989753015339375)"
Line 19,"We also conducted an ethnic diversity analysis in the United States,  which included all genders, and found that for every $1.00 that  white employees with a certain job title earned, ethnically diverse  employees earned $0.99.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9750916361808777)","('Employee_Health_And_Safety', 0.0018605742370709777)","('Labor_Practices', 0.0018235889729112387)","(['Human Capital Development'], 0.9750916361808777)","('NON-ESG', 0.0018605742370709777)","('NON-ESG', 0.0018235889729112387)"
Line 20,"While we are pleased with these results,   I assure you that our journey won’t stop until we ensure and sustain  100% pay equity for all.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5360223054885864)","('Competitive_Behavior', 0.164021834731102)","('Business_Ethics', 0.06448978930711746)","(['Corporate Governance'], 0.5360223054885864)","('NON-ESG', 0.164021834731102)","('NON-ESG', 0.06448978930711746)"
Line 21,"Further , I want to highlight some other notable accomplishments   in FY19.
","('Employee_Engagement_Inclusion_And_Diversity', 0.15764737129211426)","('Director_Removal', 0.147183358669281)","('Business_Model_Resilience', 0.10755830258131027)","('NON-ESG', 0.15764737129211426)","('NON-ESG', 0.147183358669281)","('NON-ESG', 0.10755830258131027)"
Line 22,"We:  Delivered strong financial results, achieving $30.6 billion in  revenue and $5.9 billion in free cash flow.
","('Systemic_Risk_Management', 0.6022557020187378)","('Business_Model_Resilience', 0.14854298532009125)","('Competitive_Behavior', 0.039703793823719025)","(['Risk & Crisis Management'], 0.6022557020187378)","('NON-ESG', 0.14854298532009125)","('NON-ESG', 0.039703793823719025)"
Line 23,"Invested $2.3 billion in research and development to advance  our innovation pipeline.
","('Business_Model_Resilience', 0.12655246257781982)","('Access_And_Affordability', 0.12033131718635559)","('Product_Design_And_Lifecycle_Management', 0.11433495581150055)","('NON-ESG', 0.12655246257781982)","('NON-ESG', 0.12033131718635559)","('NON-ESG', 0.11433495581150055)"
Line 24,"This included the costs of 279+ ongoing  clinical studies.
","('Access_And_Affordability', 0.26851916313171387)","('Competitive_Behavior', 0.07893520593643188)","('Customer_Welfare', 0.07577725499868393)","('NON-ESG', 0.26851916313171387)","('NON-ESG', 0.07893520593643188)","('NON-ESG', 0.07577725499868393)"
Line 25,"Increased healthcare capacity and access by investing $142  million in training for more than 83,000 medical professionals, and  $28.6 million in patient education.
","('Access_And_Affordability', 0.8327505588531494)","('Employee_Engagement_Inclusion_And_Diversity', 0.027081293985247612)","('Employee_Health_And_Safety', 0.014878889545798302)","(['Health Outcome Contribution'], 0.8327505588531494)","('NON-ESG', 0.027081293985247612)","('NON-ESG', 0.014878889545798302)"
Line 26,"Continued our commitment to ethics in sales and marketing  by reaching more than 21,000 marketing and sales employees  (97% of employees in these roles) through expanded product- promotion trainings.
","('Customer_Welfare', 0.2427404522895813)","('Selling_Practices_And_Product_Labeling', 0.14578129351139069)","('Employee_Engagement_Inclusion_And_Diversity', 0.10152480006217957)","('NON-ESG', 0.2427404522895813)","('NON-ESG', 0.14578129351139069)","('NON-ESG', 0.10152480006217957)"
Line 27,"4 Directed 24% of our U.S. supplier spend to small and diverse  companies, reinforcing our commitment to a diverse   supply chain.
","('Supply_Chain_Management', 0.9457876682281494)","('Labor_Practices', 0.004815381485968828)","('Product_Design_And_Lifecycle_Management', 0.004077923484146595)","(['Supply Chain Management'], 0.9457876682281494)","('NON-ESG', 0.004815381485968828)","('NON-ESG', 0.004077923484146595)"
Line 28,"Continued to shift our philanthropic activities toward programs  with measurable impact on improving health outcomes for  underserved populations.
","('Access_And_Affordability', 0.9478475451469421)","('Product_Quality_And_Safety', 0.004687419626861811)","('Critical_Incident_Risk_Management', 0.004653641488403082)","(['Health Outcome Contribution'], 0.9478475451469421)","('NON-ESG', 0.004687419626861811)","('NON-ESG', 0.004653641488403082)"
Line 29,"Our philanthropic contributions total  more than $1 billion since 2003, including our support of the  Medtronic Foundation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6834868788719177)","('Business_Ethics', 0.029859669506549835)","('Ecological_Impacts', 0.029184749349951744)","(['Corporate Governance'], 0.6834868788719177)","('NON-ESG', 0.029859669506549835)","('NON-ESG', 0.029184749349951744)"
Line 30,"Continued to reduce energy use, emissions, regulated waste,  and water use.
","('Waste_And_Hazardous_Materials_Management', 0.6940531134605408)","('Energy_Management', 0.10463740676641464)","('Water_And_Wastewater_Management', 0.06221822649240494)","(['Operational Eco-Efficiency'], 0.6940531134605408)","('NON-ESG', 0.10463740676641464)","('NON-ESG', 0.06221822649240494)"
Line 31,"Energy projects completed in FY19 will provide  Medtronic an estimated $4.3 million in operational cost savings  — reinforcing the business case for environmental responsibility.
","('Energy_Management', 0.8043736219406128)","('Management_Of_Legal_And_Regulatory_Framework', 0.037095390260219574)","('Product_Design_And_Lifecycle_Management', 0.024836421012878418)","(['Operational Eco-Efficiency'], 0.8043736219406128)","('NON-ESG', 0.037095390260219574)","('NON-ESG', 0.024836421012878418)"
Line 32,"In FY20, we will launch new environmental goals, committing us to  further reduce our footprint by 2025.
","('Physical_Impacts_Of_Climate_Change', 0.27074316143989563)","('Business_Model_Resilience', 0.21480543911457062)","('GHG_Emissions', 0.10703124850988388)","('NON-ESG', 0.27074316143989563)","('NON-ESG', 0.21480543911457062)","('NON-ESG', 0.10703124850988388)"
Line 33,"Since joining Medtronic over eight years ago, I have been truly  honored to lead this organization and its team of highly talented,  dedicated employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6167290210723877)","('Employee_Health_And_Safety', 0.05514191463589668)","('Product_Design_And_Lifecycle_Management', 0.03668053075671196)","(['Human Capital Development'], 0.6167290210723877)","('NON-ESG', 0.05514191463589668)","('NON-ESG', 0.03668053075671196)"
Line 34,"Looking ahead, I recently announced my  intention to retire as CEO at the end of FY20 and the board of  directors named Geoff Martha as the next Medtronic CEO.
","('Director_Removal', 0.5016946792602539)","('Business_Model_Resilience', 0.1493811458349228)","('Product_Design_And_Lifecycle_Management', 0.03539811447262764)","(['Anti-Crime Policy & Measures'], 0.5016946792602539)","('NON-ESG', 0.1493811458349228)","('NON-ESG', 0.03539811447262764)"
Line 35,"Geoff has the ability, judgement, values, and strategic vision to  propel our company to new heights into the future.
","('Business_Model_Resilience', 0.5818698406219482)","('Employee_Engagement_Inclusion_And_Diversity', 0.07156506925821304)","('Human_Rights_And_Community_Relations', 0.0511862114071846)","(['Codes of Business Conduct'], 0.5818698406219482)","('NON-ESG', 0.07156506925821304)","('NON-ESG', 0.0511862114071846)"
Line 36,"In closing, we are proud of the progress we have made to date and  are excited about the future, but we know there is still much work to  be done.
","('Business_Model_Resilience', 0.28796783089637756)","('Human_Rights_And_Community_Relations', 0.1563786417245865)","('Director_Removal', 0.06888604164123535)","('NON-ESG', 0.28796783089637756)","('NON-ESG', 0.1563786417245865)","('NON-ESG', 0.06888604164123535)"
Line 37,"Not only have we built the strongest product pipeline in the  company’s history, but we are also committed to lead the industry in  all that we do and the way that we do it — focusing on environmental  and social responsibilities, while also delivering on profitability.
","('Human_Rights_And_Community_Relations', 0.9259725213050842)","('Ecological_Impacts', 0.008097715675830841)","('Access_And_Affordability', 0.0063223810866475105)","(['Community Relations'], 0.9259725213050842)","('NON-ESG', 0.008097715675830841)","('NON-ESG', 0.0063223810866475105)"
Line 38,"And  most importantly, we will continue to extend the reach of Medtronic  to impact even more patients around the globe — furthering our  Mission to use technology to alleviate pain, restore health, and  extend life.
","('Employee_Health_And_Safety', 0.8532118201255798)","('Access_And_Affordability', 0.025024430826306343)","('Critical_Incident_Risk_Management', 0.01242035161703825)","(['Operational Eco-Efficiency'], 0.8532118201255798)","('NON-ESG', 0.025024430826306343)","('NON-ESG', 0.01242035161703825)"
Line 39,"Omar Ishrak  Chairman and CEO, Medtronic COMPANY  OVERVIEW7Since 1949, Medtronic has developed medical technology to alleviate pain, restore health, and extend life.
","('Employee_Health_And_Safety', 0.9359792470932007)","('Product_Design_And_Lifecycle_Management', 0.008829533122479916)","('Product_Quality_And_Safety', 0.005727842450141907)","(['Operational Eco-Efficiency'], 0.9359792470932007)","('NON-ESG', 0.008829533122479916)","('NON-ESG', 0.005727842450141907)"
Line 40,"As a company built on innovation, we’re  collaborating with others who also believe that by working together , we can improve both our healthcare systems and the quality of care   for everyone.
","('Access_And_Affordability', 0.7063555717468262)","('Customer_Welfare', 0.0322079136967659)","('Energy_Management', 0.026995517313480377)","(['Health Outcome Contribution'], 0.7063555717468262)","('NON-ESG', 0.0322079136967659)","('NON-ESG', 0.026995517313480377)"
Line 41,"MEDTRONIC   FY19 SNAPSHOTCOMPANY  OVERVIEW  Corporate Responsibility  Magazine — 2019 100 Best  Corporate Citizens  North American Dow Jones  Sustainability Index —   12th consecutive year  JUST 100 — Companies  Doing Right by America for  2019; T op U.S. Companies  Supporting Healthy  Communities and Families  for  Human Rights Campaign —  2018 Best Places to Work 2019 FTSE4Good Index   Edison Awards — 2019   Best New Products  Innovation Leader —   2018 Innovation Awards  DiversityInc — 2019 T op 50  Companies for Diversity  Thomson Reuters —   2018 T op 100 Most   Diverse and Inclusive  Organizations GloballyRECENT RECOGNITION  FOR OUR   CORPORA TE CITIZENSHIP  AND INNOVA TION 90,000+ Employees 150+ Countries   in Which   We Operate  $2.3B   Research and  Development  Spend   47,800+ Patents75M+ Patients   Served 8Acting on our Mission Written nearly 60 years ago,   the tenets of our Mission drive  our focus and contributions to  enable more people to benefit  from affordable, effective  healthcare globally.
","('Human_Rights_And_Community_Relations', 0.952360212802887)","('Access_And_Affordability', 0.007697021123021841)","('Employee_Health_And_Safety', 0.003611746709793806)","(['Community Relations'], 0.952360212802887)","('NON-ESG', 0.007697021123021841)","('NON-ESG', 0.003611746709793806)"
Line 42,"MEDTRONIC   FY19 SNAPSHOTCOMPANY  OVERVIEW  Corporate Responsibility  Magazine — 2019 100 Best  Corporate Citizens  North American Dow Jones  Sustainability Index —   12th consecutive year  JUST 100 — Companies  Doing Right by America for  2019; T op U.S. Companies  Supporting Healthy  Communities and Families  for  Human Rights Campaign —  2018 Best Places to Work 2019 FTSE4Good Index   Edison Awards — 2019   Best New Products  Innovation Leader —   2018 Innovation Awards  DiversityInc — 2019 T op 50  Companies for Diversity  Thomson Reuters —   2018 T op 100 Most   Diverse and Inclusive  Organizations GloballyRECENT RECOGNITION  FOR OUR   CORPORA TE CITIZENSHIP  AND INNOVA TION 90,000+ Employees 150+ Countries   in Which   We Operate  $2.3B   Research and  Development  Spend   47,800+ Patents75M+ Patients   Served 8Acting on our Mission Written nearly 60 years ago,   the tenets of our Mission drive  our focus and contributions to  enable more people to benefit  from affordable, effective  healthcare globally.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9693939685821533)","('Human_Rights_And_Community_Relations', 0.0025553428567945957)","('Employee_Health_And_Safety', 0.0025124831590801477)","(['Human Capital Development'], 0.9693939685821533)","('NON-ESG', 0.0025553428567945957)","('NON-ESG', 0.0025124831590801477)"
Line 43,"MEDTRONIC   FY19 SNAPSHOTCOMPANY  OVERVIEW  Corporate Responsibility  Magazine — 2019 100 Best  Corporate Citizens  North American Dow Jones  Sustainability Index —   12th consecutive year  JUST 100 — Companies  Doing Right by America for  2019; T op U.S. Companies  Supporting Healthy  Communities and Families  for  Human Rights Campaign —  2018 Best Places to Work 2019 FTSE4Good Index   Edison Awards — 2019   Best New Products  Innovation Leader —   2018 Innovation Awards  DiversityInc — 2019 T op 50  Companies for Diversity  Thomson Reuters —   2018 T op 100 Most   Diverse and Inclusive  Organizations GloballyRECENT RECOGNITION  FOR OUR   CORPORA TE CITIZENSHIP  AND INNOVA TION 90,000+ Employees 150+ Countries   in Which   We Operate  $2.3B   Research and  Development  Spend   47,800+ Patents75M+ Patients   Served 8Acting on our Mission Written nearly 60 years ago,   the tenets of our Mission drive  our focus and contributions to  enable more people to benefit  from affordable, effective  healthcare globally.
","('Management_Of_Legal_And_Regulatory_Framework', 0.16783051192760468)","('Business_Model_Resilience', 0.12004505097866058)","('Director_Removal', 0.06753679364919662)","('NON-ESG', 0.16783051192760468)","('NON-ESG', 0.12004505097866058)","('NON-ESG', 0.06753679364919662)"
Line 44,"THE   MEDTRONIC   MISSIONT o contribute to human welfare by application of  biomedical engineering in the research, design,  manufacture, and sale of instruments or appliances  that alleviate pain, restore health, and extend life.
","('Employee_Health_And_Safety', 0.9703388214111328)","('Product_Design_And_Lifecycle_Management', 0.002981753321364522)","('Employee_Engagement_Inclusion_And_Diversity', 0.0025293854996562004)","(['Operational Eco-Efficiency'], 0.9703388214111328)","('NON-ESG', 0.002981753321364522)","('NON-ESG', 0.0025293854996562004)"
Line 45,"T o direct our growth in the areas of biomedical  engineering where we display maximum strength  and ability; to gather people and facilities that tend  to augment these areas; to continuously build on  these areas through education and knowledge  assimilation; to avoid participation in areas where  we cannot make unique and worthy contributions.
","('Access_And_Affordability', 0.5987818241119385)","('Employee_Engagement_Inclusion_And_Diversity', 0.10331740975379944)","('Ecological_Impacts', 0.03315400704741478)","(['Health Outcome Contribution'], 0.5987818241119385)","('NON-ESG', 0.10331740975379944)","('NON-ESG', 0.03315400704741478)"
Line 46,"T o strive without reserve for the greatest possible  reliability and quality in our products; to be the  unsurpassed standard of comparison and to be  recognized as a company of dedication, honesty,  integrity, and service.
","('Product_Design_And_Lifecycle_Management', 0.29731228947639465)","('Product_Quality_And_Safety', 0.21646876633167267)","('Business_Ethics', 0.13589240610599518)","('NON-ESG', 0.29731228947639465)","('NON-ESG', 0.21646876633167267)","('NON-ESG', 0.13589240610599518)"
Line 47,"T o make a fair profit on current operations to   meet our obligations, sustain our growth, and   reach our goals.
","('Business_Model_Resilience', 0.5958232879638672)","('Systemic_Risk_Management', 0.09484092891216278)","('Supply_Chain_Management', 0.06397517025470734)","(['Codes of Business Conduct'], 0.5958232879638672)","('NON-ESG', 0.09484092891216278)","('NON-ESG', 0.06397517025470734)"
Line 48,"T o recognize the personal worth of all employees  by providing an employment framework that  allows personal satisfaction in work accomplished,  security, advancement opportunity, and means   to share in the company’s success.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6234591007232666)","('Labor_Practices', 0.1496376246213913)","('Human_Rights_And_Community_Relations', 0.045485831797122955)","(['Human Capital Development'], 0.6234591007232666)","('NON-ESG', 0.1496376246213913)","('NON-ESG', 0.045485831797122955)"
Line 49,"T o maintain good citizenship as a company.69EARL  BAKKEN 1924-2018It is my hope  that one day,  every Medtronic  employee, and  every patient  with a Medtronic  device, will  participate  in giving  back to their  community,  toward the  improvement of  humankind.
","('Human_Rights_And_Community_Relations', 0.6881849765777588)","('Employee_Health_And_Safety', 0.0442296601831913)","('Employee_Engagement_Inclusion_And_Diversity', 0.043510351330041885)","(['Community Relations'], 0.6881849765777588)","('NON-ESG', 0.0442296601831913)","('NON-ESG', 0.043510351330041885)"
Line 50,"– Earl Bakken Medtronic   Co-founder““How we are organized Medtronic has four operating groups: Cardiac and Vascular , Minimally Invasive Therapies, Restorative Therapies, and Diabetes.
","('Access_And_Affordability', 0.3451994061470032)","('Customer_Welfare', 0.12275602668523788)","('Employee_Health_And_Safety', 0.052801717072725296)","('NON-ESG', 0.3451994061470032)","('NON-ESG', 0.12275602668523788)","('NON-ESG', 0.052801717072725296)"
Line 51,"Each group is  separated into business divisions that deliver a wide range of medical technologies, therapies, services, and solutions.
","('Product_Design_And_Lifecycle_Management', 0.5722046494483948)","('Customer_Welfare', 0.1169167160987854)","('Business_Model_Resilience', 0.04938780888915062)","(['Product Stewardship'], 0.5722046494483948)","('NON-ESG', 0.1169167160987854)","('NON-ESG', 0.04938780888915062)"
Line 52,"Medtronic Operating Groups FY19 T otal Sales and Business Divisions  OPERA TING SEGMENTS  AND BUSINESS DIVISIONSFY19 NET SALES  ($ MILLION) Cardiac and Vascular Group    Cardiac Rhythm and Heart Failure   Coronary and Structural Heart   Aortic, Peripheral, and Venous $11,Minimally Invasive Therapies Group   Surgical Innovations   Respiratory, Gastrointestinal, and Renal$8,Restorative Therapies Group   Spine   Brain Therapies   Specialty Therapies   Pain Therapies $8,Diabetes Group $2,TOT AL NET SALES $30,557Global Footprint FY19 Net Sales to External Customers by Region ($ Million) United       States*   $16,194   (53%)Non-U.S.   Developed   Markets†  $9,631   (32%)Emerging   Markets** $4,732   (15%)    * The United States includes the U.S. and U.S. territories.
","('Access_And_Affordability', 0.1999492198228836)","('Customer_Welfare', 0.14913171529769897)","('Employee_Health_And_Safety', 0.07883074134588242)","('NON-ESG', 0.1999492198228836)","('NON-ESG', 0.14913171529769897)","('NON-ESG', 0.07883074134588242)"
Line 53,"Medtronic Operating Groups FY19 T otal Sales and Business Divisions  OPERA TING SEGMENTS  AND BUSINESS DIVISIONSFY19 NET SALES  ($ MILLION) Cardiac and Vascular Group    Cardiac Rhythm and Heart Failure   Coronary and Structural Heart   Aortic, Peripheral, and Venous $11,Minimally Invasive Therapies Group   Surgical Innovations   Respiratory, Gastrointestinal, and Renal$8,Restorative Therapies Group   Spine   Brain Therapies   Specialty Therapies   Pain Therapies $8,Diabetes Group $2,TOT AL NET SALES $30,557Global Footprint FY19 Net Sales to External Customers by Region ($ Million) United       States*   $16,194   (53%)Non-U.S.   Developed   Markets†  $9,631   (32%)Emerging   Markets** $4,732   (15%)    * The United States includes the U.S. and U.S. territories.
","('Systemic_Risk_Management', 0.3243677616119385)","('Business_Model_Resilience', 0.27289119362831116)","('Competitive_Behavior', 0.13004781305789948)","('NON-ESG', 0.3243677616119385)","('NON-ESG', 0.27289119362831116)","('NON-ESG', 0.13004781305789948)"
Line 54,"† Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada,  and the countries of Western Europe.
","('Competitive_Behavior', 0.7175076603889465)","('Business_Model_Resilience', 0.06147845834493637)","('Systemic_Risk_Management', 0.05352971330285072)","(['Business Ethics'], 0.7175076603889465)","('NON-ESG', 0.06147845834493637)","('NON-ESG', 0.05352971330285072)"
Line 55,"** Emerging markets include the countries of the Middle East, Africa, Latin America,  Eastern Europe, and the countries of Asia that are not included in the non-U.S.  developed markets, as defined above.11As we deliver on our Mission, we are conscious of our impact on the world in which we operate.
","('Business_Model_Resilience', 0.5215286612510681)","('Systemic_Risk_Management', 0.1633090376853943)","('Competitive_Behavior', 0.13227479159832)","(['Codes of Business Conduct'], 0.5215286612510681)","('NON-ESG', 0.1633090376853943)","('NON-ESG', 0.13227479159832)"
Line 56,"Being genuinely sustainable means balancing  profitability with environmental and social responsibilities.
","('Human_Rights_And_Community_Relations', 0.9120674133300781)","('Ecological_Impacts', 0.016234783455729485)","('Business_Model_Resilience', 0.007252589333802462)","(['Community Relations'], 0.9120674133300781)","('NON-ESG', 0.016234783455729485)","('NON-ESG', 0.007252589333802462)"
Line 57,"We must be held accountable for what we do and the way we do it.
","('Business_Ethics', 0.5925281047821045)","('Management_Of_Legal_And_Regulatory_Framework', 0.07785695791244507)","('Competitive_Behavior', 0.06899025291204453)","(['Business Ethics'], 0.5925281047821045)","('NON-ESG', 0.07785695791244507)","('NON-ESG', 0.06899025291204453)"
Line 58,"Our Material  Issues We activate our commitment  to good corporate citizenship  through a continuous cycle  of foresight, planning, and  reporting on our most  significant sustainability issues.
","('Business_Model_Resilience', 0.4696614444255829)","('Human_Rights_And_Community_Relations', 0.08378478139638901)","('Product_Design_And_Lifecycle_Management', 0.07888176292181015)","('NON-ESG', 0.4696614444255829)","('NON-ESG', 0.08378478139638901)","('NON-ESG', 0.07888176292181015)"
Line 59,"By conducting regular reviews  of our sustainability strategies  and priorities, we are able to  stay ahead of emerging risks  and opportunities.
","('Systemic_Risk_Management', 0.7659748196601868)","('Business_Model_Resilience', 0.06714870780706406)","('Physical_Impacts_Of_Climate_Change', 0.048215802758932114)","(['Risk & Crisis Management'], 0.7659748196601868)","('NON-ESG', 0.06714870780706406)","('NON-ESG', 0.048215802758932114)"
Line 60,"The review  process informs planning and  operations across our business,  extending into our supply chain  and the way we design and make  our products.
","('Product_Design_And_Lifecycle_Management', 0.7656471133232117)","('Supply_Chain_Management', 0.12324094772338867)","('Waste_And_Hazardous_Materials_Management', 0.010280328802764416)","(['Product Stewardship'], 0.7656471133232117)","('NON-ESG', 0.12324094772338867)","('NON-ESG', 0.010280328802764416)"
Line 61,"It ensures that we  drive innovation and efficiency  with deep awareness of our  responsibility to people   and planet.SUST AINABILITY  PRIORITIES &  STRA TEGIES We focus on the issues that:  Have the potential to  significantly impact our  business growth, finances, or  reputation  Are important to our  stakeholders  Are aligned with our Mission to  alleviate pain, restore health,  and extend life for people  around the world This analysis informs our  sustainability priorities   and strategies:  Access to care — we work with  health systems around the  world, sharing technologies,  services, resources, and  expertise to remove barriers to  affordable treatment of  chronic diseases  Product stewardship —  we aspire to minimize the  life cycle footprint of our  products and packaging  through innovative design  Ethics in sales and  marketing — we earn and  maintain the trust of our  stakeholders through the  responsible marketing,  communication, and  promotion of our products  and services  Supply chain responsibility  — we collaborate with our  suppliers to develop long- term relationships that  improve product quality,  promote responsible  business practices, and  support small and   diverse businesses Product quality — we  ensure that our products  and services clearly meet the  highest standards of safety  and reliability We explain our approach to  these and other material issues  throughout this report and  in our 2019 ESG Disclosure  Index.
","('Human_Rights_And_Community_Relations', 0.4731508493423462)","('Employee_Health_And_Safety', 0.18090322613716125)","('Access_And_Affordability', 0.07984589785337448)","('NON-ESG', 0.4731508493423462)","('NON-ESG', 0.18090322613716125)","('NON-ESG', 0.07984589785337448)"
Line 62,"It ensures that we  drive innovation and efficiency  with deep awareness of our  responsibility to people   and planet.SUST AINABILITY  PRIORITIES &  STRA TEGIES We focus on the issues that:  Have the potential to  significantly impact our  business growth, finances, or  reputation  Are important to our  stakeholders  Are aligned with our Mission to  alleviate pain, restore health,  and extend life for people  around the world This analysis informs our  sustainability priorities   and strategies:  Access to care — we work with  health systems around the  world, sharing technologies,  services, resources, and  expertise to remove barriers to  affordable treatment of  chronic diseases  Product stewardship —  we aspire to minimize the  life cycle footprint of our  products and packaging  through innovative design  Ethics in sales and  marketing — we earn and  maintain the trust of our  stakeholders through the  responsible marketing,  communication, and  promotion of our products  and services  Supply chain responsibility  — we collaborate with our  suppliers to develop long- term relationships that  improve product quality,  promote responsible  business practices, and  support small and   diverse businesses Product quality — we  ensure that our products  and services clearly meet the  highest standards of safety  and reliability We explain our approach to  these and other material issues  throughout this report and  in our 2019 ESG Disclosure  Index.
","('Product_Design_And_Lifecycle_Management', 0.944068431854248)","('Selling_Practices_And_Product_Labeling', 0.012484630569815636)","('Product_Quality_And_Safety', 0.00739097548648715)","(['Product Stewardship'], 0.944068431854248)","('NON-ESG', 0.012484630569815636)","('NON-ESG', 0.00739097548648715)"
Line 63,"It ensures that we  drive innovation and efficiency  with deep awareness of our  responsibility to people   and planet.SUST AINABILITY  PRIORITIES &  STRA TEGIES We focus on the issues that:  Have the potential to  significantly impact our  business growth, finances, or  reputation  Are important to our  stakeholders  Are aligned with our Mission to  alleviate pain, restore health,  and extend life for people  around the world This analysis informs our  sustainability priorities   and strategies:  Access to care — we work with  health systems around the  world, sharing technologies,  services, resources, and  expertise to remove barriers to  affordable treatment of  chronic diseases  Product stewardship —  we aspire to minimize the  life cycle footprint of our  products and packaging  through innovative design  Ethics in sales and  marketing — we earn and  maintain the trust of our  stakeholders through the  responsible marketing,  communication, and  promotion of our products  and services  Supply chain responsibility  — we collaborate with our  suppliers to develop long- term relationships that  improve product quality,  promote responsible  business practices, and  support small and   diverse businesses Product quality — we  ensure that our products  and services clearly meet the  highest standards of safety  and reliability We explain our approach to  these and other material issues  throughout this report and  in our 2019 ESG Disclosure  Index.
","('Product_Quality_And_Safety', 0.8767409920692444)","('Product_Design_And_Lifecycle_Management', 0.03842916339635849)","('Selling_Practices_And_Product_Labeling', 0.014087190851569176)","(['Product Quality & Recall Management'], 0.8767409920692444)","('NON-ESG', 0.03842916339635849)","('NON-ESG', 0.014087190851569176)"
Line 64,"These five areas have guided  the focus of our sustainability  program since FY15.
","('Business_Model_Resilience', 0.334759920835495)","('Product_Design_And_Lifecycle_Management', 0.12301808595657349)","('Supply_Chain_Management', 0.08417532593011856)","('NON-ESG', 0.334759920835495)","('NON-ESG', 0.12301808595657349)","('NON-ESG', 0.08417532593011856)"
Line 65,"In FY19,  we refreshed our materiality  assessment and are using  the outputs to define our  performance and disclosure  strategies for the coming years.12HOW WE ENGAGE   WITH OUR ST AKEHOLDERS We do more when we work together with others.
","('Business_Model_Resilience', 0.331878662109375)","('Management_Of_Legal_And_Regulatory_Framework', 0.1980966031551361)","('Systemic_Risk_Management', 0.17001740634441376)","('NON-ESG', 0.331878662109375)","('NON-ESG', 0.1980966031551361)","('NON-ESG', 0.17001740634441376)"
Line 66,"Engagement and collaboration enable us to share our aspirations and challenges, be held  accountable, and achieve positive outcomes for patients more effectively.
","('Human_Rights_And_Community_Relations', 0.7523946166038513)","('Access_And_Affordability', 0.08381805568933487)","('Employee_Engagement_Inclusion_And_Diversity', 0.019185854122042656)","(['Community Relations'], 0.7523946166038513)","('NON-ESG', 0.08381805568933487)","('NON-ESG', 0.019185854122042656)"
Line 67,"As part of our daily operations, we capture learnings through our ongoing engagements.
","('Business_Model_Resilience', 0.20875565707683563)","('Human_Rights_And_Community_Relations', 0.11193554103374481)","('Employee_Engagement_Inclusion_And_Diversity', 0.10806187242269516)","('NON-ESG', 0.20875565707683563)","('NON-ESG', 0.11193554103374481)","('NON-ESG', 0.10806187242269516)"
Line 68,"These are described in the table below.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3501277565956116)","('Competitive_Behavior', 0.139877051115036)","('Systemic_Risk_Management', 0.06578390300273895)","('NON-ESG', 0.3501277565956116)","('NON-ESG', 0.139877051115036)","('NON-ESG', 0.06578390300273895)"
Line 69,"ANTICIPA TING RISKS AND OPPORTUNITIES OUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Healthcare  Professionals and  Administrators  T raining and capacity building   Collaborative product  development   Clinical research and trials   Value-based and integrated   care partnerships  Product donations  Environmentally preferred  purchasing    Product reprocessing programs  Healthcare professional training  and capacity building   Clinical trials standards  development and data sharing   Data privacy and security  programs   Physician Collaboration Policy    Post-market surveillance  partnerships and clinical studies   Customer service and   complaint handling Patients and Patient  Advocacy Groups  Education programs   Remote and connected   care programs  Product donations  Clinical trials  Patient Advocacy Group  capacity building via Medtronic  Foundation partnerships   Sharing patient stories through  companywide events and   communications  Customer service and   complaint handling Shareholders  and Institutional  Investors  Quarterly calls and one-on-one  engagements about product  pipeline, acquisitions, and  emerging market growth CDP disclosure   Engagements on climate risk  Engagements on labor practices,  human rights, and inclusion and  diversity  One-on-one engagements  about environmental, social,   and governance issues Suppliers and  Distributors  Product manufacturing   and innovation   Supplier quality training  Global Supplier Standards,  environmental impacts  Global Supplier Standards,  human rights and labor  practices   Global Supplier Standards,  business ethics   Distributor Code of   Conduct training   Vendor privacy and   security training   Supplier sustainability risk  assessments  Supplier diversity eventsOUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  (CONTINUED) Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Employees  Disaster relief  Volunteerism  Matched giving Product Stewardship Program   Sustainable Packaging Working  Group   Enterprise-wide operational  environmental goals  Employee diversity networks and  resource groups   Global inclusion and diversity  initiatives  Professional training  Career development  Engagement surveys   Health, safety, and wellness  programs  Awards and recognition  Employee training on:  –Workplace safety   – Ethics and compliance and   Code of Conduct   – Privacy and security,  including GDPR  –Supplier diversity   – Responsible supply  management Government  Regulators and   Policymakers  Product approval and  reimbursement   Advocacy for universal  healthcare coverage   Public-private partnerships that  increase access to care   Medical Device Innovation  Consortium  Environmental inspections and  compliance with CA Prop 65,  RoHS, REACH, and E.U. Medical  Device Directive U.S. EEOC reporting  Gender pay gap reporting  European works councils  Regulatory inspections  Public policy engagement  Political contributions disclosure  Disclosure of:  – Payments to healthcare  professionals  –Security breaches  – Conflict minerals and human  trafficking reports  Supplier diversity reporting Nongovernmental  Organizations  Medtronic Foundation Global  Health grants supporting  healthcare and patient advocacy  Medtronic Labs partnerships  Membership in Healthcare  Plastics Recycling Council and  Minnesota Sustainable Growth  Coalition  Grants to advance STEM and  develop future talent Member of:  – Clinical T rials T ransformation  Initiative  – Sustainable Purchasing  Leadership Council Local Communities   Community health   worker training  Disaster relief  Community Foundation grants   Employee volunteerism   and giving  Support of and participation in  community solar gardens  Employment opportunities   Partnerships with learning  institutions to develop talent  Compliance with local laws   and regulations14 We manage physical risk  through our business  continuity management,  which includes hurricane  readiness planning and  infrastructure improvement  as well as risk-exposure  analyses that encompass   hurricanes, earthquakes,   and water scarcity.
","('Product_Design_And_Lifecycle_Management', 0.8787029385566711)","('Customer_Welfare', 0.03022412210702896)","('Product_Quality_And_Safety', 0.016181282699108124)","(['Product Stewardship'], 0.8787029385566711)","('NON-ESG', 0.03022412210702896)","('NON-ESG', 0.016181282699108124)"
Line 70,"ANTICIPA TING RISKS AND OPPORTUNITIES OUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Healthcare  Professionals and  Administrators  T raining and capacity building   Collaborative product  development   Clinical research and trials   Value-based and integrated   care partnerships  Product donations  Environmentally preferred  purchasing    Product reprocessing programs  Healthcare professional training  and capacity building   Clinical trials standards  development and data sharing   Data privacy and security  programs   Physician Collaboration Policy    Post-market surveillance  partnerships and clinical studies   Customer service and   complaint handling Patients and Patient  Advocacy Groups  Education programs   Remote and connected   care programs  Product donations  Clinical trials  Patient Advocacy Group  capacity building via Medtronic  Foundation partnerships   Sharing patient stories through  companywide events and   communications  Customer service and   complaint handling Shareholders  and Institutional  Investors  Quarterly calls and one-on-one  engagements about product  pipeline, acquisitions, and  emerging market growth CDP disclosure   Engagements on climate risk  Engagements on labor practices,  human rights, and inclusion and  diversity  One-on-one engagements  about environmental, social,   and governance issues Suppliers and  Distributors  Product manufacturing   and innovation   Supplier quality training  Global Supplier Standards,  environmental impacts  Global Supplier Standards,  human rights and labor  practices   Global Supplier Standards,  business ethics   Distributor Code of   Conduct training   Vendor privacy and   security training   Supplier sustainability risk  assessments  Supplier diversity eventsOUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  (CONTINUED) Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Employees  Disaster relief  Volunteerism  Matched giving Product Stewardship Program   Sustainable Packaging Working  Group   Enterprise-wide operational  environmental goals  Employee diversity networks and  resource groups   Global inclusion and diversity  initiatives  Professional training  Career development  Engagement surveys   Health, safety, and wellness  programs  Awards and recognition  Employee training on:  –Workplace safety   – Ethics and compliance and   Code of Conduct   – Privacy and security,  including GDPR  –Supplier diversity   – Responsible supply  management Government  Regulators and   Policymakers  Product approval and  reimbursement   Advocacy for universal  healthcare coverage   Public-private partnerships that  increase access to care   Medical Device Innovation  Consortium  Environmental inspections and  compliance with CA Prop 65,  RoHS, REACH, and E.U. Medical  Device Directive U.S. EEOC reporting  Gender pay gap reporting  European works councils  Regulatory inspections  Public policy engagement  Political contributions disclosure  Disclosure of:  – Payments to healthcare  professionals  –Security breaches  – Conflict minerals and human  trafficking reports  Supplier diversity reporting Nongovernmental  Organizations  Medtronic Foundation Global  Health grants supporting  healthcare and patient advocacy  Medtronic Labs partnerships  Membership in Healthcare  Plastics Recycling Council and  Minnesota Sustainable Growth  Coalition  Grants to advance STEM and  develop future talent Member of:  – Clinical T rials T ransformation  Initiative  – Sustainable Purchasing  Leadership Council Local Communities   Community health   worker training  Disaster relief  Community Foundation grants   Employee volunteerism   and giving  Support of and participation in  community solar gardens  Employment opportunities   Partnerships with learning  institutions to develop talent  Compliance with local laws   and regulations14 We manage physical risk  through our business  continuity management,  which includes hurricane  readiness planning and  infrastructure improvement  as well as risk-exposure  analyses that encompass   hurricanes, earthquakes,   and water scarcity.
","('Data_Security', 0.936911404132843)","('Customer_Privacy', 0.015459745191037655)","('Business_Ethics', 0.0058964951895177364)","(['Information Security/Cybersecurity & System Availability'], 0.936911404132843)","('NON-ESG', 0.015459745191037655)","('NON-ESG', 0.0058964951895177364)"
Line 71,"ANTICIPA TING RISKS AND OPPORTUNITIES OUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Healthcare  Professionals and  Administrators  T raining and capacity building   Collaborative product  development   Clinical research and trials   Value-based and integrated   care partnerships  Product donations  Environmentally preferred  purchasing    Product reprocessing programs  Healthcare professional training  and capacity building   Clinical trials standards  development and data sharing   Data privacy and security  programs   Physician Collaboration Policy    Post-market surveillance  partnerships and clinical studies   Customer service and   complaint handling Patients and Patient  Advocacy Groups  Education programs   Remote and connected   care programs  Product donations  Clinical trials  Patient Advocacy Group  capacity building via Medtronic  Foundation partnerships   Sharing patient stories through  companywide events and   communications  Customer service and   complaint handling Shareholders  and Institutional  Investors  Quarterly calls and one-on-one  engagements about product  pipeline, acquisitions, and  emerging market growth CDP disclosure   Engagements on climate risk  Engagements on labor practices,  human rights, and inclusion and  diversity  One-on-one engagements  about environmental, social,   and governance issues Suppliers and  Distributors  Product manufacturing   and innovation   Supplier quality training  Global Supplier Standards,  environmental impacts  Global Supplier Standards,  human rights and labor  practices   Global Supplier Standards,  business ethics   Distributor Code of   Conduct training   Vendor privacy and   security training   Supplier sustainability risk  assessments  Supplier diversity eventsOUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  (CONTINUED) Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Employees  Disaster relief  Volunteerism  Matched giving Product Stewardship Program   Sustainable Packaging Working  Group   Enterprise-wide operational  environmental goals  Employee diversity networks and  resource groups   Global inclusion and diversity  initiatives  Professional training  Career development  Engagement surveys   Health, safety, and wellness  programs  Awards and recognition  Employee training on:  –Workplace safety   – Ethics and compliance and   Code of Conduct   – Privacy and security,  including GDPR  –Supplier diversity   – Responsible supply  management Government  Regulators and   Policymakers  Product approval and  reimbursement   Advocacy for universal  healthcare coverage   Public-private partnerships that  increase access to care   Medical Device Innovation  Consortium  Environmental inspections and  compliance with CA Prop 65,  RoHS, REACH, and E.U. Medical  Device Directive U.S. EEOC reporting  Gender pay gap reporting  European works councils  Regulatory inspections  Public policy engagement  Political contributions disclosure  Disclosure of:  – Payments to healthcare  professionals  –Security breaches  – Conflict minerals and human  trafficking reports  Supplier diversity reporting Nongovernmental  Organizations  Medtronic Foundation Global  Health grants supporting  healthcare and patient advocacy  Medtronic Labs partnerships  Membership in Healthcare  Plastics Recycling Council and  Minnesota Sustainable Growth  Coalition  Grants to advance STEM and  develop future talent Member of:  – Clinical T rials T ransformation  Initiative  – Sustainable Purchasing  Leadership Council Local Communities   Community health   worker training  Disaster relief  Community Foundation grants   Employee volunteerism   and giving  Support of and participation in  community solar gardens  Employment opportunities   Partnerships with learning  institutions to develop talent  Compliance with local laws   and regulations14 We manage physical risk  through our business  continuity management,  which includes hurricane  readiness planning and  infrastructure improvement  as well as risk-exposure  analyses that encompass   hurricanes, earthquakes,   and water scarcity.
","('Human_Rights_And_Community_Relations', 0.3641328513622284)","('Employee_Engagement_Inclusion_And_Diversity', 0.2714400291442871)","('Labor_Practices', 0.18560291826725006)","('NON-ESG', 0.3641328513622284)","('NON-ESG', 0.2714400291442871)","('NON-ESG', 0.18560291826725006)"
Line 72,"ANTICIPA TING RISKS AND OPPORTUNITIES OUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Healthcare  Professionals and  Administrators  T raining and capacity building   Collaborative product  development   Clinical research and trials   Value-based and integrated   care partnerships  Product donations  Environmentally preferred  purchasing    Product reprocessing programs  Healthcare professional training  and capacity building   Clinical trials standards  development and data sharing   Data privacy and security  programs   Physician Collaboration Policy    Post-market surveillance  partnerships and clinical studies   Customer service and   complaint handling Patients and Patient  Advocacy Groups  Education programs   Remote and connected   care programs  Product donations  Clinical trials  Patient Advocacy Group  capacity building via Medtronic  Foundation partnerships   Sharing patient stories through  companywide events and   communications  Customer service and   complaint handling Shareholders  and Institutional  Investors  Quarterly calls and one-on-one  engagements about product  pipeline, acquisitions, and  emerging market growth CDP disclosure   Engagements on climate risk  Engagements on labor practices,  human rights, and inclusion and  diversity  One-on-one engagements  about environmental, social,   and governance issues Suppliers and  Distributors  Product manufacturing   and innovation   Supplier quality training  Global Supplier Standards,  environmental impacts  Global Supplier Standards,  human rights and labor  practices   Global Supplier Standards,  business ethics   Distributor Code of   Conduct training   Vendor privacy and   security training   Supplier sustainability risk  assessments  Supplier diversity eventsOUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  (CONTINUED) Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Employees  Disaster relief  Volunteerism  Matched giving Product Stewardship Program   Sustainable Packaging Working  Group   Enterprise-wide operational  environmental goals  Employee diversity networks and  resource groups   Global inclusion and diversity  initiatives  Professional training  Career development  Engagement surveys   Health, safety, and wellness  programs  Awards and recognition  Employee training on:  –Workplace safety   – Ethics and compliance and   Code of Conduct   – Privacy and security,  including GDPR  –Supplier diversity   – Responsible supply  management Government  Regulators and   Policymakers  Product approval and  reimbursement   Advocacy for universal  healthcare coverage   Public-private partnerships that  increase access to care   Medical Device Innovation  Consortium  Environmental inspections and  compliance with CA Prop 65,  RoHS, REACH, and E.U. Medical  Device Directive U.S. EEOC reporting  Gender pay gap reporting  European works councils  Regulatory inspections  Public policy engagement  Political contributions disclosure  Disclosure of:  – Payments to healthcare  professionals  –Security breaches  – Conflict minerals and human  trafficking reports  Supplier diversity reporting Nongovernmental  Organizations  Medtronic Foundation Global  Health grants supporting  healthcare and patient advocacy  Medtronic Labs partnerships  Membership in Healthcare  Plastics Recycling Council and  Minnesota Sustainable Growth  Coalition  Grants to advance STEM and  develop future talent Member of:  – Clinical T rials T ransformation  Initiative  – Sustainable Purchasing  Leadership Council Local Communities   Community health   worker training  Disaster relief  Community Foundation grants   Employee volunteerism   and giving  Support of and participation in  community solar gardens  Employment opportunities   Partnerships with learning  institutions to develop talent  Compliance with local laws   and regulations14 We manage physical risk  through our business  continuity management,  which includes hurricane  readiness planning and  infrastructure improvement  as well as risk-exposure  analyses that encompass   hurricanes, earthquakes,   and water scarcity.
","('Supply_Chain_Management', 0.8855928182601929)","('Labor_Practices', 0.027879072353243828)","('Employee_Health_And_Safety', 0.00893103051930666)","(['Supply Chain Management'], 0.8855928182601929)","('NON-ESG', 0.027879072353243828)","('NON-ESG', 0.00893103051930666)"
Line 73,"ANTICIPA TING RISKS AND OPPORTUNITIES OUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Healthcare  Professionals and  Administrators  T raining and capacity building   Collaborative product  development   Clinical research and trials   Value-based and integrated   care partnerships  Product donations  Environmentally preferred  purchasing    Product reprocessing programs  Healthcare professional training  and capacity building   Clinical trials standards  development and data sharing   Data privacy and security  programs   Physician Collaboration Policy    Post-market surveillance  partnerships and clinical studies   Customer service and   complaint handling Patients and Patient  Advocacy Groups  Education programs   Remote and connected   care programs  Product donations  Clinical trials  Patient Advocacy Group  capacity building via Medtronic  Foundation partnerships   Sharing patient stories through  companywide events and   communications  Customer service and   complaint handling Shareholders  and Institutional  Investors  Quarterly calls and one-on-one  engagements about product  pipeline, acquisitions, and  emerging market growth CDP disclosure   Engagements on climate risk  Engagements on labor practices,  human rights, and inclusion and  diversity  One-on-one engagements  about environmental, social,   and governance issues Suppliers and  Distributors  Product manufacturing   and innovation   Supplier quality training  Global Supplier Standards,  environmental impacts  Global Supplier Standards,  human rights and labor  practices   Global Supplier Standards,  business ethics   Distributor Code of   Conduct training   Vendor privacy and   security training   Supplier sustainability risk  assessments  Supplier diversity eventsOUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  (CONTINUED) Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Employees  Disaster relief  Volunteerism  Matched giving Product Stewardship Program   Sustainable Packaging Working  Group   Enterprise-wide operational  environmental goals  Employee diversity networks and  resource groups   Global inclusion and diversity  initiatives  Professional training  Career development  Engagement surveys   Health, safety, and wellness  programs  Awards and recognition  Employee training on:  –Workplace safety   – Ethics and compliance and   Code of Conduct   – Privacy and security,  including GDPR  –Supplier diversity   – Responsible supply  management Government  Regulators and   Policymakers  Product approval and  reimbursement   Advocacy for universal  healthcare coverage   Public-private partnerships that  increase access to care   Medical Device Innovation  Consortium  Environmental inspections and  compliance with CA Prop 65,  RoHS, REACH, and E.U. Medical  Device Directive U.S. EEOC reporting  Gender pay gap reporting  European works councils  Regulatory inspections  Public policy engagement  Political contributions disclosure  Disclosure of:  – Payments to healthcare  professionals  –Security breaches  – Conflict minerals and human  trafficking reports  Supplier diversity reporting Nongovernmental  Organizations  Medtronic Foundation Global  Health grants supporting  healthcare and patient advocacy  Medtronic Labs partnerships  Membership in Healthcare  Plastics Recycling Council and  Minnesota Sustainable Growth  Coalition  Grants to advance STEM and  develop future talent Member of:  – Clinical T rials T ransformation  Initiative  – Sustainable Purchasing  Leadership Council Local Communities   Community health   worker training  Disaster relief  Community Foundation grants   Employee volunteerism   and giving  Support of and participation in  community solar gardens  Employment opportunities   Partnerships with learning  institutions to develop talent  Compliance with local laws   and regulations14 We manage physical risk  through our business  continuity management,  which includes hurricane  readiness planning and  infrastructure improvement  as well as risk-exposure  analyses that encompass   hurricanes, earthquakes,   and water scarcity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9580789804458618)","('Employee_Health_And_Safety', 0.011441655457019806)","('Access_And_Affordability', 0.002403278835117817)","(['Human Capital Development'], 0.9580789804458618)","('NON-ESG', 0.011441655457019806)","('NON-ESG', 0.002403278835117817)"
Line 74,"ANTICIPA TING RISKS AND OPPORTUNITIES OUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Healthcare  Professionals and  Administrators  T raining and capacity building   Collaborative product  development   Clinical research and trials   Value-based and integrated   care partnerships  Product donations  Environmentally preferred  purchasing    Product reprocessing programs  Healthcare professional training  and capacity building   Clinical trials standards  development and data sharing   Data privacy and security  programs   Physician Collaboration Policy    Post-market surveillance  partnerships and clinical studies   Customer service and   complaint handling Patients and Patient  Advocacy Groups  Education programs   Remote and connected   care programs  Product donations  Clinical trials  Patient Advocacy Group  capacity building via Medtronic  Foundation partnerships   Sharing patient stories through  companywide events and   communications  Customer service and   complaint handling Shareholders  and Institutional  Investors  Quarterly calls and one-on-one  engagements about product  pipeline, acquisitions, and  emerging market growth CDP disclosure   Engagements on climate risk  Engagements on labor practices,  human rights, and inclusion and  diversity  One-on-one engagements  about environmental, social,   and governance issues Suppliers and  Distributors  Product manufacturing   and innovation   Supplier quality training  Global Supplier Standards,  environmental impacts  Global Supplier Standards,  human rights and labor  practices   Global Supplier Standards,  business ethics   Distributor Code of   Conduct training   Vendor privacy and   security training   Supplier sustainability risk  assessments  Supplier diversity eventsOUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  (CONTINUED) Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Employees  Disaster relief  Volunteerism  Matched giving Product Stewardship Program   Sustainable Packaging Working  Group   Enterprise-wide operational  environmental goals  Employee diversity networks and  resource groups   Global inclusion and diversity  initiatives  Professional training  Career development  Engagement surveys   Health, safety, and wellness  programs  Awards and recognition  Employee training on:  –Workplace safety   – Ethics and compliance and   Code of Conduct   – Privacy and security,  including GDPR  –Supplier diversity   – Responsible supply  management Government  Regulators and   Policymakers  Product approval and  reimbursement   Advocacy for universal  healthcare coverage   Public-private partnerships that  increase access to care   Medical Device Innovation  Consortium  Environmental inspections and  compliance with CA Prop 65,  RoHS, REACH, and E.U. Medical  Device Directive U.S. EEOC reporting  Gender pay gap reporting  European works councils  Regulatory inspections  Public policy engagement  Political contributions disclosure  Disclosure of:  – Payments to healthcare  professionals  –Security breaches  – Conflict minerals and human  trafficking reports  Supplier diversity reporting Nongovernmental  Organizations  Medtronic Foundation Global  Health grants supporting  healthcare and patient advocacy  Medtronic Labs partnerships  Membership in Healthcare  Plastics Recycling Council and  Minnesota Sustainable Growth  Coalition  Grants to advance STEM and  develop future talent Member of:  – Clinical T rials T ransformation  Initiative  – Sustainable Purchasing  Leadership Council Local Communities   Community health   worker training  Disaster relief  Community Foundation grants   Employee volunteerism   and giving  Support of and participation in  community solar gardens  Employment opportunities   Partnerships with learning  institutions to develop talent  Compliance with local laws   and regulations14 We manage physical risk  through our business  continuity management,  which includes hurricane  readiness planning and  infrastructure improvement  as well as risk-exposure  analyses that encompass   hurricanes, earthquakes,   and water scarcity.
","('Product_Quality_And_Safety', 0.6725161671638489)","('Business_Ethics', 0.1186956837773323)","('Supply_Chain_Management', 0.01976683922111988)","(['Product Quality & Recall Management'], 0.6725161671638489)","('NON-ESG', 0.1186956837773323)","('NON-ESG', 0.01976683922111988)"
Line 75,"ANTICIPA TING RISKS AND OPPORTUNITIES OUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Healthcare  Professionals and  Administrators  T raining and capacity building   Collaborative product  development   Clinical research and trials   Value-based and integrated   care partnerships  Product donations  Environmentally preferred  purchasing    Product reprocessing programs  Healthcare professional training  and capacity building   Clinical trials standards  development and data sharing   Data privacy and security  programs   Physician Collaboration Policy    Post-market surveillance  partnerships and clinical studies   Customer service and   complaint handling Patients and Patient  Advocacy Groups  Education programs   Remote and connected   care programs  Product donations  Clinical trials  Patient Advocacy Group  capacity building via Medtronic  Foundation partnerships   Sharing patient stories through  companywide events and   communications  Customer service and   complaint handling Shareholders  and Institutional  Investors  Quarterly calls and one-on-one  engagements about product  pipeline, acquisitions, and  emerging market growth CDP disclosure   Engagements on climate risk  Engagements on labor practices,  human rights, and inclusion and  diversity  One-on-one engagements  about environmental, social,   and governance issues Suppliers and  Distributors  Product manufacturing   and innovation   Supplier quality training  Global Supplier Standards,  environmental impacts  Global Supplier Standards,  human rights and labor  practices   Global Supplier Standards,  business ethics   Distributor Code of   Conduct training   Vendor privacy and   security training   Supplier sustainability risk  assessments  Supplier diversity eventsOUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  (CONTINUED) Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Employees  Disaster relief  Volunteerism  Matched giving Product Stewardship Program   Sustainable Packaging Working  Group   Enterprise-wide operational  environmental goals  Employee diversity networks and  resource groups   Global inclusion and diversity  initiatives  Professional training  Career development  Engagement surveys   Health, safety, and wellness  programs  Awards and recognition  Employee training on:  –Workplace safety   – Ethics and compliance and   Code of Conduct   – Privacy and security,  including GDPR  –Supplier diversity   – Responsible supply  management Government  Regulators and   Policymakers  Product approval and  reimbursement   Advocacy for universal  healthcare coverage   Public-private partnerships that  increase access to care   Medical Device Innovation  Consortium  Environmental inspections and  compliance with CA Prop 65,  RoHS, REACH, and E.U. Medical  Device Directive U.S. EEOC reporting  Gender pay gap reporting  European works councils  Regulatory inspections  Public policy engagement  Political contributions disclosure  Disclosure of:  – Payments to healthcare  professionals  –Security breaches  – Conflict minerals and human  trafficking reports  Supplier diversity reporting Nongovernmental  Organizations  Medtronic Foundation Global  Health grants supporting  healthcare and patient advocacy  Medtronic Labs partnerships  Membership in Healthcare  Plastics Recycling Council and  Minnesota Sustainable Growth  Coalition  Grants to advance STEM and  develop future talent Member of:  – Clinical T rials T ransformation  Initiative  – Sustainable Purchasing  Leadership Council Local Communities   Community health   worker training  Disaster relief  Community Foundation grants   Employee volunteerism   and giving  Support of and participation in  community solar gardens  Employment opportunities   Partnerships with learning  institutions to develop talent  Compliance with local laws   and regulations14 We manage physical risk  through our business  continuity management,  which includes hurricane  readiness planning and  infrastructure improvement  as well as risk-exposure  analyses that encompass   hurricanes, earthquakes,   and water scarcity.
","('Business_Ethics', 0.7017216086387634)","('Management_Of_Legal_And_Regulatory_Framework', 0.11734610795974731)","('Labor_Practices', 0.0324457585811615)","(['Business Ethics'], 0.7017216086387634)","('NON-ESG', 0.11734610795974731)","('NON-ESG', 0.0324457585811615)"
Line 76,"ANTICIPA TING RISKS AND OPPORTUNITIES OUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Healthcare  Professionals and  Administrators  T raining and capacity building   Collaborative product  development   Clinical research and trials   Value-based and integrated   care partnerships  Product donations  Environmentally preferred  purchasing    Product reprocessing programs  Healthcare professional training  and capacity building   Clinical trials standards  development and data sharing   Data privacy and security  programs   Physician Collaboration Policy    Post-market surveillance  partnerships and clinical studies   Customer service and   complaint handling Patients and Patient  Advocacy Groups  Education programs   Remote and connected   care programs  Product donations  Clinical trials  Patient Advocacy Group  capacity building via Medtronic  Foundation partnerships   Sharing patient stories through  companywide events and   communications  Customer service and   complaint handling Shareholders  and Institutional  Investors  Quarterly calls and one-on-one  engagements about product  pipeline, acquisitions, and  emerging market growth CDP disclosure   Engagements on climate risk  Engagements on labor practices,  human rights, and inclusion and  diversity  One-on-one engagements  about environmental, social,   and governance issues Suppliers and  Distributors  Product manufacturing   and innovation   Supplier quality training  Global Supplier Standards,  environmental impacts  Global Supplier Standards,  human rights and labor  practices   Global Supplier Standards,  business ethics   Distributor Code of   Conduct training   Vendor privacy and   security training   Supplier sustainability risk  assessments  Supplier diversity eventsOUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  (CONTINUED) Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Employees  Disaster relief  Volunteerism  Matched giving Product Stewardship Program   Sustainable Packaging Working  Group   Enterprise-wide operational  environmental goals  Employee diversity networks and  resource groups   Global inclusion and diversity  initiatives  Professional training  Career development  Engagement surveys   Health, safety, and wellness  programs  Awards and recognition  Employee training on:  –Workplace safety   – Ethics and compliance and   Code of Conduct   – Privacy and security,  including GDPR  –Supplier diversity   – Responsible supply  management Government  Regulators and   Policymakers  Product approval and  reimbursement   Advocacy for universal  healthcare coverage   Public-private partnerships that  increase access to care   Medical Device Innovation  Consortium  Environmental inspections and  compliance with CA Prop 65,  RoHS, REACH, and E.U. Medical  Device Directive U.S. EEOC reporting  Gender pay gap reporting  European works councils  Regulatory inspections  Public policy engagement  Political contributions disclosure  Disclosure of:  – Payments to healthcare  professionals  –Security breaches  – Conflict minerals and human  trafficking reports  Supplier diversity reporting Nongovernmental  Organizations  Medtronic Foundation Global  Health grants supporting  healthcare and patient advocacy  Medtronic Labs partnerships  Membership in Healthcare  Plastics Recycling Council and  Minnesota Sustainable Growth  Coalition  Grants to advance STEM and  develop future talent Member of:  – Clinical T rials T ransformation  Initiative  – Sustainable Purchasing  Leadership Council Local Communities   Community health   worker training  Disaster relief  Community Foundation grants   Employee volunteerism   and giving  Support of and participation in  community solar gardens  Employment opportunities   Partnerships with learning  institutions to develop talent  Compliance with local laws   and regulations14 We manage physical risk  through our business  continuity management,  which includes hurricane  readiness planning and  infrastructure improvement  as well as risk-exposure  analyses that encompass   hurricanes, earthquakes,   and water scarcity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4874162971973419)","('Access_And_Affordability', 0.12014485895633698)","('Employee_Health_And_Safety', 0.09803462773561478)","('NON-ESG', 0.4874162971973419)","('NON-ESG', 0.12014485895633698)","('NON-ESG', 0.09803462773561478)"
Line 77,"ANTICIPA TING RISKS AND OPPORTUNITIES OUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Healthcare  Professionals and  Administrators  T raining and capacity building   Collaborative product  development   Clinical research and trials   Value-based and integrated   care partnerships  Product donations  Environmentally preferred  purchasing    Product reprocessing programs  Healthcare professional training  and capacity building   Clinical trials standards  development and data sharing   Data privacy and security  programs   Physician Collaboration Policy    Post-market surveillance  partnerships and clinical studies   Customer service and   complaint handling Patients and Patient  Advocacy Groups  Education programs   Remote and connected   care programs  Product donations  Clinical trials  Patient Advocacy Group  capacity building via Medtronic  Foundation partnerships   Sharing patient stories through  companywide events and   communications  Customer service and   complaint handling Shareholders  and Institutional  Investors  Quarterly calls and one-on-one  engagements about product  pipeline, acquisitions, and  emerging market growth CDP disclosure   Engagements on climate risk  Engagements on labor practices,  human rights, and inclusion and  diversity  One-on-one engagements  about environmental, social,   and governance issues Suppliers and  Distributors  Product manufacturing   and innovation   Supplier quality training  Global Supplier Standards,  environmental impacts  Global Supplier Standards,  human rights and labor  practices   Global Supplier Standards,  business ethics   Distributor Code of   Conduct training   Vendor privacy and   security training   Supplier sustainability risk  assessments  Supplier diversity eventsOUR ENGAGEMENT WITH ST AKEHOLDERS ACROSS OUR CITIZENSHIP PILLARS  (CONTINUED) Adding Value   to SocietyPromoting Environmental  StewardshipSupporting a   Global WorkforceWorking   Responsibly Employees  Disaster relief  Volunteerism  Matched giving Product Stewardship Program   Sustainable Packaging Working  Group   Enterprise-wide operational  environmental goals  Employee diversity networks and  resource groups   Global inclusion and diversity  initiatives  Professional training  Career development  Engagement surveys   Health, safety, and wellness  programs  Awards and recognition  Employee training on:  –Workplace safety   – Ethics and compliance and   Code of Conduct   – Privacy and security,  including GDPR  –Supplier diversity   – Responsible supply  management Government  Regulators and   Policymakers  Product approval and  reimbursement   Advocacy for universal  healthcare coverage   Public-private partnerships that  increase access to care   Medical Device Innovation  Consortium  Environmental inspections and  compliance with CA Prop 65,  RoHS, REACH, and E.U. Medical  Device Directive U.S. EEOC reporting  Gender pay gap reporting  European works councils  Regulatory inspections  Public policy engagement  Political contributions disclosure  Disclosure of:  – Payments to healthcare  professionals  –Security breaches  – Conflict minerals and human  trafficking reports  Supplier diversity reporting Nongovernmental  Organizations  Medtronic Foundation Global  Health grants supporting  healthcare and patient advocacy  Medtronic Labs partnerships  Membership in Healthcare  Plastics Recycling Council and  Minnesota Sustainable Growth  Coalition  Grants to advance STEM and  develop future talent Member of:  – Clinical T rials T ransformation  Initiative  – Sustainable Purchasing  Leadership Council Local Communities   Community health   worker training  Disaster relief  Community Foundation grants   Employee volunteerism   and giving  Support of and participation in  community solar gardens  Employment opportunities   Partnerships with learning  institutions to develop talent  Compliance with local laws   and regulations14 We manage physical risk  through our business  continuity management,  which includes hurricane  readiness planning and  infrastructure improvement  as well as risk-exposure  analyses that encompass   hurricanes, earthquakes,   and water scarcity.
","('Water_And_Wastewater_Management', 0.7143757343292236)","('Physical_Impacts_Of_Climate_Change', 0.09569551050662994)","('Supply_Chain_Management', 0.027258936315774918)","(['Operational Eco-Efficiency'], 0.7143757343292236)","('NON-ESG', 0.09569551050662994)","('NON-ESG', 0.027258936315774918)"
Line 78,"The business impact of  unforeseen ethical, social, and  environmental regulations  Our Government Affairs,  Human Resources,  Environmental, Health, and  Safety, and Procurement  groups monitor relevant  regulations in global markets.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9566199779510498)","('Human_Rights_And_Community_Relations', 0.006723418831825256)","('Ecological_Impacts', 0.0030401793774217367)","(['Corporate Governance'], 0.9566199779510498)","('NON-ESG', 0.006723418831825256)","('NON-ESG', 0.0030401793774217367)"
Line 79,"Our legal and compliance  teams oversee compliance  with those regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9506948590278625)","('Business_Ethics', 0.0057848612777888775)","('Director_Removal', 0.003815196920186281)","(['Corporate Governance'], 0.9506948590278625)","('NON-ESG', 0.0057848612777888775)","('NON-ESG', 0.003815196920186281)"
Line 80,"We engage industry  organizations and regulators  to share our perspectives  and prepare for potential and  pending regulation.ANTICIPA TING   RISK AND   OPPORTUNITIES In the face of social, political,  and environmental change, we  constantly monitor emerging  issues and agendas.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9307284355163574)","('Systemic_Risk_Management', 0.01159768644720316)","('Physical_Impacts_Of_Climate_Change', 0.005751582328230143)","(['Corporate Governance'], 0.9307284355163574)","('NON-ESG', 0.01159768644720316)","('NON-ESG', 0.005751582328230143)"
Line 81,"We work  to anticipate, adapt, and  respond to evolving trends,  risks, and opportunities through  innovation and partnership.
","('Business_Model_Resilience', 0.6152187585830688)","('Systemic_Risk_Management', 0.18963024020195007)","('Physical_Impacts_Of_Climate_Change', 0.060316573828458786)","(['Codes of Business Conduct'], 0.6152187585830688)","('NON-ESG', 0.18963024020195007)","('NON-ESG', 0.060316573828458786)"
Line 82,"Managing risk Our key risks occur in the  following areas: Climate risk and resilience  We manage transitional risk  through routine monitoring   of carbon regulations,  including carbon taxes,  and proactively installing  renewable and alternate  energy sources as they  become more cost-effective  and readily available.
","('Physical_Impacts_Of_Climate_Change', 0.6727702021598816)","('Business_Model_Resilience', 0.1272476464509964)","('Systemic_Risk_Management', 0.031457219272851944)","(['Climate Change'], 0.6727702021598816)","('NON-ESG', 0.1272476464509964)","('NON-ESG', 0.031457219272851944)"
Line 83,"Failure to meet customer  sustainability requirements  We aim to meet or exceed  customer requirements on  all aspects of sustainability,  including product quality,  access to healthcare,  environmental impacts, labor  practices, and responsible  supply management.
","('Product_Design_And_Lifecycle_Management', 0.9345710873603821)","('Product_Quality_And_Safety', 0.014065898954868317)","('Supply_Chain_Management', 0.009481443092226982)","(['Product Stewardship'], 0.9345710873603821)","('NON-ESG', 0.014065898954868317)","('NON-ESG', 0.009481443092226982)"
Line 84,"Our Global Human Rights  Program and Responsible  Supply Management Program  ensure a consistent approach  to key sustainability issues  across our operations   and supply chain.
","('Supply_Chain_Management', 0.9461576342582703)","('Product_Design_And_Lifecycle_Management', 0.005764023866504431)","('Labor_Practices', 0.004651491530239582)","(['Supply Chain Management'], 0.9461576342582703)","('NON-ESG', 0.005764023866504431)","('NON-ESG', 0.004651491530239582)"
Line 85,"Risk of reputational damage  from unethical behavior  We regularly train employees  to comply with our Code of  Conduct, and we have clear  processes for reporting and   acting on ethical concerns.
","('Business_Ethics', 0.9665613174438477)","('Competitive_Behavior', 0.0028938092291355133)","('Product_Quality_And_Safety', 0.002609438030049205)","(['Business Ethics'], 0.9665613174438477)","('NON-ESG', 0.0028938092291355133)","('NON-ESG', 0.002609438030049205)"
Line 86,"Additional compliance  training for employees in  certain roles further mitigates   the risk of corruption   and misconduct.We include more detail about  our most significant business  risks in our 2019 Form 10-K   and 10-Q filings with the   U.S. Securities and   Exchange Commission.
","('Business_Ethics', 0.9742903709411621)","('Management_Of_Legal_And_Regulatory_Framework', 0.002784592565149069)","('Data_Security', 0.0019175520865246654)","(['Business Ethics'], 0.9742903709411621)","('NON-ESG', 0.002784592565149069)","('NON-ESG', 0.0019175520865246654)"
Line 87,"Creating opportunities Beyond avoiding negative  impact, we also seek to generate  value from sustainable business  practices, in line with our Mission  and values.
","('Business_Model_Resilience', 0.5988010168075562)","('Product_Design_And_Lifecycle_Management', 0.0985054075717926)","('Human_Rights_And_Community_Relations', 0.03762632980942726)","(['Codes of Business Conduct'], 0.5988010168075562)","('NON-ESG', 0.0985054075717926)","('NON-ESG', 0.03762632980942726)"
Line 88,"Our opportunity  areas include:  Leading the industry in  meaningful innovation and  value-based healthcare   The speed of global  technological and societal  change is faster than ever .
","('Business_Model_Resilience', 0.4169098436832428)","('Competitive_Behavior', 0.09183264523744583)","('Product_Design_And_Lifecycle_Management', 0.07127079367637634)","('NON-ESG', 0.4169098436832428)","('NON-ESG', 0.09183264523744583)","('NON-ESG', 0.07127079367637634)"
Line 89,"This evolution presents  a significant opportunity  for us to identify emerging  solutions and develop  innovative, effective, value- driven products and business  models that improve lives.15 Forming bold, impactful  partnerships   Collaboration with a range of  national and local partners  enables us to accelerate  global access to lifesaving  therapies.
","('Product_Design_And_Lifecycle_Management', 0.9474985003471375)","('Customer_Welfare', 0.00799109973013401)","('Product_Quality_And_Safety', 0.007462200243026018)","(['Product Stewardship'], 0.9474985003471375)","('NON-ESG', 0.00799109973013401)","('NON-ESG', 0.007462200243026018)"
Line 90,"Our partners  challenge us to think  differently and engage in new  ways of working.
","('Human_Rights_And_Community_Relations', 0.3234730660915375)","('Management_Of_Legal_And_Regulatory_Framework', 0.15416069328784943)","('Director_Removal', 0.0689655989408493)","('NON-ESG', 0.3234730660915375)","('NON-ESG', 0.15416069328784943)","('NON-ESG', 0.0689655989408493)"
Line 91,"Driving business efficiency  As we increase efficiency  throughout our own  operations, we extend this  positive impact by sharing our  learning and approach with  others, including business  partners and suppliers.Business continuity and  crisis management Unexpected events — such  as natural disasters, extreme  weather , and sudden power  outages — can disrupt our  operations or supply chain on  short notice.
","('Supply_Chain_Management', 0.9431775808334351)","('Physical_Impacts_Of_Climate_Change', 0.007992705330252647)","('Systemic_Risk_Management', 0.005248477216809988)","(['Supply Chain Management'], 0.9431775808334351)","('NON-ESG', 0.007992705330252647)","('NON-ESG', 0.005248477216809988)"
Line 92,"Our preparedness  and resilience practices protect  our ability to do business  sustainably and are of interest to  our stakeholders.
","('Business_Model_Resilience', 0.9152520298957825)","('Physical_Impacts_Of_Climate_Change', 0.011323177255690098)","('Product_Design_And_Lifecycle_Management', 0.008839388377964497)","(['Codes of Business Conduct'], 0.9152520298957825)","('NON-ESG', 0.011323177255690098)","('NON-ESG', 0.008839388377964497)"
Line 93,"Our Business  Continuity Management  program helps us to plan for the  risk of unexpected events, with a  focus on:  Business continuity —  ensuring that we can  continue to operate and   meet demand in adverse  circumstances Crisis management and  mobilization — coordinating  responses in crisis situations  Emergency response —  keeping people and assets  safe and minimizing  environmental impact   in emergencies  IT response and   recovery — responding  quickly to technological  failures and reinstating  affected infrastructure We also provide philanthropic  support during natural disasters;  more information on this is  available in Philanthropy.
","('Critical_Incident_Risk_Management', 0.9763961434364319)","('Employee_Health_And_Safety', 0.002432948909699917)","('Physical_Impacts_Of_Climate_Change', 0.0023004072718322277)","(['Risk & Crisis Management'], 0.9763961434364319)","('NON-ESG', 0.002432948909699917)","('NON-ESG', 0.0023004072718322277)"
Line 94,"Our Business  Continuity Management  program helps us to plan for the  risk of unexpected events, with a  focus on:  Business continuity —  ensuring that we can  continue to operate and   meet demand in adverse  circumstances Crisis management and  mobilization — coordinating  responses in crisis situations  Emergency response —  keeping people and assets  safe and minimizing  environmental impact   in emergencies  IT response and   recovery — responding  quickly to technological  failures and reinstating  affected infrastructure We also provide philanthropic  support during natural disasters;  more information on this is  available in Philanthropy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4591176211833954)","('Access_And_Affordability', 0.11007752269506454)","('Human_Rights_And_Community_Relations', 0.07491683214902878)","('NON-ESG', 0.4591176211833954)","('NON-ESG', 0.11007752269506454)","('NON-ESG', 0.07491683214902878)"
Line 95,"Our crisis   management system              COORDINA TION RESPONSE   OVERSIGHTMedtronic Crisis   Management T eam Escalates issues with  potentially significant  business impact Medtronic Global  Command Center  (Corporate Crisis   Filter T eam) Provides   regular updates Executive   Committee16SUST AINABILITY MANAGEMENT   AND GOVERNANCE Embedding and evolving a strong sustainability strategy requires   clear leadership.
","('Systemic_Risk_Management', 0.3938138484954834)","('Critical_Incident_Risk_Management', 0.27881574630737305)","('Physical_Impacts_Of_Climate_Change', 0.14745396375656128)","('NON-ESG', 0.3938138484954834)","('NON-ESG', 0.27881574630737305)","('NON-ESG', 0.14745396375656128)"
Line 96,"Our Sustainability Steering Committee (SSC) guides  our companywide approach.
","('Business_Model_Resilience', 0.5423867702484131)","('Supply_Chain_Management', 0.0593472495675087)","('Director_Removal', 0.05386241152882576)","(['Codes of Business Conduct'], 0.5423867702484131)","('NON-ESG', 0.0593472495675087)","('NON-ESG', 0.05386241152882576)"
Line 97,"T o embed sustainability considerations throughout our   operations, we:  Include executive leaders from a range of corporate functions on  the SSC  Make a close link between sustainability and economic oversight —  our chief financial officer is the SSC’s executive champion  Distribute management of environmental, social, and governance  responsibilities across the enterprise  Include oversight of our environmental, social, and governance  practices in the formal responsibilities of our board of directors’  Nominating and Governance Committee            EXTERNAL REPORTING, RECOGNITION,  AND BENCHMARKING A number of external frameworks guide our sustainability strategy and  reporting.
","('Director_Removal', 0.23131181299686432)","('Human_Rights_And_Community_Relations', 0.16278396546840668)","('Management_Of_Legal_And_Regulatory_Framework', 0.14584851264953613)","('NON-ESG', 0.23131181299686432)","('NON-ESG', 0.16278396546840668)","('NON-ESG', 0.14584851264953613)"
Line 98,"T o embed sustainability considerations throughout our   operations, we:  Include executive leaders from a range of corporate functions on  the SSC  Make a close link between sustainability and economic oversight —  our chief financial officer is the SSC’s executive champion  Distribute management of environmental, social, and governance  responsibilities across the enterprise  Include oversight of our environmental, social, and governance  practices in the formal responsibilities of our board of directors’  Nominating and Governance Committee            EXTERNAL REPORTING, RECOGNITION,  AND BENCHMARKING A number of external frameworks guide our sustainability strategy and  reporting.
","('Management_Of_Legal_And_Regulatory_Framework', 0.41196587681770325)","('Business_Model_Resilience', 0.20495015382766724)","('Systemic_Risk_Management', 0.05530316010117531)","('NON-ESG', 0.41196587681770325)","('NON-ESG', 0.20495015382766724)","('NON-ESG', 0.05530316010117531)"
Line 99,"Our current activities include:  Reporting on indicators set by the Global Reporting Initiative   and the Sustainability Accounting Standards Board —   available throughout this Integrated Performance Report and our   2019 ESG Disclosure Index  Mapping our contributions to relevant Sustainable   Development Goals  Participating in the annual RobecoSAM/Dow Jones Sustainability  Index survey  Submitting environmental data to CDP annually17We live in a time of unprecedented potential, where the possibilities of technology have never been greater .
","('Business_Model_Resilience', 0.38085612654685974)","('Systemic_Risk_Management', 0.1401425153017044)","('Management_Of_Legal_And_Regulatory_Framework', 0.10815621167421341)","('NON-ESG', 0.38085612654685974)","('NON-ESG', 0.1401425153017044)","('NON-ESG', 0.10815621167421341)"
Line 100,"Our current activities include:  Reporting on indicators set by the Global Reporting Initiative   and the Sustainability Accounting Standards Board —   available throughout this Integrated Performance Report and our   2019 ESG Disclosure Index  Mapping our contributions to relevant Sustainable   Development Goals  Participating in the annual RobecoSAM/Dow Jones Sustainability  Index survey  Submitting environmental data to CDP annually17We live in a time of unprecedented potential, where the possibilities of technology have never been greater .
","('Energy_Management', 0.14705541729927063)","('Data_Security', 0.1324184089899063)","('Product_Design_And_Lifecycle_Management', 0.13098947703838348)","('NON-ESG', 0.14705541729927063)","('NON-ESG', 0.1324184089899063)","('NON-ESG', 0.13098947703838348)"
Line 101,"Still, the world is faced with pressing  environmental and social challenges that require urgent action.
","('Human_Rights_And_Community_Relations', 0.7062870860099792)","('Ecological_Impacts', 0.04872303456068039)","('Physical_Impacts_Of_Climate_Change', 0.048659779131412506)","(['Community Relations'], 0.7062870860099792)","('NON-ESG', 0.04872303456068039)","('NON-ESG', 0.048659779131412506)"
Line 102,"These challenges cannot be solved by organizations acting alone.
","('Systemic_Risk_Management', 0.28519582748413086)","('Competitive_Behavior', 0.14544562995433807)","('Business_Ethics', 0.09605272114276886)","('NON-ESG', 0.28519582748413086)","('NON-ESG', 0.14544562995433807)","('NON-ESG', 0.09605272114276886)"
Line 103,"Now is the  time to come together — businesses, governments, and international organizations — to create change where it is needed the most.
","('Human_Rights_And_Community_Relations', 0.32972797751426697)","('Business_Model_Resilience', 0.1565731018781662)","('Management_Of_Legal_And_Regulatory_Framework', 0.13785023987293243)","('NON-ESG', 0.32972797751426697)","('NON-ESG', 0.1565731018781662)","('NON-ESG', 0.13785023987293243)"
Line 104,"We support the UN Sustainable Development Goals (SDGs) to achieve “peace and prosperity for people and the planet.” We are focused on  the goals where we can have the largest impact:  SUST AINABLE DEVELOPMENT  GOALS 18SDG 3: Good health and well-being  As a leading global medical technology company, we have the expertise, innovation, and commitment to partnership needed to help improve the  health and well-being of people around the world.
","('Employee_Health_And_Safety', 0.5229694843292236)","('Access_And_Affordability', 0.2095119208097458)","('Human_Rights_And_Community_Relations', 0.06781505793333054)","(['Operational Eco-Efficiency'], 0.5229694843292236)","('NON-ESG', 0.2095119208097458)","('NON-ESG', 0.06781505793333054)"
Line 105,"These skills are pivotal to addressing the healthcare challenges facing us today.
","('Access_And_Affordability', 0.1839694231748581)","('Supply_Chain_Management', 0.14847370982170105)","('Systemic_Risk_Management', 0.10535083711147308)","('NON-ESG', 0.1839694231748581)","('NON-ESG', 0.14847370982170105)","('NON-ESG', 0.10535083711147308)"
Line 106,"Globally, 32 million people died in 2016 due to cardiovascular disease, cancer , diabetes, or chronic respiratory disease.
","('Employee_Health_And_Safety', 0.6791654825210571)","('Employee_Engagement_Inclusion_And_Diversity', 0.04716256260871887)","('Access_And_Affordability', 0.043864499777555466)","(['Operational Eco-Efficiency'], 0.6791654825210571)","('NON-ESG', 0.04716256260871887)","('NON-ESG', 0.043864499777555466)"
Line 107,"For decades, Medtronic has  dedicated much of its time and talent to finding solutions to noncommunicable illnesses such as these.
","('Employee_Health_And_Safety', 0.6699161529541016)","('Product_Quality_And_Safety', 0.05458984524011612)","('Access_And_Affordability', 0.03323788195848465)","(['Operational Eco-Efficiency'], 0.6699161529541016)","('NON-ESG', 0.05458984524011612)","('NON-ESG', 0.03323788195848465)"
Line 108,"We, along with our peers, governments,  and other organizations, intend to tackle this alarming statistic by expanding the affordability and accessibility of care.
","('Access_And_Affordability', 0.6462316513061523)","('Employee_Health_And_Safety', 0.09489209204912186)","('Product_Quality_And_Safety', 0.029523052275180817)","(['Health Outcome Contribution'], 0.6462316513061523)","('NON-ESG', 0.09489209204912186)","('NON-ESG', 0.029523052275180817)"
Line 109,"The table below describes  some of the ways Medtronic is leading this transition.
","('Systemic_Risk_Management', 0.40822452306747437)","('Business_Model_Resilience', 0.16392195224761963)","('Supply_Chain_Management', 0.10544700175523758)","('NON-ESG', 0.40822452306747437)","('NON-ESG', 0.16392195224761963)","('NON-ESG', 0.10544700175523758)"
Line 110,"SDG MEDTRONIC CONTRIBUTION  Medtronic continues to innovate and partner to reduce premature mortality from noncommunicable diseases:  We served more than 75 million patients in FY19.
","('Employee_Health_And_Safety', 0.7829351425170898)","('Access_And_Affordability', 0.05820022523403168)","('Critical_Incident_Risk_Management', 0.02296321652829647)","(['Operational Eco-Efficiency'], 0.7829351425170898)","('NON-ESG', 0.05820022523403168)","('NON-ESG', 0.02296321652829647)"
Line 111," We invest in R&D, innovation hubs, and clinical trials that drive new therapies, services, and solutions for noncommunicable diseases.
","('Customer_Welfare', 0.1418313980102539)","('Access_And_Affordability', 0.13248951733112335)","('Business_Model_Resilience', 0.10882313549518585)","('NON-ESG', 0.1418313980102539)","('NON-ESG', 0.13248951733112335)","('NON-ESG', 0.10882313549518585)"
Line 112," We expand access to healthcare through our care-delivery initiatives such as Integrated Health Solutions, Medtronic Care Management Services, and  Patient Access Acceleration.
","('Access_And_Affordability', 0.8378763794898987)","('Energy_Management', 0.018617140129208565)","('Customer_Welfare', 0.01828116923570633)","(['Health Outcome Contribution'], 0.8378763794898987)","('NON-ESG', 0.018617140129208565)","('NON-ESG', 0.01828116923570633)"
Line 113," We invested $142 million in healthcare capacity building and training for medical professionals in FY19, reaching 83,000 people.
","('Access_And_Affordability', 0.4145117700099945)","('Employee_Engagement_Inclusion_And_Diversity', 0.14920149743556976)","('Employee_Health_And_Safety', 0.0753631442785263)","('NON-ESG', 0.4145117700099945)","('NON-ESG', 0.14920149743556976)","('NON-ESG', 0.0753631442785263)"
Line 114," We collaborate with global product donation partners to distribute Medtronic products to nonprofit organizations and in-country clinics to meet the  needs of underserved groups — in FY19, we donated $9.2 million in products.
","('Access_And_Affordability', 0.8334223628044128)","('Product_Design_And_Lifecycle_Management', 0.028873110190033913)","('Energy_Management', 0.01766389235854149)","(['Health Outcome Contribution'], 0.8334223628044128)","('NON-ESG', 0.028873110190033913)","('NON-ESG', 0.01766389235854149)"
Line 115,"  We invested $28.6 million in patient outreach and education.
","('Access_And_Affordability', 0.8667009472846985)","('Human_Rights_And_Community_Relations', 0.02135888673365116)","('Employee_Engagement_Inclusion_And_Diversity', 0.0131922522559762)","(['Health Outcome Contribution'], 0.8667009472846985)","('NON-ESG', 0.02135888673365116)","('NON-ESG', 0.0131922522559762)"
Line 116,"We are strengthening the prevention and treatment of substance abuse through education and the advancement of key therapies:   We collaborate with others in pain management to broaden therapy awareness and advocacy, deliver innovation, and advance clinical and economic  evidence in favor of device-delivered pain therapies as an alternative to opioids.
","('Employee_Health_And_Safety', 0.5136480331420898)","('Access_And_Affordability', 0.06228845566511154)","('Customer_Welfare', 0.060759883373975754)","(['Operational Eco-Efficiency'], 0.5136480331420898)","('NON-ESG', 0.06228845566511154)","('NON-ESG', 0.060759883373975754)"
Line 117,"We develop new business models and partner with others around the world to achieve universal access to healthcare:   Our Government Affairs team and executive leadership champion universal health coverage.
","('Access_And_Affordability', 0.8641982078552246)","('Product_Quality_And_Safety', 0.012514611706137657)","('Energy_Management', 0.012272528372704983)","(['Health Outcome Contribution'], 0.8641982078552246)","('NON-ESG', 0.012514611706137657)","('NON-ESG', 0.012272528372704983)"
Line 118,"In September 2019, Medtronic CEO Omar Ishrak chaired  a panel at the UN High-Level Meeting on Universal Health Coverage.
","('Access_And_Affordability', 0.4981320798397064)","('Product_Quality_And_Safety', 0.07508089393377304)","('Employee_Health_And_Safety', 0.05482202395796776)","('NON-ESG', 0.4981320798397064)","('NON-ESG', 0.07508089393377304)","('NON-ESG', 0.05482202395796776)"
Line 119,"We invest in infrastructure in emerging markets through our hub-and-spoke model.19We also contribute to SDG goals aligned to social and environmental progress, including equality, decent work, innovation, responsible  consumption and production, and partnerships.
","('Human_Rights_And_Community_Relations', 0.8205409049987793)","('Business_Model_Resilience', 0.02669113129377365)","('Management_Of_Legal_And_Regulatory_Framework', 0.019715934991836548)","(['Community Relations'], 0.8205409049987793)","('NON-ESG', 0.02669113129377365)","('NON-ESG', 0.019715934991836548)"
Line 120,"SDG MEDTRONIC CONTRIBUTION   Goal of 40% or more of global management positions to be held by women   Medtronic CEO Omar Ishrak joins Catalyst CEO Champions for Change initiative  T wenty-seven percent female representation on our board of directors    Medtronic Women’s Network initiatives promote the advancement of female employees through development, opportunities, mentoring,   and education  Goal of 20% or more of U.S. management positions to be held by ethnically diverse talent   Equal Employment Opportunity Policy   Global Inclusion, Diversity, and Engagement initiatives, including commitment to gender representation at all levels  Global Human Rights and Labor Practices Policy and program   Global Supplier Standards and Responsible Supply Management program  Global Environmental, Health, and Safety Policy and program  Long-term public targets for greenhouse gas emissions reduction  R&D and innovation hubs in China, Brazil, and T urkey  MedT ech Innovation Accelerator in Shanghai to empower startups aimed at improving patient outcomes   Medtronic African and Asian Healthcare Innovation competitions  Artificial Intelligence lab partnership with Shanghai Jiao T ong University  Medtronic Foundation’s Global Health programs  Corporate energy and water conservation initiatives and targets  Product stewardship program, including materials of concern and sustainable packaging activities  Waste reduction through recycling, reuse, and inventory management that reduces excess scrap and obsolescence  Strategic internal and external partnerships across the enterprise that advance healthcare access and outcomes globally  Healthcare capacity building and innovation centers in emerging markets  Public-private partnerships to increase the provision of life-improving treatments council and related initiativesADDING VALUE TO SOCIETY The full size and reach of our company help us  contribute to the health of communities around the  world.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9773345589637756)","('Employee_Health_And_Safety', 0.0016319936839863658)","('Labor_Practices', 0.0015220828354358673)","(['Human Capital Development'], 0.9773345589637756)","('NON-ESG', 0.0016319936839863658)","('NON-ESG', 0.0015220828354358673)"
Line 121,"SDG MEDTRONIC CONTRIBUTION   Goal of 40% or more of global management positions to be held by women   Medtronic CEO Omar Ishrak joins Catalyst CEO Champions for Change initiative  T wenty-seven percent female representation on our board of directors    Medtronic Women’s Network initiatives promote the advancement of female employees through development, opportunities, mentoring,   and education  Goal of 20% or more of U.S. management positions to be held by ethnically diverse talent   Equal Employment Opportunity Policy   Global Inclusion, Diversity, and Engagement initiatives, including commitment to gender representation at all levels  Global Human Rights and Labor Practices Policy and program   Global Supplier Standards and Responsible Supply Management program  Global Environmental, Health, and Safety Policy and program  Long-term public targets for greenhouse gas emissions reduction  R&D and innovation hubs in China, Brazil, and T urkey  MedT ech Innovation Accelerator in Shanghai to empower startups aimed at improving patient outcomes   Medtronic African and Asian Healthcare Innovation competitions  Artificial Intelligence lab partnership with Shanghai Jiao T ong University  Medtronic Foundation’s Global Health programs  Corporate energy and water conservation initiatives and targets  Product stewardship program, including materials of concern and sustainable packaging activities  Waste reduction through recycling, reuse, and inventory management that reduces excess scrap and obsolescence  Strategic internal and external partnerships across the enterprise that advance healthcare access and outcomes globally  Healthcare capacity building and innovation centers in emerging markets  Public-private partnerships to increase the provision of life-improving treatments council and related initiativesADDING VALUE TO SOCIETY The full size and reach of our company help us  contribute to the health of communities around the  world.
","('Supply_Chain_Management', 0.43452975153923035)","('Labor_Practices', 0.3448541760444641)","('Employee_Engagement_Inclusion_And_Diversity', 0.03592348098754883)","('NON-ESG', 0.43452975153923035)","('NON-ESG', 0.3448541760444641)","('NON-ESG', 0.03592348098754883)"
Line 122,"SDG MEDTRONIC CONTRIBUTION   Goal of 40% or more of global management positions to be held by women   Medtronic CEO Omar Ishrak joins Catalyst CEO Champions for Change initiative  T wenty-seven percent female representation on our board of directors    Medtronic Women’s Network initiatives promote the advancement of female employees through development, opportunities, mentoring,   and education  Goal of 20% or more of U.S. management positions to be held by ethnically diverse talent   Equal Employment Opportunity Policy   Global Inclusion, Diversity, and Engagement initiatives, including commitment to gender representation at all levels  Global Human Rights and Labor Practices Policy and program   Global Supplier Standards and Responsible Supply Management program  Global Environmental, Health, and Safety Policy and program  Long-term public targets for greenhouse gas emissions reduction  R&D and innovation hubs in China, Brazil, and T urkey  MedT ech Innovation Accelerator in Shanghai to empower startups aimed at improving patient outcomes   Medtronic African and Asian Healthcare Innovation competitions  Artificial Intelligence lab partnership with Shanghai Jiao T ong University  Medtronic Foundation’s Global Health programs  Corporate energy and water conservation initiatives and targets  Product stewardship program, including materials of concern and sustainable packaging activities  Waste reduction through recycling, reuse, and inventory management that reduces excess scrap and obsolescence  Strategic internal and external partnerships across the enterprise that advance healthcare access and outcomes globally  Healthcare capacity building and innovation centers in emerging markets  Public-private partnerships to increase the provision of life-improving treatments council and related initiativesADDING VALUE TO SOCIETY The full size and reach of our company help us  contribute to the health of communities around the  world.
","('Product_Design_And_Lifecycle_Management', 0.8143601417541504)","('Waste_And_Hazardous_Materials_Management', 0.08545399457216263)","('Product_Quality_And_Safety', 0.014431126415729523)","(['Product Stewardship'], 0.8143601417541504)","('NON-ESG', 0.08545399457216263)","('NON-ESG', 0.014431126415729523)"
Line 123,"SDG MEDTRONIC CONTRIBUTION   Goal of 40% or more of global management positions to be held by women   Medtronic CEO Omar Ishrak joins Catalyst CEO Champions for Change initiative  T wenty-seven percent female representation on our board of directors    Medtronic Women’s Network initiatives promote the advancement of female employees through development, opportunities, mentoring,   and education  Goal of 20% or more of U.S. management positions to be held by ethnically diverse talent   Equal Employment Opportunity Policy   Global Inclusion, Diversity, and Engagement initiatives, including commitment to gender representation at all levels  Global Human Rights and Labor Practices Policy and program   Global Supplier Standards and Responsible Supply Management program  Global Environmental, Health, and Safety Policy and program  Long-term public targets for greenhouse gas emissions reduction  R&D and innovation hubs in China, Brazil, and T urkey  MedT ech Innovation Accelerator in Shanghai to empower startups aimed at improving patient outcomes   Medtronic African and Asian Healthcare Innovation competitions  Artificial Intelligence lab partnership with Shanghai Jiao T ong University  Medtronic Foundation’s Global Health programs  Corporate energy and water conservation initiatives and targets  Product stewardship program, including materials of concern and sustainable packaging activities  Waste reduction through recycling, reuse, and inventory management that reduces excess scrap and obsolescence  Strategic internal and external partnerships across the enterprise that advance healthcare access and outcomes globally  Healthcare capacity building and innovation centers in emerging markets  Public-private partnerships to increase the provision of life-improving treatments council and related initiativesADDING VALUE TO SOCIETY The full size and reach of our company help us  contribute to the health of communities around the  world.
","('Access_And_Affordability', 0.859844446182251)","('Human_Rights_And_Community_Relations', 0.028844349086284637)","('Employee_Health_And_Safety', 0.016077671200037003)","(['Health Outcome Contribution'], 0.859844446182251)","('NON-ESG', 0.028844349086284637)","('NON-ESG', 0.016077671200037003)"
Line 124,"We achieve this through our efforts to expand  access to high-quality healthcare, give back through  philanthropic initiatives, and support local economies  through our business operations.21Our business was founded on innovation.
","('Access_And_Affordability', 0.8759629726409912)","('Human_Rights_And_Community_Relations', 0.012765243649482727)","('Product_Quality_And_Safety', 0.011326195672154427)","(['Health Outcome Contribution'], 0.8759629726409912)","('NON-ESG', 0.012765243649482727)","('NON-ESG', 0.011326195672154427)"
Line 125,"T oday, we continue to develop  new solutions to global healthcare challenges.
","('Business_Model_Resilience', 0.19167368113994598)","('Systemic_Risk_Management', 0.18190856277942657)","('Supply_Chain_Management', 0.17069390416145325)","('NON-ESG', 0.19167368113994598)","('NON-ESG', 0.18190856277942657)","('NON-ESG', 0.17069390416145325)"
Line 126,"We focus particularly  on the treatment of chronic, noncommunicable diseases, including  conditions that disproportionately affect people in emerging markets.
","('Employee_Health_And_Safety', 0.4812474548816681)","('Systemic_Risk_Management', 0.0848352313041687)","('Access_And_Affordability', 0.07026740163564682)","('NON-ESG', 0.4812474548816681)","('NON-ESG', 0.0848352313041687)","('NON-ESG', 0.07026740163564682)"
Line 127,"Our Mission drives us to make our products available to the people  who need them — whoever and wherever they are.
","('Product_Design_And_Lifecycle_Management', 0.9576476216316223)","('Product_Quality_And_Safety', 0.005044655408710241)","('Selling_Practices_And_Product_Labeling', 0.005016525276005268)","(['Product Stewardship'], 0.9576476216316223)","('NON-ESG', 0.005044655408710241)","('NON-ESG', 0.005016525276005268)"
Line 128,"Universal access to  healthcare is a global priority, with millions of people unable to receive  essential treatment.
","('Access_And_Affordability', 0.9168921709060669)","('Human_Rights_And_Community_Relations', 0.010424152947962284)","('Critical_Incident_Risk_Management', 0.01004774309694767)","(['Health Outcome Contribution'], 0.9168921709060669)","('NON-ESG', 0.010424152947962284)","('NON-ESG', 0.01004774309694767)"
Line 129,"We develop new business models and partner with  others around the world to reduce barriers to access and affordability.
","('Access_And_Affordability', 0.8310397267341614)","('Product_Quality_And_Safety', 0.021904775872826576)","('Management_Of_Legal_And_Regulatory_Framework', 0.015512133948504925)","(['Health Outcome Contribution'], 0.8310397267341614)","('NON-ESG', 0.021904775872826576)","('NON-ESG', 0.015512133948504925)"
Line 130,"TECHNOLOGY   INNOVA TION As the pace of technological change accelerates, we anticipate  and invest in high-potential technologies.
","('Business_Model_Resilience', 0.33833250403404236)","('Product_Design_And_Lifecycle_Management', 0.0992095023393631)","('Systemic_Risk_Management', 0.09206581115722656)","('NON-ESG', 0.33833250403404236)","('NON-ESG', 0.0992095023393631)","('NON-ESG', 0.09206581115722656)"
Line 131,"We develop promising  discoveries into effective treatments and make these available to  the patients who need them most.
","('Access_And_Affordability', 0.24814757704734802)","('Customer_Welfare', 0.1729956865310669)","('Product_Quality_And_Safety', 0.08391962200403214)","('NON-ESG', 0.24814757704734802)","('NON-ESG', 0.1729956865310669)","('NON-ESG', 0.08391962200403214)"
Line 132,"The future of healthcare will be connected, precise,   and personalized.
","('Customer_Privacy', 0.2033408284187317)","('Access_And_Affordability', 0.12002996355295181)","('Data_Security', 0.08785004168748856)","('NON-ESG', 0.2033408284187317)","('NON-ESG', 0.12002996355295181)","('NON-ESG', 0.08785004168748856)"
Line 133,"Our strong pipeline ensures that we will stay   at the forefront of our evolving industry.
","('Business_Model_Resilience', 0.48924946784973145)","('Supply_Chain_Management', 0.10690871626138687)","('Systemic_Risk_Management', 0.07235247641801834)","('NON-ESG', 0.48924946784973145)","('NON-ESG', 0.10690871626138687)","('NON-ESG', 0.07235247641801834)"
Line 134,"GLOBAL  HEAL THCARE  ACCESS Adding   Business Value   Business growth is intrinsically linked to patient access and  affordability.
","('Access_And_Affordability', 0.8792896866798401)","('Employee_Health_And_Safety', 0.013639337383210659)","('Product_Quality_And_Safety', 0.011696629226207733)","(['Health Outcome Contribution'], 0.8792896866798401)","('NON-ESG', 0.013639337383210659)","('NON-ESG', 0.011696629226207733)"
Line 135,"This drives us to create new healthcare models  based on value, efficiency, and outcomes.
","('Business_Model_Resilience', 0.4849778711795807)","('Product_Design_And_Lifecycle_Management', 0.11843632906675339)","('Supply_Chain_Management', 0.060840655118227005)","('NON-ESG', 0.4849778711795807)","('NON-ESG', 0.11843632906675339)","('NON-ESG', 0.060840655118227005)"
Line 136,"Increasing access  also requires us to invest in infrastructure development, therapy  awareness, and specialized physician training.
","('Access_And_Affordability', 0.7796496748924255)","('Employee_Engagement_Inclusion_And_Diversity', 0.03459661081433296)","('Critical_Incident_Risk_Management', 0.019321706146001816)","(['Health Outcome Contribution'], 0.7796496748924255)","('NON-ESG', 0.03459661081433296)","('NON-ESG', 0.019321706146001816)"
Line 137,"In this way, we serve society by widening access for underserved  communities — and we serve our business by growing   our markets.
","('Access_And_Affordability', 0.9463455677032471)","('Human_Rights_And_Community_Relations', 0.0051655336283147335)","('Critical_Incident_Risk_Management', 0.004802724812179804)","(['Health Outcome Contribution'], 0.9463455677032471)","('NON-ESG', 0.0051655336283147335)","('NON-ESG', 0.004802724812179804)"
Line 138,"In FY19, Medtronic products and services IMPROVED  THE LIVES OF  MORE THAN 75 MILLION  PEOPLE THE DRIVERS  BEHIND OUR  COMMITMENT Creating an inclusive   and diverse culture:clinical studies  started clinical studies  completedongoing   clinical studies  at the end   of FY19  OUR INNOVA TION PIPELINE Our Applied Innovation Lab  “holodeck” video screen  provides an immersive  experience to help scientists  and engineers understand  healthcare needs in remote  geographic regions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8345814943313599)","('Access_And_Affordability', 0.02918887510895729)","('Customer_Welfare', 0.01739651896059513)","(['Human Capital Development'], 0.8345814943313599)","('NON-ESG', 0.02918887510895729)","('NON-ESG', 0.01739651896059513)"
Line 139,"We test and revisit a design  multiple times during product  development to minimize the  risk of problems further along  in the process.
","('Product_Design_And_Lifecycle_Management', 0.9538045525550842)","('Product_Quality_And_Safety', 0.007429540157318115)","('Customer_Welfare', 0.0036014418583363295)","(['Product Stewardship'], 0.9538045525550842)","('NON-ESG', 0.007429540157318115)","('NON-ESG', 0.0036014418583363295)"
Line 140,"We test potential new  solutions through clinical trials  — establishing safety and  effectiveness with a consistent  drive to improve patient  experience and outcomes.
","('Product_Quality_And_Safety', 0.8111040592193604)","('Customer_Welfare', 0.025248399004340172)","('Employee_Health_And_Safety', 0.025019187480211258)","(['Product Quality & Recall Management'], 0.8111040592193604)","('NON-ESG', 0.025248399004340172)","('NON-ESG', 0.025019187480211258)"
Line 141,"We explore advanced statistical  methodology and modeling  simulations to generate   cost-effective evidence.
","('Competitive_Behavior', 0.2871134579181671)","('Management_Of_Legal_And_Regulatory_Framework', 0.2155398428440094)","('GHG_Emissions', 0.06551320105791092)","('NON-ESG', 0.2871134579181671)","('NON-ESG', 0.2155398428440094)","('NON-ESG', 0.06551320105791092)"
Line 142,"Read more about our approach  to clinical trials.
","('Competitive_Behavior', 0.17549216747283936)","('Customer_Welfare', 0.11987236142158508)","('GHG_Emissions', 0.07796669006347656)","('NON-ESG', 0.17549216747283936)","('NON-ESG', 0.11987236142158508)","('NON-ESG', 0.07796669006347656)"
Line 143,"In FY19, we invested $2.3 billion  in research and development  (R&D) and launched 55 new   clinical studies.Research and   clinical trials Emerging technologies offer  new opportunities to meet  pervasive health challenges.
","('Access_And_Affordability', 0.30482518672943115)","('Customer_Welfare', 0.1298743188381195)","('Competitive_Behavior', 0.058813802897930145)","('NON-ESG', 0.30482518672943115)","('NON-ESG', 0.1298743188381195)","('NON-ESG', 0.058813802897930145)"
Line 144,"We develop, monitor , and  refine novel applications of  existing and new technologies,  including artificial intelligence,  miniaturization, bio- printing, 3D printing, and  many more.
","('Product_Design_And_Lifecycle_Management', 0.20220538973808289)","('Business_Model_Resilience', 0.11987391859292984)","('Data_Security', 0.11071731150150299)","('NON-ESG', 0.20220538973808289)","('NON-ESG', 0.11987391859292984)","('NON-ESG', 0.11071731150150299)"
Line 145,"Our research  extends to the exploration  of new materials, evolving  microelectronics and sensor  technology, biomarkers, tissue  regeneration, and targeted  drug delivery.
","('Customer_Welfare', 0.24259786307811737)","('Product_Design_And_Lifecycle_Management', 0.20054778456687927)","('Supply_Chain_Management', 0.10009322315454483)","('NON-ESG', 0.24259786307811737)","('NON-ESG', 0.20054778456687927)","('NON-ESG', 0.10009322315454483)"
Line 146,"Our development processes  utilize state-of-the-art  technology to predict and  improve real-life product  performance.
","('Product_Design_And_Lifecycle_Management', 0.9650538563728333)","('Product_Quality_And_Safety', 0.0031276391819119453)","('Energy_Management', 0.002660023747012019)","(['Product Stewardship'], 0.9650538563728333)","('NON-ESG', 0.0031276391819119453)","('NON-ESG', 0.002660023747012019)"
Line 147,"For example:  Predictive engineering  ensures that finished  products perform as  intended in the   clinical setting.
","('Product_Design_And_Lifecycle_Management', 0.9468708038330078)","('Customer_Welfare', 0.008115374483168125)","('Product_Quality_And_Safety', 0.007919523864984512)","(['Product Stewardship'], 0.9468708038330078)","('NON-ESG', 0.008115374483168125)","('NON-ESG', 0.007919523864984512)"
Line 148,"With a 40-plus-year history of developing  innovative medical devices that have been  shown to alleviate pain in different disease  states, we recognize that we have a role to  play in disrupting this epidemic.
","('Employee_Health_And_Safety', 0.663941502571106)","('Critical_Incident_Risk_Management', 0.07035616040229797)","('Access_And_Affordability', 0.033616188913583755)","(['Operational Eco-Efficiency'], 0.663941502571106)","('NON-ESG', 0.07035616040229797)","('NON-ESG', 0.033616188913583755)"
Line 149,"No single  entity can solve America’s opioid and pain  crisis alone, which is why we are working in  collaboration to address the unmet needs   of pain patients .
","('Employee_Health_And_Safety', 0.5843362212181091)","('Critical_Incident_Risk_Management', 0.08924339711666107)","('Access_And_Affordability', 0.08518006652593613)","(['Operational Eco-Efficiency'], 0.5843362212181091)","('NON-ESG', 0.08924339711666107)","('NON-ESG', 0.08518006652593613)"
Line 150,"– Marshall Stanton President, Medtronic Pain Therapies 1  Institute of Medicine.
","('Employee_Health_And_Safety', 0.5639759302139282)","('Access_And_Affordability', 0.06420975923538208)","('Product_Quality_And_Safety', 0.05481017380952835)","(['Operational Eco-Efficiency'], 0.5639759302139282)","('NON-ESG', 0.06420975923538208)","('NON-ESG', 0.05481017380952835)"
Line 151,"Relieving pain in America: a blueprint for transforming prevention, care,  education, and research.
","('Employee_Health_And_Safety', 0.8886570334434509)","('Critical_Incident_Risk_Management', 0.015968939289450645)","('Access_And_Affordability', 0.012900137342512608)","(['Operational Eco-Efficiency'], 0.8886570334434509)","('NON-ESG', 0.015968939289450645)","('NON-ESG', 0.012900137342512608)"
Line 152,"Washington DC, United States: The National Academies Press.
","('Ecological_Impacts', 0.3169271647930145)","('Management_Of_Legal_And_Regulatory_Framework', 0.2710273563861847)","('Product_Design_And_Lifecycle_Management', 0.03528548777103424)","('NON-ESG', 0.3169271647930145)","('NON-ESG', 0.2710273563861847)","('NON-ESG', 0.03528548777103424)"
Line 153,"2011.
","('Management_Of_Legal_And_Regulatory_Framework', 0.11624126881361008)","('Ecological_Impacts', 0.10781123489141464)","('GHG_Emissions', 0.07575494796037674)","('NON-ESG', 0.11624126881361008)","('NON-ESG', 0.10781123489141464)","('NON-ESG', 0.07575494796037674)"
Line 154,"2  Injection into the spinal canal or the subarachnoid space.CASE STUDY OUR ROLE IN DISRUPTING THE OPIOID EPIDEMIC The opioid epidemic has had a devastating impact across the  United States, and public officials have declared the epidemic  “the worst drug crisis in American history.” At the same time,  the ongoing public health problem of pain management  constitutes a crisis of its own.
","('Critical_Incident_Risk_Management', 0.4710541069507599)","('Access_And_Affordability', 0.0996231734752655)","('Systemic_Risk_Management', 0.07763248682022095)","('NON-ESG', 0.4710541069507599)","('NON-ESG', 0.0996231734752655)","('NON-ESG', 0.07763248682022095)"
Line 155,"Despite availability of effective  pain treatments, barriers to achieving adequate pain relief  remain for many Americans.Medtronic Pain Therapies is working to disrupt the opioid  crisis in collaboration with patients, providers, regulators,  elected officials, patient advocacy groups, and employers.
","('Employee_Health_And_Safety', 0.7994479537010193)","('Critical_Incident_Risk_Management', 0.02062940038740635)","('Access_And_Affordability', 0.019939279183745384)","(['Operational Eco-Efficiency'], 0.7994479537010193)","('NON-ESG', 0.02062940038740635)","('NON-ESG', 0.019939279183745384)"
Line 156,"We are raising awareness of alternatives to conventional pain  medication and researching clinical and economic evidence for  their effectiveness.
","('Employee_Health_And_Safety', 0.2903420031070709)","('Customer_Welfare', 0.1431232988834381)","('Product_Quality_And_Safety', 0.09619783610105515)","('NON-ESG', 0.2903420031070709)","('NON-ESG', 0.1431232988834381)","('NON-ESG', 0.09619783610105515)"
Line 157,"For example, the Embrace T argeted Drug Delivery study is  evaluating intrathecal2 morphine as an alternative to systemic  opioids for the treatment of chronic, intractable, non- malignant primary back pain with or without leg pain.
","('Employee_Health_And_Safety', 0.9197162985801697)","('Systemic_Risk_Management', 0.006413775030523539)","('Employee_Engagement_Inclusion_And_Diversity', 0.005732468329370022)","(['Operational Eco-Efficiency'], 0.9197162985801697)","('NON-ESG', 0.006413775030523539)","('NON-ESG', 0.005732468329370022)"
Line 158,"The study will:  Follow patients who wean completely from all oral opioids  and have a positive response to intrathecal drug trial  Assess pain control and opioid-related side effects at   six months following a route of delivery change to intrathecal  preservative-free morphine sulfate 23““CASE STUDY PA TENTS FOR HUMANITY   In FY19, the U.S. Patent and T rademark Office named our  hemodialysis system, currently under development, as one of  its 2018 “Patents for Humanity” award winners.
","('Competitive_Behavior', 0.27631986141204834)","('Product_Quality_And_Safety', 0.18677178025245667)","('Customer_Welfare', 0.17063191533088684)","('NON-ESG', 0.27631986141204834)","('NON-ESG', 0.18677178025245667)","('NON-ESG', 0.17063191533088684)"
Line 159,"The program  honors innovators who create game-changing technology to  meet global humanitarian challenges.
","('Business_Model_Resilience', 0.42904090881347656)","('Product_Design_And_Lifecycle_Management', 0.20092208683490753)","('Supply_Chain_Management', 0.053258541971445084)","('NON-ESG', 0.42904090881347656)","('NON-ESG', 0.20092208683490753)","('NON-ESG', 0.053258541971445084)"
Line 160,"T oday’s hemodialysis systems — used to treat chronic  kidney disease — require costly infrastructure such as water  purification facilities.
","('Water_And_Wastewater_Management', 0.9695837497711182)","('Energy_Management', 0.0031806298065930605)","('Waste_And_Hazardous_Materials_Management', 0.0030551638919860125)","(['Operational Eco-Efficiency'], 0.9695837497711182)","('NON-ESG', 0.0031806298065930605)","('NON-ESG', 0.0030551638919860125)"
Line 161,"They are often only available at urban  hospitals and clinics far from many patients.
","('Access_And_Affordability', 0.5412017107009888)","('Employee_Health_And_Safety', 0.07017742097377777)","('Critical_Incident_Risk_Management', 0.06862581521272659)","(['Health Outcome Contribution'], 0.5412017107009888)","('NON-ESG', 0.07017742097377777)","('NON-ESG', 0.06862581521272659)"
Line 162,"Our goal is to  design a portable hemodialysis system that is significantly   smaller and that requires 75% less water than traditional  systems.
","('Water_And_Wastewater_Management', 0.9622945189476013)","('Energy_Management', 0.006342421285808086)","('Waste_And_Hazardous_Materials_Management', 0.004092023707926273)","(['Operational Eco-Efficiency'], 0.9622945189476013)","('NON-ESG', 0.006342421285808086)","('NON-ESG', 0.004092023707926273)"
Line 163,"We intend to address the biggest barriers to chronic  kidney disease care — especially in emerging markets, where  the need is great.Launching new products Our new product launches in  FY19 included:  Accurian™ Nerve Ablation  Platform conducts radio  frequency ablation of nervous  tissue.
","('Product_Design_And_Lifecycle_Management', 0.6229314208030701)","('Customer_Welfare', 0.1477544754743576)","('Product_Quality_And_Safety', 0.07149115949869156)","(['Product Stewardship'], 0.6229314208030701)","('NON-ESG', 0.1477544754743576)","('NON-ESG', 0.07149115949869156)"
Line 164,"The Accurian system  combines proprietary  hardware with advanced  software for power and  temperature control, resulting  in consistent and predictable  lesion formation.
","('Energy_Management', 0.5341632962226868)","('Water_And_Wastewater_Management', 0.08342640101909637)","('Air_Quality', 0.08231240510940552)","(['Operational Eco-Efficiency'], 0.5341632962226868)","('NON-ESG', 0.08342640101909637)","('NON-ESG', 0.08231240510940552)"
Line 165,"Clinician Programmer for  deep brain stimulation  (DBS) is a digital interface  that enables physicians  to deliver secure, patient- focused DBS sessions.
","('Access_And_Affordability', 0.39732733368873596)","('Customer_Welfare', 0.07787977159023285)","('Competitive_Behavior', 0.07455448061227798)","('NON-ESG', 0.39732733368873596)","('NON-ESG', 0.07787977159023285)","('NON-ESG', 0.07455448061227798)"
Line 166,"MiniMed™ 670G System is  our hybrid, closed-loop insulin  delivery system.
","('Access_And_Affordability', 0.3808872103691101)","('Customer_Welfare', 0.17824164032936096)","('Energy_Management', 0.05319394916296005)","('NON-ESG', 0.3808872103691101)","('NON-ESG', 0.17824164032936096)","('NON-ESG', 0.05319394916296005)"
Line 167,"In FY19, the  system received approval for  use in patients with T ype 1  diabetes aged seven years  3  The MiniMed™ 670G System is for T ype 1 ages 7 and over .
","('Access_And_Affordability', 0.6148799657821655)","('Product_Quality_And_Safety', 0.05296875908970833)","('Employee_Health_And_Safety', 0.052277255803346634)","(['Health Outcome Contribution'], 0.6148799657821655)","('NON-ESG', 0.05296875908970833)","('NON-ESG', 0.052277255803346634)"
Line 168,"Prescription required.
","('Selling_Practices_And_Product_Labeling', 0.4444425106048584)","('Product_Quality_And_Safety', 0.08864478766918182)","('Customer_Privacy', 0.07565034925937653)","('NON-ESG', 0.4444425106048584)","('NON-ESG', 0.08864478766918182)","('NON-ESG', 0.07565034925937653)"
Line 169,"Individual results  may vary.
","('Competitive_Behavior', 0.3286489248275757)","('Business_Ethics', 0.08078671246767044)","('Employee_Engagement_Inclusion_And_Diversity', 0.07260744273662567)","('NON-ESG', 0.3286489248275757)","('NON-ESG', 0.08078671246767044)","('NON-ESG', 0.07260744273662567)"
Line 170,"WARNING: May not be safe under age 7 or using less than 8 units insulin/day.
","('Access_And_Affordability', 0.42383578419685364)","('Product_Quality_And_Safety', 0.20286938548088074)","('Selling_Practices_And_Product_Labeling', 0.06455203145742416)","('NON-ESG', 0.42383578419685364)","('NON-ESG', 0.20286938548088074)","('NON-ESG', 0.06455203145742416)"
Line 171,"See https:/ / www.medtronicdiabetes.com/important-safety-information#minimed-670g for additional  important details.and older (previously only  available to those aged 13  and over).
","('Product_Quality_And_Safety', 0.7883118987083435)","('Access_And_Affordability', 0.04208098724484444)","('Employee_Health_And_Safety', 0.04029671847820282)","(['Product Quality & Recall Management'], 0.7883118987083435)","('NON-ESG', 0.04208098724484444)","('NON-ESG', 0.04029671847820282)"
Line 172,"Solitaire™ X  revascularization device  is designed for procedural  efficiency and smooth  navigation, to give surgeons  greater confidence during  interventional stroke  procedures.
","('Employee_Health_And_Safety', 0.5888227224349976)","('Access_And_Affordability', 0.13262653350830078)","('Critical_Incident_Risk_Management', 0.04309979826211929)","(['Operational Eco-Efficiency'], 0.5888227224349976)","('NON-ESG', 0.13262653350830078)","('NON-ESG', 0.04309979826211929)"
Line 173,"Read more about products  receiving Food and Drug  Administration (FDA) clearance   or approval and CE mark  approval (a certification  indicating a product conforms  with European Union safety,  health, and environmental  standards) in FY19 at the  Medtronic Newsroom.
","('Product_Quality_And_Safety', 0.9152016043663025)","('Selling_Practices_And_Product_Labeling', 0.013392409309744835)","('Product_Design_And_Lifecycle_Management', 0.007686012424528599)","(['Product Quality & Recall Management'], 0.9152016043663025)","('NON-ESG', 0.013392409309744835)","('NON-ESG', 0.007686012424528599)"
Line 174,"Partnerships and  acquisitions We partner with universities,  hospitals, and healthcare  startups to develop new  ideas, tackle global or local  challenges, and ultimately  increase the provision of  life-improving treatments.
","('Access_And_Affordability', 0.5679900050163269)","('Systemic_Risk_Management', 0.039658304303884506)","('Human_Rights_And_Community_Relations', 0.03730179741978645)","(['Health Outcome Contribution'], 0.5679900050163269)","('NON-ESG', 0.039658304303884506)","('NON-ESG', 0.03730179741978645)"
Line 175,"Highlights from FY19 include:   A Medtronic appointee to  the European Institute of  Innovation and T echnology  (EIT) Health consortium.
","('Access_And_Affordability', 0.22788496315479279)","('Employee_Engagement_Inclusion_And_Diversity', 0.10289959609508514)","('Ecological_Impacts', 0.09415353089570999)","('NON-ESG', 0.22788496315479279)","('NON-ESG', 0.10289959609508514)","('NON-ESG', 0.09415353089570999)"
Line 176,"This network of 140 leading  healthcare organizations  aims to address the  challenges associated with  the increase in chronic  disease patients and multi- morbidity.
","('Employee_Health_And_Safety', 0.5872682929039001)","('Access_And_Affordability', 0.15702612698078156)","('Critical_Incident_Risk_Management', 0.04834314435720444)","(['Operational Eco-Efficiency'], 0.5872682929039001)","('NON-ESG', 0.15702612698078156)","('NON-ESG', 0.04834314435720444)"
Line 177,"We have received  E.U. funding for six research  projects with multiple  external partners.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3428623080253601)","('Access_And_Affordability', 0.2776614725589752)","('GHG_Emissions', 0.04681150242686272)","('NON-ESG', 0.3428623080253601)","('NON-ESG', 0.2776614725589752)","('NON-ESG', 0.04681150242686272)"
Line 178,"The launch of the Medtronic  MedT ech Innovation  Accelerator in Shanghai,  China.
","('Business_Model_Resilience', 0.18962520360946655)","('Product_Design_And_Lifecycle_Management', 0.1271248608827591)","('Supply_Chain_Management', 0.0895565003156662)","('NON-ESG', 0.18962520360946655)","('NON-ESG', 0.1271248608827591)","('NON-ESG', 0.0895565003156662)"
Line 179,"This collaborative innovation platform will  provide services for MedT ech  startups worldwide and  address unmet clinical needs  in China.
","('Access_And_Affordability', 0.3143748342990875)","('Customer_Welfare', 0.11851660907268524)","('Competitive_Behavior', 0.06842289119958878)","('NON-ESG', 0.3143748342990875)","('NON-ESG', 0.11851660907268524)","('NON-ESG', 0.06842289119958878)"
Line 180,"The establishment of a joint  lab on artificial intelligence  (AI) with Shanghai Jiao T ong  University — one of the top  AI research universities in  China.
","('Data_Security', 0.2588750422000885)","('Business_Model_Resilience', 0.10056141763925552)","('Systemic_Risk_Management', 0.076945960521698)","('NON-ESG', 0.2588750422000885)","('NON-ESG', 0.10056141763925552)","('NON-ESG', 0.076945960521698)"
Line 181,"The ultimate aim is  to improve medical device  performance, with the first  year of research focusing   on visualization and   deep learning–based   image processing.
","('Customer_Welfare', 0.15968027710914612)","('Product_Design_And_Lifecycle_Management', 0.11687171459197998)","('Access_And_Affordability', 0.10017992556095123)","('NON-ESG', 0.15968027710914612)","('NON-ESG', 0.11687171459197998)","('NON-ESG', 0.10017992556095123)"
Line 182,"We look for opportunities  to invest in or acquire other  medical technology companies  that offer groundbreaking  healthcare solutions.
","('Energy_Management', 0.14967229962348938)","('Data_Security', 0.14665354788303375)","('Product_Design_And_Lifecycle_Management', 0.14060823619365692)","('NON-ESG', 0.14967229962348938)","('NON-ESG', 0.14665354788303375)","('NON-ESG', 0.14060823619365692)"
Line 183,"Our  total strategic investment and  acquisition spend in FY19 was  $5.49 billion.4 Read more about  our acquisitions.
","('Business_Model_Resilience', 0.5183956027030945)","('Systemic_Risk_Management', 0.19368192553520203)","('Competitive_Behavior', 0.03635860234498978)","(['Codes of Business Conduct'], 0.5183956027030945)","('NON-ESG', 0.19368192553520203)","('NON-ESG', 0.03635860234498978)"
Line 184,"4  Includes acquisitions, additions to property, plant and equipment, and purchases of investment.Focusing on value may  reduce barriers to access by  demonstrating positive impact  and enabling payment for  treatments to be spread over  time, contingent on patient  outcomes.
","('Access_And_Affordability', 0.7776406407356262)","('Customer_Welfare', 0.02500569447875023)","('Product_Quality_And_Safety', 0.02380000613629818)","(['Health Outcome Contribution'], 0.7776406407356262)","('NON-ESG', 0.02500569447875023)","('NON-ESG', 0.02380000613629818)"
Line 185,"This financial model  rewards hospitals for providing  care that results in better  patient outcomes, by focusing  on cost relative to outcomes,  rather than on cost alone.
","('Access_And_Affordability', 0.5542535185813904)","('Energy_Management', 0.06803198158740997)","('Customer_Welfare', 0.04739556461572647)","(['Health Outcome Contribution'], 0.5542535185813904)","('NON-ESG', 0.06803198158740997)","('NON-ESG', 0.04739556461572647)"
Line 186,"Our Global VBHC Council —  comprising leaders from   across our business divisions,  regions, and functions —   steers our approach to   value-based models.Systems take time to  change.
","('Business_Model_Resilience', 0.7499243021011353)","('Systemic_Risk_Management', 0.03326204791665077)","('Director_Removal', 0.02942398563027382)","(['Codes of Business Conduct'], 0.7499243021011353)","('NON-ESG', 0.03326204791665077)","('NON-ESG', 0.02942398563027382)"
Line 187,"We advocate and  collaborate with others to  drive transformation by:  Embedding value- based clinical and  economic standards  into R&D and  commercial processes  Partnering with  providers and payers  using new financial  models for care  accountability   Sharing our learnings  and insights through  respected forums  Work to improve our  products’ efficiency and  effectiveness simultaneously,  to achieve better outcomes  at lower cost  Partner with others to  increase economic value  across global healthcare  systems Value-based healthcare T raditional healthcare models  involve payment by volume of  product or therapy.
","('Competitive_Behavior', 0.21258509159088135)","('Product_Quality_And_Safety', 0.16122440993785858)","('Product_Design_And_Lifecycle_Management', 0.1274527609348297)","('NON-ESG', 0.21258509159088135)","('NON-ESG', 0.16122440993785858)","('NON-ESG', 0.1274527609348297)"
Line 188,"We advocate and  collaborate with others to  drive transformation by:  Embedding value- based clinical and  economic standards  into R&D and  commercial processes  Partnering with  providers and payers  using new financial  models for care  accountability   Sharing our learnings  and insights through  respected forums  Work to improve our  products’ efficiency and  effectiveness simultaneously,  to achieve better outcomes  at lower cost  Partner with others to  increase economic value  across global healthcare  systems Value-based healthcare T raditional healthcare models  involve payment by volume of  product or therapy.
","('Product_Design_And_Lifecycle_Management', 0.3752242624759674)","('Customer_Welfare', 0.12234606593847275)","('Management_Of_Legal_And_Regulatory_Framework', 0.07016469538211823)","('NON-ESG', 0.3752242624759674)","('NON-ESG', 0.12234606593847275)","('NON-ESG', 0.07016469538211823)"
Line 189,"This can  lead to unsustainable healthcare  systems where limited resources  may be spent on ineffective  or expensive treatment.
","('Access_And_Affordability', 0.7631801962852478)","('Employee_Health_And_Safety', 0.028358841314911842)","('Product_Quality_And_Safety', 0.023667586967349052)","(['Health Outcome Contribution'], 0.7631801962852478)","('NON-ESG', 0.028358841314911842)","('NON-ESG', 0.023667586967349052)"
Line 190,"We  continue to advocate for a shift  to value-based healthcare  (VBHC).DEVELOPING  AFFORDABLE,  SUST AINABLE  HEAL THCARE  MODELS Even the most innovative  product is ineffective if it is  unaffordable to the people who  need it.
","('Product_Design_And_Lifecycle_Management', 0.770071804523468)","('Customer_Welfare', 0.050502710044384)","('Access_And_Affordability', 0.029567454010248184)","(['Product Stewardship'], 0.770071804523468)","('NON-ESG', 0.050502710044384)","('NON-ESG', 0.029567454010248184)"
Line 191,"We work to develop new  business models that improve  affordability while advocating  for the adoption of value- based healthcare models.
","('Competitive_Behavior', 0.18457506597042084)","('Customer_Welfare', 0.14223116636276245)","('Access_And_Affordability', 0.10879767686128616)","('NON-ESG', 0.18457506597042084)","('NON-ESG', 0.14223116636276245)","('NON-ESG', 0.10879767686128616)"
Line 192,"We  aim to price our products in a  fair and reasonable manner , in  the context of local healthcare  system structures and  market dynamics.
","('Product_Design_And_Lifecycle_Management', 0.5982909202575684)","('Selling_Practices_And_Product_Labeling', 0.09748319536447525)","('Customer_Welfare', 0.08538790047168732)","(['Product Stewardship'], 0.5982909202575684)","('NON-ESG', 0.09748319536447525)","('NON-ESG', 0.08538790047168732)"
Line 193,"T o increase  affordability and value, we:  Offer a variety of pricing  models, including volume  pricing or rebate options   for hospitals, adaptive   pricing for treating long-  term conditions, and  programs to assist new   and existing patients5  Based on combined data from studies of high-risk patients.CASE STUDY MAXIMIZING THE VALUE OF OUR PRODUCTS   BY EXPLORING NEW APPLICA TIONS   Cardiac implantable electronic devices (CIEDs) —  including implantable defibrillators and pacemakers  — can be lifesaving for people with chronic heart  conditions.
","('Product_Design_And_Lifecycle_Management', 0.7221754193305969)","('Customer_Welfare', 0.07924097776412964)","('Competitive_Behavior', 0.03431972116231918)","(['Product Stewardship'], 0.7221754193305969)","('NON-ESG', 0.07924097776412964)","('NON-ESG', 0.03431972116231918)"
Line 194,"T o increase  affordability and value, we:  Offer a variety of pricing  models, including volume  pricing or rebate options   for hospitals, adaptive   pricing for treating long-  term conditions, and  programs to assist new   and existing patients5  Based on combined data from studies of high-risk patients.CASE STUDY MAXIMIZING THE VALUE OF OUR PRODUCTS   BY EXPLORING NEW APPLICA TIONS   Cardiac implantable electronic devices (CIEDs) —  including implantable defibrillators and pacemakers  — can be lifesaving for people with chronic heart  conditions.
","('Employee_Health_And_Safety', 0.3291803300380707)","('Critical_Incident_Risk_Management', 0.107900470495224)","('Product_Quality_And_Safety', 0.059618253260850906)","('NON-ESG', 0.3291803300380707)","('NON-ESG', 0.107900470495224)","('NON-ESG', 0.059618253260850906)"
Line 195,"But infections occur in 1% to 4% of all CIED  implantations, leading to a higher risk of mortality and  increased treatment costs.
","('Employee_Health_And_Safety', 0.5994825959205627)","('Access_And_Affordability', 0.0665363222360611)","('Product_Quality_And_Safety', 0.054677315056324005)","(['Operational Eco-Efficiency'], 0.5994825959205627)","('NON-ESG', 0.0665363222360611)","('NON-ESG', 0.054677315056324005)"
Line 196,"The Medtronic TYRX™ Absorbable Antibacterial  Envelope is the only fully absorbable antibacterial  envelope available for CIEDs. It contains two powerful  antibiotics and has been shown to reduce infection by  70% to 100% in high-risk patients.
","('Employee_Health_And_Safety', 0.1662808656692505)","('Product_Quality_And_Safety', 0.11039792001247406)","('Access_And_Affordability', 0.1053035631775856)","('NON-ESG', 0.1662808656692505)","('NON-ESG', 0.11039792001247406)","('NON-ESG', 0.1053035631775856)"
Line 197,"As of FY19, it is available in 55 countries, with more than   350,000 patients treated worldwide and projected net  savings of $507 per patient.5    In addition to CIEDs, the TYRX Envelope is cleared for   use with implantable neurostimulators, and we are  exploring additional applications for the technology,  which would enable access to its benefits in a wider range  of clinical settings.T ransforming   healthcare systems T reating patients in need is  the priority for any healthcare  system.
","('Access_And_Affordability', 0.7662251591682434)","('Customer_Welfare', 0.02982424944639206)","('Critical_Incident_Risk_Management', 0.019733333960175514)","(['Health Outcome Contribution'], 0.7662251591682434)","('NON-ESG', 0.02982424944639206)","('NON-ESG', 0.019733333960175514)"
Line 198,"In the midst of everyday  healthcare delivery, it can be  challenging for providers to  focus on improving value,  access, and quality.
","('Access_And_Affordability', 0.9043919444084167)","('Human_Rights_And_Community_Relations', 0.00858558714389801)","('Product_Quality_And_Safety', 0.008479677140712738)","(['Health Outcome Contribution'], 0.9043919444084167)","('NON-ESG', 0.00858558714389801)","('NON-ESG', 0.008479677140712738)"
Line 199,"Medtronic Integrated Health  Solutions (IHS) helps optimize  clinical and operational  processes at healthcare  facilities to improve hospital  efficiency and patient access  to care.
","('Access_And_Affordability', 0.3546876907348633)","('Energy_Management', 0.2501617968082428)","('Customer_Welfare', 0.0817357748746872)","('NON-ESG', 0.3546876907348633)","('NON-ESG', 0.2501617968082428)","('NON-ESG', 0.0817357748746872)"
Line 200,"Our value-based healthcare  partnership programs enable  practitioners at healthcare  systems and payers to apply  the right Medtronic therapy  to the right patients at the  right time.
","('Access_And_Affordability', 0.7981740236282349)","('Customer_Welfare', 0.024331308901309967)","('Energy_Management', 0.022243857383728027)","(['Health Outcome Contribution'], 0.7981740236282349)","('NON-ESG', 0.024331308901309967)","('NON-ESG', 0.022243857383728027)"
Line 201,"These programs  enable care to be delivered for  reduced cost, in a consistent  and accountable way.
","('Access_And_Affordability', 0.8689064383506775)","('Energy_Management', 0.012854021973907948)","('Critical_Incident_Risk_Management', 0.010801124386489391)","(['Health Outcome Contribution'], 0.8689064383506775)","('NON-ESG', 0.012854021973907948)","('NON-ESG', 0.010801124386489391)"
Line 202,"EXPANDING  GLOBAL  HEAL THCARE  ACCESSIBILITY  AND AVAILABILITY T oo many people lack access to  prevention and treatment for  noncommunicable diseases.
","('Access_And_Affordability', 0.8447359204292297)","('Product_Quality_And_Safety', 0.028481073677539825)","('Employee_Health_And_Safety', 0.01860511489212513)","(['Health Outcome Contribution'], 0.8447359204292297)","('NON-ESG', 0.028481073677539825)","('NON-ESG', 0.01860511489212513)"
Line 203,"We constantly look for novel  solutions to expand availability  and access to our products  and services in underserved  communities.
","('Access_And_Affordability', 0.9459165930747986)","('Critical_Incident_Risk_Management', 0.005286841187626123)","('Human_Rights_And_Community_Relations', 0.0044428943656384945)","(['Health Outcome Contribution'], 0.9459165930747986)","('NON-ESG', 0.005286841187626123)","('NON-ESG', 0.0044428943656384945)"
Line 204,"Our range  of programs and strategic  partnerships continue to evolve  as we learn more about local  needs and barriers.
","('Human_Rights_And_Community_Relations', 0.8486669063568115)","('Access_And_Affordability', 0.03545340523123741)","('Employee_Engagement_Inclusion_And_Diversity', 0.014825941063463688)","(['Community Relations'], 0.8486669063568115)","('NON-ESG', 0.03545340523123741)","('NON-ESG', 0.014825941063463688)"
Line 205,"Our focus on  value-based, patient-centered  solutions helps us to reimagine  healthcare delivery.
","('Business_Model_Resilience', 0.21871821582317352)","('Product_Design_And_Lifecycle_Management', 0.20228837430477142)","('Supply_Chain_Management', 0.08529592305421829)","('NON-ESG', 0.21871821582317352)","('NON-ESG', 0.20228837430477142)","('NON-ESG', 0.08529592305421829)"
Line 206,"CASE STUDY REDUCING WAIT TIMES FOR CARDIAC PA TIENTS  AWAITING CA THETERIZA TION Eastern Health, the largest regional health authority in  Newfoundland and Labrador , Canada, operates the province’s   only cardiac catheter lab.
","('Access_And_Affordability', 0.18933391571044922)","('Employee_Health_And_Safety', 0.18058466911315918)","('Critical_Incident_Risk_Management', 0.12689702212810516)","('NON-ESG', 0.18933391571044922)","('NON-ESG', 0.18058466911315918)","('NON-ESG', 0.12689702212810516)"
Line 207,"Many patients with heart conditions  requiring catheterization must travel long distances to get there,  sometimes by air ambulance.
","('Employee_Health_And_Safety', 0.31638672947883606)","('Critical_Incident_Risk_Management', 0.23407946527004242)","('Access_And_Affordability', 0.1381162405014038)","('NON-ESG', 0.31638672947883606)","('NON-ESG', 0.23407946527004242)","('NON-ESG', 0.1381162405014038)"
Line 208,"Until recently, difficulties with scheduling and utilization frequently  led to lengthy wait times for patients and uncertainty over when  they would have their procedures.
","('Access_And_Affordability', 0.1101050078868866)","('Management_Of_Legal_And_Regulatory_Framework', 0.10014278441667557)","('Employee_Health_And_Safety', 0.09803116321563721)","('NON-ESG', 0.1101050078868866)","('NON-ESG', 0.10014278441667557)","('NON-ESG', 0.09803116321563721)"
Line 209,"The impact was felt across the  province, as patients waiting for catheterization took up beds in  other hospitals.
","('Access_And_Affordability', 0.5653785467147827)","('Employee_Health_And_Safety', 0.07565946877002716)","('Critical_Incident_Risk_Management', 0.04243046045303345)","(['Health Outcome Contribution'], 0.5653785467147827)","('NON-ESG', 0.07565946877002716)","('NON-ESG', 0.04243046045303345)"
Line 210,"In December 2017, Eastern Health began a collaboration with  Medtronic IHS with the aim of developing a workable long-term  solution to wait times.
","('Energy_Management', 0.14028701186180115)","('Access_And_Affordability', 0.12619800865650177)","('Customer_Welfare', 0.11775490641593933)","('NON-ESG', 0.14028701186180115)","('NON-ESG', 0.12619800865650177)","('NON-ESG', 0.11775490641593933)"
Line 211,"Following a review of issues and goals,  development of an improvement framework, and work on internal  culture, Eastern Health launched a new strategy in October 2018.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3430134057998657)","('Human_Rights_And_Community_Relations', 0.24575501680374146)","('Access_And_Affordability', 0.056784674525260925)","('NON-ESG', 0.3430134057998657)","('NON-ESG', 0.24575501680374146)","('NON-ESG', 0.056784674525260925)"
Line 212,"The effects became evident within weeks:  By the end of the year , utilization in the catheter lab had   increased by 37%.
","('Access_And_Affordability', 0.5609527230262756)","('Customer_Welfare', 0.048726052045822144)","('Employee_Health_And_Safety', 0.042010411620140076)","(['Health Outcome Contribution'], 0.5609527230262756)","('NON-ESG', 0.048726052045822144)","('NON-ESG', 0.042010411620140076)"
Line 213,"By March 2019, the outpatient waitlist had been reduced by 15%.
","('Access_And_Affordability', 0.3863898515701294)","('Management_Of_Legal_And_Regulatory_Framework', 0.10755817592144012)","('Systemic_Risk_Management', 0.04520923271775246)","('NON-ESG', 0.3863898515701294)","('NON-ESG', 0.10755817592144012)","('NON-ESG', 0.04520923271775246)"
Line 214,"In January 2019, the province-wide average wait time from date  of acceptance to date of procedure was down by an average of  56.5% (compared with FY18).CASE STUDY ENABLING EFFICIENT RESPONSES   TO CARDIAC EMERGENCIES Tijuana, Mexico, has a population of more than 1.6 million people —  most of whom are not covered by insurance.
","('Critical_Incident_Risk_Management', 0.9133495688438416)","('Employee_Health_And_Safety', 0.02026021108031273)","('Physical_Impacts_Of_Climate_Change', 0.009839929640293121)","(['Risk & Crisis Management'], 0.9133495688438416)","('NON-ESG', 0.02026021108031273)","('NON-ESG', 0.009839929640293121)"
Line 215,"As a result, the Red   Cross responds to 98% of emergency calls.
","('Critical_Incident_Risk_Management', 0.9732064008712769)","('Air_Quality', 0.0028376192785799503)","('Access_And_Affordability', 0.002355907578021288)","(['Risk & Crisis Management'], 0.9732064008712769)","('NON-ESG', 0.0028376192785799503)","('NON-ESG', 0.002355907578021288)"
Line 216,"Around 3,000 calls   each year relate to brain and heart diseases.
","('Employee_Health_And_Safety', 0.22642119228839874)","('Access_And_Affordability', 0.15473683178424835)","('Employee_Engagement_Inclusion_And_Diversity', 0.06536941230297089)","('NON-ESG', 0.22642119228839874)","('NON-ESG', 0.15473683178424835)","('NON-ESG', 0.06536941230297089)"
Line 217,"T o increase treatment  capacity and facilitate efficient response to these calls, Medtronic   IHS partnered with the Red Cross to:  Open a state-of-the-art catheter lab  Equip 13 ambulances with Cardiac Alert — a fast-track   assessment tool that ensures a diagnosis is available by the time   the patient arrives for treatment  T rain 120 paramedics and 13 other staff members to use   Cardiac Alert  chronic, co-morbid conditions.
","('Employee_Health_And_Safety', 0.40980759263038635)","('Critical_Incident_Risk_Management', 0.21527646481990814)","('Access_And_Affordability', 0.080382339656353)","('NON-ESG', 0.40980759263038635)","('NON-ESG', 0.21527646481990814)","('NON-ESG', 0.080382339656353)"
Line 218,"MCMS programs combine care  management services and  patient engagement solutions  with data analytics and reporting:  Care management services  MCMS disease management  programs, clinical decision  support technology, and  patient outreach services  help escalate at-risk patients.
","('Access_And_Affordability', 0.7670267224311829)","('Customer_Welfare', 0.03033367171883583)","('Critical_Incident_Risk_Management', 0.018883462995290756)","(['Health Outcome Contribution'], 0.7670267224311829)","('NON-ESG', 0.03033367171883583)","('NON-ESG', 0.018883462995290756)"
Line 219,"These tools support  healthcare professionals,  payers, and post-acute care  providers to make stronger  clinical decisions.
","('Access_And_Affordability', 0.5120043158531189)","('Customer_Welfare', 0.10955039411783218)","('Energy_Management', 0.0380435585975647)","(['Health Outcome Contribution'], 0.5120043158531189)","('NON-ESG', 0.10955039411783218)","('NON-ESG', 0.0380435585975647)"
Line 220,"Patient engagement  solutions   Patient platforms, disease  management programs,   and biometric peripheral  devices help to optimize  patient experience,  supporting individuals to stay  engaged in the program and  securely share their health  information daily.
","('Customer_Privacy', 0.3340202867984772)","('Access_And_Affordability', 0.18266582489013672)","('Data_Security', 0.049652501940727234)","('NON-ESG', 0.3340202867984772)","('NON-ESG', 0.18266582489013672)","('NON-ESG', 0.049652501940727234)"
Line 221,"Harnessing automation  and connectivity Much of the care for patients  with complex, chronic,   co-morbid conditions happens  outside of the hospital setting.
","('Access_And_Affordability', 0.5369139909744263)","('Employee_Health_And_Safety', 0.1890210211277008)","('Critical_Incident_Risk_Management', 0.04689163714647293)","(['Health Outcome Contribution'], 0.5369139909744263)","('NON-ESG', 0.1890210211277008)","('NON-ESG', 0.04689163714647293)"
Line 222,"The increasing use of   connected devices to monitor  health is enabling access to   near real-time patient data  through remote monitoring,  wearables, and telehealth.
","('Customer_Privacy', 0.22377650439739227)","('Access_And_Affordability', 0.13633868098258972)","('Critical_Incident_Risk_Management', 0.12534594535827637)","('NON-ESG', 0.22377650439739227)","('NON-ESG', 0.13633868098258972)","('NON-ESG', 0.12534594535827637)"
Line 223,"Because of its ability to   improve patient outcomes and  reduce administrative costs,  connected health is likely to   play a significant role in  increasing the value of future  healthcare models.
","('Access_And_Affordability', 0.6379088163375854)","('Employee_Health_And_Safety', 0.10808613896369934)","('Customer_Welfare', 0.02781665325164795)","(['Health Outcome Contribution'], 0.6379088163375854)","('NON-ESG', 0.10808613896369934)","('NON-ESG', 0.02781665325164795)"
Line 224,"Medtronic Care Management  Services (MCMS) works with  health systems, post-acute  care providers, and health plans  to provide remote monitoring  and care management services  for patients with complex,  Data analytics   and reporting   Advanced data analytics  support healthcare  professionals to assess  patient cohorts, discover  insights about at-risk  patients, and act faster on  potential health risks.
","('Access_And_Affordability', 0.48912081122398376)","('Employee_Health_And_Safety', 0.09458102285861969)","('Critical_Incident_Risk_Management', 0.09197819977998734)","('NON-ESG', 0.48912081122398376)","('NON-ESG', 0.09458102285861969)","('NON-ESG', 0.09197819977998734)"
Line 225,"These programs are designed  to help patients get involved  in their care at home and  support provider care teams to  monitor patient health data and  intervene if needed.
","('Access_And_Affordability', 0.6939115524291992)","('Employee_Health_And_Safety', 0.07480743527412415)","('Critical_Incident_Risk_Management', 0.025151602923870087)","(['Health Outcome Contribution'], 0.6939115524291992)","('NON-ESG', 0.07480743527412415)","('NON-ESG', 0.025151602923870087)"
Line 226,"MCMS has a strong legacy   of more than 20 years in  telehealth.
","('Access_And_Affordability', 0.22998373210430145)","('Management_Of_Legal_And_Regulatory_Framework', 0.15469811856746674)","('Employee_Engagement_Inclusion_And_Diversity', 0.05333651602268219)","('NON-ESG', 0.22998373210430145)","('NON-ESG', 0.15469811856746674)","('NON-ESG', 0.05333651602268219)"
Line 227,"During this time,   the MCMS team has spent   7 million telehealth months  monitoring health data,  interacting with patients, and  supporting care teams in clinical  decision-making.Operating in resource- constrained regions Lack of resources and  connectivity are often barriers to  effective, sustainable healthcare  systems.
","('Access_And_Affordability', 0.392528235912323)","('Supply_Chain_Management', 0.1323758214712143)","('Customer_Welfare', 0.06974941492080688)","('NON-ESG', 0.392528235912323)","('NON-ESG', 0.1323758214712143)","('NON-ESG', 0.06974941492080688)"
Line 228,"Our hub-and-spoke  model offers a solution.
","('Business_Model_Resilience', 0.1866777241230011)","('Product_Design_And_Lifecycle_Management', 0.136014923453331)","('Systemic_Risk_Management', 0.10905960947275162)","('NON-ESG', 0.1866777241230011)","('NON-ESG', 0.136014923453331)","('NON-ESG', 0.10905960947275162)"
Line 229,"A  state-of-the-art hospital (the  hub) connects with healthcare  centers in surrounding  communities to create a well- defined patient pathway (the  spokes).
","('Access_And_Affordability', 0.7123278975486755)","('Critical_Incident_Risk_Management', 0.042851150035858154)","('Customer_Welfare', 0.02908928133547306)","(['Health Outcome Contribution'], 0.7123278975486755)","('NON-ESG', 0.042851150035858154)","('NON-ESG', 0.02908928133547306)"
Line 230,"A coordinated care  approach enables convenient  access to diagnostics and  referrals through the spokes,  with highly complex treatments  and procedures available at the  hub when needed.
","('Access_And_Affordability', 0.7401959896087646)","('Customer_Welfare', 0.03676695376634598)","('Product_Quality_And_Safety', 0.0315147340297699)","(['Health Outcome Contribution'], 0.7401959896087646)","('NON-ESG', 0.03676695376634598)","('NON-ESG', 0.0315147340297699)"
Line 231,"30Reaching underserved populations Healthcare needs are complex for people living with chronic  conditions such as hypertension and diabetes.
","('Access_And_Affordability', 0.9343207478523254)","('Critical_Incident_Risk_Management', 0.006922785192728043)","('Employee_Health_And_Safety', 0.006078215781599283)","(['Health Outcome Contribution'], 0.9343207478523254)","('NON-ESG', 0.006922785192728043)","('NON-ESG', 0.006078215781599283)"
Line 232,"Limited access to  appropriate care compounds these challenges.
","('Access_And_Affordability', 0.865805983543396)","('Employee_Health_And_Safety', 0.020186515524983406)","('Critical_Incident_Risk_Management', 0.014673654921352863)","(['Health Outcome Contribution'], 0.865805983543396)","('NON-ESG', 0.020186515524983406)","('NON-ESG', 0.014673654921352863)"
Line 233,"Medtronic Labs  works to expand access to healthcare for underserved patients,  families, and communities across the world, with a focus on financially  sustainable solutions that maximize social impact.
","('Access_And_Affordability', 0.9465020298957825)","('Critical_Incident_Risk_Management', 0.005640250165015459)","('Human_Rights_And_Community_Relations', 0.005181454122066498)","(['Health Outcome Contribution'], 0.9465020298957825)","('NON-ESG', 0.005640250165015459)","('NON-ESG', 0.005181454122066498)"
Line 234,"Medtronic Labs designs healthcare delivery models that integrate  digital and product technologies across the care continuum.
","('Product_Design_And_Lifecycle_Management', 0.8728148937225342)","('Customer_Welfare', 0.027688033878803253)","('Business_Model_Resilience', 0.014402900822460651)","(['Product Stewardship'], 0.8728148937225342)","('NON-ESG', 0.027688033878803253)","('NON-ESG', 0.014402900822460651)"
Line 235,"Partnerships — with local technology entrepreneurs, healthcare  providers, NGOs, governments, and other stakeholders — amplify  impact and scale.
","('Human_Rights_And_Community_Relations', 0.37506935000419617)","('Access_And_Affordability', 0.30120307207107544)","('Management_Of_Legal_And_Regulatory_Framework', 0.08851894736289978)","('NON-ESG', 0.37506935000419617)","('NON-ESG', 0.30120307207107544)","('NON-ESG', 0.08851894736289978)"
Line 236,"Medtronic Labs’ solutions are built upon five principles:   Design with and for communities to address local barriers across  the care continuum   Employ evidence-based practices and protocols for  uncompromised clinical excellence   Address the social determinants at the root of poor health  Integrate digital and product technologies for high-tech,   high-touch models of care  Innovate operational models that enable efficiency at scale 3031support, and timely referrals.
","('Access_And_Affordability', 0.37206825613975525)","('Human_Rights_And_Community_Relations', 0.2152595967054367)","('Employee_Health_And_Safety', 0.05425602197647095)","('NON-ESG', 0.37206825613975525)","('NON-ESG', 0.2152595967054367)","('NON-ESG', 0.05425602197647095)"
Line 237,"Location: Kenya Prerna — a comprehensive  healthcare delivery model for  people living with, or at risk of,  T ype 2 diabetes, hypertension,  and co-morbid diseases.
","('Access_And_Affordability', 0.4095412492752075)","('Employee_Health_And_Safety', 0.17701375484466553)","('Product_Quality_And_Safety', 0.06111307069659233)","('NON-ESG', 0.4095412492752075)","('NON-ESG', 0.17701375484466553)","('NON-ESG', 0.06111307069659233)"
Line 238,"The model integrates social  and clinical interventions in a  group-based setting, close to  home.
","('Access_And_Affordability', 0.6578489542007446)","('Human_Rights_And_Community_Relations', 0.1475629210472107)","('Employee_Engagement_Inclusion_And_Diversity', 0.027227723971009254)","(['Health Outcome Contribution'], 0.6578489542007446)","('NON-ESG', 0.1475629210472107)","('NON-ESG', 0.027227723971009254)"
Line 239,"Once enrolled, Prerna  patients have access to point- of-care lab testing, doctor  visits, medication, education,  and behavioral coaching.
","('Access_And_Affordability', 0.8847006559371948)","('Product_Quality_And_Safety', 0.011866849847137928)","('Employee_Engagement_Inclusion_And_Diversity', 0.01149834506213665)","(['Health Outcome Contribution'], 0.8847006559371948)","('NON-ESG', 0.011866849847137928)","('NON-ESG', 0.01149834506213665)"
Line 240,"This  provides everything they need  to live with their condition for  the long term, in the comfort  of their own community.
","('Access_And_Affordability', 0.7052398324012756)","('Human_Rights_And_Community_Relations', 0.10895385593175888)","('Employee_Health_And_Safety', 0.026381678879261017)","(['Health Outcome Contribution'], 0.7052398324012756)","('NON-ESG', 0.10895385593175888)","('NON-ESG', 0.026381678879261017)"
Line 241,"Location: Indiaaids integrated with a digital  application for remote fitting  and tele-audiology.
","('Energy_Management', 0.3593580424785614)","('Data_Security', 0.12650932371616364)","('Management_Of_Legal_And_Regulatory_Framework', 0.07956134527921677)","('NON-ESG', 0.3593580424785614)","('NON-ESG', 0.12650932371616364)","('NON-ESG', 0.07956134527921677)"
Line 242,"With this  integrated offering, Shruti  patients receive comprehensive  community-based diagnosis for  ear diseases and hearing loss,  with targeted referrals to our  network of affordable therapies.
","('Employee_Health_And_Safety', 0.36648479104042053)","('Access_And_Affordability', 0.2350345253944397)","('Employee_Engagement_Inclusion_And_Diversity', 0.10243227332830429)","('NON-ESG', 0.36648479104042053)","('NON-ESG', 0.2350345253944397)","('NON-ESG', 0.10243227332830429)"
Line 243,"Pilot programs Maisha Mapya6 — an expansion  of the Empower Health model  that aims to manage and  mitigate complications during  the antenatal and postpartum  time periods for low- and high- risk pregnant women.
","('Employee_Health_And_Safety', 0.796013593673706)","('Access_And_Affordability', 0.042906731367111206)","('Employee_Engagement_Inclusion_And_Diversity', 0.025798195973038673)","(['Operational Eco-Efficiency'], 0.796013593673706)","('NON-ESG', 0.042906731367111206)","('NON-ESG', 0.025798195973038673)"
Line 244,"Maisha  Mapya provides patients and  clinicians with ongoing risk  assessment, home-based  visibility of health status, and  access to education, community Kenyan Ministry of Health and  county governments lead  on program oversight and  community engagement.
","('Access_And_Affordability', 0.9140116572380066)","('Employee_Health_And_Safety', 0.00970474909991026)","('Critical_Incident_Risk_Management', 0.009130637161433697)","(['Health Outcome Contribution'], 0.9140116572380066)","('NON-ESG', 0.00970474909991026)","('NON-ESG', 0.009130637161433697)"
Line 245,"Shruti — a program to address  ear diseases and hearing loss  in underserved populations.
","('Access_And_Affordability', 0.9019829034805298)","('Employee_Health_And_Safety', 0.012650146149098873)","('Product_Quality_And_Safety', 0.01081228069961071)","(['Health Outcome Contribution'], 0.9019829034805298)","('NON-ESG', 0.012650146149098873)","('NON-ESG', 0.01081228069961071)"
Line 246,"Shruti utilizes a community  health worker–based service  model, enabled by point-of-care  diagnostics, hearing implants,  and digital tools.
","('Employee_Health_And_Safety', 0.7603926658630371)","('Access_And_Affordability', 0.09844844043254852)","('Product_Quality_And_Safety', 0.020993931218981743)","(['Operational Eco-Efficiency'], 0.7603926658630371)","('NON-ESG', 0.09844844043254852)","('NON-ESG', 0.020993931218981743)"
Line 247,"Location: Bangladesh and India FY19 Highlight: In partnership  with hearing aid manufacturer  Sivantos, Medtronic Labs  launched a service that provides  affordable hearing care.
","('Employee_Health_And_Safety', 0.3989773392677307)","('Access_And_Affordability', 0.12098199129104614)","('Employee_Engagement_Inclusion_And_Diversity', 0.08816099911928177)","('NON-ESG', 0.3989773392677307)","('NON-ESG', 0.12098199129104614)","('NON-ESG', 0.08816099911928177)"
Line 248,"The  Sivantos technology includes  high-quality, affordable hearing Current Medtronic Labs’  programs include:  Empower Health —   a technology-enabled model of  care that allows clinicians and  providers to manage a cohort  of hypertensive or diabetic  patients remotely.
","('Access_And_Affordability', 0.5633001923561096)","('Customer_Welfare', 0.09084110707044601)","('Product_Quality_And_Safety', 0.0381813645362854)","(['Health Outcome Contribution'], 0.5633001923561096)","('NON-ESG', 0.09084110707044601)","('NON-ESG', 0.0381813645362854)"
Line 249,"Empower  Health extends the reach of  the health system directly into  the community, improving the  efficiency and effectiveness   of care.
","('Access_And_Affordability', 0.8096323609352112)","('Human_Rights_And_Community_Relations', 0.026351841166615486)","('Employee_Health_And_Safety', 0.025712186470627785)","(['Health Outcome Contribution'], 0.8096323609352112)","('NON-ESG', 0.026351841166615486)","('NON-ESG', 0.025712186470627785)"
Line 250,"Location: Ghana and Kenya FY19 Highlight: In April 2019,  Medtronic Labs launched  Afya Dumu, a public-private  partnership in Kenya.
","('Access_And_Affordability', 0.3304918110370636)","('Management_Of_Legal_And_Regulatory_Framework', 0.11243584007024765)","('Systemic_Risk_Management', 0.053827088326215744)","('NON-ESG', 0.3304918110370636)","('NON-ESG', 0.11243584007024765)","('NON-ESG', 0.053827088326215744)"
Line 251,"The  project leverages the Empower  Health technology and model  of care to manage large cohorts  of patients.
","('Access_And_Affordability', 0.7810367345809937)","('Critical_Incident_Risk_Management', 0.020622849464416504)","('Customer_Welfare', 0.020245512947440147)","(['Health Outcome Contribution'], 0.7810367345809937)","('NON-ESG', 0.020622849464416504)","('NON-ESG', 0.020245512947440147)"
Line 252,"It aims to improve  patient outcomes and reduce  county health system costs.
","('Access_And_Affordability', 0.7013623118400574)","('Employee_Health_And_Safety', 0.10462561249732971)","('Critical_Incident_Risk_Management', 0.031677067279815674)","(['Health Outcome Contribution'], 0.7013623118400574)","('NON-ESG', 0.10462561249732971)","('NON-ESG', 0.031677067279815674)"
Line 253,"Novartis Social Business  provides affordable medications,  and Management Sciences for  Health delivers health system-  strengthening activities.
","('Access_And_Affordability', 0.7977022528648376)","('Human_Rights_And_Community_Relations', 0.025189325213432312)","('Employee_Health_And_Safety', 0.02339613065123558)","(['Health Outcome Contribution'], 0.7977022528648376)","('NON-ESG', 0.025189325213432312)","('NON-ESG', 0.02339613065123558)"
Line 254,"The MEDTRONIC LABS  IMPACT TO DA TE650,patients  screened 16,500+   patients with better clinical and social outcomes  400+ health workers  trained 65   operational sites throughout   India, Ghana, and Kenya  6  With funding from Gates Grand Challenges.Advocating for   increased access We engage with governments  and other organizations to  advocate for improved access  to essential treatment by  removing barriers and creating  opportunities.
","('Access_And_Affordability', 0.9077568054199219)","('Product_Quality_And_Safety', 0.009861676953732967)","('Human_Rights_And_Community_Relations', 0.007009448017925024)","(['Health Outcome Contribution'], 0.9077568054199219)","('NON-ESG', 0.009861676953732967)","('NON-ESG', 0.007009448017925024)"
Line 255,"For example, for  the past three years we have  been working in Chile to expand  access to deep brain stimulation  (DBS) — a treatment for  conditions such as Parkinson’s  and dystonia.
","('Access_And_Affordability', 0.2858876585960388)","('Employee_Health_And_Safety', 0.15249592065811157)","('Employee_Engagement_Inclusion_And_Diversity', 0.09043573588132858)","('NON-ESG', 0.2858876585960388)","('NON-ESG', 0.15249592065811157)","('NON-ESG', 0.09043573588132858)"
Line 256,"Chile had no short- or long-term  financial coverage for DBS, as  well as a limited provision and  lack of awareness of treatment  options.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3017931580543518)","('Access_And_Affordability', 0.29558008909225464)","('Systemic_Risk_Management', 0.11095412820577621)","('NON-ESG', 0.3017931580543518)","('NON-ESG', 0.29558008909225464)","('NON-ESG', 0.11095412820577621)"
Line 257,"We undertook  sustained engagement  and partnership with key  stakeholders — including  developing an awareness- raising campaign and a financial  support program for patients.
","('Access_And_Affordability', 0.7304884791374207)","('Human_Rights_And_Community_Relations', 0.06787943094968796)","('Employee_Health_And_Safety', 0.03298212215304375)","(['Health Outcome Contribution'], 0.7304884791374207)","('NON-ESG', 0.06787943094968796)","('NON-ESG', 0.03298212215304375)"
Line 258,"In FY19, for example, we began  providing patients with access  to lifesaving dialysis treatment  through our new partnership  with Angelica Medical Suppliers  and the Kenyan government.
","('Access_And_Affordability', 0.886344850063324)","('Employee_Health_And_Safety', 0.01155769545584917)","('Product_Quality_And_Safety', 0.010789649561047554)","(['Health Outcome Contribution'], 0.886344850063324)","('NON-ESG', 0.01155769545584917)","('NON-ESG', 0.010789649561047554)"
Line 259,"Before the partnership, Kenya  had just two dialysis clinics, both  in Nairobi — a two-day drive  from some regions.
","('Access_And_Affordability', 0.556441068649292)","('Employee_Health_And_Safety', 0.05650685727596283)","('Customer_Welfare', 0.047318488359451294)","(['Health Outcome Contribution'], 0.556441068649292)","('NON-ESG', 0.05650685727596283)","('NON-ESG', 0.047318488359451294)"
Line 260,"In a country  where 30% of the population  lives on less than $2 per day,  the $90 cost of each session is  prohibitive for many.
","('Access_And_Affordability', 0.3413507044315338)","('Energy_Management', 0.15626969933509827)","('Labor_Practices', 0.09223482012748718)","('NON-ESG', 0.3413507044315338)","('NON-ESG', 0.15626969933509827)","('NON-ESG', 0.09223482012748718)"
Line 261,"Through the partnership,  Angelica set up 25 dialysis  clinics at county hospitals, while  Medtronic provided training  to more than 400 nurses and  60 biomedical engineers.
","('Access_And_Affordability', 0.6281745433807373)","('Employee_Engagement_Inclusion_And_Diversity', 0.06032347306609154)","('Employee_Health_And_Safety', 0.03898366913199425)","(['Health Outcome Contribution'], 0.6281745433807373)","('NON-ESG', 0.06032347306609154)","('NON-ESG', 0.03898366913199425)"
Line 262,"The  Kenyan government is funding  the cost of equipment over  time, based on measurable  performance.
","('Energy_Management', 0.5579366087913513)","('Management_Of_Legal_And_Regulatory_Framework', 0.25329259037971497)","('Supply_Chain_Management', 0.022198297083377838)","(['Operational Eco-Efficiency'], 0.5579366087913513)","('NON-ESG', 0.25329259037971497)","('NON-ESG', 0.022198297083377838)"
Line 263,"This affordable,  sustainable solution offers new  hope for people suffering with  renal disease who previously had  limited access to care.
","('Access_And_Affordability', 0.9295653700828552)","('Product_Quality_And_Safety', 0.00783586222678423)","('Critical_Incident_Risk_Management', 0.006223012693226337)","(['Health Outcome Contribution'], 0.9295653700828552)","('NON-ESG', 0.00783586222678423)","('NON-ESG', 0.006223012693226337)"
Line 264,"PARTNERSHIPS  AND ADVOCACY   TO ACCELERA TE  CHANGE Public-Private  Partnerships Public-Private Partnerships  (PPP) offer significant  opportunities to increase  patient access to our products  and services in new markets.
","('Access_And_Affordability', 0.6028226017951965)","('Customer_Welfare', 0.07292759418487549)","('Selling_Practices_And_Product_Labeling', 0.05473526194691658)","(['Health Outcome Contribution'], 0.6028226017951965)","('NON-ESG', 0.07292759418487549)","('NON-ESG', 0.05473526194691658)"
Line 265,"Guided by the Medtronic PPP  council, we actively pursue  partnerships around the world  that address gaps in healthcare.
","('Access_And_Affordability', 0.6693275570869446)","('Human_Rights_And_Community_Relations', 0.04461483284831047)","('Employee_Engagement_Inclusion_And_Diversity', 0.025518594309687614)","(['Health Outcome Contribution'], 0.6693275570869446)","('NON-ESG', 0.04461483284831047)","('NON-ESG', 0.025518594309687614)"
Line 266,"These PPPs tend to be longer- term contracts that enable us  to create sustainable, scalable  projects and programs in four  key areas:  R&D  Manufacturing  Clinical training and education  Health system strengthening      Working within   local contexts Using our Patient Access  Acceleration (PAA) approach,  we quantify treatment needs  in a specific location before  formulating strategies to  tackle barriers to access.
","('Access_And_Affordability', 0.8461122512817383)","('Customer_Welfare', 0.015354009345173836)","('Product_Quality_And_Safety', 0.014684335328638554)","(['Health Outcome Contribution'], 0.8461122512817383)","('NON-ESG', 0.015354009345173836)","('NON-ESG', 0.014684335328638554)"
Line 267,"By combining data from  thousands of PAA assessments,  we improve planning and  reduce risks associated with  future investments in market  development.
","('Systemic_Risk_Management', 0.866217315196991)","('Business_Model_Resilience', 0.05082383379340172)","('Physical_Impacts_Of_Climate_Change', 0.010053806938230991)","(['Risk & Crisis Management'], 0.866217315196991)","('NON-ESG', 0.05082383379340172)","('NON-ESG', 0.010053806938230991)"
Line 268,"We partner with hospitals  around the world to deliver  our Patient Access Insights  (PAI) consulting service.
","('Access_And_Affordability', 0.7926267385482788)","('Energy_Management', 0.020995158702135086)","('Customer_Welfare', 0.019792795181274414)","(['Health Outcome Contribution'], 0.7926267385482788)","('NON-ESG', 0.020995158702135086)","('NON-ESG', 0.019792795181274414)"
Line 269,"PAI  identifies local needs and  barriers to access, informing  the development of appropriate  solutions.
","('Access_And_Affordability', 0.8088845014572144)","('Human_Rights_And_Community_Relations', 0.05286945402622223)","('Employee_Engagement_Inclusion_And_Diversity', 0.011968797072768211)","(['Health Outcome Contribution'], 0.8088845014572144)","('NON-ESG', 0.05286945402622223)","('NON-ESG', 0.011968797072768211)"
Line 270,"In FY19, we completed  four PAI engagements in   three countries.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4568336009979248)","('Systemic_Risk_Management', 0.13878589868545532)","('Business_Ethics', 0.06361652165651321)","('NON-ESG', 0.4568336009979248)","('NON-ESG', 0.13878589868545532)","('NON-ESG', 0.06361652165651321)"
Line 271,"anatomy through interactive,  3D, computer-generated  organ models.
","('Employee_Health_And_Safety', 0.18999777734279633)","('Ecological_Impacts', 0.16199785470962524)","('Employee_Engagement_Inclusion_And_Diversity', 0.1583828628063202)","('NON-ESG', 0.18999777734279633)","('NON-ESG', 0.16199785470962524)","('NON-ESG', 0.1583828628063202)"
Line 272,"Medtronic Restorative  Therapies Group (RTG) led  education events for 8,488  healthcare professionals  — including hands-on  workshops, hospital-based  training, surgical coaching,  and visiting clinician  programs.update their knowledge and  skills.
","('Access_And_Affordability', 0.6775400638580322)","('Employee_Engagement_Inclusion_And_Diversity', 0.09091535955667496)","('Employee_Health_And_Safety', 0.026426004245877266)","(['Health Outcome Contribution'], 0.6775400638580322)","('NON-ESG', 0.09091535955667496)","('NON-ESG', 0.026426004245877266)"
Line 273,"In FY19, MICs in Japan  and Korea hosted nearly  10,000 physicians, offering  access to state-of-the-art  virtual and augmented reality  and 360-degree imaging  training tools.
","('Access_And_Affordability', 0.27306169271469116)","('Employee_Engagement_Inclusion_And_Diversity', 0.13572822511196136)","('Product_Design_And_Lifecycle_Management', 0.07382354885339737)","('NON-ESG', 0.27306169271469116)","('NON-ESG', 0.13572822511196136)","('NON-ESG', 0.07382354885339737)"
Line 274,"At the 11th Implantable  Device Congress, we  collaborated with Japanese  startup HoloEyes Inc.
","('Employee_Health_And_Safety', 0.16910681128501892)","('Customer_Welfare', 0.13905692100524902)","('Product_Design_And_Lifecycle_Management', 0.10897254198789597)","('NON-ESG', 0.16910681128501892)","('NON-ESG', 0.13905692100524902)","('NON-ESG', 0.10897254198789597)"
Line 275,"to  educate 73 physicians on  venipuncture using virtual  reality.
","('Employee_Health_And_Safety', 0.22194616496562958)","('Employee_Engagement_Inclusion_And_Diversity', 0.10060031712055206)","('Access_And_Affordability', 0.09509983658790588)","('NON-ESG', 0.22194616496562958)","('NON-ESG', 0.10060031712055206)","('NON-ESG', 0.09509983658790588)"
Line 276,"Physicians were  also able to learn detailed is matched by the capacity,   skills, and knowledge of the  people — including patients   and professionals.
","('Employee_Engagement_Inclusion_And_Diversity', 0.630305826663971)","('Access_And_Affordability', 0.10631074011325836)","('Employee_Health_And_Safety', 0.03719306364655495)","(['Human Capital Development'], 0.630305826663971)","('NON-ESG', 0.10631074011325836)","('NON-ESG', 0.03719306364655495)"
Line 277,"In FY19, we invested $142   million in capacity building   and training for medical  professionals (reaching more  than 83,000 people) and   $28.6 million in patient   education.
","('Access_And_Affordability', 0.7280731201171875)","('Employee_Engagement_Inclusion_And_Diversity', 0.05489228665828705)","('Employee_Health_And_Safety', 0.03436283767223358)","(['Health Outcome Contribution'], 0.7280731201171875)","('NON-ESG', 0.05489228665828705)","('NON-ESG', 0.03436283767223358)"
Line 278,"For example, in our  Asia Pacific and China region:   Medtronic Innovation Centers  (MICs) provide specialist  training to healthcare  professionals to expand and Our efforts have so far:  Improved the health of more  than 90 Parkinson’s and  dystonia patients  Paved the way for financial  reimbursement of more  than 8,000 patients awaiting  access to DBS therapy  BUILDING  CAPACITY AND  ACCESS TO  KNOWLEDGE Healthcare systems function  most effectively when the   quality of the infrastructure   Healthcare Capacity Building     $150.$140.$130.$120.0$139.7 $139.0$142.0EDUCA TION FOR MEDICAL PROFESSIONALS  ($ MILLION) FY17 FY18 FY19$35.$30.$25.$20.$15.$10.$0.0$22.6$33.$28.6EDUCA TION FOR PA TIENTS  ($ MILLION) FY17 FY18 FY19100,80,60,40,20,10,052,19389,83,123MEDICAL PROFESSIONALS REACHED  FY17 FY18 FY1934We engage in a range of philanthropic activities to extend essential  healthcare access to the people who need it most.
","('Access_And_Affordability', 0.8693709373474121)","('Employee_Health_And_Safety', 0.018116747960448265)","('Product_Quality_And_Safety', 0.015201964415609837)","(['Health Outcome Contribution'], 0.8693709373474121)","('NON-ESG', 0.018116747960448265)","('NON-ESG', 0.015201964415609837)"
Line 279,"For example, in our  Asia Pacific and China region:   Medtronic Innovation Centers  (MICs) provide specialist  training to healthcare  professionals to expand and Our efforts have so far:  Improved the health of more  than 90 Parkinson’s and  dystonia patients  Paved the way for financial  reimbursement of more  than 8,000 patients awaiting  access to DBS therapy  BUILDING  CAPACITY AND  ACCESS TO  KNOWLEDGE Healthcare systems function  most effectively when the   quality of the infrastructure   Healthcare Capacity Building     $150.$140.$130.$120.0$139.7 $139.0$142.0EDUCA TION FOR MEDICAL PROFESSIONALS  ($ MILLION) FY17 FY18 FY19$35.$30.$25.$20.$15.$10.$0.0$22.6$33.$28.6EDUCA TION FOR PA TIENTS  ($ MILLION) FY17 FY18 FY19100,80,60,40,20,10,052,19389,83,123MEDICAL PROFESSIONALS REACHED  FY17 FY18 FY1934We engage in a range of philanthropic activities to extend essential  healthcare access to the people who need it most.
","('Access_And_Affordability', 0.8567378520965576)","('Product_Quality_And_Safety', 0.014276806265115738)","('Human_Rights_And_Community_Relations', 0.013098766095936298)","(['Health Outcome Contribution'], 0.8567378520965576)","('NON-ESG', 0.014276806265115738)","('NON-ESG', 0.013098766095936298)"
Line 280,"We collaborate  with local and global partners to accelerate our effort, and our  strategic investments focus on underserved communities.
","('Access_And_Affordability', 0.9415252804756165)","('Human_Rights_And_Community_Relations', 0.006059668958187103)","('Critical_Incident_Risk_Management', 0.005401660688221455)","(['Health Outcome Contribution'], 0.9415252804756165)","('NON-ESG', 0.006059668958187103)","('NON-ESG', 0.005401660688221455)"
Line 281,"OUR CONTRIBUTIONS T o date, our company’s philanthropic contributions total more than   $1 billion, including our support of the Medtronic Foundation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7478288412094116)","('Human_Rights_And_Community_Relations', 0.02846916764974594)","('Director_Removal', 0.025835413485765457)","(['Corporate Governance'], 0.7478288412094116)","('NON-ESG', 0.02846916764974594)","('NON-ESG', 0.025835413485765457)"
Line 282,"We want  to ensure that each dollar we invest makes a real difference.In FY19, we continued to shift our philanthropic activities toward  strategic impact-focused charitable giving.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6421321630477905)","('Access_And_Affordability', 0.07249166071414948)","('Human_Rights_And_Community_Relations', 0.029948946088552475)","(['Corporate Governance'], 0.6421321630477905)","('NON-ESG', 0.07249166071414948)","('NON-ESG', 0.029948946088552475)"
Line 283,"We will measure our  success not by the amount of money we give, but by the beneficial  effect of our contributions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6839529871940613)","('Business_Ethics', 0.05425490066409111)","('Competitive_Behavior', 0.053708214312791824)","(['Corporate Governance'], 0.6839529871940613)","('NON-ESG', 0.05425490066409111)","('NON-ESG', 0.053708214312791824)"
Line 284,"Medtronic Foundation We fund the Medtronic Foundation’s work to expand access to  healthcare for underserved people worldwide and support   healthy communities.
","('Access_And_Affordability', 0.9459455013275146)","('Critical_Incident_Risk_Management', 0.005136293824762106)","('Product_Quality_And_Safety', 0.0048487214371562)","(['Health Outcome Contribution'], 0.9459455013275146)","('NON-ESG', 0.005136293824762106)","('NON-ESG', 0.0048487214371562)"
Line 285,"Volunteering We encourage our employees to give back to communities through  skilled service and hands-on volunteering year-round.
","('Employee_Health_And_Safety', 0.26661014556884766)","('Human_Rights_And_Community_Relations', 0.20202206075191498)","('Access_And_Affordability', 0.15814898908138275)","('NON-ESG', 0.26661014556884766)","('NON-ESG', 0.20202206075191498)","('NON-ESG', 0.15814898908138275)"
Line 286,"Read more  about our employee volunteering programs.PHILANTHROPY Adding   Business Value   Our philanthropic programs are an important extension of our  work to expand access to our products.
","('Product_Design_And_Lifecycle_Management', 0.210847869515419)","('Access_And_Affordability', 0.14644324779510498)","('Management_Of_Legal_And_Regulatory_Framework', 0.14396870136260986)","('NON-ESG', 0.210847869515419)","('NON-ESG', 0.14644324779510498)","('NON-ESG', 0.14396870136260986)"
Line 287,"Medtronic and the  Medtronic Foundation partner with others to make investments  based on impact and outcomes for underserved communities,  while strengthening our reputation and social license   to operate.Each year ,  MILLION  PEOPLEAGED 30–69  DIE FROM A NONCOMMUNICABLE  DISEASE (NCD)86% OF PREMA TURE NCD  DEA THS OCCUR IN   LOW- AND MIDDLE- INCOME COUNTRIES T o date, our company’s philanthropic  contributions total more than $1 billion.
","('Access_And_Affordability', 0.9261663556098938)","('Human_Rights_And_Community_Relations', 0.009589387103915215)","('Product_Quality_And_Safety', 0.007044389843940735)","(['Health Outcome Contribution'], 0.9261663556098938)","('NON-ESG', 0.009589387103915215)","('NON-ESG', 0.007044389843940735)"
Line 288,"CASE STUDY SUPPORTING THE MEDICAL TECHNOLOGY   T ALENT PIPELINE   T oday’s schoolchildren are the future of the medical technology  industry.
","('Product_Design_And_Lifecycle_Management', 0.38358741998672485)","('Energy_Management', 0.294779896736145)","('Access_And_Affordability', 0.04877118021249771)","('NON-ESG', 0.38358741998672485)","('NON-ESG', 0.294779896736145)","('NON-ESG', 0.04877118021249771)"
Line 289,"It’s vital to encourage children to see science and technology  as aspirational and exciting career options if we are to build upon the  wealth of innovation and talent that exists in our sector today.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8205556273460388)","('Business_Model_Resilience', 0.018150098621845245)","('Product_Design_And_Lifecycle_Management', 0.016835566610097885)","(['Human Capital Development'], 0.8205556273460388)","('NON-ESG', 0.018150098621845245)","('NON-ESG', 0.016835566610097885)"
Line 290,"Medtronic supports FIRST® — For Inspiration & Recognition of   Science & T echnology — which sponsors robotics competitions for  kids from kindergarten to grade 12 (age 18–19).
","('Access_And_Affordability', 0.336076021194458)","('Employee_Engagement_Inclusion_And_Diversity', 0.23772035539150238)","('Product_Quality_And_Safety', 0.05841722711920738)","('NON-ESG', 0.336076021194458)","('NON-ESG', 0.23772035539150238)","('NON-ESG', 0.05841722711920738)"
Line 291,"In the FIRST®   2018–2019 season, more than 570,000 students participated in more  than 67,000 teams worldwide.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4386001229286194)","('Access_And_Affordability', 0.168657585978508)","('Management_Of_Legal_And_Regulatory_Framework', 0.032318707555532455)","('NON-ESG', 0.4386001229286194)","('NON-ESG', 0.168657585978508)","('NON-ESG', 0.032318707555532455)"
Line 292,"FIRST® participants are more than four times as likely to major in a  STEM (science, technology, engineering, and mathematics) fields  than equivalent non-participants.7 They also show improved problem  solving, time management, conflict resolution, and communication  skills as a result of participating.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3042759597301483)","('Human_Rights_And_Community_Relations', 0.10378184169530869)","('Business_Ethics', 0.05824912711977959)","('NON-ESG', 0.3042759597301483)","('NON-ESG', 0.10378184169530869)","('NON-ESG', 0.05824912711977959)"
Line 293,"Since 2006, Medtronic and the Medtronic Foundation have supported  FIRST Robotics Competition teams and events with financial  contributions and volunteer team mentors.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2509726583957672)","('Access_And_Affordability', 0.1144571527838707)","('Competitive_Behavior', 0.09115545451641083)","('NON-ESG', 0.2509726583957672)","('NON-ESG', 0.1144571527838707)","('NON-ESG', 0.09115545451641083)"
Line 294,"In FY19:  50 Medtronic employees volunteered more than 5,300 hours.8    We formed the Medtronic FIRST® Robotics Council to   promote internal awareness of the program and grow our  involvement worldwide.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2987828850746155)","('Employee_Health_And_Safety', 0.2936351001262665)","('Labor_Practices', 0.2070467323064804)","('NON-ESG', 0.2987828850746155)","('NON-ESG', 0.2936351001262665)","('NON-ESG', 0.2070467323064804)"
Line 295,"The Medtronic Foundation Global Volunteer Engagement Council  named FIRST® one of its key STEM programs to focus on   scaling worldwide.7  See the FIRST® Longitudinal Study for   more detail.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3856712877750397)","('Access_And_Affordability', 0.14805716276168823)","('Human_Rights_And_Community_Relations', 0.09036651253700256)","('NON-ESG', 0.3856712877750397)","('NON-ESG', 0.14805716276168823)","('NON-ESG', 0.09036651253700256)"
Line 296,"8  Based on hours logged on the Medtronic  Foundation website.
","('Labor_Practices', 0.2681771516799927)","('Access_And_Affordability', 0.07336271554231644)","('Data_Security', 0.07209625095129013)","('NON-ESG', 0.2681771516799927)","('NON-ESG', 0.07336271554231644)","('NON-ESG', 0.07209625095129013)"
Line 297,"Actual hours are likely to  be higher .Since 1992, we have  donated pacemakers to  the Hospital General de  Mexico in Mexico City.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1574910432100296)","('Labor_Practices', 0.14397528767585754)","('Employee_Health_And_Safety', 0.1018337681889534)","('NON-ESG', 0.1574910432100296)","('NON-ESG', 0.14397528767585754)","('NON-ESG', 0.1018337681889534)"
Line 298,"Approximately 3,000  patients who were unable  to afford treatment  have benefited from  the pacemakers.
","('Access_And_Affordability', 0.7922717928886414)","('Product_Quality_And_Safety', 0.020630238577723503)","('Employee_Health_And_Safety', 0.017496729269623756)","(['Health Outcome Contribution'], 0.7922717928886414)","('NON-ESG', 0.020630238577723503)","('NON-ESG', 0.017496729269623756)"
Line 299,"A local  cardiologist runs the  program and oversees  the surgeries, teaching  other physicians how to  perform the procedure  so they can bring these  new skills to their  patients.
","('Access_And_Affordability', 0.2584744989871979)","('Employee_Health_And_Safety', 0.23810702562332153)","('Employee_Engagement_Inclusion_And_Diversity', 0.15153464674949646)","('NON-ESG', 0.2584744989871979)","('NON-ESG', 0.23810702562332153)","('NON-ESG', 0.15153464674949646)"
Line 300,"Watch more here.Product donations We collaborate with global  product donation partners to  distribute Medtronic products  to nonprofit organizations and  in-country clinics focused on  underserved communities.
","('Access_And_Affordability', 0.7132498621940613)","('Product_Design_And_Lifecycle_Management', 0.04904015734791756)","('Energy_Management', 0.03191820904612541)","(['Health Outcome Contribution'], 0.7132498621940613)","('NON-ESG', 0.04904015734791756)","('NON-ESG', 0.03191820904612541)"
Line 301,"These product donations also  contribute to essential supplies  during disaster recovery efforts.
","('Critical_Incident_Risk_Management', 0.9529008269309998)","('Physical_Impacts_Of_Climate_Change', 0.006445473060011864)","('Employee_Health_And_Safety', 0.00550089729949832)","(['Risk & Crisis Management'], 0.9529008269309998)","('NON-ESG', 0.006445473060011864)","('NON-ESG', 0.00550089729949832)"
Line 302,"Charitable third-party  medical education We fund medical fellowship  positions and provide support  for independent, third-  party sponsored health  education programs.36Medtronic Foundation   Global Health Programs The Medtronic Foundation works in partnership with local  nonprofits and governments to invest in impactful healthcare  projects aimed at improving access for underserved  communities.
","('Access_And_Affordability', 0.9451107978820801)","('Product_Quality_And_Safety', 0.004992807749658823)","('Critical_Incident_Risk_Management', 0.004732347559183836)","(['Health Outcome Contribution'], 0.9451107978820801)","('NON-ESG', 0.004992807749658823)","('NON-ESG', 0.004732347559183836)"
Line 303,"In FY19, the Medtronic Foundation contributed  to three global health signature efforts:  HeartRescue — measuring and improving care for sudden  cardiac arrest (SCA) and ST -elevation myocardial infarction  (STEMI)  Impact: United States HeartRescue has treated more than  71,000 SCA patients, contributing to an 8% increase in cardiac  arrest survival and a 17% increase in survival after bystander  intervention.9 Since its inception in 2015, Global HeartRescue  in China, India, and Brazil has:  T rained more than 4,000 health workers and   7,800 community members  Provided reperfusion treatment for more than   750 STEMI patients Location: 19 U.S. states, Brazil, China, India    SPLIT OF PHILANTHROPIC CONTRIBUTIONS  IN FYMedtronic  Foundation  grant-makingPhilanthropy  (charitable third-party  medical education,  product donations,  financial contributions,  volunteerism)70.7%29.3% 9  U.S. HeartRescue data from the State of Illinois through 2017.CORPORA TE CASH DONA TIONSPHILANTHROPIC CONTRIBUTIONS BY TYPE IN FYMEDTRONIC  FOUNDA TION GIVING PRODUCT  DONA TIONS VALUE OF  VOLUNTEERING* TOT AL GIVING$57.2 M $29.3 M $9.2 M $4.4 M $100.1 M * Calculated with an hourly rate of $24.14 in FY19, provided bythe Independent  Sector.
","('Employee_Health_And_Safety', 0.4574909508228302)","('Critical_Incident_Risk_Management', 0.1703999787569046)","('Access_And_Affordability', 0.07824009656906128)","('NON-ESG', 0.4574909508228302)","('NON-ESG', 0.1703999787569046)","('NON-ESG', 0.07824009656906128)"
Line 304,"In FY19, the Medtronic Foundation contributed  to three global health signature efforts:  HeartRescue — measuring and improving care for sudden  cardiac arrest (SCA) and ST -elevation myocardial infarction  (STEMI)  Impact: United States HeartRescue has treated more than  71,000 SCA patients, contributing to an 8% increase in cardiac  arrest survival and a 17% increase in survival after bystander  intervention.9 Since its inception in 2015, Global HeartRescue  in China, India, and Brazil has:  T rained more than 4,000 health workers and   7,800 community members  Provided reperfusion treatment for more than   750 STEMI patients Location: 19 U.S. states, Brazil, China, India    SPLIT OF PHILANTHROPIC CONTRIBUTIONS  IN FYMedtronic  Foundation  grant-makingPhilanthropy  (charitable third-party  medical education,  product donations,  financial contributions,  volunteerism)70.7%29.3% 9  U.S. HeartRescue data from the State of Illinois through 2017.CORPORA TE CASH DONA TIONSPHILANTHROPIC CONTRIBUTIONS BY TYPE IN FYMEDTRONIC  FOUNDA TION GIVING PRODUCT  DONA TIONS VALUE OF  VOLUNTEERING* TOT AL GIVING$57.2 M $29.3 M $9.2 M $4.4 M $100.1 M * Calculated with an hourly rate of $24.14 in FY19, provided bythe Independent  Sector.
","('Management_Of_Legal_And_Regulatory_Framework', 0.37758779525756836)","('Access_And_Affordability', 0.1891670525074005)","('Human_Rights_And_Community_Relations', 0.08344975858926773)","('NON-ESG', 0.37758779525756836)","('NON-ESG', 0.1891670525074005)","('NON-ESG', 0.08344975858926773)"
Line 305,"In FY19, the Medtronic Foundation contributed  to three global health signature efforts:  HeartRescue — measuring and improving care for sudden  cardiac arrest (SCA) and ST -elevation myocardial infarction  (STEMI)  Impact: United States HeartRescue has treated more than  71,000 SCA patients, contributing to an 8% increase in cardiac  arrest survival and a 17% increase in survival after bystander  intervention.9 Since its inception in 2015, Global HeartRescue  in China, India, and Brazil has:  T rained more than 4,000 health workers and   7,800 community members  Provided reperfusion treatment for more than   750 STEMI patients Location: 19 U.S. states, Brazil, China, India    SPLIT OF PHILANTHROPIC CONTRIBUTIONS  IN FYMedtronic  Foundation  grant-makingPhilanthropy  (charitable third-party  medical education,  product donations,  financial contributions,  volunteerism)70.7%29.3% 9  U.S. HeartRescue data from the State of Illinois through 2017.CORPORA TE CASH DONA TIONSPHILANTHROPIC CONTRIBUTIONS BY TYPE IN FYMEDTRONIC  FOUNDA TION GIVING PRODUCT  DONA TIONS VALUE OF  VOLUNTEERING* TOT AL GIVING$57.2 M $29.3 M $9.2 M $4.4 M $100.1 M * Calculated with an hourly rate of $24.14 in FY19, provided bythe Independent  Sector.
","('Management_Of_Legal_And_Regulatory_Framework', 0.48545145988464355)","('Access_And_Affordability', 0.10210445523262024)","('Labor_Practices', 0.07554072886705399)","('NON-ESG', 0.48545145988464355)","('NON-ESG', 0.10210445523262024)","('NON-ESG', 0.07554072886705399)"
Line 306,"Volunteer hours reflect hours that are self-reported by the Medtronic  employees and represent hours of volunteerism during normal business hours.mortality risk among people  living with RHD  Conducted more than  13,000 echo screenings for  children10    Created a national network  with four regional Centers  of Excellence in RHD care  Established the largest RHD  register globally, with more  than 2,000 patients RHD Action supported  significant advocacy and  mobilization efforts that  resulted in successful passage to control groups, the proportion  of patients with controlled status  increased by an average of 20%.
","('Employee_Health_And_Safety', 0.3287773132324219)","('Access_And_Affordability', 0.3282020688056946)","('Human_Rights_And_Community_Relations', 0.07022175192832947)","('NON-ESG', 0.3287773132324219)","('NON-ESG', 0.3282020688056946)","('NON-ESG', 0.07022175192832947)"
Line 307,"Volunteer hours reflect hours that are self-reported by the Medtronic  employees and represent hours of volunteerism during normal business hours.mortality risk among people  living with RHD  Conducted more than  13,000 echo screenings for  children10    Created a national network  with four regional Centers  of Excellence in RHD care  Established the largest RHD  register globally, with more  than 2,000 patients RHD Action supported  significant advocacy and  mobilization efforts that  resulted in successful passage to control groups, the proportion  of patients with controlled status  increased by an average of 20%.
","('Access_And_Affordability', 0.6594990491867065)","('Employee_Health_And_Safety', 0.04031835496425629)","('Product_Quality_And_Safety', 0.0392281636595726)","(['Health Outcome Contribution'], 0.6594990491867065)","('NON-ESG', 0.04031835496425629)","('NON-ESG', 0.0392281636595726)"
Line 308,"The support for patients and  health workers continues  through the many partners that  contributed to HealthRise and  through public sector partners  in ministries of health and local  health systems.
","('Employee_Health_And_Safety', 0.6157760620117188)","('Access_And_Affordability', 0.19189095497131348)","('Critical_Incident_Risk_Management', 0.04538406431674957)","(['Operational Eco-Efficiency'], 0.6157760620117188)","('NON-ESG', 0.19189095497131348)","('NON-ESG', 0.04538406431674957)"
Line 309,"These partners  are enabling greater scale  to reach more underserved  patients and support effective  and empowered chronic care  management.
","('Access_And_Affordability', 0.9466279745101929)","('Critical_Incident_Risk_Management', 0.005421983078122139)","('Product_Quality_And_Safety', 0.00464136665686965)","(['Health Outcome Contribution'], 0.9466279745101929)","('NON-ESG', 0.005421983078122139)","('NON-ESG', 0.00464136665686965)"
Line 310,"Location: Brazil, India, South  Africa, United States RHD Action — working to end  rheumatic heart disease (RHD) in  vulnerable populations Impact: RHD Action Uganda has:  Achieved 91% penicillin  adherence for patients  retained in care — resulting  in a 33% decrease in    HealthRise — expanded  access to chronic care and  worked to improve health  outcomes among underserved  populations over five years.
","('Access_And_Affordability', 0.9421655535697937)","('Product_Quality_And_Safety', 0.006367294117808342)","('Energy_Management', 0.004576492588967085)","(['Health Outcome Contribution'], 0.9421655535697937)","('NON-ESG', 0.006367294117808342)","('NON-ESG', 0.004576492588967085)"
Line 311,"The  program ended in FYImpact: Across nine sites in  four countries, HealthRise  partners trained more than  3,600 health workers in chronic  care, resulting in:    65,000 people newly  screened   9,000 cases of diabetes and  hypertension identified  More than 3,100 underserved  patients demonstrated blood  pressure control and over 1,000  achieved blood sugar control.
","('Access_And_Affordability', 0.858773946762085)","('Employee_Health_And_Safety', 0.0183942262083292)","('Product_Quality_And_Safety', 0.015704547986388206)","(['Health Outcome Contribution'], 0.858773946762085)","('NON-ESG', 0.0183942262083292)","('NON-ESG', 0.015704547986388206)"
Line 312,"On average, 65% of all patients  in managed care showed  critical reductions in blood  pressure and blood sugar .
","('Energy_Management', 0.1726427674293518)","('Customer_Welfare', 0.13073962926864624)","('Access_And_Affordability', 0.11791756004095078)","('NON-ESG', 0.1726427674293518)","('NON-ESG', 0.13073962926864624)","('NON-ESG', 0.11791756004095078)"
Line 313,"Across the U.S. and Brazil  sites, where changes were  statistically significant relative  10  RHD Action data from Case Western Reserve University 2013–2018.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5274982452392578)","('Systemic_Risk_Management', 0.09232863038778305)","('Competitive_Behavior', 0.061600521206855774)","(['Corporate Governance'], 0.5274982452392578)","('NON-ESG', 0.09232863038778305)","('NON-ESG', 0.061600521206855774)"
Line 314,"of the Global Resolution on  Rheumatic Fever RHD at the  71st World Health Assembly.
","('Employee_Health_And_Safety', 0.5937640070915222)","('Access_And_Affordability', 0.0694628432393074)","('Product_Quality_And_Safety', 0.05705534666776657)","(['Operational Eco-Efficiency'], 0.5937640070915222)","('NON-ESG', 0.0694628432393074)","('NON-ESG', 0.05705534666776657)"
Line 315,"Following the Global  Resolution, high-burden  countries have prioritized  action and resources to  prevent, detect, and treat  RHD.
","('Management_Of_Legal_And_Regulatory_Framework', 0.13870978355407715)","('Access_And_Affordability', 0.13581106066703796)","('Business_Ethics', 0.11360934376716614)","('NON-ESG', 0.13870978355407715)","('NON-ESG', 0.13581106066703796)","('NON-ESG', 0.11360934376716614)"
Line 316,"Countries will report  on implementation of the  resolution at the World  Health Assembly in 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.49144089221954346)","('Human_Rights_And_Community_Relations', 0.17659392952919006)","('Access_And_Affordability', 0.08311014622449875)","('NON-ESG', 0.49144089221954346)","('NON-ESG', 0.17659392952919006)","('NON-ESG', 0.08311014622449875)"
Line 317,"Location: Uganda, T anzania,  globallyCASE STUDY ELEVA TING THE ROLE OF   COMMUNITY HEAL TH WORKERS By 2030, a global shortfall of 18 million health workers is expected.11  With demand currently outpacing supply, more and better-trained  health workers are needed in and outside of clinics.
","('Employee_Health_And_Safety', 0.9690761566162109)","('Critical_Incident_Risk_Management', 0.004781829193234444)","('Labor_Practices', 0.0035870661959052086)","(['Operational Eco-Efficiency'], 0.9690761566162109)","('NON-ESG', 0.004781829193234444)","('NON-ESG', 0.0035870661959052086)"
Line 318,"The 72nd World Health Assembly further emphasized the global  significance of this issue by passing a resolution on opportunities  and challenges for community healthcare workers delivering  primary healthcare.
","('Access_And_Affordability', 0.7307995557785034)","('Human_Rights_And_Community_Relations', 0.06365469098091125)","('Employee_Health_And_Safety', 0.05226510763168335)","(['Health Outcome Contribution'], 0.7307995557785034)","('NON-ESG', 0.06365469098091125)","('NON-ESG', 0.05226510763168335)"
Line 319,"Because patient and healthcare worker voices need to be heard  in this global conversation, in FY19, the Medtronic Foundation  engaged in a listening exercise to better understand its potential  role in addressing this emerging crisis.
","('Critical_Incident_Risk_Management', 0.4781476557254791)","('Physical_Impacts_Of_Climate_Change', 0.11198215186595917)","('Employee_Health_And_Safety', 0.07917244732379913)","('NON-ESG', 0.4781476557254791)","('NON-ESG', 0.11198215186595917)","('NON-ESG', 0.07917244732379913)"
Line 320,"It led regional design- thinking workshops and asked patients, national and local  policymakers, and those on the front lines of care: “How can we  solve tomorrow’s healthcare issues, starting now?” The messages from nearly 100 listening sessions across four  continents were clear:  Develop radical self-care solutions to address the rise in chronic  conditions.
","('Access_And_Affordability', 0.34663334488868713)","('Employee_Health_And_Safety', 0.09777224808931351)","('Critical_Incident_Risk_Management', 0.07415138930082321)","('NON-ESG', 0.34663334488868713)","('NON-ESG', 0.09777224808931351)","('NON-ESG', 0.07415138930082321)"
Line 321,"Be patient-centric by engaging the communities most in need.
","('Human_Rights_And_Community_Relations', 0.4461858868598938)","('Access_And_Affordability', 0.3907484710216522)","('Critical_Incident_Risk_Management', 0.027599196881055832)","('NON-ESG', 0.4461858868598938)","('NON-ESG', 0.3907484710216522)","('NON-ESG', 0.027599196881055832)"
Line 322,"11  World Health Organization Biennium report 2016-2017.
","('Access_And_Affordability', 0.37446722388267517)","('Management_Of_Legal_And_Regulatory_Framework', 0.09337934106588364)","('Product_Quality_And_Safety', 0.08538706600666046)","('NON-ESG', 0.37446722388267517)","('NON-ESG', 0.09337934106588364)","('NON-ESG', 0.08538706600666046)"
Line 323,"Meet people where they are to get to better outcomes.
","('Access_And_Affordability', 0.4505128562450409)","('Human_Rights_And_Community_Relations', 0.14089931547641754)","('Employee_Engagement_Inclusion_And_Diversity', 0.05128971114754677)","('NON-ESG', 0.4505128562450409)","('NON-ESG', 0.14089931547641754)","('NON-ESG', 0.05128971114754677)"
Line 324,"T rain more health workers who are compensated and valued, in  order to deliver services at scale.
","('Employee_Health_And_Safety', 0.8835243582725525)","('Labor_Practices', 0.05594239383935928)","('Critical_Incident_Risk_Management', 0.0061823599971830845)","(['Operational Eco-Efficiency'], 0.8835243582725525)","('NON-ESG', 0.05594239383935928)","('NON-ESG', 0.0061823599971830845)"
Line 325,"In response, the Medtronic Foundation is increasing its focus on  supporting and strengthening healthcare workers.
","('Employee_Health_And_Safety', 0.6643683910369873)","('Access_And_Affordability', 0.08963571488857269)","('Labor_Practices', 0.05070425942540169)","(['Operational Eco-Efficiency'], 0.6643683910369873)","('NON-ESG', 0.08963571488857269)","('NON-ESG', 0.05070425942540169)"
Line 326,"In FY19, the Medtronic Foundation developed and refined its impact  assessment framework to ensure that future funding maximizes  positive outcomes.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6685780882835388)","('Access_And_Affordability', 0.10502732545137405)","('Human_Rights_And_Community_Relations', 0.0330333337187767)","(['Corporate Governance'], 0.6685780882835388)","('NON-ESG', 0.10502732545137405)","('NON-ESG', 0.0330333337187767)"
Line 327,"The Medtronic Foundation tested the framework  during the selection of a small number of Opportunity Grant partners.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8054094314575195)","('GHG_Emissions', 0.019922785460948944)","('Competitive_Behavior', 0.01969328708946705)","(['Corporate Governance'], 0.8054094314575195)","('NON-ESG', 0.019922785460948944)","('NON-ESG', 0.01969328708946705)"
Line 328,"The focus was on testable, scalable solutions that address healthcare  efficiency and produce demonstrable positive outcomes.
","('Energy_Management', 0.35211318731307983)","('Product_Design_And_Lifecycle_Management', 0.35058459639549255)","('Supply_Chain_Management', 0.05788423866033554)","('NON-ESG', 0.35211318731307983)","('NON-ESG', 0.35058459639549255)","('NON-ESG', 0.05788423866033554)"
Line 329,"From nearly 200 applicants, 7 were selected to receive 1-year grants.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5703874230384827)","('Access_And_Affordability', 0.11389927566051483)","('Employee_Engagement_Inclusion_And_Diversity', 0.03811468929052353)","(['Corporate Governance'], 0.5703874230384827)","('NON-ESG', 0.11389927566051483)","('NON-ESG', 0.03811468929052353)"
Line 330,"All partner organizations participated in a Medtronic Foundation- led Learning Collaborative, to share lessons across markets and  approaches to improve healthcare efficiency for underserved  populations.
","('Access_And_Affordability', 0.9489931464195251)","('Critical_Incident_Risk_Management', 0.004709326662123203)","('Energy_Management', 0.004071837291121483)","(['Health Outcome Contribution'], 0.9489931464195251)","('NON-ESG', 0.004709326662123203)","('NON-ESG', 0.004071837291121483)"
Line 331,"The process helped Medtronic Foundation hone our framework for  measuring and delivering social impact in a financially sustainable  manner , through local organizations.
","('Human_Rights_And_Community_Relations', 0.9455061554908752)","('Access_And_Affordability', 0.0049779098480939865)","('Management_Of_Legal_And_Regulatory_Framework', 0.0041258130222558975)","(['Community Relations'], 0.9455061554908752)","('NON-ESG', 0.0049779098480939865)","('NON-ESG', 0.0041258130222558975)"
Line 332,"In FY20, the framework will be rolled out across all Medtronic  Foundation activities to aid decision-making about current and future  partnerships.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47600027918815613)","('Business_Model_Resilience', 0.11035128682851791)","('Access_And_Affordability', 0.09925681352615356)","('NON-ESG', 0.47600027918815613)","('NON-ESG', 0.11035128682851791)","('NON-ESG', 0.09925681352615356)"
Line 333,"PROMOTING EMPLOYEE VOLUNTEERING  AND GIVING We support and encourage employees to play an active role in  Medtronic and Medtronic Foundation philanthropic efforts: Project 6 — an enterprise-wide volunteer program during the sixth  month of the year that supports T enet 6 of the Medtronic Mission:  good corporate citizenshipVolunteer Grants — a Medtronic Foundation program that donates  funds to support the nonprofits where individual employees volunteer  25 hours or more during the year Matching Grants — a Medtronic Foundation program that matches  employee contributions to approved nonprofits, dollar for dollar , up to  $5,000 per calendar year Our year-round programs empower Medtronic employees to pursue  their personal passions and philanthropic engagements.
","('Employee_Health_And_Safety', 0.21731381118297577)","('Employee_Engagement_Inclusion_And_Diversity', 0.1946060061454773)","('Access_And_Affordability', 0.166619211435318)","('NON-ESG', 0.21731381118297577)","('NON-ESG', 0.1946060061454773)","('NON-ESG', 0.166619211435318)"
Line 334,"PROMOTING EMPLOYEE VOLUNTEERING  AND GIVING We support and encourage employees to play an active role in  Medtronic and Medtronic Foundation philanthropic efforts: Project 6 — an enterprise-wide volunteer program during the sixth  month of the year that supports T enet 6 of the Medtronic Mission:  good corporate citizenshipVolunteer Grants — a Medtronic Foundation program that donates  funds to support the nonprofits where individual employees volunteer  25 hours or more during the year Matching Grants — a Medtronic Foundation program that matches  employee contributions to approved nonprofits, dollar for dollar , up to  $5,000 per calendar year Our year-round programs empower Medtronic employees to pursue  their personal passions and philanthropic engagements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.508777916431427)","('Human_Rights_And_Community_Relations', 0.10740140080451965)","('Access_And_Affordability', 0.057646866887807846)","(['Corporate Governance'], 0.508777916431427)","('NON-ESG', 0.10740140080451965)","('NON-ESG', 0.057646866887807846)"
Line 335,"Employee Volunteering and Community Engagement  FYProject Volunteers 17,T otal Volunteer Hours 60,Countries Employee-Led Projects Volunteer Grants Volunteer Grants 1,Volunteer Grants ($ Raised) $704,Global Matching Grants Employee Contributions ($ Million) $8.Medtronic Match ($ Million) * $6.*  Medtronic Matches are made on a 1:1 basis up to $5,000.
","('Access_And_Affordability', 0.33210963010787964)","('Human_Rights_And_Community_Relations', 0.17285248637199402)","('Employee_Health_And_Safety', 0.1678646355867386)","('NON-ESG', 0.33210963010787964)","('NON-ESG', 0.17285248637199402)","('NON-ESG', 0.1678646355867386)"
Line 336,"As a result, matches are not the same  amount as employee contributions.40 Paid time off   Medtronic offers employees  five days of paid time  off (PTO) per year to  support disaster-relief  and recovery efforts by  volunteering with a nonprofit  or nongovernmental  organization.
","('Critical_Incident_Risk_Management', 0.7758574485778809)","('Employee_Health_And_Safety', 0.13032490015029907)","('Physical_Impacts_Of_Climate_Change', 0.009649989195168018)","(['Risk & Crisis Management'], 0.7758574485778809)","('NON-ESG', 0.13032490015029907)","('NON-ESG', 0.009649989195168018)"
Line 337,"For example,  in FY19, more than 40  Medtronic employees used  the PTO program to volunteer  with relief and recovery  efforts in Puerto Rico in the  aftermath of Hurricane Maria.
","('Critical_Incident_Risk_Management', 0.4354156255722046)","('Physical_Impacts_Of_Climate_Change', 0.42420893907546997)","('Air_Quality', 0.016055826097726822)","('NON-ESG', 0.4354156255722046)","('NON-ESG', 0.42420893907546997)","('NON-ESG', 0.016055826097726822)"
Line 338,"In addition, many Puerto  Rico-based employees also  gave their time to support   the community.
","('Human_Rights_And_Community_Relations', 0.477830171585083)","('Employee_Health_And_Safety', 0.15450744330883026)","('Employee_Engagement_Inclusion_And_Diversity', 0.11335142701864243)","('NON-ESG', 0.477830171585083)","('NON-ESG', 0.15450744330883026)","('NON-ESG', 0.11335142701864243)"
Line 339,"Grants  The Medtronic Foundation  distributes grants to  organizations that pre- position supplies and build  staffing capacity for fast,  strategic deployment.
","('Supply_Chain_Management', 0.2609129846096039)","('Access_And_Affordability', 0.15856249630451202)","('Energy_Management', 0.07077264785766602)","('NON-ESG', 0.2609129846096039)","('NON-ESG', 0.15856249630451202)","('NON-ESG', 0.07077264785766602)"
Line 340,"It  also matches employee  contributions to eligible  organizations.In FY19, the Medtronic  Foundation awarded the Bakken  Invitation to 12 individuals  from 12 different countries.
","('Labor_Practices', 0.34727975726127625)","('Employee_Engagement_Inclusion_And_Diversity', 0.23659875988960266)","('Management_Of_Legal_And_Regulatory_Framework', 0.11165318638086319)","('NON-ESG', 0.34727975726127625)","('NON-ESG', 0.23659875988960266)","('NON-ESG', 0.11165318638086319)"
Line 341,"The Invitation recognizes  people who benefited from  medical technology and are  now making a difference in  communities through advocacy  and innovation.
","('Human_Rights_And_Community_Relations', 0.3838489353656769)","('Access_And_Affordability', 0.2727724313735962)","('Employee_Engagement_Inclusion_And_Diversity', 0.06596247106790543)","('NON-ESG', 0.3838489353656769)","('NON-ESG', 0.2727724313735962)","('NON-ESG', 0.06596247106790543)"
Line 342,"Since 2013, the  program has honored more than  70 individuals from around the  world who are using their gift of  renewed health to improve the  lives of others.
","('Employee_Health_And_Safety', 0.6705995798110962)","('Access_And_Affordability', 0.1144418865442276)","('Human_Rights_And_Community_Relations', 0.04262884706258774)","(['Operational Eco-Efficiency'], 0.6705995798110962)","('NON-ESG', 0.1144418865442276)","('NON-ESG', 0.04262884706258774)"
Line 343,"Read more about  their stories.
","('Data_Security', 0.09908650815486908)","('Access_And_Affordability', 0.08779395371675491)","('Human_Rights_And_Community_Relations', 0.0857706293463707)","('NON-ESG', 0.09908650815486908)","('NON-ESG', 0.08779395371675491)","('NON-ESG', 0.0857706293463707)"
Line 344,"DISASTER  RESPONSE Natural disasters and severe  weather can devastate entire  communities, damaging basic  infrastructure and limiting  access to vital services.
","('Critical_Incident_Risk_Management', 0.9690586924552917)","('Physical_Impacts_Of_Climate_Change', 0.00467516528442502)","('Access_And_Affordability', 0.002720152959227562)","(['Risk & Crisis Management'], 0.9690586924552917)","('NON-ESG', 0.00467516528442502)","('NON-ESG', 0.002720152959227562)"
Line 345,"Medtronic and the Medtronic  Foundation focus on long-term  partnership and recovery.
","('Business_Model_Resilience', 0.3469657897949219)","('Access_And_Affordability', 0.08495189994573593)","('Human_Rights_And_Community_Relations', 0.08438502252101898)","('NON-ESG', 0.3469657897949219)","('NON-ESG', 0.08495189994573593)","('NON-ESG', 0.08438502252101898)"
Line 346,"Medtronic and Medtronic  Foundation disaster-response  activities include: Employee assistance   The Medtronic Employee Assistance Fund provides grants to  employees who suffer financial hardship due to natural disasters.
","('Critical_Incident_Risk_Management', 0.9731369614601135)","('Employee_Health_And_Safety', 0.003415896790102124)","('Physical_Impacts_Of_Climate_Change', 0.002839349675923586)","(['Risk & Crisis Management'], 0.9731369614601135)","('NON-ESG', 0.003415896790102124)","('NON-ESG', 0.002839349675923586)"
Line 347,"The Medtronic Foundation matches Medtronic employee  contributions to the fund, dollar-for-dollar (subject to the annual  $5,000 cap on employee philanthropic donations).
","('Management_Of_Legal_And_Regulatory_Framework', 0.6095132827758789)","('Labor_Practices', 0.05437757074832916)","('Human_Rights_And_Community_Relations', 0.04997028782963753)","(['Corporate Governance'], 0.6095132827758789)","('NON-ESG', 0.05437757074832916)","('NON-ESG', 0.04997028782963753)"
Line 348,"In FY19, the  fund distributed $1.38 million to impacted employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.30471888184547424)","('Labor_Practices', 0.2962642312049866)","('Employee_Health_And_Safety', 0.12848520278930664)","('NON-ESG', 0.30471888184547424)","('NON-ESG', 0.2962642312049866)","('NON-ESG', 0.12848520278930664)"
Line 349,"In FY19, we supported ongoing recovery efforts in Puerto Rico and in  Santa Rosa, California, following the hurricane and wildfires in these  locations in FY18.
","('Physical_Impacts_Of_Climate_Change', 0.6783415675163269)","('Critical_Incident_Risk_Management', 0.18158841133117676)","('Air_Quality', 0.026464607566595078)","(['Climate Change'], 0.6783415675163269)","('NON-ESG', 0.18158841133117676)","('NON-ESG', 0.026464607566595078)"
Line 350,"We also responded to several disasters across  the globe, including the drought in Australia, wildfires in Greece, and  flooding in India.
","('Critical_Incident_Risk_Management', 0.9145166873931885)","('Physical_Impacts_Of_Climate_Change', 0.0297841913998127)","('Air_Quality', 0.009059722535312176)","(['Risk & Crisis Management'], 0.9145166873931885)","('NON-ESG', 0.0297841913998127)","('NON-ESG', 0.009059722535312176)"
Line 351,"Information on how we prepare our business to respond to natural  disasters is available in Sustainability Priorities and Strategies.
","('Physical_Impacts_Of_Climate_Change', 0.49218082427978516)","('Critical_Incident_Risk_Management', 0.2551708519458771)","('Business_Model_Resilience', 0.0665527880191803)","('NON-ESG', 0.49218082427978516)","('NON-ESG', 0.2551708519458771)","('NON-ESG', 0.0665527880191803)"
Line 352,"Medtronic Foundation Disaster Relief Contributions  FY17 FY18 FYDisaster Relief ($ Million) $0.7 $5.6 $2.CASE STUDY SUPPORTING EMPLOYEE AND COMMUNITY  RESILIENCE DURING TIMES OF CRISIS  In FY19, a number of crises — including Hurricane Maria,  California wildfires, and others — affected Medtronic employees,  our operations, and the communities we serve.
","('Critical_Incident_Risk_Management', 0.9442802667617798)","('Physical_Impacts_Of_Climate_Change', 0.014302480034530163)","('Employee_Health_And_Safety', 0.005334511864930391)","(['Risk & Crisis Management'], 0.9442802667617798)","('NON-ESG', 0.014302480034530163)","('NON-ESG', 0.005334511864930391)"
Line 353,"These events  devastated neighborhoods, businesses, and infrastructure.
","('Critical_Incident_Risk_Management', 0.6757621169090271)","('Physical_Impacts_Of_Climate_Change', 0.0460985004901886)","('Systemic_Risk_Management', 0.045372046530246735)","(['Risk & Crisis Management'], 0.6757621169090271)","('NON-ESG', 0.0460985004901886)","('NON-ESG', 0.045372046530246735)"
Line 354,"In each instance, Medtronic crisis management teams activated  our response plans as soon as the potential impact became  apparent.
","('Critical_Incident_Risk_Management', 0.9542853236198425)","('Physical_Impacts_Of_Climate_Change', 0.007559677120298147)","('Employee_Health_And_Safety', 0.0037258840166032314)","(['Risk & Crisis Management'], 0.9542853236198425)","('NON-ESG', 0.007559677120298147)","('NON-ESG', 0.0037258840166032314)"
Line 355,"We started by verifying that all employees were safe  and accounted for , and then worked to assess and support their  needs, alongside those of the communities.
","('Employee_Health_And_Safety', 0.8937613368034363)","('Human_Rights_And_Community_Relations', 0.01868589036166668)","('Labor_Practices', 0.011688369326293468)","(['Operational Eco-Efficiency'], 0.8937613368034363)","('NON-ESG', 0.01868589036166668)","('NON-ESG', 0.011688369326293468)"
Line 356,"But initial support is not enough.
","('Systemic_Risk_Management', 0.14684128761291504)","('Management_Of_Legal_And_Regulatory_Framework', 0.11658469587564468)","('Access_And_Affordability', 0.10233844816684723)","('NON-ESG', 0.14684128761291504)","('NON-ESG', 0.11658469587564468)","('NON-ESG', 0.10233844816684723)"
Line 357,"The effects of a natural disaster  are felt long after the event has passed.
","('Critical_Incident_Risk_Management', 0.9662784337997437)","('Physical_Impacts_Of_Climate_Change', 0.004273122176527977)","('Employee_Health_And_Safety', 0.003988887649029493)","(['Risk & Crisis Management'], 0.9662784337997437)","('NON-ESG', 0.004273122176527977)","('NON-ESG', 0.003988887649029493)"
Line 358,"In FY19, the Medtronic  Foundation pledged $1 million to help improve the health of  people and communities affected by natural disasters and other  crisis events.
","('Critical_Incident_Risk_Management', 0.8724356293678284)","('Physical_Impacts_Of_Climate_Change', 0.026347799226641655)","('Human_Rights_And_Community_Relations', 0.021665606647729874)","(['Risk & Crisis Management'], 0.8724356293678284)","('NON-ESG', 0.026347799226641655)","('NON-ESG', 0.021665606647729874)"
Line 359,"It continues to work closely with local nonprofit  organizations and employees to assess how to best support  ongoing relief and recovery efforts.Continuing relief efforts in Santa Rosa  The North Bay wildfires in October 2017 were some of the  most destructive in California state history.
","('Critical_Incident_Risk_Management', 0.6360523700714111)","('Physical_Impacts_Of_Climate_Change', 0.23522765934467316)","('Air_Quality', 0.01633998565375805)","(['Risk & Crisis Management'], 0.6360523700714111)","('NON-ESG', 0.23522765934467316)","('NON-ESG', 0.01633998565375805)"
Line 360,"They claimed  44 lives and burned more than 6,000 homes.
","('Critical_Incident_Risk_Management', 0.47253087162971497)","('Employee_Health_And_Safety', 0.18802468478679657)","('Air_Quality', 0.09574752300977707)","('NON-ESG', 0.47253087162971497)","('NON-ESG', 0.18802468478679657)","('NON-ESG', 0.09574752300977707)"
Line 361,"As the slow  process of recovery continues, providing affordable housing  is essential.
","('Access_And_Affordability', 0.6420730948448181)","('Energy_Management', 0.07597963511943817)","('Critical_Incident_Risk_Management', 0.036659058183431625)","(['Health Outcome Contribution'], 0.6420730948448181)","('NON-ESG', 0.07597963511943817)","('NON-ESG', 0.036659058183431625)"
Line 362,"In Sonoma County, Medtronic and the Medtronic Foundation  have partnered with the local chapter of nonprofit Habitat  for Humanity to provide new homes for survivors.
","('Employee_Health_And_Safety', 0.3341332674026489)","('Access_And_Affordability', 0.21421584486961365)","('Human_Rights_And_Community_Relations', 0.1304016262292862)","('NON-ESG', 0.3341332674026489)","('NON-ESG', 0.21421584486961365)","('NON-ESG', 0.1304016262292862)"
Line 363,"As part   of this initiative:  Medtronic provided land for housing at its   Fountaingrove campus.
","('Access_And_Affordability', 0.38756901025772095)","('Employee_Engagement_Inclusion_And_Diversity', 0.08091753721237183)","('Ecological_Impacts', 0.07449795305728912)","('NON-ESG', 0.38756901025772095)","('NON-ESG', 0.08091753721237183)","('NON-ESG', 0.07449795305728912)"
Line 364,"The Medtronic Foundation donated $100,000 to help  fund construction.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5263838171958923)","('Access_And_Affordability', 0.12220580875873566)","('Customer_Welfare', 0.03125346824526787)","(['Corporate Governance'], 0.5263838171958923)","('NON-ESG', 0.12220580875873566)","('NON-ESG', 0.03125346824526787)"
Line 365,"Habitat for Humanity Sonoma County is building eight  compact houses for fire survivors.
","('Critical_Incident_Risk_Management', 0.8926832675933838)","('Employee_Health_And_Safety', 0.025819791480898857)","('Air_Quality', 0.010763667523860931)","(['Risk & Crisis Management'], 0.8926832675933838)","('NON-ESG', 0.025819791480898857)","('NON-ESG', 0.010763667523860931)"
Line 366,"Medtronic employees and other volunteers help to ready  the homes to live in.
","('Access_And_Affordability', 0.4567488431930542)","('Employee_Engagement_Inclusion_And_Diversity', 0.08855196833610535)","('Employee_Health_And_Safety', 0.07838863134384155)","('NON-ESG', 0.4567488431930542)","('NON-ESG', 0.08855196833610535)","('NON-ESG', 0.07838863134384155)"
Line 367,"This collaborative effort is a small but important part of   the overall goal to rebuild a community in the aftermath   of disaster .
","('Critical_Incident_Risk_Management', 0.9659464955329895)","('Employee_Health_And_Safety', 0.006815796252340078)","('Access_And_Affordability', 0.0031410467345267534)","(['Risk & Crisis Management'], 0.9659464955329895)","('NON-ESG', 0.006815796252340078)","('NON-ESG', 0.0031410467345267534)"
Line 368,"42As a leading global medical  technology company,  our priority is to improve  healthcare for all.
","('Product_Design_And_Lifecycle_Management', 0.21360692381858826)","('Energy_Management', 0.16839852929115295)","('Access_And_Affordability', 0.14935719966888428)","('NON-ESG', 0.21360692381858826)","('NON-ESG', 0.16839852929115295)","('NON-ESG', 0.14935719966888428)"
Line 369,"By doing  this, our business plays an  even greater role in improving  lives — not just for patients,  but also for our employees  and the communities in which  we operate.
","('Access_And_Affordability', 0.3465542495250702)","('Human_Rights_And_Community_Relations', 0.23676349222660065)","('Employee_Health_And_Safety', 0.14322088658809662)","('NON-ESG', 0.3465542495250702)","('NON-ESG', 0.23676349222660065)","('NON-ESG', 0.14322088658809662)"
Line 370,"Our financial  success means we can  continue to make important  economic contributions  to society by creating jobs,  contributing taxes, and  making capital investments.
","('Business_Model_Resilience', 0.26839467883110046)","('Human_Rights_And_Community_Relations', 0.148373544216156)","('Management_Of_Legal_And_Regulatory_Framework', 0.14366143941879272)","('NON-ESG', 0.26839467883110046)","('NON-ESG', 0.148373544216156)","('NON-ESG', 0.14366143941879272)"
Line 371,"Financial performance In FY19, we earned revenue  of $30.6 billion.
","('Systemic_Risk_Management', 0.45543065667152405)","('Business_Model_Resilience', 0.26978734135627747)","('Supply_Chain_Management', 0.028566019609570503)","('NON-ESG', 0.45543065667152405)","('NON-ESG', 0.26978734135627747)","('NON-ESG', 0.028566019609570503)"
Line 372,"Our revenue- growth strategy starts with  executing on our technology  pipeline, while our growth  accelerators, Globalization and Economic Value, enhance  our growth profile, expand  our markets, and increase our  competitiveness.
","('Competitive_Behavior', 0.7580162286758423)","('Business_Model_Resilience', 0.10825797915458679)","('Systemic_Risk_Management', 0.03330625966191292)","(['Business Ethics'], 0.7580162286758423)","('NON-ESG', 0.10825797915458679)","('NON-ESG', 0.03330625966191292)"
Line 373,"Our emerging market revenue  grew 13% on a comparable  constant currency basis in FY19  compared to FY18.
","('Systemic_Risk_Management', 0.40592777729034424)","('Business_Model_Resilience', 0.1374346911907196)","('Management_Of_Legal_And_Regulatory_Framework', 0.11958296597003937)","('NON-ESG', 0.40592777729034424)","('NON-ESG', 0.1374346911907196)","('NON-ESG', 0.11958296597003937)"
Line 374,"We were  able to drive growth in these  key markets by optimizing  our distribution channels,  developing our public and private  partnerships, and localizing  our research and development  (R&D) and manufacturing.
","('Business_Model_Resilience', 0.4251372814178467)","('Competitive_Behavior', 0.15137933194637299)","('Systemic_Risk_Management', 0.09680132567882538)","('NON-ESG', 0.4251372814178467)","('NON-ESG', 0.15137933194637299)","('NON-ESG', 0.09680132567882538)"
Line 375,"For more information on our  financial performance, please  see our 2019 Form 10-K, on  file with the U.S. Securities and  Exchange Commission.THE ECONOMIC  IMPACT OF  OUR BUSINESSCONSECUTIVE   YEAR  OF DIVIDEND INCREASES 42ndWE REMAIN IN THE  S&P 500 DIVIDEND ARISTOCRA TS INDEX  — MARKING OUR Return to shareholders Our commitment to return a minimum 50% of our annual free cash  flow back to shareholders is part of our strategy for balanced capital  deployment.
","('Systemic_Risk_Management', 0.7675764560699463)","('Business_Model_Resilience', 0.07635734230279922)","('Management_Of_Legal_And_Regulatory_Framework', 0.025086326524615288)","(['Risk & Crisis Management'], 0.7675764560699463)","('NON-ESG', 0.07635734230279922)","('NON-ESG', 0.025086326524615288)"
Line 376,"In FY19, Medtronic had a free cash flow of $5.9 billion.
","('Systemic_Risk_Management', 0.8259193301200867)","('Competitive_Behavior', 0.0247129425406456)","('Supply_Chain_Management', 0.022376161068677902)","(['Risk & Crisis Management'], 0.8259193301200867)","('NON-ESG', 0.0247129425406456)","('NON-ESG', 0.022376161068677902)"
Line 377,"We returned $4.6 billion — 78% of the free cash we generated —   to our shareholders through dividends and net share repurchase.
","('Competitive_Behavior', 0.5085242390632629)","('Systemic_Risk_Management', 0.21210810542106628)","('Management_Of_Legal_And_Regulatory_Framework', 0.07696236670017242)","(['Business Ethics'], 0.5085242390632629)","('NON-ESG', 0.21210810542106628)","('NON-ESG', 0.07696236670017242)"
Line 378,"Dividend Per Share FY17 FY18 FY19$2.$2.$1.$1.00$1.72$1.84$2.0043Employee Compensation* ($ Millions)     FY17 FY18 FYEmployees 91,000+ 86,000+ 90,000+$9,$8,$8,$7,$6,$5,$5,000$8,486$8,796$9,179TOT AL COMPENSA TION† FY17 FY18 FY19parity, compares pay for all men and women, regardless of their job,  which factors in representation across all job levels.
","('Labor_Practices', 0.9499880075454712)","('Employee_Engagement_Inclusion_And_Diversity', 0.00922882929444313)","('Director_Removal', 0.005164049565792084)","(['Labor Practice Indicators'], 0.9499880075454712)","('NON-ESG', 0.00922882929444313)","('NON-ESG', 0.005164049565792084)"
Line 379,"Our latest report  reveals that our pay parity is at 13%, an improvement over last year  and smaller than the national average of 18%.
","('Labor_Practices', 0.9466182589530945)","('Director_Removal', 0.007016063667833805)","('Business_Ethics', 0.0037530167028307915)","(['Labor Practice Indicators'], 0.9466182589530945)","('NON-ESG', 0.007016063667833805)","('NON-ESG', 0.0037530167028307915)"
Line 380,"Pay parity differs from equal pay for equal work.
","('Labor_Practices', 0.9769462943077087)","('Director_Removal', 0.0020706423092633486)","('Waste_And_Hazardous_Materials_Management', 0.0014729686081409454)","(['Labor Practice Indicators'], 0.9769462943077087)","('NON-ESG', 0.0020706423092633486)","('NON-ESG', 0.0014729686081409454)"
Line 381,"More information on  our approach to pay equity is in the Inclusion and Diversity section.Compensation  We have achieved — and maintained — our position as a leading  medical technology company through the work of our talented  employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9678024649620056)","('Labor_Practices', 0.004208914004266262)","('Employee_Health_And_Safety', 0.004049124661833048)","(['Human Capital Development'], 0.9678024649620056)","('NON-ESG', 0.004208914004266262)","('NON-ESG', 0.004049124661833048)"
Line 382,"In FY19, Medtronic employed around 90,000 people in  more than 150 countries.
","('Labor_Practices', 0.25888386368751526)","('Supply_Chain_Management', 0.12078260630369186)","('Employee_Health_And_Safety', 0.08850756287574768)","('NON-ESG', 0.25888386368751526)","('NON-ESG', 0.12078260630369186)","('NON-ESG', 0.08850756287574768)"
Line 383,"We hire locally, stimulating the economies of  communities near our operations.
","('Human_Rights_And_Community_Relations', 0.3836282193660736)","('Employee_Engagement_Inclusion_And_Diversity', 0.10610806941986084)","('Competitive_Behavior', 0.08536762744188309)","('NON-ESG', 0.3836282193660736)","('NON-ESG', 0.10610806941986084)","('NON-ESG', 0.08536762744188309)"
Line 384,"Medtronic continues to report U.K. employee gender pay gap data  in line with disclosure requirements.
","('Labor_Practices', 0.9698015451431274)","('Employee_Engagement_Inclusion_And_Diversity', 0.00488131633028388)","('Director_Removal', 0.0022744196467101574)","(['Labor Practice Indicators'], 0.9698015451431274)","('NON-ESG', 0.00488131633028388)","('NON-ESG', 0.0022744196467101574)"
Line 385,"The pay gap, also known as pay  $5,$5,$4,$4,$3,500$5,006$5,127$5,355SALARY AND WAGES FY17 FY18 FY19 FY17 FY18 FY19$$$$$$$$300$$552$539RETIREMENT BENEFIT PLANS**    * All amounts are based on actual exchange rate.
","('Labor_Practices', 0.968798816204071)","('Director_Removal', 0.0027751533780246973)","('Management_Of_Legal_And_Regulatory_Framework', 0.0025704025756567717)","(['Labor Practice Indicators'], 0.968798816204071)","('NON-ESG', 0.0027751533780246973)","('NON-ESG', 0.0025704025756567717)"
Line 386,"†   T otal Compensation includes salary and wages, incentives, overtime, severance pay, payroll taxes,  retirement benefits, auto allowance, and other benefits.
","('Labor_Practices', 0.9763205647468567)","('Director_Removal', 0.0022091984283179045)","('Waste_And_Hazardous_Materials_Management', 0.00180633005220443)","(['Labor Practice Indicators'], 0.9763205647468567)","('NON-ESG', 0.0022091984283179045)","('NON-ESG', 0.00180633005220443)"
Line 387,"**  Retirement benefits spend fluctuates based on a variable 401k match component, incremental   to the standard 401k match.
","('Systemic_Risk_Management', 0.5897751450538635)","('Management_Of_Legal_And_Regulatory_Framework', 0.07227595895528793)","('Business_Model_Resilience', 0.059903230518102646)","(['Risk & Crisis Management'], 0.5897751450538635)","('NON-ESG', 0.07227595895528793)","('NON-ESG', 0.059903230518102646)"
Line 388,"FY17 reflects incremental expenses for voluntary early   retirement packages.Investments and expenditures Capital investments and operating expenses are required for  our continued success and growth, and they also support local  economies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3104669153690338)","('Business_Model_Resilience', 0.2725119888782501)","('Systemic_Risk_Management', 0.13441535830497742)","('NON-ESG', 0.3104669153690338)","('NON-ESG', 0.2725119888782501)","('NON-ESG', 0.13441535830497742)"
Line 389,"The wages and taxes we pay directly benefit individuals  and communities, while our business with suppliers leads to indirect  benefits by allowing them to hire and pay additional workers.
","('Labor_Practices', 0.978912889957428)","('Director_Removal', 0.001838657190091908)","('Management_Of_Legal_And_Regulatory_Framework', 0.0016030416591092944)","(['Labor Practice Indicators'], 0.978912889957428)","('NON-ESG', 0.001838657190091908)","('NON-ESG', 0.0016030416591092944)"
Line 390,"Acquisitions and divestitures Our aim is to offer a broad range of therapies to restore patients’  health and extend lives.
","('Access_And_Affordability', 0.456142783164978)","('Employee_Health_And_Safety', 0.19378845393657684)","('Customer_Welfare', 0.040700025856494904)","('NON-ESG', 0.456142783164978)","('NON-ESG', 0.19378845393657684)","('NON-ESG', 0.040700025856494904)"
Line 391,"We primarily achieve this through continued  investment in R&D but also through acquisitions.
","('Business_Model_Resilience', 0.2493796944618225)","('Management_Of_Legal_And_Regulatory_Framework', 0.17842243611812592)","('Systemic_Risk_Management', 0.13838519155979156)","('NON-ESG', 0.2493796944618225)","('NON-ESG', 0.17842243611812592)","('NON-ESG', 0.13838519155979156)"
Line 392,"We pursue  acquisitions that align with our Mission and bring new technology,  strategic skills, capabilities, and expertise to Medtronic.
","('Business_Model_Resilience', 0.49841833114624023)","('Product_Design_And_Lifecycle_Management', 0.18137525022029877)","('Employee_Engagement_Inclusion_And_Diversity', 0.03547506034374237)","('NON-ESG', 0.49841833114624023)","('NON-ESG', 0.18137525022029877)","('NON-ESG', 0.03547506034374237)"
Line 393,"Notable  acquisitions during FY19 include:   EPIX Therapeutics — expands our portfolio of tools to treat  patients with cardiac arrhythmias  Mazor Robotics — strengthens our position as a global leader in  technologies for spine surgery  Nutrino Health — enhances our ability to improve clinical  outcomes for people with diabetes  When appropriate, we use divestitures to more closely align our  product and therapy portfolio and business activities with our  strategic priorities.
","('Customer_Welfare', 0.29724276065826416)","('Product_Quality_And_Safety', 0.09268947690725327)","('Access_And_Affordability', 0.09106642752885818)","('NON-ESG', 0.29724276065826416)","('NON-ESG', 0.09268947690725327)","('NON-ESG', 0.09106642752885818)"
Line 394,"In FY19, we had no significant divestitures.
","('Systemic_Risk_Management', 0.4949188828468323)","('Business_Model_Resilience', 0.11145493388175964)","('Competitive_Behavior', 0.0895315557718277)","('NON-ESG', 0.4949188828468323)","('NON-ESG', 0.11145493388175964)","('NON-ESG', 0.0895315557718277)"
Line 395,"44PROMOTING  ENVIRONMENT AL STEWARDSHIP Contributing to human welfare  is central to our work.
","('Human_Rights_And_Community_Relations', 0.7755348086357117)","('Ecological_Impacts', 0.03822183609008789)","('Access_And_Affordability', 0.03359907865524292)","(['Community Relations'], 0.7755348086357117)","('NON-ESG', 0.03822183609008789)","('NON-ESG', 0.03359907865524292)"
Line 396,"We take a  holistic approach to improving  our efficiency and reducing our  impacts across our value chain,  starting with the development of  our products and extending to our  operations.
","('Product_Design_And_Lifecycle_Management', 0.9687527418136597)","('Product_Quality_And_Safety', 0.002751107094809413)","('Energy_Management', 0.0025108931586146355)","(['Product Stewardship'], 0.9687527418136597)","('NON-ESG', 0.002751107094809413)","('NON-ESG', 0.0025108931586146355)"
Line 397,"46REDUCING OUR   OPERA TIONAL FOOTPRINT Our planet provides clean air , water , and other natural resources  that communities and businesses depend on.
","('Ecological_Impacts', 0.958605170249939)","('GHG_Emissions', 0.008477662689983845)","('Water_And_Wastewater_Management', 0.007944841869175434)","(['Natural Capital'], 0.958605170249939)","('NON-ESG', 0.008477662689983845)","('NON-ESG', 0.007944841869175434)"
Line 398,"We are guided by  our Mission to make the world a healthier place, which we connect  with mitigating the impact we have on the environment.
","('Ecological_Impacts', 0.3573841452598572)","('Human_Rights_And_Community_Relations', 0.20267614722251892)","('Physical_Impacts_Of_Climate_Change', 0.0958341434597969)","('NON-ESG', 0.3573841452598572)","('NON-ESG', 0.20267614722251892)","('NON-ESG', 0.0958341434597969)"
Line 399,"Without a  healthy planet, we cannot have healthy people.
","('Access_And_Affordability', 0.32647478580474854)","('Human_Rights_And_Community_Relations', 0.14125202596187592)","('Employee_Engagement_Inclusion_And_Diversity', 0.0647682473063469)","('NON-ESG', 0.32647478580474854)","('NON-ESG', 0.14125202596187592)","('NON-ESG', 0.0647682473063469)"
Line 400,"We focus our efforts  on reducing the energy emissions, water , and waste footprint of our  operations and products.
","('Product_Design_And_Lifecycle_Management', 0.9239212274551392)","('Waste_And_Hazardous_Materials_Management', 0.017457786947488785)","('Energy_Management', 0.007098100148141384)","(['Product Stewardship'], 0.9239212274551392)","('NON-ESG', 0.017457786947488785)","('NON-ESG', 0.007098100148141384)"
Line 401,"Being a good environmental steward is part of our business  strategy.
","('Business_Model_Resilience', 0.3050974905490875)","('Ecological_Impacts', 0.22801902890205383)","('Product_Design_And_Lifecycle_Management', 0.12794330716133118)","('NON-ESG', 0.3050974905490875)","('NON-ESG', 0.22801902890205383)","('NON-ESG', 0.12794330716133118)"
Line 402,"Our global Environmental Health and Safety (EHS)  Policy establishes our performance management system to set  goals, measure progress, and integrate sustainability into decision- making.
","('Employee_Health_And_Safety', 0.9446593523025513)","('Critical_Incident_Risk_Management', 0.011225796304643154)","('Product_Quality_And_Safety', 0.007863250561058521)","(['Operational Eco-Efficiency'], 0.9446593523025513)","('NON-ESG', 0.011225796304643154)","('NON-ESG', 0.007863250561058521)"
Line 403,"It also addresses climate change — an issue that presents  risks and potential disruption for global business.
","('Physical_Impacts_Of_Climate_Change', 0.9560636878013611)","('Business_Model_Resilience', 0.00813448429107666)","('Supply_Chain_Management', 0.004082944709807634)","(['Climate Change'], 0.9560636878013611)","('NON-ESG', 0.00813448429107666)","('NON-ESG', 0.004082944709807634)"
Line 404,"Potential risks to our business from climate change include severe  weather events, unexpected or sweeping policy changes, and  reputational harm from lack of engagement regarding potential  impacts.
","('Physical_Impacts_Of_Climate_Change', 0.9481520056724548)","('Business_Model_Resilience', 0.015056817792356014)","('Systemic_Risk_Management', 0.003897779854014516)","(['Climate Change'], 0.9481520056724548)","('NON-ESG', 0.015056817792356014)","('NON-ESG', 0.003897779854014516)"
Line 405,"T ransitioning where possible to resilient power sources  may help drive innovation and accelerate the supply of competitively  priced renewable energy.
","('Business_Model_Resilience', 0.5579835176467896)","('Supply_Chain_Management', 0.13560877740383148)","('Product_Design_And_Lifecycle_Management', 0.06192687153816223)","(['Codes of Business Conduct'], 0.5579835176467896)","('NON-ESG', 0.13560877740383148)","('NON-ESG', 0.06192687153816223)"
Line 406,"Our response to these risks and  opportunities is to continue to invest in renewable energy and  business resilience programs.
","('Business_Model_Resilience', 0.9113878607749939)","('Physical_Impacts_Of_Climate_Change', 0.015903232619166374)","('Supply_Chain_Management', 0.009265173226594925)","(['Codes of Business Conduct'], 0.9113878607749939)","('NON-ESG', 0.015903232619166374)","('NON-ESG', 0.009265173226594925)"
Line 407,"Our climate strategy and detailed environmental data are available  in our CDP disclosure.
","('Physical_Impacts_Of_Climate_Change', 0.910205066204071)","('Business_Model_Resilience', 0.023168301209807396)","('GHG_Emissions', 0.013272542506456375)","(['Climate Change'], 0.910205066204071)","('NON-ESG', 0.023168301209807396)","('NON-ESG', 0.013272542506456375)"
Line 408,"Our corporate EHS teams oversee compliance, environmental  management and remediation, health and safety, and training.
","('Critical_Incident_Risk_Management', 0.43222206830978394)","('Employee_Health_And_Safety', 0.2536347210407257)","('Management_Of_Legal_And_Regulatory_Framework', 0.04661380872130394)","('NON-ESG', 0.43222206830978394)","('NON-ESG', 0.2536347210407257)","('NON-ESG', 0.04661380872130394)"
Line 409,"The  EHS teams collaborate with regional directors who are responsible  for policy and programs across our global regions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8091274499893188)","('Human_Rights_And_Community_Relations', 0.04854133725166321)","('Director_Removal', 0.024746621027588844)","(['Corporate Governance'], 0.8091274499893188)","('NON-ESG', 0.04854133725166321)","('NON-ESG', 0.024746621027588844)"
Line 410,"The Medtronic  Nominating and Corporate Governance Committee oversees our  sustainability strategy, including environmental topics.PROMOTING  ENVIRONMENT AL  STEWARDSHIP Adding   Business Value   Actively managing our environmental impacts and reducing  our footprint is not only the responsible thing to do — it fosters  positive relationships with communities and other stakeholders  and reduces operating costs.WITH REDUCTIONS  IN ENERGY USE, EMISSIONS, NON- REGULA TED WASTE, &  WA TER USE SINCE 2013.4                    5OUT  OF AS OF FY19,, WE SURPASSED ENVIRONMENT AL PERFORMANCE   GOALS FOR FY2047inspections resulted in fines.
","('Ecological_Impacts', 0.13965973258018494)","('Human_Rights_And_Community_Relations', 0.13901859521865845)","('Energy_Management', 0.11098357290029526)","('NON-ESG', 0.13965973258018494)","('NON-ESG', 0.13901859521865845)","('NON-ESG', 0.11098357290029526)"
Line 411,"The Medtronic  Nominating and Corporate Governance Committee oversees our  sustainability strategy, including environmental topics.PROMOTING  ENVIRONMENT AL  STEWARDSHIP Adding   Business Value   Actively managing our environmental impacts and reducing  our footprint is not only the responsible thing to do — it fosters  positive relationships with communities and other stakeholders  and reduces operating costs.WITH REDUCTIONS  IN ENERGY USE, EMISSIONS, NON- REGULA TED WASTE, &  WA TER USE SINCE 2013.4                    5OUT  OF AS OF FY19,, WE SURPASSED ENVIRONMENT AL PERFORMANCE   GOALS FOR FY2047inspections resulted in fines.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6409348249435425)","('Business_Ethics', 0.25688353180885315)","('Systemic_Risk_Management', 0.012269149534404278)","(['Corporate Governance'], 0.6409348249435425)","('NON-ESG', 0.25688353180885315)","('NON-ESG', 0.012269149534404278)"
Line 412,"We  implemented and completed  corrective actions for every  noncompliance identified.
","('Business_Ethics', 0.7551312446594238)","('Management_Of_Legal_And_Regulatory_Framework', 0.12855033576488495)","('Product_Quality_And_Safety', 0.015864234417676926)","(['Business Ethics'], 0.7551312446594238)","('NON-ESG', 0.12855033576488495)","('NON-ESG', 0.015864234417676926)"
Line 413,"Globally, Medtronic manages   25 cleanup sites.
","('Waste_And_Hazardous_Materials_Management', 0.6094334125518799)","('Ecological_Impacts', 0.08863118290901184)","('Employee_Health_And_Safety', 0.033489890396595)","(['Operational Eco-Efficiency'], 0.6094334125518799)","('NON-ESG', 0.08863118290901184)","('NON-ESG', 0.033489890396595)"
Line 414,"Nine of the   U.S. sites fall under the  Comprehensive Environmental  Response, Compensation,   and Liability Act, also known   as Superfund.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20322862267494202)","('Systemic_Risk_Management', 0.20071637630462646)","('Physical_Impacts_Of_Climate_Change', 0.138094961643219)","('NON-ESG', 0.20322862267494202)","('NON-ESG', 0.20071637630462646)","('NON-ESG', 0.138094961643219)"
Line 415,"FY20 environmental  performance goals We designed our environmental  performance goals to drive  improvement across the  organization in the areas of energy  use, emissions, waste, and water .
","('Water_And_Wastewater_Management', 0.28291550278663635)","('Ecological_Impacts', 0.12949450314044952)","('GHG_Emissions', 0.10694149881601334)","('NON-ESG', 0.28291550278663635)","('NON-ESG', 0.12949450314044952)","('NON-ESG', 0.10694149881601334)"
Line 416,"As of FY19, we surpassed four of  our five FY20 goals with reductions  in energy use, greenhouse gas  (GHG) emissions, non-regulated  waste, and water use since FY13.
","('GHG_Emissions', 0.9701041579246521)","('Ecological_Impacts', 0.0034452315885573626)","('Air_Quality', 0.0027816963847726583)","(['Climate Change'], 0.9701041579246521)","('NON-ESG', 0.0034452315885573626)","('NON-ESG', 0.0027816963847726583)"
Line 417,"In FY20, we will launch new goals,  committing us to further reduce  the environmental impact of our  operations by FY25.Mitigating impacts with  management systems  Manufacturing facilities  account for most of our energy  consumption, water use, and  waste generation.
","('Energy_Management', 0.8431668281555176)","('Water_And_Wastewater_Management', 0.035202059894800186)","('Product_Design_And_Lifecycle_Management', 0.028893956914544106)","(['Operational Eco-Efficiency'], 0.8431668281555176)","('NON-ESG', 0.035202059894800186)","('NON-ESG', 0.028893956914544106)"
Line 418,"At those sites  we use management systems,  based on the ISO 14001 and  OHSAS 18001 standards, to  track EHS performance.
","('Product_Quality_And_Safety', 0.38589808344841003)","('Management_Of_Legal_And_Regulatory_Framework', 0.1256953477859497)","('Business_Model_Resilience', 0.06806313991546631)","('NON-ESG', 0.38589808344841003)","('NON-ESG', 0.1256953477859497)","('NON-ESG', 0.06806313991546631)"
Line 419,"At  certain facilities we pursue  third-party certification for our  management systems.
","('Management_Of_Legal_And_Regulatory_Framework', 0.17836719751358032)","('Product_Design_And_Lifecycle_Management', 0.1252819448709488)","('Product_Quality_And_Safety', 0.10745242238044739)","('NON-ESG', 0.17836719751358032)","('NON-ESG', 0.1252819448709488)","('NON-ESG', 0.10745242238044739)"
Line 420,"Environmental compliance We strive for 100%  compliance with applicable  environmental laws and  regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9453241229057312)","('Human_Rights_And_Community_Relations', 0.007402218412607908)","('Ecological_Impacts', 0.005989333149045706)","(['Corporate Governance'], 0.9453241229057312)","('NON-ESG', 0.007402218412607908)","('NON-ESG', 0.005989333149045706)"
Line 421,"In instances where  a noncompliance event occurs,  we have programs in place to  investigate the matter and  institute corrective actions to  effectively address issues.
","('Business_Ethics', 0.665482759475708)","('Management_Of_Legal_And_Regulatory_Framework', 0.20519107580184937)","('Product_Quality_And_Safety', 0.017163429409265518)","(['Business Ethics'], 0.665482759475708)","('NON-ESG', 0.20519107580184937)","('NON-ESG', 0.017163429409265518)"
Line 422,"In FY19, we had 26  environmental compliance  inspections, with 9 inspections  resulting in noncompliance  notices.
","('Business_Ethics', 0.5110729336738586)","('Management_Of_Legal_And_Regulatory_Framework', 0.23550032079219818)","('Product_Quality_And_Safety', 0.04246801882982254)","(['Business Ethics'], 0.5110729336738586)","('NON-ESG', 0.23550032079219818)","('NON-ESG', 0.04246801882982254)"
Line 423,"None of these FY20  ENVIRONMENT AL PERFORMANCE GOALS IN ENERGY USE,   GHG EMISSIONS,   AND NON-REGULA TED WASTEREDUCTION   REDUCTION 15% 10% IN WA TER USE AND   REGULA TED WASTEProgress T oward Our Environmental Performance Goals*  31.28.2133.FY20 Goal0FY17** FY18 FY19kWh/$ Million Revenue Fiscal Y earENERGY USE -26%  Change from FY13Achieved    * All percentage reduction goals are based on a FY13 baseline year recalculated to account for  Covidien acquisition in FY15.
","('Waste_And_Hazardous_Materials_Management', 0.8021142482757568)","('GHG_Emissions', 0.03733592480421066)","('Energy_Management', 0.02805059589445591)","(['Operational Eco-Efficiency'], 0.8021142482757568)","('NON-ESG', 0.03733592480421066)","('NON-ESG', 0.02805059589445591)"
Line 424,"All data reflects Medtronic and Covidien operations.
","('Business_Model_Resilience', 0.3287164270877838)","('Systemic_Risk_Management', 0.29867008328437805)","('Supply_Chain_Management', 0.09143244475126266)","('NON-ESG', 0.3287164270877838)","('NON-ESG', 0.29867008328437805)","('NON-ESG', 0.09143244475126266)"
Line 425,"**FY17 was recalculated to account for Cardinal divestiture.10.9.4512.0FY17** FY18 FY19Metric T ons/$ Million Revenue Fiscal Y earGHG EMISSIONS -38%*  Change from FY13FY20 GoalAchieved 757901FY20 Goal1,1001,1,1,0FY17** FY18 FY19Metric T ons/$ Billion Revenue Fiscal Y earNON-REGULA TED WASTE -33%*  Change from FY13Achieved FY20 Goal0FY17** FY18 FY19Metric T ons/$ Billion Revenue Fiscal Y earREGULA TED WASTE -8%*  Change from FY13697573FY20 Goal0FY17** FY18 FY19Cubic Meters/$ Million Revenue Fiscal Y earWA TER USE -23%*  Change from FY13Achieved49FY19 Performance FY20 Goal 862,040908,874 900,28.231.133.3Fiscal Y ear Fiscal Y ear28.231.133.31,400,1,200,1,000,400,000600,000800,200,FY17 * FY18 FY19FY17 * FY18 FY19MWh MWh/$ Million RevenueMWh/$ Million Revenue*FY16 data reﬂects January 2015 Covidien acquisition.
","('Systemic_Risk_Management', 0.3138495981693268)","('Competitive_Behavior', 0.15057556331157684)","('Management_Of_Legal_And_Regulatory_Framework', 0.14836347103118896)","('NON-ESG', 0.3138495981693268)","('NON-ESG', 0.15057556331157684)","('NON-ESG', 0.14836347103118896)"
Line 426,"**FY17 was recalculated to account for Cardinal divestiture.10.9.4512.0FY17** FY18 FY19Metric T ons/$ Million Revenue Fiscal Y earGHG EMISSIONS -38%*  Change from FY13FY20 GoalAchieved 757901FY20 Goal1,1001,1,1,0FY17** FY18 FY19Metric T ons/$ Billion Revenue Fiscal Y earNON-REGULA TED WASTE -33%*  Change from FY13Achieved FY20 Goal0FY17** FY18 FY19Metric T ons/$ Billion Revenue Fiscal Y earREGULA TED WASTE -8%*  Change from FY13697573FY20 Goal0FY17** FY18 FY19Cubic Meters/$ Million Revenue Fiscal Y earWA TER USE -23%*  Change from FY13Achieved49FY19 Performance FY20 Goal 862,040908,874 900,28.231.133.3Fiscal Y ear Fiscal Y ear28.231.133.31,400,1,200,1,000,400,000600,000800,200,FY17 * FY18 FY19FY17 * FY18 FY19MWh MWh/$ Million RevenueMWh/$ Million Revenue*FY16 data reﬂects January 2015 Covidien acquisition.
","('Systemic_Risk_Management', 0.35973894596099854)","('Business_Model_Resilience', 0.3042283058166504)","('Supply_Chain_Management', 0.040428441017866135)","('NON-ESG', 0.35973894596099854)","('NON-ESG', 0.3042283058166504)","('NON-ESG', 0.040428441017866135)"
Line 427,"Prior year data does not include legacy Covidien operations.
","('Business_Model_Resilience', 0.2710798978805542)","('Systemic_Risk_Management', 0.20118145644664764)","('Customer_Privacy', 0.08708885312080383)","('NON-ESG', 0.2710798978805542)","('NON-ESG', 0.20118145644664764)","('NON-ESG', 0.08708885312080383)"
Line 428,"†FY16 and FY17 were recalculated to account for the Cardinal divestiture.
","('Business_Model_Resilience', 0.5617088079452515)","('Systemic_Risk_Management', 0.15803587436676025)","('Director_Removal', 0.04305316135287285)","(['Codes of Business Conduct'], 0.5617088079452515)","('NON-ESG', 0.15803587436676025)","('NON-ESG', 0.04305316135287285)"
Line 429,"ENERGY USEMANAGING GHG EMISSIONS   AND ENERGY USE Compared to our FY13 baseline, in FY19 we consumed 26% less  energy and generated 38% fewer GHG emissions per million dollars  revenue.
","('GHG_Emissions', 0.9606128334999084)","('Air_Quality', 0.006878867279738188)","('Energy_Management', 0.004203427582979202)","(['Climate Change'], 0.9606128334999084)","('NON-ESG', 0.006878867279738188)","('NON-ESG', 0.004203427582979202)"
Line 430,"Our global energy strategy reduces emissions through  conservation, renewable energy sourcing, and onsite generation.
","('Energy_Management', 0.9736986756324768)","('Management_Of_Legal_And_Regulatory_Framework', 0.0037612044252455235)","('Product_Design_And_Lifecycle_Management', 0.0024726204574108124)","(['Operational Eco-Efficiency'], 0.9736986756324768)","('NON-ESG', 0.0037612044252455235)","('NON-ESG', 0.0024726204574108124)"
Line 431,"Emissions In FY19, our combined Scope 1 and 2 emissions were 289,000 metric  tons (MT) carbon dioxide equivalent, a nearly 4% decrease from  the prior year .
","('GHG_Emissions', 0.9293427467346191)","('Air_Quality', 0.027564547955989838)","('Ecological_Impacts', 0.005338048562407494)","(['Climate Change'], 0.9293427467346191)","('NON-ESG', 0.027564547955989838)","('NON-ESG', 0.005338048562407494)"
Line 432,"We produced 9.5 MT of emissions per million dollars  revenue in FY19 compared to 10.2 MT per million dollars revenue in  FY18.
","('Energy_Management', 0.5277745127677917)","('GHG_Emissions', 0.2078949362039566)","('Management_Of_Legal_And_Regulatory_Framework', 0.07452056556940079)","(['Operational Eco-Efficiency'], 0.5277745127677917)","('NON-ESG', 0.2078949362039566)","('NON-ESG', 0.07452056556940079)"
Line 433,"We achieved this reduction by implementing 133 conservation  projects, generating 75,500 MWh of energy onsite and sourcing  renewables for 35% of our total energy needs.
","('Energy_Management', 0.9798415899276733)","('Management_Of_Legal_And_Regulatory_Framework', 0.0022198844235390425)","('Critical_Incident_Risk_Management', 0.001681676832959056)","(['Operational Eco-Efficiency'], 0.9798415899276733)","('NON-ESG', 0.0022198844235390425)","('NON-ESG', 0.001681676832959056)"
Line 434,"Greenhouse Gas Emissions (MT) CO2e  FY17 FY18 FYScope 1   (natural gas, fuels, refrigerants)74,992 65,312 62,Scope 2   (electricity, district cooling)269,008 233,364 225,841299,10.212.7Fiscal Y ear Fiscal Y ear9.5289,000FY20 Goal400,300,200,100,FY17 * FY18 FY19FY17 * FY18 FY19Metric T ons Metric T ons/$ Million RevenueMetric T ons/$ Million Revenue1012.10.9.5GHG EMISSIONS 344,* FY17 was recalculated to account for the Cardinal divestiture.
","('GHG_Emissions', 0.9636130332946777)","('Air_Quality', 0.007153209764510393)","('Ecological_Impacts', 0.003448059083893895)","(['Climate Change'], 0.9636130332946777)","('NON-ESG', 0.007153209764510393)","('NON-ESG', 0.003448059083893895)"
Line 435,"Onsite Energy Generation T ype of Project Installation  DateEnergy Generated   (Per Y ear) (MWh)Location Fuel Cell FY18 2,600 North Haven,  Connecticut  Fuel Cell FY18 1,700 North Haven,  Connecticut  Fuel Cell FY17 12,400 Northridge,  California Fuel Cell FY15 3,500 Santa Rosa,  California Cogeneration FY12 2,500 Mirandola, Italy Cogeneration FY11 3,400 Athlone, Ireland Cogeneration FY09 43,000 North Haven,  Connecticut Solar FY20 6,000 Juncos, Puerto  Rico* Solar FY18 105 Tijuana, Mexico Solar FY16 110 Mirandola, Italy Solar FY13 220 Santa Rosa,  California * Site came online in January 2017 but was decommissioned after Hurricane Maria in September 2017.
","('Energy_Management', 0.9680641889572144)","('GHG_Emissions', 0.0038593693170696497)","('Management_Of_Legal_And_Regulatory_Framework', 0.003758458187803626)","(['Operational Eco-Efficiency'], 0.9680641889572144)","('NON-ESG', 0.0038593693170696497)","('NON-ESG', 0.003758458187803626)"
Line 436,"Onsite Energy Generation T ype of Project Installation  DateEnergy Generated   (Per Y ear) (MWh)Location Fuel Cell FY18 2,600 North Haven,  Connecticut  Fuel Cell FY18 1,700 North Haven,  Connecticut  Fuel Cell FY17 12,400 Northridge,  California Fuel Cell FY15 3,500 Santa Rosa,  California Cogeneration FY12 2,500 Mirandola, Italy Cogeneration FY11 3,400 Athlone, Ireland Cogeneration FY09 43,000 North Haven,  Connecticut Solar FY20 6,000 Juncos, Puerto  Rico* Solar FY18 105 Tijuana, Mexico Solar FY16 110 Mirandola, Italy Solar FY13 220 Santa Rosa,  California * Site came online in January 2017 but was decommissioned after Hurricane Maria in September 2017.
","('Physical_Impacts_Of_Climate_Change', 0.8958942294120789)","('Business_Model_Resilience', 0.013813151977956295)","('GHG_Emissions', 0.01257322821766138)","(['Climate Change'], 0.8958942294120789)","('NON-ESG', 0.013813151977956295)","('NON-ESG', 0.01257322821766138)"
Line 437,"A rebuild is underway and we expect to recommission the site in 2019.and process water systems at  20 Medtronic locations.
","('Water_And_Wastewater_Management', 0.9736673831939697)","('Waste_And_Hazardous_Materials_Management', 0.002650848589837551)","('GHG_Emissions', 0.0019190463935956359)","(['Operational Eco-Efficiency'], 0.9736673831939697)","('NON-ESG', 0.002650848589837551)","('NON-ESG', 0.0019190463935956359)"
Line 438,"This  work brought part of our utility  infrastructure equipment back  to maximum efficiency and  extended its useful life.
","('Energy_Management', 0.9526696801185608)","('Product_Design_And_Lifecycle_Management', 0.010134367272257805)","('Management_Of_Legal_And_Regulatory_Framework', 0.0034130304120481014)","(['Operational Eco-Efficiency'], 0.9526696801185608)","('NON-ESG', 0.010134367272257805)","('NON-ESG', 0.0034130304120481014)"
Line 439,"In FY20,  Medtronic will complete an  optimization initiative focused  on global building automation,  HVAC, and compressed   air systems.
","('Energy_Management', 0.4360419809818268)","('Air_Quality', 0.4186597764492035)","('Water_And_Wastewater_Management', 0.022881263867020607)","('NON-ESG', 0.4360419809818268)","('NON-ESG', 0.4186597764492035)","('NON-ESG', 0.022881263867020607)"
Line 440,"Sourcing renewable grid  electricity has been part of our  energy strategy since 2007.
","('Energy_Management', 0.9635377526283264)","('Management_Of_Legal_And_Regulatory_Framework', 0.00540552381426096)","('Product_Design_And_Lifecycle_Management', 0.003482585772871971)","(['Operational Eco-Efficiency'], 0.9635377526283264)","('NON-ESG', 0.00540552381426096)","('NON-ESG', 0.003482585772871971)"
Line 441,"In  FY19, we sourced 22,000 MWh  of renewable energy.
","('Energy_Management', 0.9700590372085571)","('Management_Of_Legal_And_Regulatory_Framework', 0.005323926452547312)","('GHG_Emissions', 0.0030594365671277046)","(['Operational Eco-Efficiency'], 0.9700590372085571)","('NON-ESG', 0.005323926452547312)","('NON-ESG', 0.0030594365671277046)"
Line 442,"Investing in energy  efficiency In FY19, our total energy use  was 862,000 megawatt-hours  (MWh), a 5% decrease from  the prior year .
","('Energy_Management', 0.980865478515625)","('Air_Quality', 0.0018098880536854267)","('Management_Of_Legal_And_Regulatory_Framework', 0.0018033779924735427)","(['Operational Eco-Efficiency'], 0.980865478515625)","('NON-ESG', 0.0018098880536854267)","('NON-ESG', 0.0018033779924735427)"
Line 443,"Of our energy  use, we generate 75,535 MWh  onsite (around 9% of our total  annual use) from renewable and  alternative energy sources.
","('Energy_Management', 0.9802125692367554)","('Management_Of_Legal_And_Regulatory_Framework', 0.0019600538071244955)","('Product_Design_And_Lifecycle_Management', 0.0016337232664227486)","(['Operational Eco-Efficiency'], 0.9802125692367554)","('NON-ESG', 0.0019600538071244955)","('NON-ESG', 0.0016337232664227486)"
Line 444,"We consumed 28 kilowatt- hours (kWh) per million dollars  revenue in FY19 compared to   31 kWh per million dollars  revenue in FY18.
","('Energy_Management', 0.9707604646682739)","('Management_Of_Legal_And_Regulatory_Framework', 0.004232089966535568)","('GHG_Emissions', 0.0028895707800984383)","(['Operational Eco-Efficiency'], 0.9707604646682739)","('NON-ESG', 0.004232089966535568)","('NON-ESG', 0.0028895707800984383)"
Line 445,"In FY19, we continued our  program to convert all Medtronic  lighting to LED bulbs.
","('Energy_Management', 0.8951389193534851)","('Product_Design_And_Lifecycle_Management', 0.025877023115754128)","('Critical_Incident_Risk_Management', 0.005347029771655798)","(['Operational Eco-Efficiency'], 0.8951389193534851)","('NON-ESG', 0.025877023115754128)","('NON-ESG', 0.005347029771655798)"
Line 446,"During the  year , we completed 17 retrofit  projects, 5 of which were site- wide upgrades.
","('Energy_Management', 0.4410577118396759)","('Product_Design_And_Lifecycle_Management', 0.08284693956375122)","('Water_And_Wastewater_Management', 0.05197408050298691)","('NON-ESG', 0.4410577118396759)","('NON-ESG', 0.08284693956375122)","('NON-ESG', 0.05197408050298691)"
Line 447,"Our transition to  LED lighting is now complete at  major sites, and we estimate we  will save 10,000 MWh per year .
","('Energy_Management', 0.9651240110397339)","('Product_Design_And_Lifecycle_Management', 0.0035650739446282387)","('Management_Of_Legal_And_Regulatory_Framework', 0.002949964487925172)","(['Operational Eco-Efficiency'], 0.9651240110397339)","('NON-ESG', 0.0035650739446282387)","('NON-ESG', 0.002949964487925172)"
Line 448,"We also conducted a  thorough assessment and  recommissioning of chilled FY19 ENERGY CONSERVA TION Energy  Conservation  Projects41,MWh/Y ear   Energy  Conservation  Savings15,MT GHG  Emissions  Avoided  $0.8M Savings from  Energy Rebates  $4.3M Estimated  Operational  Costs Savings as  a Result of FY19  Energy Projects CASE STUDY REBUILDING IN  PUERTO RICO AFTER  HURRICANE MARIA When Hurricane Maria   hit Puerto Rico in  September 2017, a solar- powered system at our  Juncos site, completed   in January 2017, was   largely destroyed by   the Category 5 storm.
","('GHG_Emissions', 0.8751290440559387)","('Energy_Management', 0.03226922079920769)","('Physical_Impacts_Of_Climate_Change', 0.020413247868418694)","(['Climate Change'], 0.8751290440559387)","('NON-ESG', 0.03226922079920769)","('NON-ESG', 0.020413247868418694)"
Line 449,"We also conducted a  thorough assessment and  recommissioning of chilled FY19 ENERGY CONSERVA TION Energy  Conservation  Projects41,MWh/Y ear   Energy  Conservation  Savings15,MT GHG  Emissions  Avoided  $0.8M Savings from  Energy Rebates  $4.3M Estimated  Operational  Costs Savings as  a Result of FY19  Energy Projects CASE STUDY REBUILDING IN  PUERTO RICO AFTER  HURRICANE MARIA When Hurricane Maria   hit Puerto Rico in  September 2017, a solar- powered system at our  Juncos site, completed   in January 2017, was   largely destroyed by   the Category 5 storm.
","('Physical_Impacts_Of_Climate_Change', 0.7500269412994385)","('Critical_Incident_Risk_Management', 0.05294128507375717)","('Business_Model_Resilience', 0.03350532799959183)","(['Climate Change'], 0.7500269412994385)","('NON-ESG', 0.05294128507375717)","('NON-ESG', 0.03350532799959183)"
Line 450,"After the storm, only   20% of the installation   was usable.
","('Physical_Impacts_Of_Climate_Change', 0.5113852024078369)","('Critical_Incident_Risk_Management', 0.22366292774677277)","('Air_Quality', 0.04215795174241066)","(['Climate Change'], 0.5113852024078369)","('NON-ESG', 0.22366292774677277)","('NON-ESG', 0.04215795174241066)"
Line 451,"Understanding  the need for renewable  energy, we are reinvesting  in the project and  rebuilding the structure  to withstand hurricane  conditions, making  Medtronic even more  resilient to severe weather .
","('Physical_Impacts_Of_Climate_Change', 0.6698436141014099)","('Business_Model_Resilience', 0.2087680697441101)","('Supply_Chain_Management', 0.013995392248034477)","(['Climate Change'], 0.6698436141014099)","('NON-ESG', 0.2087680697441101)","('NON-ESG', 0.013995392248034477)"
Line 452,"Medtronic proactively manages  hazardous waste to prevent  negative environmental  impacts and reduce liability  risks.
","('Waste_And_Hazardous_Materials_Management', 0.9840770363807678)","('Data_Security', 0.0011586516629904509)","('Air_Quality', 0.0010847111698240042)","(['Operational Eco-Efficiency'], 0.9840770363807678)","('NON-ESG', 0.0011586516629904509)","('NON-ESG', 0.0010847111698240042)"
Line 453,"Prior to contracting  vendors, we assess their  waste management process  against our expectations and  requirements.
","('Waste_And_Hazardous_Materials_Management', 0.9787960648536682)","('Water_And_Wastewater_Management', 0.0020449901930987835)","('Air_Quality', 0.0016530680004507303)","(['Operational Eco-Efficiency'], 0.9787960648536682)","('NON-ESG', 0.0020449901930987835)","('NON-ESG', 0.0016530680004507303)"
Line 454,"We participate in  programs to audit and assess  vendors for best practices in the  waste management field.
","('Waste_And_Hazardous_Materials_Management', 0.9790729284286499)","('Water_And_Wastewater_Management', 0.001787828397937119)","('Product_Design_And_Lifecycle_Management', 0.0016108249546959996)","(['Operational Eco-Efficiency'], 0.9790729284286499)","('NON-ESG', 0.001787828397937119)","('NON-ESG', 0.0016108249546959996)"
Line 455,"We  monitor vendors throughout our  relationship to ensure that they  meet or exceed our standards.
","('Product_Quality_And_Safety', 0.33651965856552124)","('Business_Ethics', 0.2802009582519531)","('Competitive_Behavior', 0.07703142613172531)","('NON-ESG', 0.33651965856552124)","('NON-ESG', 0.2802009582519531)","('NON-ESG', 0.07703142613172531)"
Line 456,"In FY19, we produced   3,005 MT of regulated waste,   a 3% decrease from the prior  year .
","('Waste_And_Hazardous_Materials_Management', 0.9830978512763977)","('Water_And_Wastewater_Management', 0.0016272453358396888)","('Air_Quality', 0.0016051033744588494)","(['Operational Eco-Efficiency'], 0.9830978512763977)","('NON-ESG', 0.0016272453358396888)","('NON-ESG', 0.0016051033744588494)"
Line 457,"In FY19, we produced   98 MT per billion dollars revenue  of regulated waste, compared  to 105 MT per billion dollars  revenue in FY18.
","('Waste_And_Hazardous_Materials_Management', 0.9789397120475769)","('Water_And_Wastewater_Management', 0.002880609128624201)","('Air_Quality', 0.0019121438963338733)","(['Operational Eco-Efficiency'], 0.9789397120475769)","('NON-ESG', 0.002880609128624201)","('NON-ESG', 0.0019121438963338733)"
Line 458,"Innovative  operational solutions and waste in FY19, compared to   757 MT per billion dollars revenue  in FY18.
","('Waste_And_Hazardous_Materials_Management', 0.9573308825492859)","('Water_And_Wastewater_Management', 0.006871421821415424)","('Air_Quality', 0.004687909036874771)","(['Operational Eco-Efficiency'], 0.9573308825492859)","('NON-ESG', 0.006871421821415424)","('NON-ESG', 0.004687909036874771)"
Line 459,"Our recycling rate   was 54%.
","('Energy_Management', 0.3078290522098541)","('Product_Design_And_Lifecycle_Management', 0.16845209896564484)","('Waste_And_Hazardous_Materials_Management', 0.08714983612298965)","('NON-ESG', 0.3078290522098541)","('NON-ESG', 0.16845209896564484)","('NON-ESG', 0.08714983612298965)"
Line 460,"Our Strategic Meetings  Management group partners  with employees to reduce  the environmental impact of  Medtronic meetings and events.
","('Management_Of_Legal_And_Regulatory_Framework', 0.21830686926841736)","('Human_Rights_And_Community_Relations', 0.15339191257953644)","('Employee_Health_And_Safety', 0.07452698796987534)","('NON-ESG', 0.21830686926841736)","('NON-ESG', 0.15339191257953644)","('NON-ESG', 0.07452698796987534)"
Line 461,"We encourage organizers to  focus on 20 actions that reduce  energy, water , and waste impacts  while providing cost savings.
","('Energy_Management', 0.9174832701683044)","('Water_And_Wastewater_Management', 0.031746987253427505)","('Product_Design_And_Lifecycle_Management', 0.00558070745319128)","(['Operational Eco-Efficiency'], 0.9174832701683044)","('NON-ESG', 0.031746987253427505)","('NON-ESG', 0.00558070745319128)"
Line 462,"For example, waste initiatives in  FY19 included going paperless,  eliminating disposable products,  and organizing food donation  and compost programs.
","('Waste_And_Hazardous_Materials_Management', 0.9787443280220032)","('Water_And_Wastewater_Management', 0.0020459117367863655)","('Product_Design_And_Lifecycle_Management', 0.0020072627812623978)","(['Operational Eco-Efficiency'], 0.9787443280220032)","('NON-ESG', 0.0020459117367863655)","('NON-ESG', 0.0020072627812623978)"
Line 463,"Throughout the year , we saved  an estimated $280,000 by  implementing more sustainable  practices at U.S. meetings   and events.
","('Product_Design_And_Lifecycle_Management', 0.2819504141807556)","('Business_Model_Resilience', 0.12176504731178284)","('Management_Of_Legal_And_Regulatory_Framework', 0.0912831574678421)","('NON-ESG', 0.2819504141807556)","('NON-ESG', 0.12176504731178284)","('NON-ESG', 0.0912831574678421)"
Line 464,"REDUCING WASTE  AND WA TER USE When we manage our waste  and water use, we reduce  our environmental impact,  operational costs, and risk.
","('Waste_And_Hazardous_Materials_Management', 0.9817482829093933)","('Water_And_Wastewater_Management', 0.001549683976918459)","('Product_Design_And_Lifecycle_Management', 0.0014648499200120568)","(['Operational Eco-Efficiency'], 0.9817482829093933)","('NON-ESG', 0.001549683976918459)","('NON-ESG', 0.0014648499200120568)"
Line 465,"Our FY19 performance shows a  33% reduction in non-regulated  waste and an 8% reduction  in regulated waste per billion  dollars revenue, compared to  our FY13 baseline.
","('Waste_And_Hazardous_Materials_Management', 0.9827200174331665)","('Water_And_Wastewater_Management', 0.0016856063157320023)","('Air_Quality', 0.0014943681890144944)","(['Operational Eco-Efficiency'], 0.9827200174331665)","('NON-ESG', 0.0016856063157320023)","('NON-ESG', 0.0014943681890144944)"
Line 466,"Reducing waste In FY19, we implemented a new  recycling process to transition  some regulated waste streams  into non-regulated waste.
","('Waste_And_Hazardous_Materials_Management', 0.9841820597648621)","('Data_Security', 0.0013215827057138085)","('Air_Quality', 0.0011741230264306068)","(['Operational Eco-Efficiency'], 0.9841820597648621)","('NON-ESG', 0.0013215827057138085)","('NON-ESG', 0.0011741230264306068)"
Line 467,"We  also improved waste reporting  across our global sites.
","('Waste_And_Hazardous_Materials_Management', 0.9815455079078674)","('Air_Quality', 0.0019357918063178658)","('Water_And_Wastewater_Management', 0.001540153520181775)","(['Operational Eco-Efficiency'], 0.9815455079078674)","('NON-ESG', 0.0019357918063178658)","('NON-ESG', 0.001540153520181775)"
Line 468,"As a  result of these efforts, our non- regulated waste increased 3%  compared to the previous year .
","('Waste_And_Hazardous_Materials_Management', 0.9830460548400879)","('Water_And_Wastewater_Management', 0.0015246012480929494)","('Air_Quality', 0.001422231667675078)","(['Operational Eco-Efficiency'], 0.9830460548400879)","('NON-ESG', 0.0015246012480929494)","('NON-ESG', 0.001422231667675078)"
Line 469,"We generated 837 MT per billion  dollars revenue of non-regulated partnerships are bringing  Medtronic closer to our   FY20 goal to reduce regulated  waste by 10%.
","('Waste_And_Hazardous_Materials_Management', 0.9645727872848511)","('Water_And_Wastewater_Management', 0.004128734581172466)","('Air_Quality', 0.00303513091057539)","(['Operational Eco-Efficiency'], 0.9645727872848511)","('NON-ESG', 0.004128734581172466)","('NON-ESG', 0.00303513091057539)"
Line 470,"The Medtronic Ireland Galway,  Parkmore, facility conducts  research and development for  our global Cardiac and Vascular  business.
","('Access_And_Affordability', 0.2544914484024048)","('Customer_Welfare', 0.11426426470279694)","('Employee_Health_And_Safety', 0.07886020094156265)","('NON-ESG', 0.2544914484024048)","('NON-ESG', 0.11426426470279694)","('NON-ESG', 0.07886020094156265)"
Line 471,"It utilizes chemicals  for the manufacture and testing  of products and is one of our  largest producers of regulated  waste.
","('Waste_And_Hazardous_Materials_Management', 0.980280339717865)","('Product_Design_And_Lifecycle_Management', 0.0023724636994302273)","('Water_And_Wastewater_Management', 0.0014309001853689551)","(['Operational Eco-Efficiency'], 0.980280339717865)","('NON-ESG', 0.0023724636994302273)","('NON-ESG', 0.0014309001853689551)"
Line 472,"In FY19, the site reduced  its total regulated waste by   24.5 MT by optimizing chemical  use and identifying secondary  uses for regulated waste  streams.
","('Waste_And_Hazardous_Materials_Management', 0.9844256639480591)","('Water_And_Wastewater_Management', 0.0014177648117765784)","('Data_Security', 0.0012528070947155356)","(['Operational Eco-Efficiency'], 0.9844256639480591)","('NON-ESG', 0.0014177648117765784)","('NON-ESG', 0.0012528070947155356)"
Line 473,"The effort resulted   in a 34% reduction in the site’s  total waste generation.533,0053,0993,98105116Fiscal Y ear Fiscal Y earFY20 Goal4,3,0003,2,0002,1,0001,FY17 * FY18 FY19FY17 * FY18 FY19Metric T ons MWh/$ Million RevenueMetric T ons/$ Billion of Revenue98105REGULA TED WASTE    *FY16 data reﬂects January 2015 Covidien acquisition.
","('Waste_And_Hazardous_Materials_Management', 0.9817687273025513)","('Water_And_Wastewater_Management', 0.002290382282808423)","('Air_Quality', 0.0015325439162552357)","(['Operational Eco-Efficiency'], 0.9817687273025513)","('NON-ESG', 0.002290382282808423)","('NON-ESG', 0.0015325439162552357)"
Line 474,"Prior-year data does not include   legacy Covidien operations.
","('Business_Model_Resilience', 0.2592921257019043)","('Systemic_Risk_Management', 0.1891799122095108)","('Customer_Privacy', 0.08800501376390457)","('NON-ESG', 0.2592921257019043)","('NON-ESG', 0.1891799122095108)","('NON-ESG', 0.08800501376390457)"
Line 475,"†FY16 and FY17 data were recalculated to account for the Cardinal divestiture.
","('Business_Model_Resilience', 0.6062368750572205)","('Systemic_Risk_Management', 0.14127853512763977)","('Director_Removal', 0.03409573435783386)","(['Codes of Business Conduct'], 0.6062368750572205)","('NON-ESG', 0.14127853512763977)","('NON-ESG', 0.03409573435783386)"
Line 476,"25,22,26824,757901Fiscal Y ear Fiscal Y earFY20 Goal 40,35,30,20,10,5,00015,00025,FY17 * FY18 FY19FY17 * FY18 FY19Metric T ons Metric T ons/$ Million Revenue1,1,1,Metric T ons/$ Billion of Revenue1,   *FY16 data reﬂects January 2015 Covidien acquisition.
","('Systemic_Risk_Management', 0.3128970265388489)","('Business_Model_Resilience', 0.19571806490421295)","('Management_Of_Legal_And_Regulatory_Framework', 0.08048027753829956)","('NON-ESG', 0.3128970265388489)","('NON-ESG', 0.19571806490421295)","('NON-ESG', 0.08048027753829956)"
Line 477,"Prior-year data does not include   legacy Covidien operations.
","('Business_Model_Resilience', 0.2592921257019043)","('Systemic_Risk_Management', 0.1891799122095108)","('Customer_Privacy', 0.08800501376390457)","('NON-ESG', 0.2592921257019043)","('NON-ESG', 0.1891799122095108)","('NON-ESG', 0.08800501376390457)"
Line 478,"†FY16 and FY17 data were recalculated to account for the Cardinal divestiture.
","('Business_Model_Resilience', 0.6062368750572205)","('Systemic_Risk_Management', 0.14127853512763977)","('Director_Removal', 0.03409573435783386)","(['Codes of Business Conduct'], 0.6062368750572205)","('NON-ESG', 0.14127853512763977)","('NON-ESG', 0.03409573435783386)"
Line 479,"NON-REGULA TED WASTE *FY17 data was recalculated to account for the Cardinal divestiture.
","('Waste_And_Hazardous_Materials_Management', 0.9789830446243286)","('Water_And_Wastewater_Management', 0.0016227796440944076)","('Data_Security', 0.0014861017698422074)","(['Operational Eco-Efficiency'], 0.9789830446243286)","('NON-ESG', 0.0016227796440944076)","('NON-ESG', 0.0014861017698422074)"
Line 480,"53Our Plainfield, Indiana, site services advanced-energy devices for our surgical innovations business and has  historically generated large volumes of regulated waste.
","('Waste_And_Hazardous_Materials_Management', 0.9813761711120605)","('Water_And_Wastewater_Management', 0.0021885489113628864)","('Air_Quality', 0.0018867620965465903)","(['Operational Eco-Efficiency'], 0.9813761711120605)","('NON-ESG', 0.0021885489113628864)","('NON-ESG', 0.0018867620965465903)"
Line 481,"In FY19, Medtronic formed a partnership with social  enterprise RecycleForce — a local nonprofit that provides recycling services as well as training and work  experience for formerly incarcerated people.
","('Waste_And_Hazardous_Materials_Management', 0.43341878056526184)","('Product_Design_And_Lifecycle_Management', 0.13536646962165833)","('Employee_Health_And_Safety', 0.09797697514295578)","('NON-ESG', 0.43341878056526184)","('NON-ESG', 0.13536646962165833)","('NON-ESG', 0.09797697514295578)"
Line 482,"In its first year , the partnership helped Plainfield recycle 30%  more regulated material.
","('Product_Design_And_Lifecycle_Management', 0.7294109463691711)","('Energy_Management', 0.04799293354153633)","('Waste_And_Hazardous_Materials_Management', 0.04555492475628853)","(['Product Stewardship'], 0.7294109463691711)","('NON-ESG', 0.04799293354153633)","('NON-ESG', 0.04555492475628853)"
Line 483,"Reducing water use Water scarcity is a growing global concern, and we are preparing our business for a time when water is less  readily available.
","('Water_And_Wastewater_Management', 0.9766799211502075)","('GHG_Emissions', 0.002189253456890583)","('Waste_And_Hazardous_Materials_Management', 0.0019605308771133423)","(['Operational Eco-Efficiency'], 0.9766799211502075)","('NON-ESG', 0.002189253456890583)","('NON-ESG', 0.0019605308771133423)"
Line 484,"Though medical device manufacturing is generally not water-intensive, we strive to be  water-efficient and to understand our water risk.
","('Water_And_Wastewater_Management', 0.9694119691848755)","('GHG_Emissions', 0.0039041955024003983)","('Energy_Management', 0.0029797505121678114)","(['Operational Eco-Efficiency'], 0.9694119691848755)","('NON-ESG', 0.0039041955024003983)","('NON-ESG', 0.0029797505121678114)"
Line 485,"In FY19, we conducted a water risk assessment of our sites that use more than 4 million gallons annually.
","('Water_And_Wastewater_Management', 0.9734663963317871)","('Waste_And_Hazardous_Materials_Management', 0.0028056225273758173)","('Energy_Management', 0.00248124310746789)","(['Operational Eco-Efficiency'], 0.9734663963317871)","('NON-ESG', 0.0028056225273758173)","('NON-ESG', 0.00248124310746789)"
Line 486,"The results revealed four locations in the Americas that are at an elevated risk for both water scarcity  and stress and a total of 10 locations globally that are at risk for either scarcity or stress.
","('Water_And_Wastewater_Management', 0.9534128904342651)","('Supply_Chain_Management', 0.00850777979940176)","('Waste_And_Hazardous_Materials_Management', 0.003920010756701231)","(['Operational Eco-Efficiency'], 0.9534128904342651)","('NON-ESG', 0.00850777979940176)","('NON-ESG', 0.003920010756701231)"
Line 487,"We shared the FY19 Performanceresults with operations leaders to integrate the results into long-term  business planning.
","('Business_Model_Resilience', 0.8941495418548584)","('Supply_Chain_Management', 0.013665555976331234)","('Product_Design_And_Lifecycle_Management', 0.011610063724219799)","(['Codes of Business Conduct'], 0.8941495418548584)","('NON-ESG', 0.013665555976331234)","('NON-ESG', 0.011610063724219799)"
Line 488,"Moving forward, we will perform a water scarcity  analysis every two years.
","('Water_And_Wastewater_Management', 0.9697214961051941)","('Supply_Chain_Management', 0.0029544937424361706)","('GHG_Emissions', 0.0028211702592670918)","(['Operational Eco-Efficiency'], 0.9697214961051941)","('NON-ESG', 0.0029544937424361706)","('NON-ESG', 0.0028211702592670918)"
Line 489,"In FY19, our water use was 2,109,000 cubic meters (m3), a 4%  decrease from the prior year .
","('Water_And_Wastewater_Management', 0.97390216588974)","('Energy_Management', 0.002851974917575717)","('GHG_Emissions', 0.0027555825654417276)","(['Operational Eco-Efficiency'], 0.97390216588974)","('NON-ESG', 0.002851974917575717)","('NON-ESG', 0.0027555825654417276)"
Line 490,"In FY19, our water use was 69 m3 per  million dollars revenue, compared to 75 m3 per million dollars revenue  in FY18.
","('Water_And_Wastewater_Management', 0.9704177975654602)","('Energy_Management', 0.0037750103510916233)","('GHG_Emissions', 0.0034128485713154078)","(['Operational Eco-Efficiency'], 0.9704177975654602)","('NON-ESG', 0.0037750103510916233)","('NON-ESG', 0.0034128485713154078)"
Line 491,"At our North Haven, Connecticut, site in FY19, we conducted an  intensive engineering program to identify and implement water  conservation projects.
","('Water_And_Wastewater_Management', 0.944236695766449)","('Ecological_Impacts', 0.021304579451680183)","('GHG_Emissions', 0.005125022958964109)","(['Operational Eco-Efficiency'], 0.944236695766449)","('NON-ESG', 0.021304579451680183)","('NON-ESG', 0.005125022958964109)"
Line 492,"By upgrading the cooling towers, reverse  osmosis system, and other equipment, the site is projected to save   an estimated 6.5 million gallons of water , 12% of the site’s annual   total usage.
","('Water_And_Wastewater_Management', 0.9444518089294434)","('Energy_Management', 0.017481643706560135)","('GHG_Emissions', 0.005636901129037142)","(['Operational Eco-Efficiency'], 0.9444518089294434)","('NON-ESG', 0.017481643706560135)","('NON-ESG', 0.005636901129037142)"
Line 493,"FY19 Performance 2,109,000 2,197,0001,981,697573Fiscal Y ear Fiscal Y earFY20 Goal 2,500,2,000,1,500,1,000,500,FY17 * FY18 FY19FY17 * FY18 FY19Cubic Meters Cubic Meters/$ Million RevenueCubic Meters/$ Million Revenue    *FY16 data reﬂects January 2015 Covidien acquisition.
","('Systemic_Risk_Management', 0.2831081449985504)","('Competitive_Behavior', 0.09767691045999527)","('Business_Model_Resilience', 0.0903298556804657)","('NON-ESG', 0.2831081449985504)","('NON-ESG', 0.09767691045999527)","('NON-ESG', 0.0903298556804657)"
Line 494,"Prior-year data does not include   legacy Covidien operations.
","('Business_Model_Resilience', 0.2592921257019043)","('Systemic_Risk_Management', 0.1891799122095108)","('Customer_Privacy', 0.08800501376390457)","('NON-ESG', 0.2592921257019043)","('NON-ESG', 0.1891799122095108)","('NON-ESG', 0.08800501376390457)"
Line 495,"†FY16 and FY17 data were recalculated to account for the Cardinal divestiture.
","('Business_Model_Resilience', 0.6062368750572205)","('Systemic_Risk_Management', 0.14127853512763977)","('Director_Removal', 0.03409573435783386)","(['Codes of Business Conduct'], 0.6062368750572205)","('NON-ESG', 0.14127853512763977)","('NON-ESG', 0.03409573435783386)"
Line 496,"WA TER USE *FY17 data was recalculated to account for the Cardinal divestiture.
","('Business_Model_Resilience', 0.5559536814689636)","('Systemic_Risk_Management', 0.18737906217575073)","('Competitive_Behavior', 0.03136321157217026)","(['Codes of Business Conduct'], 0.5559536814689636)","('NON-ESG', 0.18737906217575073)","('NON-ESG', 0.03136321157217026)"
Line 497,"PRODUCT  STEWARDSHIP Patient safety is our absolute  priority in manufacturing medical  devices.
","('Product_Quality_And_Safety', 0.8387615084648132)","('Product_Design_And_Lifecycle_Management', 0.04817710444331169)","('Employee_Health_And_Safety', 0.01784205622971058)","(['Product Quality & Recall Management'], 0.8387615084648132)","('NON-ESG', 0.04817710444331169)","('NON-ESG', 0.01784205622971058)"
Line 498,"This means we focus on  quality, sterility, and compliance.
","('Employee_Health_And_Safety', 0.5941402316093445)","('Product_Quality_And_Safety', 0.15532369911670685)","('Access_And_Affordability', 0.05848533660173416)","(['Operational Eco-Efficiency'], 0.5941402316093445)","('NON-ESG', 0.15532369911670685)","('NON-ESG', 0.05848533660173416)"
Line 499,"Increasingly, in line with our  customers’ priorities, we are also  working to reduce the lifecycle  footprint of Medtronic products  and packaging.
","('Product_Design_And_Lifecycle_Management', 0.9650843739509583)","('Product_Quality_And_Safety', 0.0029067411087453365)","('Supply_Chain_Management', 0.0027735193725675344)","(['Product Stewardship'], 0.9650843739509583)","('NON-ESG', 0.0029067411087453365)","('NON-ESG', 0.0027735193725675344)"
Line 500,"Regulatory compliance Medtronic scientists and  engineers follow EHS guidelines  when developing new products.
","('Management_Of_Legal_And_Regulatory_Framework', 0.637557327747345)","('Product_Quality_And_Safety', 0.15820039808750153)","('Business_Ethics', 0.037471018731594086)","(['Corporate Governance'], 0.637557327747345)","('NON-ESG', 0.15820039808750153)","('NON-ESG', 0.037471018731594086)"
Line 501,"Our standardized approach  helps us meet regulatory  requirements for products  and product communications  aligned with:  California Proposition 65  (required product disclosures  are available at www.
","('Product_Design_And_Lifecycle_Management', 0.4378676116466522)","('Product_Quality_And_Safety', 0.291068971157074)","('Selling_Practices_And_Product_Labeling', 0.10047999769449234)","('NON-ESG', 0.4378676116466522)","('NON-ESG', 0.291068971157074)","('NON-ESG', 0.10047999769449234)"
Line 502,"medtronic.com/caprop65)  E.U. Directive on Restriction  of Hazardous Substances  (RoHS) E.U. Registration, Evaluation,  Authorization, and Restriction  of Chemicals (REACH)  E.U. Medical Device Directive  (MDD) and Active Implantable  Medical Device Directive In FY19, we streamlined the way  Medtronic manages materials   of concern (MOC).
","('Waste_And_Hazardous_Materials_Management', 0.9325641989707947)","('Product_Quality_And_Safety', 0.008824124932289124)","('Selling_Practices_And_Product_Labeling', 0.00856687594205141)","(['Operational Eco-Efficiency'], 0.9325641989707947)","('NON-ESG', 0.008824124932289124)","('NON-ESG', 0.00856687594205141)"
Line 503,"We revised  our existing Chemical Risk  and Hazard Policy to create a  formal MOC Policy.
","('Physical_Impacts_Of_Climate_Change', 0.1338598132133484)","('Systemic_Risk_Management', 0.1264968067407608)","('Product_Quality_And_Safety', 0.11264817416667938)","('NON-ESG', 0.1338598132133484)","('NON-ESG', 0.1264968067407608)","('NON-ESG', 0.11264817416667938)"
Line 504,"We also  established a companywide  MOC assessment procedure  and published an MOC list.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8600766658782959)","('Ecological_Impacts', 0.01395111158490181)","('Systemic_Risk_Management', 0.012682550586760044)","(['Corporate Governance'], 0.8600766658782959)","('NON-ESG', 0.01395111158490181)","('NON-ESG', 0.012682550586760044)"
Line 505,"This  approach prepares us for the  forthcoming E.U. Medical Device  Regulation (effective May 2020)  and helps us address evolving  customer requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.95456463098526)","('Competitive_Behavior', 0.006674499250948429)","('Energy_Management', 0.003648236859589815)","(['Corporate Governance'], 0.95456463098526)","('NON-ESG', 0.006674499250948429)","('NON-ESG', 0.003648236859589815)"
Line 506,"Medtronic had zero instances  of noncompliance with product  labeling or environmental laws   in FY19.
","('Selling_Practices_And_Product_Labeling', 0.7481859922409058)","('Product_Quality_And_Safety', 0.09048523753881454)","('Customer_Welfare', 0.038231316953897476)","(['Marketing Practices'], 0.7481859922409058)","('NON-ESG', 0.09048523753881454)","('NON-ESG', 0.038231316953897476)"
Line 507,"evaluate packaging attributes  and calculate the environmental  impact of design decisions.
","('Product_Design_And_Lifecycle_Management', 0.9533666372299194)","('Business_Model_Resilience', 0.004318916238844395)","('Selling_Practices_And_Product_Labeling', 0.004310301970690489)","(['Product Stewardship'], 0.9533666372299194)","('NON-ESG', 0.004318916238844395)","('NON-ESG', 0.004310301970690489)"
Line 508,"We  are also assessing our systems  for tracking and reporting  packaging waste reduction.
","('Waste_And_Hazardous_Materials_Management', 0.9779862761497498)","('Water_And_Wastewater_Management', 0.0021734621841460466)","('Product_Design_And_Lifecycle_Management', 0.001938040368258953)","(['Operational Eco-Efficiency'], 0.9779862761497498)","('NON-ESG', 0.0021734621841460466)","('NON-ESG', 0.001938040368258953)"
Line 509,"In FY19, Medtronic received  an Institute of Packaging  Professionals Ameristar award  for innovations in our SC and  NC Euphora™ medical product  packaging.
","('Product_Design_And_Lifecycle_Management', 0.9564411640167236)","('Product_Quality_And_Safety', 0.005169907119125128)","('Selling_Practices_And_Product_Labeling', 0.00490451930090785)","(['Product Stewardship'], 0.9564411640167236)","('NON-ESG', 0.005169907119125128)","('NON-ESG', 0.00490451930090785)"
Line 510,"We designed the  packaging to be easier and  safer to use, We also reduced  more than 20 metric tons (MT)  of paper waste by shifting to  electronic instructions for use.Product footprint and  circular economy We are reducing the life cycle  impact of our products through  packaging and circular economy  initiatives.
","('Product_Design_And_Lifecycle_Management', 0.9294129610061646)","('Waste_And_Hazardous_Materials_Management', 0.019215188920497894)","('Product_Quality_And_Safety', 0.005591726861894131)","(['Product Stewardship'], 0.9294129610061646)","('NON-ESG', 0.019215188920497894)","('NON-ESG', 0.005591726861894131)"
Line 511,"Our products  consume relatively low energy,  and safety requirements   prevent us from reducing   energy requirements.
","('Product_Design_And_Lifecycle_Management', 0.7254245281219482)","('Product_Quality_And_Safety', 0.15138940513134003)","('Customer_Welfare', 0.017576204612851143)","(['Product Stewardship'], 0.7254245281219482)","('NON-ESG', 0.15138940513134003)","('NON-ESG', 0.017576204612851143)"
Line 512,"One opportunity to reduce  product waste is secondary  packaging — the packaging  that protects products without  coming in direct contact  with them.
","('Waste_And_Hazardous_Materials_Management', 0.905901312828064)","('Product_Design_And_Lifecycle_Management', 0.03821951895952225)","('Employee_Health_And_Safety', 0.0050748432986438274)","(['Operational Eco-Efficiency'], 0.905901312828064)","('NON-ESG', 0.03821951895952225)","('NON-ESG', 0.0050748432986438274)"
Line 513,"The Medtronic  Sustainable Packaging Working  Group champions our efforts  to integrate environmental  factors into the product  development process.
","('Product_Design_And_Lifecycle_Management', 0.9657319784164429)","('Product_Quality_And_Safety', 0.003488707821816206)","('Business_Model_Resilience', 0.002497865119948983)","(['Product Stewardship'], 0.9657319784164429)","('NON-ESG', 0.003488707821816206)","('NON-ESG', 0.002497865119948983)"
Line 514,"In  FY19, the group developed a  product sustainability packaging  scorecard and organized a  FY20 pilot for our Cardiac  and Vascular teams to trial  lifecycle analysis software.
","('Product_Design_And_Lifecycle_Management', 0.9623288512229919)","('Product_Quality_And_Safety', 0.004898482467979193)","('Selling_Practices_And_Product_Labeling', 0.003228604793548584)","(['Product Stewardship'], 0.9623288512229919)","('NON-ESG', 0.004898482467979193)","('NON-ESG', 0.003228604793548584)"
Line 515,"The scorecard and pilot will  help our development teams CASE STUDY REDUCING   PLASTIC WASTE   IN HEAL THCARE Each day, U.S. healthcare  facilities generate  approximately 12,700  metric tons of waste, with  as much as 25% comprised  of plastic packaging and  products.
","('Waste_And_Hazardous_Materials_Management', 0.9830377101898193)","('Product_Design_And_Lifecycle_Management', 0.0013285595923662186)","('Water_And_Wastewater_Management', 0.0012239153729751706)","(['Operational Eco-Efficiency'], 0.9830377101898193)","('NON-ESG', 0.0013285595923662186)","('NON-ESG', 0.0012239153729751706)"
Line 516,"As members of  the Healthcare Plastics  Recycling Council, we  are working toward an  economically viable  solution where plastic is  diverted from landfill and  given a second life.
","('Waste_And_Hazardous_Materials_Management', 0.9370535016059875)","('Product_Design_And_Lifecycle_Management', 0.017021656036376953)","('Water_And_Wastewater_Management', 0.005988100543618202)","(['Operational Eco-Efficiency'], 0.9370535016059875)","('NON-ESG', 0.017021656036376953)","('NON-ESG', 0.005988100543618202)"
Line 517,"Medtronic follows international  guidelines and regulations for  the disposal of electronic waste.
","('Waste_And_Hazardous_Materials_Management', 0.9848566651344299)","('Data_Security', 0.0011799460044130683)","('Water_And_Wastewater_Management', 0.0010016168234869838)","(['Operational Eco-Efficiency'], 0.9848566651344299)","('NON-ESG', 0.0011799460044130683)","('NON-ESG', 0.0010016168234869838)"
Line 518,"Where possible, we reduce  landfill waste by recycling  products at their end of useful  life.
","('Waste_And_Hazardous_Materials_Management', 0.9691269993782043)","('Product_Design_And_Lifecycle_Management', 0.0062032463029026985)","('Water_And_Wastewater_Management', 0.0021720065269619226)","(['Operational Eco-Efficiency'], 0.9691269993782043)","('NON-ESG', 0.0062032463029026985)","('NON-ESG', 0.0021720065269619226)"
Line 519,"In FY19, our Memphis  distribution center increased its  diversion rate.
","('Water_And_Wastewater_Management', 0.16975732147693634)","('Systemic_Risk_Management', 0.1099833995103836)","('Air_Quality', 0.08029093593358994)","('NON-ESG', 0.16975732147693634)","('NON-ESG', 0.1099833995103836)","('NON-ESG', 0.08029093593358994)"
Line 520,"Each year , the site  is responsible for processing  approximately 11 MT of products that are no longer  usable.
","('Product_Design_And_Lifecycle_Management', 0.9336602687835693)","('Waste_And_Hazardous_Materials_Management', 0.012945608235895634)","('Product_Quality_And_Safety', 0.008248296566307545)","(['Product Stewardship'], 0.9336602687835693)","('NON-ESG', 0.012945608235895634)","('NON-ESG', 0.008248296566307545)"
Line 521,"Working with a zero- waste electronics recycling  partner in FY19, the site now  recycles 100% of these  products.
","('Waste_And_Hazardous_Materials_Management', 0.84332275390625)","('Product_Design_And_Lifecycle_Management', 0.08060252666473389)","('Employee_Health_And_Safety', 0.007441593799740076)","(['Operational Eco-Efficiency'], 0.84332275390625)","('NON-ESG', 0.08060252666473389)","('NON-ESG', 0.007441593799740076)"
Line 522,"In FY19, we continued to recycle,  reuse, and remanufacture  medical sensors from our  Nellcor™ business, which  specializes in pulse oximetry  devices.
","('Product_Design_And_Lifecycle_Management', 0.8912872076034546)","('Energy_Management', 0.014423198066651821)","('Supply_Chain_Management', 0.012440339662134647)","(['Product Stewardship'], 0.8912872076034546)","('NON-ESG', 0.014423198066651821)","('NON-ESG', 0.012440339662134647)"
Line 523,"Through this program,  we diverted 190 MT of devices  from landfill.
","('Waste_And_Hazardous_Materials_Management', 0.9304710626602173)","('Water_And_Wastewater_Management', 0.018649838864803314)","('Ecological_Impacts', 0.007033433765172958)","(['Operational Eco-Efficiency'], 0.9304710626602173)","('NON-ESG', 0.018649838864803314)","('NON-ESG', 0.007033433765172958)"
Line 524,"For more information on  product recycling, see our  product packaging and  disposition page.
","('Product_Design_And_Lifecycle_Management', 0.9351746439933777)","('Selling_Practices_And_Product_Labeling', 0.009897496551275253)","('Product_Quality_And_Safety', 0.009477496147155762)","(['Product Stewardship'], 0.9351746439933777)","('NON-ESG', 0.009897496551275253)","('NON-ESG', 0.009477496147155762)"
Line 525,"SUPPORTING A  GLOBAL  WORKFORCE Cultivating an inclusive, diverse, and  healthy workforce is foundational to our  Mission and essential for innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9732154011726379)","('Employee_Health_And_Safety', 0.0021147888619452715)","('Business_Model_Resilience', 0.001853186055086553)","(['Human Capital Development'], 0.9732154011726379)","('NON-ESG', 0.0021147888619452715)","('NON-ESG', 0.001853186055086553)"
Line 526,"We support our employees to be their  best selves through personal and  professional development and health  and well-being.
","('Employee_Health_And_Safety', 0.4562406837940216)","('Human_Rights_And_Community_Relations', 0.16812941431999207)","('Access_And_Affordability', 0.15295058488845825)","('NON-ESG', 0.4562406837940216)","('NON-ESG', 0.16812941431999207)","('NON-ESG', 0.15295058488845825)"
Line 527,"57INCLUSION   & DIVERSITY Adding   Business Value    Research shows that diversity increases innovation by nearly  20%.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9726589918136597)","('Employee_Health_And_Safety', 0.0022988105192780495)","('Human_Rights_And_Community_Relations', 0.001740918611176312)","(['Human Capital Development'], 0.9726589918136597)","('NON-ESG', 0.0022988105192780495)","('NON-ESG', 0.001740918611176312)"
Line 528,"It strengthens our workplace culture, distinguishes  us from competitors, and ultimately helps us meet global  healthcare needs.50% 36%AS OF FY19, WOMEN REPRESENTED AND ETHNICALL Y  DIVERSE T ALENT REPRESENTED OF OUR GLOBAL WORKFORCE OF OUR U.S. WORKFORCE At Medtronic, our history of  inclusion and diversity began  with our Mission, written by co- founder Earl Bakken in 1960, well  before diversity and inclusion  efforts were proven to be key  drivers of business innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9764164090156555)","('Employee_Health_And_Safety', 0.002168230712413788)","('Human_Rights_And_Community_Relations', 0.0015193996950984001)","(['Human Capital Development'], 0.9764164090156555)","('NON-ESG', 0.002168230712413788)","('NON-ESG', 0.0015193996950984001)"
Line 529,"T oday, it continues to guide our  global culture, directing us to  serve all people in need of our  therapies — to alleviate pain,  restore health, and extend life.
","('Employee_Health_And_Safety', 0.648444414138794)","('Access_And_Affordability', 0.13246621191501617)","('Human_Rights_And_Community_Relations', 0.0426558181643486)","(['Operational Eco-Efficiency'], 0.648444414138794)","('NON-ESG', 0.13246621191501617)","('NON-ESG', 0.0426558181643486)"
Line 530,"The fifth tenet of our Mission, to recognize the personal worth   of all employees, underlies   our approach to inclusion   and diversity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9720826745033264)","('Human_Rights_And_Community_Relations', 0.0025517940521240234)","('Employee_Health_And_Safety', 0.0023178248666226864)","(['Human Capital Development'], 0.9720826745033264)","('NON-ESG', 0.0025517940521240234)","('NON-ESG', 0.0023178248666226864)"
Line 531,"We are a stronger , better  company when we foster an  inclusive workplace and bring  diversity of thought to our work  by employing a workforce that  represents our patients and  customers.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9744030833244324)","('Employee_Health_And_Safety', 0.0023670790251344442)","('Human_Rights_And_Community_Relations', 0.0017674093833193183)","(['Human Capital Development'], 0.9744030833244324)","('NON-ESG', 0.0023670790251344442)","('NON-ESG', 0.0017674093833193183)"
Line 532,"INCLUSION AND   DIVERSITY HIGHLIGHTS In FY19, we made significant progress toward our 2020  diversity goals, surpassing our 20% or more target for  ethnically diverse leadership in the U.S. and on track to meet  our 40% or more target for women leadership globally,  putting us closer to our ultimate aspiration of 50% or more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.975786030292511)","('Employee_Health_And_Safety', 0.0017671964596956968)","('Business_Model_Resilience', 0.0015946595231071115)","(['Human Capital Development'], 0.975786030292511)","('NON-ESG', 0.0017671964596956968)","('NON-ESG', 0.0015946595231071115)"
Line 533,"From a pay perspective, we  believe all people should  be paid equally for the  same work.
","('Labor_Practices', 0.9679996967315674)","('Employee_Health_And_Safety', 0.004693033639341593)","('Director_Removal', 0.003130863420665264)","(['Labor Practice Indicators'], 0.9679996967315674)","('NON-ESG', 0.004693033639341593)","('NON-ESG', 0.003130863420665264)"
Line 534,"In FY19, we  achieved 99% gender pay  equity globally, and 100% in  several countries, including  the United States.
","('Labor_Practices', 0.8822759389877319)","('Employee_Engagement_Inclusion_And_Diversity', 0.033962760120630264)","('Competitive_Behavior', 0.010504338890314102)","(['Labor Practice Indicators'], 0.8822759389877319)","('NON-ESG', 0.033962760120630264)","('NON-ESG', 0.010504338890314102)"
Line 535,"In the  United States, for every  $1.00 Caucasian employees  earn, ethnically diverse  employees with the same  job title earn $0.99.22% OF U.S. MANAGEMENT POSITIONS HELD BY ETHNICALL Y DIVERSE T ALENT38% OF GLOBAL MANAGEMENT POSITIONS HELD BY WOMEN 99% GLOBAL  GENDER  PA Y EQUITY 100% U.S. GENDER  PA Y EQUITY58With diversity in the workplace  that mirrors our communities,  we have better insight into the  experiences of our customers  and other partners.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9767479300498962)","('Employee_Health_And_Safety', 0.0016977573977783322)","('Human_Rights_And_Community_Relations', 0.0016523131635040045)","(['Human Capital Development'], 0.9767479300498962)","('NON-ESG', 0.0016977573977783322)","('NON-ESG', 0.0016523131635040045)"
Line 536,"Ultimately,  we will be able to better deliver  technologies, services, and  solutions that serve patients  because we understand the  specific needs of different  populations.
","('Customer_Welfare', 0.19465765357017517)","('Product_Design_And_Lifecycle_Management', 0.1656341552734375)","('Access_And_Affordability', 0.1602603793144226)","('NON-ESG', 0.19465765357017517)","('NON-ESG', 0.1656341552734375)","('NON-ESG', 0.1602603793144226)"
Line 537,"However , having a  diverse set of perspectives from  employees is only valuable if they  feel confident contributing and voicing their opinions without  anxiety or fear .
","('Employee_Engagement_Inclusion_And_Diversity', 0.7907156348228455)","('Business_Ethics', 0.027474654838442802)","('Competitive_Behavior', 0.02639436349272728)","(['Human Capital Development'], 0.7907156348228455)","('NON-ESG', 0.027474654838442802)","('NON-ESG', 0.02639436349272728)"
Line 538,"This means  making sure that employees  feel confident knowing they can  be their best selves and grow  a fulfilling career at Medtronic  by embracing and celebrating  their individual identities and  backgrounds.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9197697043418884)","('Human_Rights_And_Community_Relations', 0.011772657744586468)","('Employee_Health_And_Safety', 0.007584092207252979)","(['Human Capital Development'], 0.9197697043418884)","('NON-ESG', 0.011772657744586468)","('NON-ESG', 0.007584092207252979)"
Line 539,"It also means  creating an enriching work  experience and a healthy, diverse  Medtronic community that truly  reflects the world in which we  live and work.A holistic approach to inclusion, diversity, and equity  As a global company, our future depends on employing world-class  talent whose ideas fuel meaningful innovation for patients and  partners.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9729655385017395)","('Employee_Health_And_Safety', 0.002435712143778801)","('Human_Rights_And_Community_Relations', 0.0022761523723602295)","(['Human Capital Development'], 0.9729655385017395)","('NON-ESG', 0.002435712143778801)","('NON-ESG', 0.0022761523723602295)"
Line 540,"Medtronic is implementing three strategic priorities to make  inclusion and diversity a differentiator for our business and culture.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9741355776786804)","('Human_Rights_And_Community_Relations', 0.002206202829256654)","('Employee_Health_And_Safety', 0.0019190730527043343)","(['Human Capital Development'], 0.9741355776786804)","('NON-ESG', 0.002206202829256654)","('NON-ESG', 0.0019190730527043343)"
Line 541,"OUR THREE STRA TEGIC PRIORITIES LEADERSHIP  COMMITMENTINTEGRA TED AND  HOLISTIC APPROACHMEASUREMENT Close the diversity gap   through accountabilityCreate sustainable  practices at all levels of  the organizationLeverage data and  technology for  powerful insight  We are dedicated to examining and advancing all the processes,  programs, and policies that influence inclusion, diversity, and equity at  Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9749798774719238)","('Employee_Health_And_Safety', 0.0021698111668229103)","('Human_Rights_And_Community_Relations', 0.0017851426964625716)","(['Human Capital Development'], 0.9749798774719238)","('NON-ESG', 0.0021698111668229103)","('NON-ESG', 0.0017851426964625716)"
Line 542,"In 2015, we created a transparent way to hold ourselves  accountable by setting five-year diversity goals and publicly reporting  progress each year .
","('Employee_Engagement_Inclusion_And_Diversity', 0.9516752362251282)","('Business_Ethics', 0.004439549054950476)","('Competitive_Behavior', 0.003999150823801756)","(['Human Capital Development'], 0.9516752362251282)","('NON-ESG', 0.004439549054950476)","('NON-ESG', 0.003999150823801756)"
Line 543,"THE DRIVERS BEHIND  OUR COMMITMENT Creating an inclusive and diverse culture: ENCOURAGES  EMPLOYEES  TO BE THEIR  BEST SEL VESCREA TES  AN ENRICHING  WORK  EXPERIENCEDRIVES  BETTER  DECISION- MAKING &  BUSINESS  OUTCOMES We are focused on inclusion first, because  we recognize that an inclusive culture is  essential to attracting and retaining diverse  talent and perspectives.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9732590317726135)","('Employee_Health_And_Safety', 0.0024071685038506985)","('Human_Rights_And_Community_Relations', 0.001898065092973411)","(['Human Capital Development'], 0.9732590317726135)","('NON-ESG', 0.0024071685038506985)","('NON-ESG', 0.001898065092973411)"
Line 544,"– Carol Surface Chief Human Resources Officer , Medtronic“ “59T o increase accountability   for results, the 2020 targets   are embedded into every   Medtronic senior leader’s   annual performance review.
","('Systemic_Risk_Management', 0.25325316190719604)","('Management_Of_Legal_And_Regulatory_Framework', 0.1736254245042801)","('Business_Model_Resilience', 0.14678165316581726)","('NON-ESG', 0.25325316190719604)","('NON-ESG', 0.1736254245042801)","('NON-ESG', 0.14678165316581726)"
Line 545,"This ensures leaders create  action plans that diversify talent  at the leadership level, resulting  in meaningful progress toward  meeting our inclusion and  diversity goals.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9753029346466064)","('Employee_Health_And_Safety', 0.0018023086013272405)","('Human_Rights_And_Community_Relations', 0.0016626319848001003)","(['Human Capital Development'], 0.9753029346466064)","('NON-ESG', 0.0018023086013272405)","('NON-ESG', 0.0016626319848001003)"
Line 546,"From a pay perspective, we  believe that women and men  should be paid equally for the  work they do.
","('Labor_Practices', 0.9759929776191711)","('Director_Removal', 0.0025654479395598173)","('Employee_Health_And_Safety', 0.0019467127276584506)","(['Labor Practice Indicators'], 0.9759929776191711)","('NON-ESG', 0.0025654479395598173)","('NON-ESG', 0.0019467127276584506)"
Line 547,"Annually, we  conduct a comprehensive  analysis of pay between our  male and female employees  to address inequity.
","('Labor_Practices', 0.9700192213058472)","('Director_Removal', 0.002870632568374276)","('Employee_Engagement_Inclusion_And_Diversity', 0.00285931839607656)","(['Labor Practice Indicators'], 0.9700192213058472)","('NON-ESG', 0.002870632568374276)","('NON-ESG', 0.00285931839607656)"
Line 548,"Globally,  women are paid 99% of what  men are paid12 and 100% in  several countries, including the  United States.By 2020, we aim to exceed 40%  or more women in manager level  and above roles globally, with an  ultimate aspiration of achieving  50%, and exceed 20% or more  ethnic diversity among manager   level and above roles in the  United States.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9690303802490234)","('Labor_Practices', 0.0026908600702881813)","('Employee_Health_And_Safety', 0.0022783856838941574)","(['Human Capital Development'], 0.9690303802490234)","('NON-ESG', 0.0026908600702881813)","('NON-ESG', 0.0022783856838941574)"
Line 549,"2020  T ARGETS WOMEN   IN MANAGEMENT POSITIONS  GLOBALL Y 50%+    ASPIRA TION 40%+ ETHNIC DIVERSITY   IN MANAGEMENT POSITIONS  WITHIN THE U.S.20%+By 2020, we aim for:In the United States, for every  $1.00 Caucasian employees  earn, ethnically diverse  employees with the same job  title earn $0.99.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9759989976882935)","('Employee_Health_And_Safety', 0.0016087957192212343)","('Customer_Privacy', 0.0014972989447414875)","(['Human Capital Development'], 0.9759989976882935)","('NON-ESG', 0.0016087957192212343)","('NON-ESG', 0.0014972989447414875)"
Line 550,"While we are  proud of our results, we will close  any remaining gaps globally to  reach 100% pay equity for   all employees.
","('Labor_Practices', 0.9688612222671509)","('Employee_Engagement_Inclusion_And_Diversity', 0.0035298457369208336)","('Director_Removal', 0.003371747210621834)","(['Labor Practice Indicators'], 0.9688612222671509)","('NON-ESG', 0.0035298457369208336)","('NON-ESG', 0.003371747210621834)"
Line 551,"We take a holistic approach,  integrating inclusion and  diversity into talent attraction,  hiring, assessment,  development, promotion, and  retention.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9757571816444397)","('Employee_Health_And_Safety', 0.0019023048225790262)","('Human_Rights_And_Community_Relations', 0.0016476284945383668)","(['Human Capital Development'], 0.9757571816444397)","('NON-ESG', 0.0019023048225790262)","('NON-ESG', 0.0016476284945383668)"
Line 552,"Every part of our  organization participates in our  inclusion and diversity efforts, creating an inclusive community  and vibrant work environment  where a broad range of talent  and identities thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9756932854652405)","('Employee_Health_And_Safety', 0.0021168245002627373)","('Human_Rights_And_Community_Relations', 0.0016821295721456409)","(['Human Capital Development'], 0.9756932854652405)","('NON-ESG', 0.0021168245002627373)","('NON-ESG', 0.0016821295721456409)"
Line 553,"T o ensure  that we achieve appropriate  representation, we leverage  external data to monitor  diversity and employment  trends at the global, national,  industry, and company level.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9749588370323181)","('Employee_Health_And_Safety', 0.0020599751733243465)","('Labor_Practices', 0.0018112064572051167)","(['Human Capital Development'], 0.9749588370323181)","('NON-ESG', 0.0020599751733243465)","('NON-ESG', 0.0018112064572051167)"
Line 554,"For  detailed workforce data, see our  2019 ESG Disclosure Index.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9146638512611389)","('Labor_Practices', 0.009817702695727348)","('Employee_Health_And_Safety', 0.00784560851752758)","(['Human Capital Development'], 0.9146638512611389)","('NON-ESG', 0.009817702695727348)","('NON-ESG', 0.00784560851752758)"
Line 555,"In FY19, Medtronic supported  four Diversity Networks  that aim to attract, develop,  and accelerate the careers  of women globally and U.S.  ethnically diverse talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9766740202903748)","('Employee_Health_And_Safety', 0.0017937462544068694)","('Human_Rights_And_Community_Relations', 0.0015386807499453425)","(['Human Capital Development'], 0.9766740202903748)","('NON-ESG', 0.0017937462544068694)","('NON-ESG', 0.0015386807499453425)"
Line 556,"These  groups are dedicated to helping  employees succeed both  professionally and personally,  and their objectives are  closely aligned to our business At Medtronic, women and men are paid  equally in several countries, including the  United States.
","('Labor_Practices', 0.7592467665672302)","('Employee_Engagement_Inclusion_And_Diversity', 0.12064213305711746)","('Employee_Health_And_Safety', 0.019116880372166634)","(['Labor Practice Indicators'], 0.7592467665672302)","('NON-ESG', 0.12064213305711746)","('NON-ESG', 0.019116880372166634)"
Line 557,"The fifth tenet of our Mission calls on   us to recognize the personal worth of   all employees.
","('Customer_Privacy', 0.19920213520526886)","('Employee_Health_And_Safety', 0.09622137993574142)","('Human_Rights_And_Community_Relations', 0.09101356565952301)","('NON-ESG', 0.19920213520526886)","('NON-ESG', 0.09622137993574142)","('NON-ESG', 0.09101356565952301)"
Line 558,"12 Pay equity compares pay for males and females who work in the same country with the same job title.60strategies.
","('Labor_Practices', 0.9740118384361267)","('Employee_Engagement_Inclusion_And_Diversity', 0.0023247292265295982)","('Waste_And_Hazardous_Materials_Management', 0.001893104170449078)","(['Labor Practice Indicators'], 0.9740118384361267)","('NON-ESG', 0.0023247292265295982)","('NON-ESG', 0.001893104170449078)"
Line 559,"The Networks are open to all employees and participation  from everyone is encouraged to introduce others to diverse cultures  and perspectives.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9621936082839966)","('Human_Rights_And_Community_Relations', 0.005149791482836008)","('Employee_Health_And_Safety', 0.0028755285311490297)","(['Human Capital Development'], 0.9621936082839966)","('NON-ESG', 0.005149791482836008)","('NON-ESG', 0.0028755285311490297)"
Line 560,"In early FY20, we added our fifth Diversity Network  — PRIDE — to support our LGBTQ+ employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9734679460525513)","('Employee_Health_And_Safety', 0.0021938870195299387)","('Human_Rights_And_Community_Relations', 0.0016945520183071494)","(['Human Capital Development'], 0.9734679460525513)","('NON-ESG', 0.0021938870195299387)","('NON-ESG', 0.0016945520183071494)"
Line 561,"A chairperson, identified by our CEO and chief human resources  officer (CHRO), and a sponsor from our executive committee lead  each of these Networks.
","('Employee_Engagement_Inclusion_And_Diversity', 0.27529004216194153)","('Director_Removal', 0.21742713451385498)","('Management_Of_Legal_And_Regulatory_Framework', 0.12343370169401169)","('NON-ESG', 0.27529004216194153)","('NON-ESG', 0.21742713451385498)","('NON-ESG', 0.12343370169401169)"
Line 562,"All executive committee members are  accountable for , and measured on, their contribution to achieving  our diversity goals.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9657739400863647)","('Business_Model_Resilience', 0.0025038383901119232)","('Human_Rights_And_Community_Relations', 0.0023763494100421667)","(['Human Capital Development'], 0.9657739400863647)","('NON-ESG', 0.0025038383901119232)","('NON-ESG', 0.0023763494100421667)"
Line 563,"T o help Networks make measurable progress, our  CEO spends a full day every quarter meeting with Network leaders  to assess their impact, review strategies, and provide support.
","('Business_Model_Resilience', 0.5582398772239685)","('Systemic_Risk_Management', 0.11909368634223938)","('Human_Rights_And_Community_Relations', 0.05009188875555992)","(['Codes of Business Conduct'], 0.5582398772239685)","('NON-ESG', 0.11909368634223938)","('NON-ESG', 0.05009188875555992)"
Line 564,"These full-day reviews have the same rigor and time commitment as  quarterly business reviews and are driven by the Network’s executive  committee sponsors and chairs.MEDTRONIC   DIVERSITY NETWORKSTHEIR IMPACT GLOBAL  Global Medtronic   Women’s  NetworkOur Networks play a critical role in our ability to:   Attract and retain a diverse workforce  Develop and advance the careers of women   and ethnically diverse employees  Establish Medtronic as an employer of  choice for diverse talent   Provide a network and community to  increase inclusion and feeling of belongingU.S.  African Descent  Network  Hispanic Latino  Descent Network   Asian Impact   @Medtronic The Global Inclusion, Diversity, and Engagement (GIDE) team  supports our efforts to build a more inclusive culture and diverse  workforce and plays a key role in helping us achieve our 2020   diversity targets.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9776185154914856)","('Employee_Health_And_Safety', 0.0019441365730017424)","('Human_Rights_And_Community_Relations', 0.0014423999236896634)","(['Human Capital Development'], 0.9776185154914856)","('NON-ESG', 0.0019441365730017424)","('NON-ESG', 0.0014423999236896634)"
Line 565,"These full-day reviews have the same rigor and time commitment as  quarterly business reviews and are driven by the Network’s executive  committee sponsors and chairs.MEDTRONIC   DIVERSITY NETWORKSTHEIR IMPACT GLOBAL  Global Medtronic   Women’s  NetworkOur Networks play a critical role in our ability to:   Attract and retain a diverse workforce  Develop and advance the careers of women   and ethnically diverse employees  Establish Medtronic as an employer of  choice for diverse talent   Provide a network and community to  increase inclusion and feeling of belongingU.S.  African Descent  Network  Hispanic Latino  Descent Network   Asian Impact   @Medtronic The Global Inclusion, Diversity, and Engagement (GIDE) team  supports our efforts to build a more inclusive culture and diverse  workforce and plays a key role in helping us achieve our 2020   diversity targets.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9764263033866882)","('Employee_Health_And_Safety', 0.0018573119305074215)","('Business_Model_Resilience', 0.0014734676806256175)","(['Human Capital Development'], 0.9764263033866882)","('NON-ESG', 0.0018573119305074215)","('NON-ESG', 0.0014734676806256175)"
Line 566,"The Mission unites employees from   all corners of the world around a  common purpose.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3231135308742523)","('Human_Rights_And_Community_Relations', 0.22512930631637573)","('Employee_Health_And_Safety', 0.07600963860750198)","('NON-ESG', 0.3231135308742523)","('NON-ESG', 0.22512930631637573)","('NON-ESG', 0.07600963860750198)"
Line 567,"The Mission also  calls on us to foster an inclusive  workplace where every employee   can participate in an enriching  personal work experience.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7019761800765991)","('Human_Rights_And_Community_Relations', 0.0742853656411171)","('Employee_Health_And_Safety', 0.04599149897694588)","(['Human Capital Development'], 0.7019761800765991)","('NON-ESG', 0.0742853656411171)","('NON-ESG', 0.04599149897694588)"
Line 568,"– Omar Ishrak Chairman & Chief Executive Officer , Medtronic““ Inclusion  An inclusive culture helps us  attract and retain diverse talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9723349809646606)","('Employee_Health_And_Safety', 0.0023515208158642054)","('Human_Rights_And_Community_Relations', 0.001908961683511734)","(['Human Capital Development'], 0.9723349809646606)","('NON-ESG', 0.0023515208158642054)","('NON-ESG', 0.001908961683511734)"
Line 569,"It cultivates a sense of belonging  among people from diverse  backgrounds and ultimately  engages and inspires all  employees to work toward   a common goal and fulfill   our Mission.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9549395442008972)","('Human_Rights_And_Community_Relations', 0.008458096534013748)","('Employee_Health_And_Safety', 0.0032238936983048916)","(['Human Capital Development'], 0.9549395442008972)","('NON-ESG', 0.008458096534013748)","('NON-ESG', 0.0032238936983048916)"
Line 570,"The annual Medtronic  Organizational Health Survey  helps us monitor the impact  of our inclusion and diversity  efforts among our 90,000  employees across 150  countries.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9763163924217224)","('Employee_Health_And_Safety', 0.0019370269728824496)","('Labor_Practices', 0.0016785351326689124)","(['Human Capital Development'], 0.9763163924217224)","('NON-ESG', 0.0019370269728824496)","('NON-ESG', 0.0016785351326689124)"
Line 571,"In FY19, 82% of  women globally and 79% of   U.S. ethnically diverse talent  reported that they feel they  belong at Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9740123152732849)","('Employee_Health_And_Safety', 0.0019627506844699383)","('Customer_Privacy', 0.0016525322571396828)","(['Human Capital Development'], 0.9740123152732849)","('NON-ESG', 0.0019627506844699383)","('NON-ESG', 0.0016525322571396828)"
Line 572,"Employee Resource Groups  (ERGs) are employee-led  affinity groups at Medtronic that  provide career development and networking opportunities  for members and strengthen  ties between employees of  many different backgrounds,  cultures, and interests.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9646941423416138)","('Employee_Health_And_Safety', 0.0051005869172513485)","('Human_Rights_And_Community_Relations', 0.0025481977500021458)","(['Human Capital Development'], 0.9646941423416138)","('NON-ESG', 0.0051005869172513485)","('NON-ESG', 0.0025481977500021458)"
Line 573,"First  founded in 1984, our ERGs  now have more than 19,000  members across more than 60  countries.
","('Employee_Engagement_Inclusion_And_Diversity', 0.24359582364559174)","('Director_Removal', 0.11286774277687073)","('Management_Of_Legal_And_Regulatory_Framework', 0.07076948881149292)","('NON-ESG', 0.24359582364559174)","('NON-ESG', 0.11286774277687073)","('NON-ESG', 0.07076948881149292)"
Line 574,"They include groups  for retirees, religious faiths,  young professionals, LGBTQ+,  women, veterans, employees  with disabilities, and more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9619239568710327)","('Labor_Practices', 0.00385359488427639)","('Human_Rights_And_Community_Relations', 0.0033153980039060116)","(['Human Capital Development'], 0.9619239568710327)","('NON-ESG', 0.00385359488427639)","('NON-ESG', 0.0033153980039060116)"
Line 575,"In  FY19, a passionate employee CASE STUDY ENABLING THE NEXT  GENERA TION OF ASIAN  WOMEN LEADERS Across industries in the  United States, Asians are  underrepresented at the  highest levels of leadership.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9586833715438843)","('Business_Model_Resilience', 0.0038295546546578407)","('Employee_Health_And_Safety', 0.0035674392711371183)","(['Human Capital Development'], 0.9586833715438843)","('NON-ESG', 0.0038295546546578407)","('NON-ESG', 0.0035674392711371183)"
Line 576,"T o address this disparity, our  Asian Impact @ Medtronic  Network developed  LEAP (Leadership  Empowerment for Asian  Female Professionals).
","('Employee_Engagement_Inclusion_And_Diversity', 0.9464955925941467)","('Human_Rights_And_Community_Relations', 0.005571439862251282)","('Employee_Health_And_Safety', 0.004489383660256863)","(['Human Capital Development'], 0.9464955925941467)","('NON-ESG', 0.005571439862251282)","('NON-ESG', 0.004489383660256863)"
Line 577,"LEAP  is a 12-month program  aimed at accelerating the  professional growth of Asian  female talent at Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9239593148231506)","('Business_Model_Resilience', 0.007676791865378618)","('Employee_Health_And_Safety', 0.005127040669322014)","(['Human Capital Development'], 0.9239593148231506)","('NON-ESG', 0.007676791865378618)","('NON-ESG', 0.005127040669322014)"
Line 578,"The program fosters  development through  mentorship and coaching  circles led by Asian women  leaders.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7919694781303406)","('Access_And_Affordability', 0.04906119033694267)","('Human_Rights_And_Community_Relations', 0.04197024181485176)","(['Human Capital Development'], 0.7919694781303406)","('NON-ESG', 0.04906119033694267)","('NON-ESG', 0.04197024181485176)"
Line 579,"LEAP contributes  to both of our diversity  targets — to increase the  number of women and  ethnically diverse talent in  management.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9755088090896606)","('Employee_Health_And_Safety', 0.0018047541379928589)","('Human_Rights_And_Community_Relations', 0.0014628389617428184)","(['Human Capital Development'], 0.9755088090896606)","('NON-ESG', 0.0018047541379928589)","('NON-ESG', 0.0014628389617428184)"
Line 580,"In FY19, 33  women participated in LEAP .with Native American heritage  led efforts to form our newest  ERG — the American Indian  Employee Resource Group.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9063200950622559)","('Human_Rights_And_Community_Relations', 0.026373978704214096)","('Employee_Health_And_Safety', 0.008996156975626945)","(['Human Capital Development'], 0.9063200950622559)","('NON-ESG', 0.026373978704214096)","('NON-ESG', 0.008996156975626945)"
Line 581,"The  group’s vision is to enhance the  professional development of  our American Indian employees  and support the American  Indian community by promoting  higher education for youth,  raising disease awareness, and  recruiting talent to work at  Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9471835494041443)","('Human_Rights_And_Community_Relations', 0.010488661006093025)","('Employee_Health_And_Safety', 0.0051419613882899284)","(['Human Capital Development'], 0.9471835494041443)","('NON-ESG', 0.010488661006093025)","('NON-ESG', 0.0051419613882899284)"
Line 582,"EMPLOYEE   RESOURCE GROUPS 12+ MEMBERS 19,000+ COUNTRIES 60+62Diversity We are determined to employ  a workforce with varying  backgrounds and experiences —  matching those of patients and  our communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9660512208938599)","('Employee_Health_And_Safety', 0.003314090659841895)","('Labor_Practices', 0.0027750381268560886)","(['Human Capital Development'], 0.9660512208938599)","('NON-ESG', 0.003314090659841895)","('NON-ESG', 0.0027750381268560886)"
Line 583,"We champion  diversity and appreciate all the  ways people are unique.
","('Employee_Engagement_Inclusion_And_Diversity', 0.970508873462677)","('Human_Rights_And_Community_Relations', 0.0028455988503992558)","('Business_Model_Resilience', 0.002169461455196142)","(['Human Capital Development'], 0.970508873462677)","('NON-ESG', 0.0028455988503992558)","('NON-ESG', 0.002169461455196142)"
Line 584,"This  approach reflects both our  Mission and business strategy.
","('Business_Model_Resilience', 0.6763710975646973)","('Human_Rights_And_Community_Relations', 0.040397804230451584)","('Director_Removal', 0.038824908435344696)","(['Codes of Business Conduct'], 0.6763710975646973)","('NON-ESG', 0.040397804230451584)","('NON-ESG', 0.038824908435344696)"
Line 585,"In FY19, Medtronic and our  CEO joined Catalyst CEO  Champions for Change,  committing to accelerate  inclusion, diversity, and  gender equality.
","('Employee_Engagement_Inclusion_And_Diversity', 0.97376549243927)","('Employee_Health_And_Safety', 0.0026125754229724407)","('Human_Rights_And_Community_Relations', 0.0021506513003259897)","(['Human Capital Development'], 0.97376549243927)","('NON-ESG', 0.0026125754229724407)","('NON-ESG', 0.0021506513003259897)"
Line 586,"The pledge  reflects our strong desire for  Medtronic leadership to be more  representative and for people  with diverse perspectives to  take part in decision-making.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9568132162094116)","('Human_Rights_And_Community_Relations', 0.005422463174909353)","('Business_Model_Resilience', 0.0034149589482694864)","(['Human Capital Development'], 0.9568132162094116)","('NON-ESG', 0.005422463174909353)","('NON-ESG', 0.0034149589482694864)"
Line 587,"Through CEO Champions for  Change, we pledge to:  Benchmark, track, and  improve the culture   of inclusion within   our organization Increase the representation  of women, including women  of color , in management  positions and on our board of  directors over five years   Share metrics with Catalyst  to benchmark our collective,  aggregate progress GENDER DIVERSITY Our 2020 gender diversity target  is for women to hold 40% or  more of our global management  and above positions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9751596450805664)","('Employee_Health_And_Safety', 0.0018236362375319004)","('Labor_Practices', 0.0017245984636247158)","(['Human Capital Development'], 0.9751596450805664)","('NON-ESG', 0.0018236362375319004)","('NON-ESG', 0.0017245984636247158)"
Line 588,"Our  ultimate aspiration is to get this  number to 50% globally, which  would truly reflect the world in  which we live and work.
","('Business_Model_Resilience', 0.3742648661136627)","('Employee_Engagement_Inclusion_And_Diversity', 0.13220061361789703)","('Human_Rights_And_Community_Relations', 0.1027522087097168)","('NON-ESG', 0.3742648661136627)","('NON-ESG', 0.13220061361789703)","('NON-ESG', 0.1027522087097168)"
Line 589,"In FY19,  women represented 38% of our  global management positions  and were directly responsible  for $6.8 billion of our annual  revenue.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5734115839004517)","('Director_Removal', 0.10640144348144531)","('Labor_Practices', 0.0625566691160202)","(['Human Capital Development'], 0.5734115839004517)","('NON-ESG', 0.10640144348144531)","('NON-ESG', 0.0625566691160202)"
Line 590,"The Global Medtronic Women’s  Network (MWN) is employing a   three-part approach to increase  the number of women in  leadership at the company: 63 Global Impact — As of  FY19, the MWN has more  than 14,000 members in  105 locations across 65  countries.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7983163595199585)","('Business_Model_Resilience', 0.029603540897369385)","('Director_Removal', 0.022789059206843376)","(['Human Capital Development'], 0.7983163595199585)","('NON-ESG', 0.029603540897369385)","('NON-ESG', 0.022789059206843376)"
Line 591,"MWN advances  women’s leadership through  local activations, such as  mentoring, networking events,  and career development.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9094966650009155)","('Human_Rights_And_Community_Relations', 0.011009805835783482)","('Business_Model_Resilience', 0.008051087148487568)","(['Human Capital Development'], 0.9094966650009155)","('NON-ESG', 0.011009805835783482)","('NON-ESG', 0.008051087148487568)"
Line 592,"T one at the T op —   The highest levels of our  organization are accountable  for driving inclusion and  diversity at Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9741587042808533)","('Employee_Health_And_Safety', 0.0022877973970025778)","('Human_Rights_And_Community_Relations', 0.001891322317533195)","(['Human Capital Development'], 0.9741587042808533)","('NON-ESG', 0.0022877973970025778)","('NON-ESG', 0.001891322317533195)"
Line 593,"Actions  and messaging from our board  Women in Science,  T echnology, Engineering,  and Math (STEM) — In FY18,  the network launched the  WISE program — Women  in Science and Engineering  — focused on increasing  gender diversity in technical  leadership to help drive  innovation and business  performance.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9685641527175903)","('Employee_Health_And_Safety', 0.002181760501116514)","('Business_Model_Resilience', 0.0021499479189515114)","(['Human Capital Development'], 0.9685641527175903)","('NON-ESG', 0.002181760501116514)","('NON-ESG', 0.0021499479189515114)"
Line 594,"In FY19,  women represented 26%   of R&D management and  above positions — on our way  to achieving our goal of at  least 30% by 2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8746961355209351)","('Labor_Practices', 0.018539421260356903)","('Director_Removal', 0.01419779285788536)","(['Human Capital Development'], 0.8746961355209351)","('NON-ESG', 0.018539421260356903)","('NON-ESG', 0.01419779285788536)"
Line 595,"of directors, CEO, CHRO, and  executive committee set  the example for the rest of the company and reinforce  the importance of advancing  women at Medtronic.50 34FY20 T argetAspiration0FY17 FY18 FY19Percentage Overall Fiscal Y ear 0FY17 FY18 FY19Percentage in Management* Fiscal Y earWOMEN REPRESENT A TION GLOBALL Y A T MEDTRONIC WOMEN IN GLOBAL MANAGEMENT A T MEDTRONIC50 34FY20 T argetAspiration0FY17 FY18 FY19Percentage Overall Fiscal Y ear 0FY17 FY18 FY19Percentage in Management* Fiscal Y earWOMEN REPRESENT A TION GLOBALL Y A T MEDTRONIC WOMEN IN GLOBAL MANAGEMENT A T MEDTRONIC * Management = managers and above Our ability to innovate relies on a constant  stream of new ideas.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5124821066856384)","('Director_Removal', 0.1295834332704544)","('Business_Model_Resilience', 0.07741762697696686)","(['Human Capital Development'], 0.5124821066856384)","('NON-ESG', 0.1295834332704544)","('NON-ESG', 0.07741762697696686)"
Line 596,"of directors, CEO, CHRO, and  executive committee set  the example for the rest of the company and reinforce  the importance of advancing  women at Medtronic.50 34FY20 T argetAspiration0FY17 FY18 FY19Percentage Overall Fiscal Y ear 0FY17 FY18 FY19Percentage in Management* Fiscal Y earWOMEN REPRESENT A TION GLOBALL Y A T MEDTRONIC WOMEN IN GLOBAL MANAGEMENT A T MEDTRONIC50 34FY20 T argetAspiration0FY17 FY18 FY19Percentage Overall Fiscal Y ear 0FY17 FY18 FY19Percentage in Management* Fiscal Y earWOMEN REPRESENT A TION GLOBALL Y A T MEDTRONIC WOMEN IN GLOBAL MANAGEMENT A T MEDTRONIC * Management = managers and above Our ability to innovate relies on a constant  stream of new ideas.
","('Business_Model_Resilience', 0.7286551594734192)","('Systemic_Risk_Management', 0.0446922741830349)","('Employee_Engagement_Inclusion_And_Diversity', 0.031526435166597366)","(['Codes of Business Conduct'], 0.7286551594734192)","('NON-ESG', 0.0446922741830349)","('NON-ESG', 0.031526435166597366)"
Line 597,"T o do this, we need  a global workplace where people can truly  be themselves and bring their diverse  perspectives forward to tackle the world’s  most pressing healthcare issues.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8500891327857971)","('Human_Rights_And_Community_Relations', 0.03796849772334099)","('Access_And_Affordability', 0.018282977864146233)","(['Human Capital Development'], 0.8500891327857971)","('NON-ESG', 0.03796849772334099)","('NON-ESG', 0.018282977864146233)"
Line 598,"– Omar Ishrak Chief Executive Officer , Medtronic““64U.S. ETHNIC DIVERSITY In FY19, ethnically diverse talent represented 36% of our U.S.  workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9742709398269653)","('Business_Model_Resilience', 0.0017625504406169057)","('Employee_Health_And_Safety', 0.0017152874497696757)","(['Human Capital Development'], 0.9742709398269653)","('NON-ESG', 0.0017625504406169057)","('NON-ESG', 0.0017152874497696757)"
Line 599,"T wenty-two percent of U.S. management positions are  held by ethnically diverse talent, exceeding our 2020 target of at  least 20%.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9725977778434753)","('Customer_Privacy', 0.0018584919162094593)","('Employee_Health_And_Safety', 0.001629158854484558)","(['Human Capital Development'], 0.9725977778434753)","('NON-ESG', 0.0018584919162094593)","('NON-ESG', 0.001629158854484558)"
Line 600,"We are committed to continual improvement and strive to  maintain or exceed this level of representation in FY20.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8193008303642273)","('Competitive_Behavior', 0.024118555709719658)","('Business_Ethics', 0.01676282100379467)","(['Human Capital Development'], 0.8193008303642273)","('NON-ESG', 0.024118555709719658)","('NON-ESG', 0.01676282100379467)"
Line 601,"In FY18, we developed a diversity scorecard that managers use to  identify gaps in hiring and representation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9748977422714233)","('Employee_Health_And_Safety', 0.0019364410545676947)","('Labor_Practices', 0.0019083592342212796)","(['Human Capital Development'], 0.9748977422714233)","('NON-ESG', 0.0019364410545676947)","('NON-ESG', 0.0019083592342212796)"
Line 602,"Based on scorecard results,  in FY19 we developed shared objectives and streamlined processes  across departments to increase collaboration and remove barriers  that affect all candidates — including ethnically diverse talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9762020707130432)","('Customer_Privacy', 0.0016291856300085783)","('Employee_Health_And_Safety', 0.001547646475955844)","(['Human Capital Development'], 0.9762020707130432)","('NON-ESG', 0.0016291856300085783)","('NON-ESG', 0.001547646475955844)"
Line 603,"There is a growing awareness of the impacts of unconscious bias —  accidental, unintended, subtle, and completely unconscious choices,  made by everyone, all the time.
","('Business_Ethics', 0.3579985797405243)","('Competitive_Behavior', 0.1418239027261734)","('Employee_Health_And_Safety', 0.07452443987131119)","('NON-ESG', 0.3579985797405243)","('NON-ESG', 0.1418239027261734)","('NON-ESG', 0.07452443987131119)"
Line 604,"T o counter this, expert-facilitated  training provides tools to adjust automatic patterns of thinking to  mitigate this bias.
","('Competitive_Behavior', 0.7331315279006958)","('Business_Ethics', 0.07924295961856842)","('Management_Of_Legal_And_Regulatory_Framework', 0.036292728036642075)","(['Business Ethics'], 0.7331315279006958)","('NON-ESG', 0.07924295961856842)","('NON-ESG', 0.036292728036642075)"
Line 605,"In FY19, Medtronic employees at the VP level  and above participated in these sessions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2303967922925949)","('Labor_Practices', 0.20191746950149536)","('Employee_Health_And_Safety', 0.13744665682315826)","('NON-ESG', 0.2303967922925949)","('NON-ESG', 0.20191746950149536)","('NON-ESG', 0.13744665682315826)"
Line 606,"We are in the process of  delivering unconscious bias awareness training to all 10,000 people  managers at Medtronic through our EDGE leadership program.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6549971103668213)","('Access_And_Affordability', 0.03965180367231369)","('Business_Ethics', 0.03709535673260689)","(['Human Capital Development'], 0.6549971103668213)","('NON-ESG', 0.03965180367231369)","('NON-ESG', 0.03709535673260689)"
Line 607,"22% of U.S. management positions are  held by ethnically diverse talent, exceeding  our 2020 target of at least 20%.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9723758697509766)","('Customer_Privacy', 0.0019220064859837294)","('Labor_Practices', 0.001592728542163968)","(['Human Capital Development'], 0.9723758697509766)","('NON-ESG', 0.0019220064859837294)","('NON-ESG', 0.001592728542163968)"
Line 608,"222119FY20 T arget0FY17 FY18 FY19Percentage of our U.S. Workforce Fiscal Y ear 0FY17 FY18 FY19Percentage of our U.S. Management Fiscal Y earU.S. ETHNICALL Y DIVERSE T ALENT  OVERALL* U.S. ETHNICALL Y DIVERSE T ALENT  IN MANAGEMENT*†222119FY20 T arget0FY17 FY18 FY19Percentage of our U.S. Workforce Fiscal Y ear 0FY17 FY18 FY19Percentage of our U.S. Management Fiscal Y earU.S. ETHNICALL Y DIVERSE T ALENT  OVERALL* U.S. ETHNICALL Y DIVERSE T ALENT  IN MANAGEMENT*† *  United States, excluding Puerto Rico (excludes blank, no data, or did not disclose) † Management = managers and aboveWe are amending our recruitment and hiring process to accelerate  hiring diverse, qualified talent and mitigate unconscious bias.
","('Employee_Engagement_Inclusion_And_Diversity', 0.970449686050415)","('Employee_Health_And_Safety', 0.00245787319727242)","('Business_Model_Resilience', 0.0023085838183760643)","(['Human Capital Development'], 0.970449686050415)","('NON-ESG', 0.00245787319727242)","('NON-ESG', 0.0023085838183760643)"
Line 609,"222119FY20 T arget0FY17 FY18 FY19Percentage of our U.S. Workforce Fiscal Y ear 0FY17 FY18 FY19Percentage of our U.S. Management Fiscal Y earU.S. ETHNICALL Y DIVERSE T ALENT  OVERALL* U.S. ETHNICALL Y DIVERSE T ALENT  IN MANAGEMENT*†222119FY20 T arget0FY17 FY18 FY19Percentage of our U.S. Workforce Fiscal Y ear 0FY17 FY18 FY19Percentage of our U.S. Management Fiscal Y earU.S. ETHNICALL Y DIVERSE T ALENT  OVERALL* U.S. ETHNICALL Y DIVERSE T ALENT  IN MANAGEMENT*† *  United States, excluding Puerto Rico (excludes blank, no data, or did not disclose) † Management = managers and aboveWe are amending our recruitment and hiring process to accelerate  hiring diverse, qualified talent and mitigate unconscious bias.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9714208841323853)","('Employee_Health_And_Safety', 0.002347339177504182)","('Competitive_Behavior', 0.0017460720846429467)","(['Human Capital Development'], 0.9714208841323853)","('NON-ESG', 0.002347339177504182)","('NON-ESG', 0.0017460720846429467)"
Line 610,"For  director and above roles, each candidate pool must include diverse  talent, and we review every hiring decision with a panel of   diverse employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9709596633911133)","('Employee_Health_And_Safety', 0.002440100535750389)","('Labor_Practices', 0.0019076127791777253)","(['Human Capital Development'], 0.9709596633911133)","('NON-ESG', 0.002440100535750389)","('NON-ESG', 0.0019076127791777253)"
Line 611,"Another focus area is our diverse high-potential talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9440618753433228)","('Human_Rights_And_Community_Relations', 0.004572859965264797)","('Employee_Health_And_Safety', 0.004341355059295893)","(['Human Capital Development'], 0.9440618753433228)","('NON-ESG', 0.004572859965264797)","('NON-ESG', 0.004341355059295893)"
Line 612,"Launched in  FY18, the Leadership Inclusion from Mentorship T oward Sponsorship  (Lift) program provides executive sponsorship and structured  professional development to prepare employees for future leadership  roles.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9282161593437195)","('Human_Rights_And_Community_Relations', 0.007383113261312246)","('Employee_Health_And_Safety', 0.007096780929714441)","(['Human Capital Development'], 0.9282161593437195)","('NON-ESG', 0.007383113261312246)","('NON-ESG', 0.007096780929714441)"
Line 613,"In Lift’s first year , half of the African Descent Network  participants earned a promotion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9518452882766724)","('Business_Model_Resilience', 0.004901240114122629)","('Customer_Privacy', 0.004114450421184301)","(['Human Capital Development'], 0.9518452882766724)","('NON-ESG', 0.004901240114122629)","('NON-ESG', 0.004114450421184301)"
Line 614,"CASE STUDY MEETING THE NEEDS  OF HEAL THCARE  WITH FEMALE  SURGEONS  By 2020, the United  States will need at least  100,000 additional  surgeons to meet  healthcare demands.
","('Employee_Health_And_Safety', 0.2949397563934326)","('Access_And_Affordability', 0.2568082809448242)","('Employee_Engagement_Inclusion_And_Diversity', 0.09969305992126465)","('NON-ESG', 0.2949397563934326)","('NON-ESG', 0.2568082809448242)","('NON-ESG', 0.09969305992126465)"
Line 615,"This  challenge is compounded  by the fact that only  13% of surgeons are  women, despite women  representing nearly half  of all medical school  applicants.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7853399515151978)","('Labor_Practices', 0.028208352625370026)","('Competitive_Behavior', 0.01598297245800495)","(['Human Capital Development'], 0.7853399515151978)","('NON-ESG', 0.028208352625370026)","('NON-ESG', 0.01598297245800495)"
Line 616,"For over  10 years, Medtronic  has partnered with the  Association of Women  Surgeons to advance  the careers of female  surgeons.
","('Employee_Engagement_Inclusion_And_Diversity', 0.48019757866859436)","('Employee_Health_And_Safety', 0.21451696753501892)","('Access_And_Affordability', 0.03112373687326908)","('NON-ESG', 0.48019757866859436)","('NON-ESG', 0.21451696753501892)","('NON-ESG', 0.03112373687326908)"
Line 617,"We support  women in surgery by  providing advanced  education, access to  innovative products, and  professional development  opportunities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3876405656337738)","('Access_And_Affordability', 0.33680883049964905)","('Human_Rights_And_Community_Relations', 0.03692595288157463)","('NON-ESG', 0.3876405656337738)","('NON-ESG', 0.33680883049964905)","('NON-ESG', 0.03692595288157463)"
Line 618,"T o date, we  have sponsored over 100  career conferences for  female surgeons.66In FY19, Medtronic joined the Human Rights  Campaign Business Coalition for the   Equality Act.Preventing discrimination We take a multifaceted  approach to ensuring that  our work environment is free  from discrimination based on  race, ethnicity, gender , gender  identity, sexual orientation,  disability, religion, and other  identities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9736416339874268)","('Employee_Health_And_Safety', 0.002795356558635831)","('Human_Rights_And_Community_Relations', 0.002395021030679345)","(['Human Capital Development'], 0.9736416339874268)","('NON-ESG', 0.002795356558635831)","('NON-ESG', 0.002395021030679345)"
Line 619,"Nondiscrimination is  addressed in our companywide  policies, including our Code of  Conduct and our Global   Human Rights and Labor  Standards Policy, which also  addresses workforce equality  and fair employment.
","('Labor_Practices', 0.9078221321105957)","('Employee_Engagement_Inclusion_And_Diversity', 0.036928221583366394)","('Human_Rights_And_Community_Relations', 0.010357865132391453)","(['Labor Practice Indicators'], 0.9078221321105957)","('NON-ESG', 0.036928221583366394)","('NON-ESG', 0.010357865132391453)"
Line 620,"For more  on how our Global Human Rights  Program prevents discrimination  against vulnerable groups, see  the Medtronic Global Human   Rights Report.
","('Human_Rights_And_Community_Relations', 0.9267052412033081)","('Labor_Practices', 0.009849980473518372)","('Employee_Engagement_Inclusion_And_Diversity', 0.008990204893052578)","(['Community Relations'], 0.9267052412033081)","('NON-ESG', 0.009849980473518372)","('NON-ESG', 0.008990204893052578)"
Line 621,"We encourage our employees  to report any issues of  discrimination through their manager , Human Resources,  Legal, or Compliance  representatives, or the Voice  Y our Concern Line.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8386649489402771)","('Labor_Practices', 0.03421403467655182)","('Business_Ethics', 0.026952337473630905)","(['Human Capital Development'], 0.8386649489402771)","('NON-ESG', 0.03421403467655182)","('NON-ESG', 0.026952337473630905)"
Line 622,"We  follow employment law by  ensuring that an objective  party investigates all claims of  discrimination.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8435702919960022)","('Labor_Practices', 0.06289985775947571)","('Employee_Health_And_Safety', 0.012365615926682949)","(['Human Capital Development'], 0.8435702919960022)","('NON-ESG', 0.06289985775947571)","('NON-ESG', 0.012365615926682949)"
Line 623,"We have a zero- tolerance policy and respond  to all confirmed claims with  disciplinary action — up   to termination.
","('Business_Ethics', 0.3663423955440521)","('Labor_Practices', 0.14351418614387512)","('Employee_Health_And_Safety', 0.12356025725603104)","('NON-ESG', 0.3663423955440521)","('NON-ESG', 0.14351418614387512)","('NON-ESG', 0.12356025725603104)"
Line 624,"Outside of our company, we  provide public support for  human rights equality.
","('Human_Rights_And_Community_Relations', 0.9472723007202148)","('Access_And_Affordability', 0.007006871048361063)","('Labor_Practices', 0.0067557282745838165)","(['Community Relations'], 0.9472723007202148)","('NON-ESG', 0.007006871048361063)","('NON-ESG', 0.0067557282745838165)"
Line 625,"In FY19,  Medtronic supported the  Equality Act, U.S. legislation to  expand the Civil Rights Act of  1964 to protect LGBTQ+ people  against discrimination.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9498143196105957)","('Human_Rights_And_Community_Relations', 0.009257921949028969)","('Employee_Health_And_Safety', 0.0043455008417367935)","(['Human Capital Development'], 0.9498143196105957)","('NON-ESG', 0.009257921949028969)","('NON-ESG', 0.0043455008417367935)"
Line 626,"We  also joined the Human Rights  Campaign Business Coalition for  the Equality Act along with more  than 235 other companies.67 Asia Society — 2019 (Best   of the Best) Promoting Asian- Pacific American Women   DiversityInc — 2019 T op 50  Companies for Diversity  Disability Equality Index —  2019 Best Places to Work Forbes — 2019 Best Employers  for Women List  Human Rights Campaign —  2019 Corporate Equality Index  Indeed — 2018 T op-Rated  Healthcare Companies to   Work For JUST Capital — 2018 T op 100  U.S. Companies Supporting  Healthy Communities   and Families  Thomson Reuters — 2018   T op 100 Most Diverse &  Inclusive Organizations GloballyINCLUSION   & DIVERSITY   AWARDS68Employees are our most valuable asset and investments in their  success improve our business performance.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9364027976989746)","('Human_Rights_And_Community_Relations', 0.01326057594269514)","('Employee_Health_And_Safety', 0.006511975545436144)","(['Human Capital Development'], 0.9364027976989746)","('NON-ESG', 0.01326057594269514)","('NON-ESG', 0.006511975545436144)"
Line 627,"We  also joined the Human Rights  Campaign Business Coalition for  the Equality Act along with more  than 235 other companies.67 Asia Society — 2019 (Best   of the Best) Promoting Asian- Pacific American Women   DiversityInc — 2019 T op 50  Companies for Diversity  Disability Equality Index —  2019 Best Places to Work Forbes — 2019 Best Employers  for Women List  Human Rights Campaign —  2019 Corporate Equality Index  Indeed — 2018 T op-Rated  Healthcare Companies to   Work For JUST Capital — 2018 T op 100  U.S. Companies Supporting  Healthy Communities   and Families  Thomson Reuters — 2018   T op 100 Most Diverse &  Inclusive Organizations GloballyINCLUSION   & DIVERSITY   AWARDS68Employees are our most valuable asset and investments in their  success improve our business performance.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9713541865348816)","('Human_Rights_And_Community_Relations', 0.0033888090401887894)","('Employee_Health_And_Safety', 0.0023389996495097876)","(['Human Capital Development'], 0.9713541865348816)","('NON-ESG', 0.0033888090401887894)","('NON-ESG', 0.0023389996495097876)"
Line 628,"By providing career  development resources, we increase engagement and strengthen   our talent pipeline.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9567650556564331)","('Employee_Health_And_Safety', 0.004737468436360359)","('Access_And_Affordability', 0.003423173213377595)","(['Human Capital Development'], 0.9567650556564331)","('NON-ESG', 0.004737468436360359)","('NON-ESG', 0.003423173213377595)"
Line 629,"Investing in the professional development of   our workforce Our learning and development programs help talent reach their career  potential, build lifelong relationship skills, and take part in our inclusive  culture.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9569007158279419)","('Employee_Health_And_Safety', 0.004259416367858648)","('Access_And_Affordability', 0.003281420562416315)","(['Human Capital Development'], 0.9569007158279419)","('NON-ESG', 0.004259416367858648)","('NON-ESG', 0.003281420562416315)"
Line 630,"We support growth by providing educational opportunities   at all levels of the organization and by promoting internally.
","('Access_And_Affordability', 0.8645814061164856)","('Employee_Engagement_Inclusion_And_Diversity', 0.01919187791645527)","('Human_Rights_And_Community_Relations', 0.013477878645062447)","(['Health Outcome Contribution'], 0.8645814061164856)","('NON-ESG', 0.01919187791645527)","('NON-ESG', 0.013477878645062447)"
Line 631,"In FY19,  we filled 32% of open roles at the company with internal candidates.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3078884780406952)","('Director_Removal', 0.24061733484268188)","('Labor_Practices', 0.0795443058013916)","('NON-ESG', 0.3078884780406952)","('NON-ESG', 0.24061733484268188)","('NON-ESG', 0.0795443058013916)"
Line 632,"At the VP level, we have moved from filling 50% to 80% of those roles  with internal candidates.
","('Director_Removal', 0.3887200653553009)","('Employee_Engagement_Inclusion_And_Diversity', 0.13886520266532898)","('Competitive_Behavior', 0.0776045173406601)","('NON-ESG', 0.3887200653553009)","('NON-ESG', 0.13886520266532898)","('NON-ESG', 0.0776045173406601)"
Line 633,"Investing in learning and development contributes to employee  satisfaction and retention.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9524775743484497)","('Employee_Health_And_Safety', 0.005605909042060375)","('Human_Rights_And_Community_Relations', 0.003749748459085822)","(['Human Capital Development'], 0.9524775743484497)","('NON-ESG', 0.005605909042060375)","('NON-ESG', 0.003749748459085822)"
Line 634,"Across our programs we’ve seen increased  engagement and retention scores from participants compared   to their peers.
","('Employee_Engagement_Inclusion_And_Diversity', 0.939499020576477)","('Access_And_Affordability', 0.005728682968765497)","('Human_Rights_And_Community_Relations', 0.004989817272871733)","(['Human Capital Development'], 0.939499020576477)","('NON-ESG', 0.005728682968765497)","('NON-ESG', 0.004989817272871733)"
Line 635,"In FY19, we spent $77.5 million on learning and  development resources.
","('Access_And_Affordability', 0.5139760375022888)","('Employee_Engagement_Inclusion_And_Diversity', 0.13240861892700195)","('Ecological_Impacts', 0.04397984966635704)","(['Health Outcome Contribution'], 0.5139760375022888)","('NON-ESG', 0.13240861892700195)","('NON-ESG', 0.04397984966635704)"
Line 636,"We take a structured approach to career conversations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7453126311302185)","('Business_Model_Resilience', 0.040040165185928345)","('Business_Ethics', 0.02313881181180477)","(['Human Capital Development'], 0.7453126311302185)","('NON-ESG', 0.040040165185928345)","('NON-ESG', 0.02313881181180477)"
Line 637,"As of FY19,  95% of our workforce has a development plan logged in our talent  management system.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9678124189376831)","('Employee_Health_And_Safety', 0.0027819073293358088)","('Business_Model_Resilience', 0.002443278208374977)","(['Human Capital Development'], 0.9678124189376831)","('NON-ESG', 0.0027819073293358088)","('NON-ESG', 0.002443278208374977)"
Line 638,"Medtronic managers meet with employees at  least three times each year to discuss career aspirations, set goals,  and review performance.
","('Employee_Engagement_Inclusion_And_Diversity', 0.890591025352478)","('Employee_Health_And_Safety', 0.01327657699584961)","('Director_Removal', 0.009016395546495914)","(['Human Capital Development'], 0.890591025352478)","('NON-ESG', 0.01327657699584961)","('NON-ESG', 0.009016395546495914)"
Line 639,"This formal process reaches 100% of the  Medtronic workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.467540442943573)","('Labor_Practices', 0.1622541844844818)","('Employee_Health_And_Safety', 0.058102741837501526)","('NON-ESG', 0.467540442943573)","('NON-ESG', 0.1622541844844818)","('NON-ESG', 0.058102741837501526)"
Line 640,"We encourage all managers to hold ongoing  one-on-one meetings to touch base with employees throughout  the year .
","('Labor_Practices', 0.3037315607070923)","('Employee_Engagement_Inclusion_And_Diversity', 0.19030478596687317)","('Employee_Health_And_Safety', 0.11685629189014435)","('NON-ESG', 0.3037315607070923)","('NON-ESG', 0.19030478596687317)","('NON-ESG', 0.11685629189014435)"
Line 641,"In FY20, we launched a pilot program to create a consistent  performance management and career development framework for  9,000 employees at our 13 manufacturing facilities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9000830054283142)","('Employee_Health_And_Safety', 0.013705098070204258)","('Labor_Practices', 0.011352486908435822)","(['Human Capital Development'], 0.9000830054283142)","('NON-ESG', 0.013705098070204258)","('NON-ESG', 0.011352486908435822)"
Line 642,"Based on the  results of the pilot, we will refine the framework to best meet   employee needs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2219734638929367)","('Human_Rights_And_Community_Relations', 0.13078299164772034)","('Access_And_Affordability', 0.1018427163362503)","('NON-ESG', 0.2219734638929367)","('NON-ESG', 0.13078299164772034)","('NON-ESG', 0.1018427163362503)"
Line 643,"In FY19, we offered more than 36,600 virtual and in-person learning  resources for employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5396750569343567)","('Access_And_Affordability', 0.2022601068019867)","('Employee_Health_And_Safety', 0.04183729737997055)","(['Human Capital Development'], 0.5396750569343567)","('NON-ESG', 0.2022601068019867)","('NON-ESG', 0.04183729737997055)"
Line 644,"These include our Experience Café platform,  which helps individuals expand their professional networks through  structured, experiential learning opportunities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6749011278152466)","('Access_And_Affordability', 0.06924621760845184)","('Human_Rights_And_Community_Relations', 0.03112003020942211)","(['Human Capital Development'], 0.6749011278152466)","('NON-ESG', 0.06924621760845184)","('NON-ESG', 0.03112003020942211)"
Line 645,"DEVELOPMENT   & ENGAGEMENT Adding   Business Value    The talent and commitment of our employees drive our  business.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9625633955001831)","('Employee_Health_And_Safety', 0.004572809673845768)","('Human_Rights_And_Community_Relations', 0.0031774179078638554)","(['Human Capital Development'], 0.9625633955001831)","('NON-ESG', 0.004572809673845768)","('NON-ESG', 0.0031774179078638554)"
Line 646,"We increase our ability to attract and retain talent with  comprehensive professional development programs, enabling  our people to create rewarding careers at Medtronic.ON LEARNING  & DEVELOPMENT RESOURCES$77.5 MIN FY19, WE SPENT 69The key drivers of engagement  identified through the   survey were:  84% of employees said   that being proactive within  their team is supported   and encouraged  81% of employees felt like  they belong at Medtronic FY19 survey results also showed  that Medtronic employees are  increasingly likely to recommend  us as an employer and to see us  as an innovative and inclusive  organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.936954915523529)","('Employee_Health_And_Safety', 0.009163940325379372)","('Access_And_Affordability', 0.004774545319378376)","(['Human Capital Development'], 0.936954915523529)","('NON-ESG', 0.009163940325379372)","('NON-ESG', 0.004774545319378376)"
Line 647,"We increase our ability to attract and retain talent with  comprehensive professional development programs, enabling  our people to create rewarding careers at Medtronic.ON LEARNING  & DEVELOPMENT RESOURCES$77.5 MIN FY19, WE SPENT 69The key drivers of engagement  identified through the   survey were:  84% of employees said   that being proactive within  their team is supported   and encouraged  81% of employees felt like  they belong at Medtronic FY19 survey results also showed  that Medtronic employees are  increasingly likely to recommend  us as an employer and to see us  as an innovative and inclusive  organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.839669406414032)","('Human_Rights_And_Community_Relations', 0.03684433922171593)","('Access_And_Affordability', 0.03376329690217972)","(['Human Capital Development'], 0.839669406414032)","('NON-ESG', 0.03684433922171593)","('NON-ESG', 0.03376329690217972)"
Line 648,"Compared to  FY18, employees reported  improvements in being able  to get work done, despite the  complexity and size of our  organization.
","('Labor_Practices', 0.3631662130355835)","('Employee_Health_And_Safety', 0.2877989411354065)","('Employee_Engagement_Inclusion_And_Diversity', 0.07336907833814621)","('NON-ESG', 0.3631662130355835)","('NON-ESG', 0.2877989411354065)","('NON-ESG', 0.07336907833814621)"
Line 649,"However , we  recognize that this area remains  one of our biggest opportunities  for improvement.
","('Human_Rights_And_Community_Relations', 0.2387426197528839)","('Access_And_Affordability', 0.16969723999500275)","('Management_Of_Legal_And_Regulatory_Framework', 0.0927479937672615)","('NON-ESG', 0.2387426197528839)","('NON-ESG', 0.16969723999500275)","('NON-ESG', 0.0927479937672615)"
Line 650,"In FY20, we are launching a  new development program for  aspiring leaders and updating  our programs to be more  inclusive of learning preferences.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6955516338348389)","('Access_And_Affordability', 0.0789279118180275)","('Business_Model_Resilience', 0.026620717719197273)","(['Human Capital Development'], 0.6955516338348389)","('NON-ESG', 0.0789279118180275)","('NON-ESG', 0.026620717719197273)"
Line 651,"Employee engagement We encourage employees  to voice their opinions at  Medtronic, and we invite their  feedback through our annual  Organizational Health Survey.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9025917053222656)","('Employee_Health_And_Safety', 0.009871618822216988)","('Human_Rights_And_Community_Relations', 0.008888054639101028)","(['Human Capital Development'], 0.9025917053222656)","('NON-ESG', 0.009871618822216988)","('NON-ESG', 0.008888054639101028)"
Line 652,"In FY19, we increased our  participation rate to 78%, with  more than 69,000 employees  responding.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3766309916973114)","('Labor_Practices', 0.22988314926624298)","('Employee_Health_And_Safety', 0.0732128694653511)","('NON-ESG', 0.3766309916973114)","('NON-ESG', 0.22988314926624298)","('NON-ESG', 0.0732128694653511)"
Line 653,"Our male and  female engagement rates were  75% and 77%, respectively,   for an overall engagement  rate of 76% — 11% above the  industry average.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8017769455909729)","('Labor_Practices', 0.030218861997127533)","('Business_Model_Resilience', 0.023838631808757782)","(['Human Capital Development'], 0.8017769455909729)","('NON-ESG', 0.030218861997127533)","('NON-ESG', 0.023838631808757782)"
Line 654,"Internal Coaching  Certification — provides  advanced coaching skills  for senior leaders to help  others unlock potential.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6074244976043701)","('Access_And_Affordability', 0.13333655893802643)","('Human_Rights_And_Community_Relations', 0.02964695170521736)","(['Human Capital Development'], 0.6074244976043701)","('NON-ESG', 0.13333655893802643)","('NON-ESG', 0.02964695170521736)"
Line 655,"The  feedback on this program has  been overwhelmingly positive,  with 92% of participants  stating they would refer this  program to a peer .
","('Access_And_Affordability', 0.635100781917572)","('Management_Of_Legal_And_Regulatory_Framework', 0.06735522300004959)","('Human_Rights_And_Community_Relations', 0.040855150669813156)","(['Health Outcome Contribution'], 0.635100781917572)","('NON-ESG', 0.06735522300004959)","('NON-ESG', 0.040855150669813156)"
Line 656,"Lift — utilizes executive  sponsorship to prepare  diverse talent for leadership  roles.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9661186337471008)","('Business_Model_Resilience', 0.0024861516430974007)","('Human_Rights_And_Community_Relations', 0.0023150972556322813)","(['Human Capital Development'], 0.9661186337471008)","('NON-ESG', 0.0024861516430974007)","('NON-ESG', 0.0023150972556322813)"
Line 657,"Vice President   Onboarding — supports a  successful transition for new  vice presidents, familiarizing  them with the business, their  team, and expectations of  their role.
","('Director_Removal', 0.3827700614929199)","('Business_Model_Resilience', 0.19061939418315887)","('Employee_Engagement_Inclusion_And_Diversity', 0.10420762747526169)","('NON-ESG', 0.3827700614929199)","('NON-ESG', 0.19061939418315887)","('NON-ESG', 0.10420762747526169)"
Line 658,"The program has  been shown to increase the  speed of proficiency and  reduce the costs associated  with VP onboarding.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3239327669143677)","('Access_And_Affordability', 0.1261052042245865)","('Product_Quality_And_Safety', 0.11022455990314484)","('NON-ESG', 0.3239327669143677)","('NON-ESG', 0.1261052042245865)","('NON-ESG', 0.11022455990314484)"
Line 659,"Through leadership  development programs, we  strengthen the capabilities  of our people managers —  benefiting employees at all  levels of the organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8884750008583069)","('Human_Rights_And_Community_Relations', 0.012665881775319576)","('Employee_Health_And_Safety', 0.010714555159211159)","(['Human Capital Development'], 0.8884750008583069)","('NON-ESG', 0.012665881775319576)","('NON-ESG', 0.010714555159211159)"
Line 660,"Our  programs in FY19 included:  EDGE — imparts leadership  skills to all Medtronic leaders,  including ways to mitigate  unconscious bias.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7491737008094788)","('Business_Ethics', 0.03180177882313728)","('Business_Model_Resilience', 0.02547387219965458)","(['Human Capital Development'], 0.7491737008094788)","('NON-ESG', 0.03180177882313728)","('NON-ESG', 0.02547387219965458)"
Line 661,"Empower — teaches  operations supervisors  leadership tools to  strengthen their teams and  achieve business results.
","('Business_Model_Resilience', 0.29885604977607727)","('Employee_Engagement_Inclusion_And_Diversity', 0.24218887090682983)","('Systemic_Risk_Management', 0.06584828346967697)","('NON-ESG', 0.29885604977607727)","('NON-ESG', 0.24218887090682983)","('NON-ESG', 0.06584828346967697)"
Line 662,"Ignite — accelerates  readiness of high-potential  directors for higher-level  leadership roles.70We integrate safety into our workplace culture to protect employees from  hazards.
","('Employee_Health_And_Safety', 0.9818090796470642)","('Employee_Engagement_Inclusion_And_Diversity', 0.0026493817567825317)","('Critical_Incident_Risk_Management', 0.00200945558026433)","(['Operational Eco-Efficiency'], 0.9818090796470642)","('NON-ESG', 0.0026493817567825317)","('NON-ESG', 0.00200945558026433)"
Line 663,"Recognizing the role that employers play in physical, mental, and  financial well-being, we provide resources to help our people thrive.
","('Employee_Health_And_Safety', 0.3874675929546356)","('Access_And_Affordability', 0.17128895223140717)","('Human_Rights_And_Community_Relations', 0.13997778296470642)","('NON-ESG', 0.3874675929546356)","('NON-ESG', 0.17128895223140717)","('NON-ESG', 0.13997778296470642)"
Line 664,"A culture of safety We maintain a robust environmental, health, and safety (EHS)  management system through the following methods:  Setting annual internal EHS goals  Proactively identifying and managing risks  Implementing training programs  Monitoring regulatory trends  Auditing sites for compliance and completing corrective actionsOur focus is on continuous improvement and in FY19, our newly  integrated EHS information system allowed us to collect more  comprehensive safety data.
","('Employee_Health_And_Safety', 0.9634600877761841)","('Product_Quality_And_Safety', 0.00888028834015131)","('Critical_Incident_Risk_Management', 0.0025550315622240305)","(['Operational Eco-Efficiency'], 0.9634600877761841)","('NON-ESG', 0.00888028834015131)","('NON-ESG', 0.0025550315622240305)"
Line 665,"We encourage employees to report  hazards and near misses as part of our safety culture.
","('Employee_Health_And_Safety', 0.9782512187957764)","('Critical_Incident_Risk_Management', 0.004531005397439003)","('Waste_And_Hazardous_Materials_Management', 0.0015982636250555515)","(['Operational Eco-Efficiency'], 0.9782512187957764)","('NON-ESG', 0.004531005397439003)","('NON-ESG', 0.0015982636250555515)"
Line 666,"In FY19,  employees reported more than 3,900 hazard observations and  logged 715 near-miss reports, which are used to improve workplace  safety.
","('Employee_Health_And_Safety', 0.9807628393173218)","('Employee_Engagement_Inclusion_And_Diversity', 0.002087506465613842)","('Critical_Incident_Risk_Management', 0.0017743700882419944)","(['Operational Eco-Efficiency'], 0.9807628393173218)","('NON-ESG', 0.002087506465613842)","('NON-ESG', 0.0017743700882419944)"
Line 667,"FY19 data also show increases in our Injury Incident rate and  our Lost/Restricted Workday Case rate.
","('Employee_Health_And_Safety', 0.9819153547286987)","('Critical_Incident_Risk_Management', 0.002901979722082615)","('Labor_Practices', 0.001692814752459526)","(['Operational Eco-Efficiency'], 0.9819153547286987)","('NON-ESG', 0.002901979722082615)","('NON-ESG', 0.001692814752459526)"
Line 668,"We attribute the increase  to improved reporting and increased engagement following  employee communications.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3830181658267975)","('Human_Rights_And_Community_Relations', 0.14919258654117584)","('Access_And_Affordability', 0.0828990712761879)","('NON-ESG', 0.3830181658267975)","('NON-ESG', 0.14919258654117584)","('NON-ESG', 0.0828990712761879)"
Line 669,"There were no work-related fatalities of  Medtronic employees.
","('Employee_Health_And_Safety', 0.9561055302619934)","('Labor_Practices', 0.01277664490044117)","('Critical_Incident_Risk_Management', 0.0036094433162361383)","(['Operational Eco-Efficiency'], 0.9561055302619934)","('NON-ESG', 0.01277664490044117)","('NON-ESG', 0.0036094433162361383)"
Line 670,"In FY19, our Organizational Health Survey showed that 90% of  respondents feel we actively encourage employees to work safely,  and 91% of respondents are comfortable reporting safety concerns  and injuries at work.
","('Employee_Health_And_Safety', 0.9837665557861328)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016627076547592878)","('Critical_Incident_Risk_Management', 0.0016238015377894044)","(['Operational Eco-Efficiency'], 0.9837665557861328)","('NON-ESG', 0.0016627076547592878)","('NON-ESG', 0.0016238015377894044)"
Line 671,"HEAL TH &   WELL -BEING Adding   Business Value    Establishing a strong culture of safety and supporting healthy  lifestyles for our employees lead to a more engaged workforce,  reduces absences due to sickness and cuts healthcare costs.
","('Employee_Health_And_Safety', 0.9705713987350464)","('Employee_Engagement_Inclusion_And_Diversity', 0.004775943700224161)","('Access_And_Affordability', 0.0023532176855951548)","(['Operational Eco-Efficiency'], 0.9705713987350464)","('NON-ESG', 0.004775943700224161)","('NON-ESG', 0.0023532176855951548)"
Line 672,"EMPLOYEES REGISTERED   ON OUR WELLNESS  PLA TFORM 57,000IN FY19, MORE THAN 71Investing in wellness  Healthier T ogether is our global wellness program, which supports  the physical, emotional, social, and financial well-being of Medtronic  employees.
","('Employee_Health_And_Safety', 0.6356762647628784)","('Employee_Engagement_Inclusion_And_Diversity', 0.1329222321510315)","('Access_And_Affordability', 0.03460090607404709)","(['Operational Eco-Efficiency'], 0.6356762647628784)","('NON-ESG', 0.1329222321510315)","('NON-ESG', 0.03460090607404709)"
Line 673,"Nearly every employee has access to this program.
","('Access_And_Affordability', 0.8635796308517456)","('Product_Quality_And_Safety', 0.01605917699635029)","('Human_Rights_And_Community_Relations', 0.010165086016058922)","(['Health Outcome Contribution'], 0.8635796308517456)","('NON-ESG', 0.01605917699635029)","('NON-ESG', 0.010165086016058922)"
Line 674,"In FY19, more than 57,000 employees registered on our wellness  platform and 56% of employees participated.
","('Labor_Practices', 0.39745309948921204)","('Employee_Engagement_Inclusion_And_Diversity', 0.23740635812282562)","('Director_Removal', 0.07501675188541412)","('NON-ESG', 0.39745309948921204)","('NON-ESG', 0.23740635812282562)","('NON-ESG', 0.07501675188541412)"
Line 675,"T wice yearly, we host Global Wellness Challenges, that encourage  physical activity through themed competitions.
","('Employee_Health_And_Safety', 0.5776835680007935)","('Employee_Engagement_Inclusion_And_Diversity', 0.07813248783349991)","('Customer_Welfare', 0.05009853467345238)","(['Operational Eco-Efficiency'], 0.5776835680007935)","('NON-ESG', 0.07813248783349991)","('NON-ESG', 0.05009853467345238)"
Line 676,"Employee teams  compete to accumulate the most steps, unlocking destinations  when activity goals are achieved.
","('Competitive_Behavior', 0.5966898202896118)","('Systemic_Risk_Management', 0.06897743046283722)","('Business_Ethics', 0.04344496876001358)","(['Business Ethics'], 0.5966898202896118)","('NON-ESG', 0.06897743046283722)","('NON-ESG', 0.04344496876001358)"
Line 677,"In FY19, employees logged over  2 billion steps during a Medtronic Foundation wellness challenge,  securing a $25,000 donation for our nonprofit partner , Children’s  Heart Link.
","('Access_And_Affordability', 0.7240840792655945)","('Human_Rights_And_Community_Relations', 0.038844943046569824)","('Management_Of_Legal_And_Regulatory_Framework', 0.02642405591905117)","(['Health Outcome Contribution'], 0.7240840792655945)","('NON-ESG', 0.038844943046569824)","('NON-ESG', 0.02642405591905117)"
Line 678,"Safety Record* FY17 FY18 FYEmployee Injury Incident Rate†0.39 0.25 0.Employee Lost/Restricted  Workday Case Rate**0.21 0.12 0.Fatalities 0 0    *  Our safety records include employees and contingent workers.
","('Employee_Health_And_Safety', 0.9836071729660034)","('Employee_Engagement_Inclusion_And_Diversity', 0.0017608056077733636)","('Critical_Incident_Risk_Management', 0.001400482258759439)","(['Operational Eco-Efficiency'], 0.9836071729660034)","('NON-ESG', 0.0017608056077733636)","('NON-ESG', 0.001400482258759439)"
Line 679,"†  The number of work-related injuries or illness serious enough to require  treatment beyond first aid, per 100 employees working a full year .
","('Employee_Health_And_Safety', 0.9844242930412292)","('Critical_Incident_Risk_Management', 0.0017935632495209575)","('Employee_Engagement_Inclusion_And_Diversity', 0.0013491539284586906)","(['Operational Eco-Efficiency'], 0.9844242930412292)","('NON-ESG', 0.0017935632495209575)","('NON-ESG', 0.0013491539284586906)"
Line 680,"**  The number of work-related injuries or illness serious enough to cause an  employee to miss one or more workdays or to have one or more workdays of  restricted duty, per 100 employees working a full year .72Our compensation framework is designed to celebrate the value  and contributions of employees and provide a means to share in  the company’s success.
","('Employee_Health_And_Safety', 0.9809540510177612)","('Labor_Practices', 0.002357303397729993)","('Employee_Engagement_Inclusion_And_Diversity', 0.0021432831417769194)","(['Operational Eco-Efficiency'], 0.9809540510177612)","('NON-ESG', 0.002357303397729993)","('NON-ESG', 0.0021432831417769194)"
Line 681,"We aim to create a feeling of personal and  professional security at Medtronic and are committed to transparent  communications on compensation.
","('Customer_Privacy', 0.40578386187553406)","('Business_Ethics', 0.40474459528923035)","('Data_Security', 0.06314501911401749)","('NON-ESG', 0.40578386187553406)","('NON-ESG', 0.40474459528923035)","('NON-ESG', 0.06314501911401749)"
Line 682,"Compensation and benefits Our competitive approach to compensation reflects industry  benchmarks and local market standards.
","('Competitive_Behavior', 0.9318572878837585)","('Business_Ethics', 0.01590627431869507)","('Management_Of_Legal_And_Regulatory_Framework', 0.00864910613745451)","(['Business Ethics'], 0.9318572878837585)","('NON-ESG', 0.01590627431869507)","('NON-ESG', 0.00864910613745451)"
Line 683,"Our programs include annual  and long-term incentives that provide the means to share in the  company’s success.
","('Management_Of_Legal_And_Regulatory_Framework', 0.28218013048171997)","('Human_Rights_And_Community_Relations', 0.1455802321434021)","('Competitive_Behavior', 0.1065676361322403)","('NON-ESG', 0.28218013048171997)","('NON-ESG', 0.1455802321434021)","('NON-ESG', 0.1065676361322403)"
Line 684,"T o attract the best leaders, we offer competitive  benefits, cash, and equity incentives.
","('Competitive_Behavior', 0.9500656127929688)","('Systemic_Risk_Management', 0.0074173142202198505)","('Business_Model_Resilience', 0.004133178852498531)","(['Business Ethics'], 0.9500656127929688)","('NON-ESG', 0.0074173142202198505)","('NON-ESG', 0.004133178852498531)"
Line 685,"The same programs and  principles govern our executive and nonexecutive compensation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3664720356464386)","('Business_Ethics', 0.22199566662311554)","('Labor_Practices', 0.1336781084537506)","('NON-ESG', 0.3664720356464386)","('NON-ESG', 0.22199566662311554)","('NON-ESG', 0.1336781084537506)"
Line 686,"In FY19, we launched the Free Cash Flow Challenge — an employee  engagement initiative designed to increase our free cash flow, a  source of funding for innovation and breakthrough research.
","('Competitive_Behavior', 0.3468732237815857)","('Systemic_Risk_Management', 0.19604744017124176)","('Management_Of_Legal_And_Regulatory_Framework', 0.08731380850076675)","('NON-ESG', 0.3468732237815857)","('NON-ESG', 0.19604744017124176)","('NON-ESG', 0.08731380850076675)"
Line 687,"T o help all 90,000+ employees contribute to our financial health,   we created informative animations, quizzes, and a library of on- demand educational resources on the topic.
","('Access_And_Affordability', 0.45583462715148926)","('Employee_Engagement_Inclusion_And_Diversity', 0.18846529722213745)","('Employee_Health_And_Safety', 0.10417033731937408)","('NON-ESG', 0.45583462715148926)","('NON-ESG', 0.18846529722213745)","('NON-ESG', 0.10417033731937408)"
Line 688,"The resulting impact   was a 62% increase in free cash flow year-over-year , and we  surpassed our FY19 goal by 10%.
","('Systemic_Risk_Management', 0.5645319223403931)","('Business_Model_Resilience', 0.12135934829711914)","('Management_Of_Legal_And_Regulatory_Framework', 0.09028303623199463)","(['Risk & Crisis Management'], 0.5645319223403931)","('NON-ESG', 0.12135934829711914)","('NON-ESG', 0.09028303623199463)"
Line 689,"Recognizing the contribution of our  workforce, we rewarded eligible employees with an ownership stake in  the company through restricted stock options.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7777632474899292)","('Labor_Practices', 0.09718682616949081)","('Director_Removal', 0.01776898093521595)","(['Human Capital Development'], 0.7777632474899292)","('NON-ESG', 0.09718682616949081)","('NON-ESG', 0.01776898093521595)"
Line 690,"COMPENSA TION,  BENEFITS, &  RECOGNITION  FY19  FREE CASH FLOW CHALLENGE AVAILABLE TO OUR EMPLOYEES90,000+ OUR COMPANY FYFREE CASH FLOW  GOAL BYSURPASSED 10%INCREASE IN FREE CASH FLOW  YEAR-OVER-YEAR62%73CASE STUDY CARING FOR FAMILIES  We aim to support our  employees in all that they  do, both personally and  professionally.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2696610391139984)","('Business_Ethics', 0.21734312176704407)","('Labor_Practices', 0.12449078261852264)","('NON-ESG', 0.2696610391139984)","('NON-ESG', 0.21734312176704407)","('NON-ESG', 0.12449078261852264)"
Line 691,"In FY19, we  launched the Medtronic Family  Care Leave benefit.
","('Access_And_Affordability', 0.5908515453338623)","('Customer_Welfare', 0.05816340819001198)","('Product_Quality_And_Safety', 0.045454174280166626)","(['Health Outcome Contribution'], 0.5908515453338623)","('NON-ESG', 0.05816340819001198)","('NON-ESG', 0.045454174280166626)"
Line 692,"It provides  up to six additional weeks of  paid time off for employees to  care for sick family members or  support family after a spouse,  child, or parent is called to  active military duty.
","('Access_And_Affordability', 0.4325956702232361)","('Employee_Health_And_Safety', 0.1970231831073761)","('Labor_Practices', 0.09017817676067352)","('NON-ESG', 0.4325956702232361)","('NON-ESG', 0.1970231831073761)","('NON-ESG', 0.09017817676067352)"
Line 693,"The benefit  also covers parents bonding  with a new child including birth,  adoptive or surrogate, and  non-birth parents.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3654521405696869)","('Access_And_Affordability', 0.29769936203956604)","('Employee_Health_And_Safety', 0.0742795467376709)","('NON-ESG', 0.3654521405696869)","('NON-ESG', 0.29769936203956604)","('NON-ESG', 0.0742795467376709)"
Line 694,"Monica Casillas, a Medtronic  Customer Service  Representative, was on  maternity leave when  Medtronic called her about the  new benefit.
","('Labor_Practices', 0.37916192412376404)","('Employee_Health_And_Safety', 0.19581449031829834)","('Employee_Engagement_Inclusion_And_Diversity', 0.06769776344299316)","('NON-ESG', 0.37916192412376404)","('NON-ESG', 0.19581449031829834)","('NON-ESG', 0.06769776344299316)"
Line 695,"“When I went into labor , I was  expecting to be back to work  in six weeks,” explains Casillas.
","('Labor_Practices', 0.9510117173194885)","('Employee_Health_And_Safety', 0.009427293203771114)","('Director_Removal', 0.004746278282254934)","(['Labor Practice Indicators'], 0.9510117173194885)","('NON-ESG', 0.009427293203771114)","('NON-ESG', 0.004746278282254934)"
Line 696,"“Now Medtronic was offering six more weeks to give me  extra time to bond with my  baby.
","('Access_And_Affordability', 0.45980924367904663)","('Employee_Health_And_Safety', 0.15263263881206512)","('Supply_Chain_Management', 0.04363402724266052)","('NON-ESG', 0.45980924367904663)","('NON-ESG', 0.15263263881206512)","('NON-ESG', 0.04363402724266052)"
Line 697,"I felt like I was really   cared about.” For birth mothers, Family  Care Leave is in addition to  maternity benefits.
","('Labor_Practices', 0.5419402122497559)","('Employee_Health_And_Safety', 0.1414848268032074)","('Employee_Engagement_Inclusion_And_Diversity', 0.07083632051944733)","(['Labor Practice Indicators'], 0.5419402122497559)","('NON-ESG', 0.1414848268032074)","('NON-ESG', 0.07083632051944733)"
Line 698,"When  combined with accrued paid  time off, and by participating  in our Healthy Pregnancy  program, a new mother may be  on leave for up to 18 weeks and  paid at 100% for the full leave.The board of directors’  Compensation Committee  evaluates and approves  executive compensation.
","('Labor_Practices', 0.6685178279876709)","('Director_Removal', 0.13630858063697815)","('Employee_Engagement_Inclusion_And_Diversity', 0.024890273809432983)","(['Labor Practice Indicators'], 0.6685178279876709)","('NON-ESG', 0.13630858063697815)","('NON-ESG', 0.024890273809432983)"
Line 699,"A discussion and analysis  of executive compensation  is available in our Proxy   Statement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34094807505607605)","('Competitive_Behavior', 0.13084934651851654)","('Labor_Practices', 0.10651845484972)","('NON-ESG', 0.34094807505607605)","('NON-ESG', 0.13084934651851654)","('NON-ESG', 0.10651845484972)"
Line 700,"We have designed our  retirement, health, and other  benefits to help employees  thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.36814743280410767)","('Employee_Health_And_Safety', 0.22801363468170166)","('Labor_Practices', 0.10006946325302124)","('NON-ESG', 0.36814743280410767)","('NON-ESG', 0.22801363468170166)","('NON-ESG', 0.10006946325302124)"
Line 701,"They are flexible,  affordable, and competitive  within our industry.
","('Competitive_Behavior', 0.8681949377059937)","('Customer_Welfare', 0.015742484480142593)","('Management_Of_Legal_And_Regulatory_Framework', 0.012692339718341827)","(['Business Ethics'], 0.8681949377059937)","('NON-ESG', 0.015742484480142593)","('NON-ESG', 0.012692339718341827)"
Line 702,"Employees  can engage with their  benefits through on-demand,  web-based tools and our  AskHR support function.
","('Labor_Practices', 0.5979447364807129)","('Employee_Engagement_Inclusion_And_Diversity', 0.1506902426481247)","('Employee_Health_And_Safety', 0.0638798400759697)","(['Labor Practice Indicators'], 0.5979447364807129)","('NON-ESG', 0.1506902426481247)","('NON-ESG', 0.0638798400759697)"
Line 703,"All  employees have 24/7 access  to an HR portal for timely and  relevant benefit information.
","('Access_And_Affordability', 0.4784887433052063)","('Product_Quality_And_Safety', 0.06371452659368515)","('Labor_Practices', 0.049824006855487823)","('NON-ESG', 0.4784887433052063)","('NON-ESG', 0.06371452659368515)","('NON-ESG', 0.049824006855487823)"
Line 704,"U.S. employees also have  access to their benefit  information through benefits.
","('Labor_Practices', 0.2646620571613312)","('Employee_Engagement_Inclusion_And_Diversity', 0.2258785516023636)","('Employee_Health_And_Safety', 0.10460377484560013)","('NON-ESG', 0.2646620571613312)","('NON-ESG', 0.2258785516023636)","('NON-ESG', 0.10460377484560013)"
Line 705,"medtronic.com, the MyChoice  mobile app, and Sofia, our  virtual benefits assistant.
","('Customer_Welfare', 0.17257098853588104)","('Competitive_Behavior', 0.1713539958000183)","('Product_Quality_And_Safety', 0.14755479991436005)","('NON-ESG', 0.17257098853588104)","('NON-ESG', 0.1713539958000183)","('NON-ESG', 0.14755479991436005)"
Line 706,"Currently, the Family Care  Leave benefit is available to   all full- and part-time  employees in the United  States.
","('Labor_Practices', 0.863246500492096)","('Employee_Engagement_Inclusion_And_Diversity', 0.02461506798863411)","('Employee_Health_And_Safety', 0.02113400027155876)","(['Labor Practice Indicators'], 0.863246500492096)","('NON-ESG', 0.02461506798863411)","('NON-ESG', 0.02113400027155876)"
Line 707,"In FY20, we will roll   out the benefit globally,   with specifics tailored to   each country.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4272981882095337)","('Systemic_Risk_Management', 0.1014673188328743)","('Business_Model_Resilience', 0.07304579019546509)","('NON-ESG', 0.4272981882095337)","('NON-ESG', 0.1014673188328743)","('NON-ESG', 0.07304579019546509)"
Line 708,"“Being able to have this extra  time off was a very helpful  thing,” Casillas said.
","('Employee_Health_And_Safety', 0.17968569695949554)","('Labor_Practices', 0.08748262375593185)","('Director_Removal', 0.07932428270578384)","('NON-ESG', 0.17968569695949554)","('NON-ESG', 0.08748262375593185)","('NON-ESG', 0.07932428270578384)"
Line 709,"“T o me  it’s a blessing, an incredible  blessing from Medtronic.” Medtronic employee Monica Casillas and her son, Gabriel74Recognition We value our employees’  diligence, innovation, and  integrity.
","('Business_Ethics', 0.5038127303123474)","('Employee_Engagement_Inclusion_And_Diversity', 0.11366400867700577)","('Director_Removal', 0.0613764226436615)","(['Business Ethics'], 0.5038127303123474)","('NON-ESG', 0.11366400867700577)","('NON-ESG', 0.0613764226436615)"
Line 710,"T o honor their  efforts, our global Recognize!  program empowers managers  and employees to reward  achievements, celebrate  milestones, share appreciation,  and sustain our culture.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3784065842628479)","('Employee_Health_And_Safety', 0.09879988431930542)","('Human_Rights_And_Community_Relations', 0.09166596829891205)","('NON-ESG', 0.3784065842628479)","('NON-ESG', 0.09879988431930542)","('NON-ESG', 0.09166596829891205)"
Line 711,"We have several formal award  programs that recognize  outstanding contributions by  individuals and teams, with a  focus on technology, quality,  ethics, and leadership.Benefits vary by country but  typically include:  Health and dental for  employees and eligible  dependents  Retirement plans  Life and disability insurance  Paid time off and leaves of  absence  Stock purchase program Employees who work fewer than  20 hours per week, representing  only 1% of our workforce,  are eligible for a select set of  benefits.
","('Labor_Practices', 0.654948890209198)","('Employee_Health_And_Safety', 0.1477741301059723)","('Employee_Engagement_Inclusion_And_Diversity', 0.06966907531023026)","(['Labor Practice Indicators'], 0.654948890209198)","('NON-ESG', 0.1477741301059723)","('NON-ESG', 0.06966907531023026)"
Line 712,"We have several formal award  programs that recognize  outstanding contributions by  individuals and teams, with a  focus on technology, quality,  ethics, and leadership.Benefits vary by country but  typically include:  Health and dental for  employees and eligible  dependents  Retirement plans  Life and disability insurance  Paid time off and leaves of  absence  Stock purchase program Employees who work fewer than  20 hours per week, representing  only 1% of our workforce,  are eligible for a select set of  benefits.
","('Competitive_Behavior', 0.21146637201309204)","('Customer_Welfare', 0.07987789064645767)","('Business_Ethics', 0.07416979223489761)","('NON-ESG', 0.21146637201309204)","('NON-ESG', 0.07987789064645767)","('NON-ESG', 0.07416979223489761)"
Line 713,"Additionally, where appropriate,  Medtronic supports the use  of flexible work arrangements,  which vary by region.AWARD DESCRIPTION Bakken Fellowship The Bakken Fellowship honors employees who  have made multiple technical contributions  to the company and to the biomedical device  industry.
","('Employee_Health_And_Safety', 0.26015669107437134)","('Labor_Practices', 0.2460295557975769)","('Employee_Engagement_Inclusion_And_Diversity', 0.2130918800830841)","('NON-ESG', 0.26015669107437134)","('NON-ESG', 0.2460295557975769)","('NON-ESG', 0.2130918800830841)"
Line 714,"T welve employees were inducted into  the Bakken Society in FY19.
","('Director_Removal', 0.19566872715950012)","('Employee_Engagement_Inclusion_And_Diversity', 0.1786222606897354)","('Employee_Health_And_Safety', 0.10390805453062057)","('NON-ESG', 0.19566872715950012)","('NON-ESG', 0.1786222606897354)","('NON-ESG', 0.10390805453062057)"
Line 715,"Compass Award The Compass Award recognizes employees  who live out the Medtronic Mission by vigilantly  demonstrating behavior that champions our  Code of Conduct and reflects high integrity.
","('Business_Ethics', 0.5399820804595947)","('Human_Rights_And_Community_Relations', 0.08853885531425476)","('Employee_Health_And_Safety', 0.0721094086766243)","(['Business Ethics'], 0.5399820804595947)","('NON-ESG', 0.08853885531425476)","('NON-ESG', 0.0721094086766243)"
Line 716,"Four employees and one team received the  Compass Award in FY19.
","('Employee_Engagement_Inclusion_And_Diversity', 0.31297147274017334)","('Employee_Health_And_Safety', 0.10353922843933105)","('Director_Removal', 0.08364711701869965)","('NON-ESG', 0.31297147274017334)","('NON-ESG', 0.10353922843933105)","('NON-ESG', 0.08364711701869965)"
Line 717,"GIDE Leadership Award The GIDE Award recognizes Medtronic vice  presidents who champion an inclusive work  environment.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5881022214889526)","('Human_Rights_And_Community_Relations', 0.11666176468133926)","('Access_And_Affordability', 0.05294722318649292)","(['Human Capital Development'], 0.5881022214889526)","('NON-ESG', 0.11666176468133926)","('NON-ESG', 0.05294722318649292)"
Line 718,"Five employees received the   GIDE Award in FY19.
","('Management_Of_Legal_And_Regulatory_Framework', 0.173160582780838)","('Business_Ethics', 0.10488524287939072)","('Employee_Engagement_Inclusion_And_Diversity', 0.09889476746320724)","('NON-ESG', 0.173160582780838)","('NON-ESG', 0.10488524287939072)","('NON-ESG', 0.09889476746320724)"
Line 719,"Star of Excellence Award The Star of Excellence is our highest recognition  for quality and innovation.
","('Product_Design_And_Lifecycle_Management', 0.26126429438591003)","('Business_Ethics', 0.12240873277187347)","('Business_Model_Resilience', 0.09526516497135162)","('NON-ESG', 0.26126429438591003)","('NON-ESG', 0.12240873277187347)","('NON-ESG', 0.09526516497135162)"
Line 720,"Seven Medtronic  teams and an individual employee received this  award in FY19.
","('Employee_Health_And_Safety', 0.5790987014770508)","('Employee_Engagement_Inclusion_And_Diversity', 0.09381607919931412)","('Labor_Practices', 0.041862547397613525)","(['Operational Eco-Efficiency'], 0.5790987014770508)","('NON-ESG', 0.09381607919931412)","('NON-ESG', 0.041862547397613525)"
Line 721,"Wallin Leadership Award The Wallin Leadership Award recognizes  employees who demonstrate world-class  people leadership, including actively fostering   an inclusive and diverse work environment   and successfully developing leadership talent   to enable superior business outcomes.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9650682806968689)","('Employee_Health_And_Safety', 0.003414727747440338)","('Human_Rights_And_Community_Relations', 0.0032557372469455004)","(['Human Capital Development'], 0.9650682806968689)","('NON-ESG', 0.003414727747440338)","('NON-ESG', 0.0032557372469455004)"
Line 722,"Six  employees received the Wallin Leadership  Award in calendar year 2018.WORKING  RESPONSIBL Y Our positive impacts on the  world are amplified by being  a responsible corporate  citizen.
","('Human_Rights_And_Community_Relations', 0.5921928882598877)","('Business_Model_Resilience', 0.07096575200557709)","('Employee_Health_And_Safety', 0.04322291165590286)","(['Community Relations'], 0.5921928882598877)","('NON-ESG', 0.07096575200557709)","('NON-ESG', 0.04322291165590286)"
Line 723,"As we continue to push  the boundaries of medical  technology to improve the  health of millions of patients  around the world, it is imperative  that we maintain and expand  our reputation for excellence.
","('Access_And_Affordability', 0.331246554851532)","('Employee_Health_And_Safety', 0.09741866588592529)","('Customer_Welfare', 0.09443216770887375)","('NON-ESG', 0.331246554851532)","('NON-ESG', 0.09741866588592529)","('NON-ESG', 0.09443216770887375)"
Line 724,"We are committed to strong  corporate governance,  impeccable ethics, high-quality  products, and a responsible and  diverse supply chain.76Strong corporate governance,  including clear policies and  procedures, protects our future.
","('Business_Ethics', 0.8979056477546692)","('Systemic_Risk_Management', 0.019315537065267563)","('Management_Of_Legal_And_Regulatory_Framework', 0.014000624418258667)","(['Business Ethics'], 0.8979056477546692)","('NON-ESG', 0.019315537065267563)","('NON-ESG', 0.014000624418258667)"
Line 725,"Governance is fundamental  to earning the trust of our  stakeholders and staying  focused on improving the lives  of patients.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5701379776000977)","('Human_Rights_And_Community_Relations', 0.17083121836185455)","('Business_Ethics', 0.06096339970827103)","(['Corporate Governance'], 0.5701379776000977)","('NON-ESG', 0.17083121836185455)","('NON-ESG', 0.06096339970827103)"
Line 726,"The Medtronic board of  directors and executive  leadership are charged with  company oversight, balancing  stakeholder interests, and  ensuring that business decisions  align with our Mission.
","('Director_Removal', 0.5598251223564148)","('Business_Model_Resilience', 0.08060301095247269)","('Management_Of_Legal_And_Regulatory_Framework', 0.05004998296499252)","(['Anti-Crime Policy & Measures'], 0.5598251223564148)","('NON-ESG', 0.08060301095247269)","('NON-ESG', 0.05004998296499252)"
Line 727,"BOARD OF DIRECTORS: LEADING WITH CLARITY ,   CONSISTENCY , AND DIVERSITY  Medtronic is governed by an independent board with 11 members as of the end of FY19, including our CEO,  Omar Ishrak, and lead independent director , Scott Donnelly.
","('Employee_Engagement_Inclusion_And_Diversity', 0.46120578050613403)","('Director_Removal', 0.2640146017074585)","('Business_Model_Resilience', 0.036463864147663116)","('NON-ESG', 0.46120578050613403)","('NON-ESG', 0.2640146017074585)","('NON-ESG', 0.036463864147663116)"
Line 728,"The board is engaged in our Citizenship efforts,  which deliver value to our employees, customers, and investors.
","('Employee_Engagement_Inclusion_And_Diversity', 0.26009249687194824)","('Human_Rights_And_Community_Relations', 0.15441158413887024)","('Business_Model_Resilience', 0.14773860573768616)","('NON-ESG', 0.26009249687194824)","('NON-ESG', 0.15441158413887024)","('NON-ESG', 0.14773860573768616)"
Line 729,"Our board has six standing committees led by independent directors, including:  Audit n    Nominating and Corporate Governance   Compensation n    Quality  Finance and Financial Risk n    T echnology and Value Creation Our board has diverse experience, skills, and backgrounds that are essential to understanding and  responding to the needs of our various stakeholders.
","('Director_Removal', 0.2954356372356415)","('Employee_Engagement_Inclusion_And_Diversity', 0.28898653388023376)","('Business_Model_Resilience', 0.10472341626882553)","('NON-ESG', 0.2954356372356415)","('NON-ESG', 0.28898653388023376)","('NON-ESG', 0.10472341626882553)"
Line 730,"When a change in board membership occurs, we view  it as an opportunity to broaden representation, and diversity is a factor in our director-selection process.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8867349028587341)","('Director_Removal', 0.02459387294948101)","('Business_Model_Resilience', 0.010671493597328663)","(['Human Capital Development'], 0.8867349028587341)","('NON-ESG', 0.02459387294948101)","('NON-ESG', 0.010671493597328663)"
Line 731,"The Nominating and Corporate Governance committee is responsible for reviewing candidates and  assessing qualifications and character .
","('Management_Of_Legal_And_Regulatory_Framework', 0.4356774687767029)","('Employee_Engagement_Inclusion_And_Diversity', 0.11178901791572571)","('Business_Ethics', 0.08001737296581268)","('NON-ESG', 0.4356774687767029)","('NON-ESG', 0.11178901791572571)","('NON-ESG', 0.08001737296581268)"
Line 732,"Our full board of directors makes the final decision, selecting people  who will steer the company with integrity and good judgment.
","('Director_Removal', 0.330679327249527)","('Business_Ethics', 0.29533153772354126)","('Employee_Engagement_Inclusion_And_Diversity', 0.040233444422483444)","('NON-ESG', 0.330679327249527)","('NON-ESG', 0.29533153772354126)","('NON-ESG', 0.040233444422483444)"
Line 733,"As of the end of FY19, 27% of board members were women, including Andrea Goldsmith, Ph.D., who joined  our board in FY19, and 18% were members of ethnically diverse groups.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9676631689071655)","('Human_Rights_And_Community_Relations', 0.002576880156993866)","('Business_Model_Resilience', 0.0021076586563140154)","(['Human Capital Development'], 0.9676631689071655)","('NON-ESG', 0.002576880156993866)","('NON-ESG', 0.0021076586563140154)"
Line 734,"CORPORA TE  GOVERNANCEnongovernmental organizations,  and advocacy groups.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9186260104179382)","('Competitive_Behavior', 0.012304777279496193)","('Business_Ethics', 0.01082529779523611)","(['Corporate Governance'], 0.9186260104179382)","('NON-ESG', 0.012304777279496193)","('NON-ESG', 0.01082529779523611)"
Line 735,"Our  stakeholders include these  groups, among others.
","('Human_Rights_And_Community_Relations', 0.5552389621734619)","('Management_Of_Legal_And_Regulatory_Framework', 0.10342904925346375)","('Business_Ethics', 0.05046865716576576)","(['Community Relations'], 0.5552389621734619)","('NON-ESG', 0.10342904925346375)","('NON-ESG', 0.05046865716576576)"
Line 736,"Recognizing the value of  stakeholder input and the  opportunity for meaningful  dialogue, Medtronic facilitates  in-person meetings.
","('Human_Rights_And_Community_Relations', 0.6595556735992432)","('Management_Of_Legal_And_Regulatory_Framework', 0.03909662365913391)","('Business_Model_Resilience', 0.03224577382206917)","(['Community Relations'], 0.6595556735992432)","('NON-ESG', 0.03909662365913391)","('NON-ESG', 0.03224577382206917)"
Line 737,"In FY19   we hosted:  A roundtable to share  advanced policies and  practices in value-based  procurement with 67  government representatives  as well as academics from  the United States and 12  European countries   More than 10 value-based  healthcare forums in Europe,  Latin America, Asia, Australia,  Canada, and the United  States, including a forum with  Harvard Business ReviewWe participate in business and  trade organizations because  we believe intra-industry  collaboration leads to greater  impact on global health.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8342851400375366)","('Competitive_Behavior', 0.02122408337891102)","('Supply_Chain_Management', 0.011595506221055984)","(['Corporate Governance'], 0.8342851400375366)","('NON-ESG', 0.02122408337891102)","('NON-ESG', 0.011595506221055984)"
Line 738,"In FY19   we hosted:  A roundtable to share  advanced policies and  practices in value-based  procurement with 67  government representatives  as well as academics from  the United States and 12  European countries   More than 10 value-based  healthcare forums in Europe,  Latin America, Asia, Australia,  Canada, and the United  States, including a forum with  Harvard Business ReviewWe participate in business and  trade organizations because  we believe intra-industry  collaboration leads to greater  impact on global health.
","('Access_And_Affordability', 0.20058071613311768)","('Human_Rights_And_Community_Relations', 0.10937655717134476)","('Competitive_Behavior', 0.09282156080007553)","('NON-ESG', 0.20058071613311768)","('NON-ESG', 0.10937655717134476)","('NON-ESG', 0.09282156080007553)"
Line 739,"Medtronic shares expertise  and advocates for a more  sustainable healthcare model  through forums in the United  States and beyond.
","('Access_And_Affordability', 0.2964061200618744)","('Product_Design_And_Lifecycle_Management', 0.18323731422424316)","('Business_Model_Resilience', 0.06520558148622513)","('NON-ESG', 0.2964061200618744)","('NON-ESG', 0.18323731422424316)","('NON-ESG', 0.06520558148622513)"
Line 740,"These  include sitting on the board of  industry organizations, including  AdvaMed, APACMed, and  MedT ech Europe.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4407998025417328)","('Customer_Welfare', 0.06256274878978729)","('Access_And_Affordability', 0.05748157575726509)","('NON-ESG', 0.4407998025417328)","('NON-ESG', 0.06256274878978729)","('NON-ESG', 0.05748157575726509)"
Line 741,"Medtronic complies with all  relevant country and state  laws on disclosure of political  contributions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9383479356765747)","('Director_Removal', 0.00984078086912632)","('Labor_Practices', 0.007374623324722052)","(['Corporate Governance'], 0.9383479356765747)","('NON-ESG', 0.00984078086912632)","('NON-ESG', 0.007374623324722052)"
Line 742,"Read more   about our Political  Contribution Policy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6577104926109314)","('Human_Rights_And_Community_Relations', 0.07715065032243729)","('Director_Removal', 0.03383764997124672)","(['Corporate Governance'], 0.6577104926109314)","('NON-ESG', 0.07715065032243729)","('NON-ESG', 0.03383764997124672)"
Line 743,"Collaborating to   improve healthcare  A network of interdependent  stakeholders is working to  improve healthcare and  overcome industry challenges.
","('Supply_Chain_Management', 0.5108376145362854)","('Systemic_Risk_Management', 0.2172187864780426)","('Business_Model_Resilience', 0.049726296216249466)","(['Supply Chain Management'], 0.5108376145362854)","('NON-ESG', 0.2172187864780426)","('NON-ESG', 0.049726296216249466)"
Line 744,"That network includes patients,  physicians, treatment facilities,  health system administrators,  regulators, nonprofits, Globally, there is growing  interest in universal health  coverage (UHC) — the idea that  everyone should have access to  the health services they need,  without risk of financial ruin or  impoverishment.
","('Access_And_Affordability', 0.8202488422393799)","('Critical_Incident_Risk_Management', 0.01845923252403736)","('Customer_Welfare', 0.016414212062954903)","(['Health Outcome Contribution'], 0.8202488422393799)","('NON-ESG', 0.01845923252403736)","('NON-ESG', 0.016414212062954903)"
Line 745,"According to  the World Health Organization,  countries with UHC have  improved health indicators, less  poverty, and stronger economic  development.13  The Medtronic Mission  and business strategy are  aligned with UN Sustainable  Development Goal 3, “Good  Health and Well-Being,” which  calls on governments to  implement UHC.
","('Access_And_Affordability', 0.5474900007247925)","('Employee_Health_And_Safety', 0.12695199251174927)","('Human_Rights_And_Community_Relations', 0.08469344675540924)","(['Health Outcome Contribution'], 0.5474900007247925)","('NON-ESG', 0.12695199251174927)","('NON-ESG', 0.08469344675540924)"
Line 746,"Through our  focus on access, efficiency,  and innovation, we are well  positioned to support leaders  with the transition.
","('Product_Design_And_Lifecycle_Management', 0.2497267723083496)","('Business_Model_Resilience', 0.16799381375312805)","('Competitive_Behavior', 0.1135997474193573)","('NON-ESG', 0.2497267723083496)","('NON-ESG', 0.16799381375312805)","('NON-ESG', 0.1135997474193573)"
Line 747,"Medtronic is taking an active role  in the global UHC conversation.
","('Access_And_Affordability', 0.24731123447418213)","('Customer_Welfare', 0.08273458480834961)","('Systemic_Risk_Management', 0.06846152991056442)","('NON-ESG', 0.24731123447418213)","('NON-ESG', 0.08273458480834961)","('NON-ESG', 0.06846152991056442)"
Line 748,"In early FY20, we participated in  the UN High-Level Meeting on  Universal Health Coverage, and  our CEO chaired a panel on   the topic.PUBLIC POLICY  Medtronic is transforming  healthcare by expanding access,  improving quality and outcomes,  and increasing efficiency.
","('Access_And_Affordability', 0.8200780749320984)","('Product_Quality_And_Safety', 0.019855592399835587)","('Energy_Management', 0.015550804324448109)","(['Health Outcome Contribution'], 0.8200780749320984)","('NON-ESG', 0.019855592399835587)","('NON-ESG', 0.015550804324448109)"
Line 749,"Public  policy engagement is one of  the tools we use to enable  this change.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7978430986404419)","('Human_Rights_And_Community_Relations', 0.04433288052678108)","('Physical_Impacts_Of_Climate_Change', 0.027044856920838356)","(['Corporate Governance'], 0.7978430986404419)","('NON-ESG', 0.04433288052678108)","('NON-ESG', 0.027044856920838356)"
Line 750,"Our Government  Affairs, Health Economics and  Reimbursement, and Regulatory  Affairs teams work with  governments, peers, and other  stakeholders to:  Enable technology  innovations  Facilitate access to lifesaving  therapies and devices  Generate economic value  for healthcare system  stakeholders   Promote outcome-driven   and value-based healthcare  Harmonize and coordinate  international regulatory  practice We are not alone in the pursuit  of a more sustainable and  accessible healthcare system.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9707603454589844)","('Business_Ethics', 0.002920314436778426)","('Access_And_Affordability', 0.0026239703875035048)","(['Corporate Governance'], 0.9707603454589844)","('NON-ESG', 0.002920314436778426)","('NON-ESG', 0.0026239703875035048)"
Line 751,"13  https:/ /www.who.int/health_financing/ UHC_ENvs_BD.PDF, page 1078In addition to annual training, employees are required to integrate  ethics into their performance goals.
","('Business_Ethics', 0.5543528199195862)","('Employee_Health_And_Safety', 0.09155026078224182)","('Product_Quality_And_Safety', 0.07256855815649033)","(['Business Ethics'], 0.5543528199195862)","('NON-ESG', 0.09155026078224182)","('NON-ESG', 0.07256855815649033)"
Line 752,"During annual reviews, managers  assess ethical behavior and their employees’ personal goals.
","('Business_Ethics', 0.8897727131843567)","('Human_Rights_And_Community_Relations', 0.015960704535245895)","('Customer_Privacy', 0.0122712766751647)","(['Business Ethics'], 0.8897727131843567)","('NON-ESG', 0.015960704535245895)","('NON-ESG', 0.0122712766751647)"
Line 753,"Efforts to ensure that employees understand and are accountable  for the Code are ongoing.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7013539671897888)","('Business_Ethics', 0.08894357830286026)","('Human_Rights_And_Community_Relations', 0.05027617886662483)","(['Corporate Governance'], 0.7013539671897888)","('NON-ESG', 0.08894357830286026)","('NON-ESG', 0.05027617886662483)"
Line 754,"In FY18, we updated our Global Business  Conduct Standards to expand guidance on how to ethically interact  with healthcare professionals and organizations.
","('Business_Ethics', 0.9622126221656799)","('Product_Quality_And_Safety', 0.005665647331625223)","('Management_Of_Legal_And_Regulatory_Framework', 0.00352883106097579)","(['Business Ethics'], 0.9622126221656799)","('NON-ESG', 0.005665647331625223)","('NON-ESG', 0.00352883106097579)"
Line 755,"In FY19, we developed  a set of situation-based training modules for targeted areas.
","('Access_And_Affordability', 0.6137707233428955)","('Product_Quality_And_Safety', 0.054444409906864166)","('Employee_Engagement_Inclusion_And_Diversity', 0.03880259022116661)","(['Health Outcome Contribution'], 0.6137707233428955)","('NON-ESG', 0.054444409906864166)","('NON-ESG', 0.03880259022116661)"
Line 756,"For  instance, we created customized conflicts of interest training for  procurement employees and about 2,000 select Medtronic leaders.
","('Competitive_Behavior', 0.4372142553329468)","('Management_Of_Legal_And_Regulatory_Framework', 0.24387526512145996)","('Business_Ethics', 0.11603589355945587)","('NON-ESG', 0.4372142553329468)","('NON-ESG', 0.24387526512145996)","('NON-ESG', 0.11603589355945587)"
Line 757,"Guiding Policies and Principles  Global Business Conduct Standards Policy  Code of Conduct  Code of Ethics for Senior Financial Officers   Code of Business Conduct and Ethics for Members   of the Board of Directors Consistent messaging keeps ethics top of mind at Medtronic.
","('Business_Ethics', 0.9676973223686218)","('Director_Removal', 0.0030104650650173426)","('Customer_Privacy', 0.002502086805179715)","(['Business Ethics'], 0.9676973223686218)","('NON-ESG', 0.0030104650650173426)","('NON-ESG', 0.002502086805179715)"
Line 758,"In FY19,  our chief ethics and compliance officer began writing a monthly email  to engage the top 500 Medtronic leaders on the topic.
","('Business_Ethics', 0.8871585726737976)","('Management_Of_Legal_And_Regulatory_Framework', 0.02021821402013302)","('Director_Removal', 0.012722177430987358)","(['Business Ethics'], 0.8871585726737976)","('NON-ESG', 0.02021821402013302)","('NON-ESG', 0.012722177430987358)"
Line 759,"Our annual We expect our employees to think critically, exercise moral decision- making, and seek support if faced with a challenging ethical dilemma.
","('Business_Ethics', 0.7576249837875366)","('Competitive_Behavior', 0.05109440162777901)","('Management_Of_Legal_And_Regulatory_Framework', 0.045661356300115585)","(['Business Ethics'], 0.7576249837875366)","('NON-ESG', 0.05109440162777901)","('NON-ESG', 0.045661356300115585)"
Line 760,"When our people act with integrity, they safeguard our reputation  and protect the best interests of patients and our company.
","('Business_Ethics', 0.8771268725395203)","('Management_Of_Legal_And_Regulatory_Framework', 0.012592697516083717)","('Director_Removal', 0.011767796240746975)","(['Business Ethics'], 0.8771268725395203)","('NON-ESG', 0.012592697516083717)","('NON-ESG', 0.011767796240746975)"
Line 761,"We  continuously reinforce a culture of ethics through annual trainings,  ongoing communications, and in-person meetings.
","('Business_Ethics', 0.9606419801712036)","('Competitive_Behavior', 0.0035597537644207478)","('Product_Quality_And_Safety', 0.003252600086852908)","(['Business Ethics'], 0.9606419801712036)","('NON-ESG', 0.0035597537644207478)","('NON-ESG', 0.003252600086852908)"
Line 762,"ENSURING A SHARED APPROACH   TO ETHICS Guiding policies and principles, including our Code of Conduct, are  used to communicate company expectations.
","('Business_Ethics', 0.9685160517692566)","('Customer_Privacy', 0.002802647417411208)","('Management_Of_Legal_And_Regulatory_Framework', 0.0027198551688343287)","(['Business Ethics'], 0.9685160517692566)","('NON-ESG', 0.002802647417411208)","('NON-ESG', 0.0027198551688343287)"
Line 763,"The Code is accessible,  explicit, and relevant to day-to-day work.
","('Labor_Practices', 0.8895359635353088)","('Employee_Health_And_Safety', 0.025880269706249237)","('Management_Of_Legal_And_Regulatory_Framework', 0.007106168661266565)","(['Labor Practice Indicators'], 0.8895359635353088)","('NON-ESG', 0.025880269706249237)","('NON-ESG', 0.007106168661266565)"
Line 764,"We have a comprehensive  program for ensuring that every employee understands and is  accountable for our Code:   We translate the Code into 22 languages so 99% of employees can  read it in their first language.
","('Human_Rights_And_Community_Relations', 0.19020035862922668)","('Access_And_Affordability', 0.1778680682182312)","('Employee_Engagement_Inclusion_And_Diversity', 0.13176918029785156)","('NON-ESG', 0.19020035862922668)","('NON-ESG', 0.1778680682182312)","('NON-ESG', 0.13176918029785156)"
Line 765,"We deliver multilingual Code training for new employees and those  joining Medtronic through acquisitions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6878049969673157)","('Employee_Health_And_Safety', 0.04945402219891548)","('Access_And_Affordability', 0.04172094166278839)","(['Human Capital Development'], 0.6878049969673157)","('NON-ESG', 0.04945402219891548)","('NON-ESG', 0.04172094166278839)"
Line 766,"Every year we retrain employees on the Code and require  everyone at Medtronic — including our board — to certify their  understanding of its contents.ETHICAL BUSINESS  CONDUCTEthics and Integrity Week  provided additional touchpoints,  driving more than 8,000 unique  visitors from 67 countries to our  internal Ethics and Compliance  website.
","('Business_Ethics', 0.9710777997970581)","('Management_Of_Legal_And_Regulatory_Framework', 0.002671230584383011)","('Product_Quality_And_Safety', 0.002583711640909314)","(['Business Ethics'], 0.9710777997970581)","('NON-ESG', 0.002671230584383011)","('NON-ESG', 0.002583711640909314)"
Line 767,"We foster learning, dialogue,  and healthy debate about ethics  and compliance through our  Ethics Circles, which engage  employees in scenario-driven  discussions.
","('Business_Ethics', 0.9619193077087402)","('Management_Of_Legal_And_Regulatory_Framework', 0.004394111689180136)","('Competitive_Behavior', 0.0033097793348133564)","(['Business Ethics'], 0.9619193077087402)","('NON-ESG', 0.004394111689180136)","('NON-ESG', 0.0033097793348133564)"
Line 768,"In FY19, we  expanded the program by  forming groups at 12 Cardiac  Rhythm and Heart Failure  Operations (CRHF-Ops)  manufacturing sites.
","('Employee_Health_And_Safety', 0.25840941071510315)","('Access_And_Affordability', 0.13351263105869293)","('Critical_Incident_Risk_Management', 0.10365698486566544)","('NON-ESG', 0.25840941071510315)","('NON-ESG', 0.13351263105869293)","('NON-ESG', 0.10365698486566544)"
Line 769,"In FY20,  we plan for all 5,400 CRHF-Ops  employees to have access to  a group.
","('Access_And_Affordability', 0.6631340384483337)","('Employee_Engagement_Inclusion_And_Diversity', 0.040975287556648254)","('Product_Quality_And_Safety', 0.03666950389742851)","(['Health Outcome Contribution'], 0.6631340384483337)","('NON-ESG', 0.040975287556648254)","('NON-ESG', 0.03666950389742851)"
Line 770,"As of FY19, we have  over 360 Ethics Circles, with  more than 10,500 employees  participating across   30 countries.
","('Business_Ethics', 0.9419612884521484)","('Management_Of_Legal_And_Regulatory_Framework', 0.0071293083019554615)","('Director_Removal', 0.005523822270333767)","(['Business Ethics'], 0.9419612884521484)","('NON-ESG', 0.0071293083019554615)","('NON-ESG', 0.005523822270333767)"
Line 771,"CASE STUDY COMPASS AWARD  RECOGNIZES  EXCELLENCE   IN ETHICS Each year , Medtronic   CEO Omar Ishrak  recognizes employees  who embody our Mission  by demonstrating  behavior that champions  our Code of Conduct.
","('Business_Ethics', 0.955949068069458)","('Competitive_Behavior', 0.004334383178502321)","('Product_Quality_And_Safety', 0.00392876286059618)","(['Business Ethics'], 0.955949068069458)","('NON-ESG', 0.004334383178502321)","('NON-ESG', 0.00392876286059618)"
Line 772,"In FY19, four employees  and one team received  the Medtronic Compass  Award for outstanding  ethical behavior .
","('Business_Ethics', 0.9087786674499512)","('Labor_Practices', 0.008216365240514278)","('Customer_Privacy', 0.00791514664888382)","(['Business Ethics'], 0.9087786674499512)","('NON-ESG', 0.008216365240514278)","('NON-ESG', 0.00791514664888382)"
Line 773,"Employee feedback informs our approach to ethics training and  communications.
","('Business_Ethics', 0.9518757462501526)","('Customer_Privacy', 0.004973773378878832)","('Product_Quality_And_Safety', 0.004692003596574068)","(['Business Ethics'], 0.9518757462501526)","('NON-ESG', 0.004973773378878832)","('NON-ESG', 0.004692003596574068)"
Line 774,"Every three years, we issue a dedicated ethics  survey to all employees, with the next survey occurring in FY20.
","('Business_Ethics', 0.8964424133300781)","('Director_Removal', 0.015184348449110985)","('Labor_Practices', 0.014094251208007336)","(['Business Ethics'], 0.8964424133300781)","('NON-ESG', 0.015184348449110985)","('NON-ESG', 0.014094251208007336)"
Line 775,"Between dedicated surveys, we integrate ethics questions into  biannual employee surveys.
","('Business_Ethics', 0.942874550819397)","('Product_Quality_And_Safety', 0.007142164278775454)","('Management_Of_Legal_And_Regulatory_Framework', 0.006250659003853798)","(['Business Ethics'], 0.942874550819397)","('NON-ESG', 0.007142164278775454)","('NON-ESG', 0.006250659003853798)"
Line 776,"Ensuring Compliance with Our Code of Conduct FY17 FY18 FYEmployees Receiving Code of  Conduct T raining and Certification97% 95% 94% New Employees Receiving Code of  Conduct T raining and Certification99% 99% 99% Employees Joining Through  Acquisitions Receiving Compliance  and Ethics T raining Within 90 Days  of the T ransaction97% 95% 95% U.S. Employees Certified as   Having Read and Understood the  Code of Conduct100% 100% 100% Employees T erminated for  Ethical and Compliance-Related  Infractions*218 193 * Based on calendar years 2016, 2017, 201880stakeholder feedback.
","('Business_Ethics', 0.9661570191383362)","('Management_Of_Legal_And_Regulatory_Framework', 0.0036194848362356424)","('Product_Quality_And_Safety', 0.0028562077786773443)","(['Business Ethics'], 0.9661570191383362)","('NON-ESG', 0.0036194848362356424)","('NON-ESG', 0.0028562077786773443)"
Line 777,"Ensuring Compliance with Our Code of Conduct FY17 FY18 FYEmployees Receiving Code of  Conduct T raining and Certification97% 95% 94% New Employees Receiving Code of  Conduct T raining and Certification99% 99% 99% Employees Joining Through  Acquisitions Receiving Compliance  and Ethics T raining Within 90 Days  of the T ransaction97% 95% 95% U.S. Employees Certified as   Having Read and Understood the  Code of Conduct100% 100% 100% Employees T erminated for  Ethical and Compliance-Related  Infractions*218 193 * Based on calendar years 2016, 2017, 201880stakeholder feedback.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3337300419807434)","('Business_Model_Resilience', 0.13426457345485687)","('Systemic_Risk_Management', 0.07610428333282471)","('NON-ESG', 0.3337300419807434)","('NON-ESG', 0.13426457345485687)","('NON-ESG', 0.07610428333282471)"
Line 778,"That  review, coupled with internal  auditing and data analysis,  helps the OEC identify high- risk areas for investigation and  remediation.
","('Business_Ethics', 0.35716530680656433)","('Systemic_Risk_Management', 0.28444144129753113)","('Management_Of_Legal_And_Regulatory_Framework', 0.148701474070549)","('NON-ESG', 0.35716530680656433)","('NON-ESG', 0.28444144129753113)","('NON-ESG', 0.148701474070549)"
Line 779,"Through review  and root-cause analysis, we take  appropriate corrective action to  prevent recurrence.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3560451567173004)","('Business_Ethics', 0.21331465244293213)","('Systemic_Risk_Management', 0.1579810082912445)","('NON-ESG', 0.3560451567173004)","('NON-ESG', 0.21331465244293213)","('NON-ESG', 0.1579810082912445)"
Line 780,"Additionally, the OEC processes  and thoroughly investigates   all reported concerns of   alleged misconduct.
","('Business_Ethics', 0.9637500047683716)","('Management_Of_Legal_And_Regulatory_Framework', 0.004160131327807903)","('Product_Quality_And_Safety', 0.0026138306129723787)","(['Business Ethics'], 0.9637500047683716)","('NON-ESG', 0.004160131327807903)","('NON-ESG', 0.0026138306129723787)"
Line 781,"When  employees require ethical  guidance or have concerns  about potential violations,   we strongly encourage them   to speak up through one of   the following channels:  Their manager  Human Resources  Legal or Compliance  representatives  The board of directors’ email  inbox (monitored by staff who  bring pertinent matters to the  board’s attention)One such program is our global  risk assessment process,  which we conduct annually.
","('Business_Ethics', 0.9539974927902222)","('Management_Of_Legal_And_Regulatory_Framework', 0.009410935454070568)","('Product_Quality_And_Safety', 0.004317713901400566)","(['Business Ethics'], 0.9539974927902222)","('NON-ESG', 0.009410935454070568)","('NON-ESG', 0.004317713901400566)"
Line 782,"Our process includes rigorous  review of internal and external  inputs, such as regulatory or  enforcement actions, hotline  reporting, audit findings,  and investigations, as well as MONITORING  ETHICS The Medtronic Office of Ethics  and Compliance (OEC) oversees,  monitors, and implements  policies and programs related  to our legal, compliance, and  ethical obligations.
","('Business_Ethics', 0.9604864120483398)","('Management_Of_Legal_And_Regulatory_Framework', 0.009301352314651012)","('Product_Quality_And_Safety', 0.002718020463362336)","(['Business Ethics'], 0.9604864120483398)","('NON-ESG', 0.009301352314651012)","('NON-ESG', 0.002718020463362336)"
Line 783,"Voice Y our Concern Line  Exit interviews (beginning in  FY19, employees who leave  the company are invited to  share ethical concerns) If our investigations confirm   any misconduct, corrective  actions may include   coaching, discussion during  performance reviews, changes  in job responsibilities (such   as a demotion), or in serious  cases, dismissal.
","('Business_Ethics', 0.9062536954879761)","('Employee_Health_And_Safety', 0.017496205866336823)","('Labor_Practices', 0.00861307978630066)","(['Business Ethics'], 0.9062536954879761)","('NON-ESG', 0.017496205866336823)","('NON-ESG', 0.00861307978630066)"
Line 784,"During calendar year 2018,  Medtronic terminated 200  employees for ethical and  compliance-related infractions.
","('Business_Ethics', 0.9586701989173889)","('Management_Of_Legal_And_Regulatory_Framework', 0.005845901556313038)","('Product_Quality_And_Safety', 0.003819865407422185)","(['Business Ethics'], 0.9586701989173889)","('NON-ESG', 0.005845901556313038)","('NON-ESG', 0.003819865407422185)"
Line 785,"In FY19, the OEC tracked   1,192 allegations of   misconduct, compared to   1,183 in FY17.
","('Business_Ethics', 0.954572319984436)","('Management_Of_Legal_And_Regulatory_Framework', 0.0044562737457454205)","('Competitive_Behavior', 0.0034150087740272284)","(['Business Ethics'], 0.954572319984436)","('NON-ESG', 0.0044562737457454205)","('NON-ESG', 0.0034150087740272284)"
Line 786,"About 35%   of FY19 allegations were   related to workplace conduct.
","('Business_Ethics', 0.9186230897903442)","('Employee_Health_And_Safety', 0.01005455944687128)","('Labor_Practices', 0.008365876972675323)","(['Business Ethics'], 0.9186230897903442)","('NON-ESG', 0.01005455944687128)","('NON-ESG', 0.008365876972675323)"
Line 787,"81Enduring customer relationships are built on trust, aligned values,   and shared goals.
","('Customer_Privacy', 0.17867030203342438)","('Business_Model_Resilience', 0.14490127563476562)","('Business_Ethics', 0.09358435124158859)","('NON-ESG', 0.17867030203342438)","('NON-ESG', 0.14490127563476562)","('NON-ESG', 0.09358435124158859)"
Line 788,"Sales and marketing employees are ambassadors  for our company, and we teach them to put integrity at the core of  their practice.RESPONSIBLE MARKETING TO  CUSTOMERS AND PA TIENTS  We promote our products based on their approved use, and  employees must adhere to the policies made explicit in our Code   of Conduct and AdvaMed’s voluntary Code of Ethics on  Interactions with Healthcare Professionals.
","('Business_Ethics', 0.8328096866607666)","('Product_Quality_And_Safety', 0.022014610469341278)","('Competitive_Behavior', 0.019990835338830948)","(['Business Ethics'], 0.8328096866607666)","('NON-ESG', 0.022014610469341278)","('NON-ESG', 0.019990835338830948)"
Line 789,"Our requirements  for product marketing are also included in our Global Business  Conduct Standards Policy and our Physician Collaboration  Policy.
","('Selling_Practices_And_Product_Labeling', 0.31022337079048157)","('Product_Quality_And_Safety', 0.3069380521774292)","('Customer_Welfare', 0.06929101049900055)","('NON-ESG', 0.31022337079048157)","('NON-ESG', 0.3069380521774292)","('NON-ESG', 0.06929101049900055)"
Line 790,"We educate employees on these requirements through  ongoing communications and trainings.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5118263959884644)","('Employee_Health_And_Safety', 0.16162176430225372)","('Access_And_Affordability', 0.05361928045749664)","(['Human Capital Development'], 0.5118263959884644)","('NON-ESG', 0.16162176430225372)","('NON-ESG', 0.05361928045749664)"
Line 791,"In FY19, we introduced five new product-promotion trainings  tailored to marketing and sales employees.
","('Customer_Welfare', 0.18309584259986877)","('Product_Quality_And_Safety', 0.1597544401884079)","('Selling_Practices_And_Product_Labeling', 0.12256792932748795)","('NON-ESG', 0.18309584259986877)","('NON-ESG', 0.1597544401884079)","('NON-ESG', 0.12256792932748795)"
Line 792,"Through this expanded  training, we reached more than 21,000 marketing and sales  employees, 97% of employees in those roles.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8349136710166931)","('Labor_Practices', 0.023463815450668335)","('Customer_Welfare', 0.019850796088576317)","(['Human Capital Development'], 0.8349136710166931)","('NON-ESG', 0.023463815450668335)","('NON-ESG', 0.019850796088576317)"
Line 793,"Our internal investigations program helps ensure that our  marketing practices comply with Medtronic policies and external  regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4905211329460144)","('Business_Ethics', 0.1761751025915146)","('Competitive_Behavior', 0.10963287949562073)","('NON-ESG', 0.4905211329460144)","('NON-ESG', 0.1761751025915146)","('NON-ESG', 0.10963287949562073)"
Line 794,"T o make this program more effective, in FY19 we  consolidated it into one center of excellence and standardized  the investigation processes.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6502050161361694)","('Business_Ethics', 0.1343967616558075)","('Access_And_Affordability', 0.03496053069829941)","(['Corporate Governance'], 0.6502050161361694)","('NON-ESG', 0.1343967616558075)","('NON-ESG', 0.03496053069829941)"
Line 795,"Throughout the year , we reviewed  43,000 transactions for sales and marketing risks, including for ETHICS IN  SALES & MARKETING Adding   Business Value   Our reputation for the highest standards of ethics in our  behavior is essential in all our business dealings, and especially  so in sales and marketing.
","('Business_Ethics', 0.970198392868042)","('Product_Quality_And_Safety', 0.0029676645062863827)","('Customer_Privacy', 0.0024527765344828367)","(['Business Ethics'], 0.970198392868042)","('NON-ESG', 0.0029676645062863827)","('NON-ESG', 0.0024527765344828367)"
Line 796,"T o create a consistent culture of  integrity across Medtronic, we train all employees on our   Code of Conduct and provide job-specific training to those in  high-risk roles.82ETHICAL INTERACTION WITH  HEAL THCARE PROFESSIONALS We work alongside physicians and healthcare systems to expand  our positive impact on patients, while adhering to our Physician  Collaboration Policy, which establishes standards for our interactions  with healthcare professionals.
","('Business_Ethics', 0.42915281653404236)","('Employee_Engagement_Inclusion_And_Diversity', 0.186472550034523)","('Product_Quality_And_Safety', 0.0537252277135849)","('NON-ESG', 0.42915281653404236)","('NON-ESG', 0.186472550034523)","('NON-ESG', 0.0537252277135849)"
Line 797,"Our collaborations include:  Inventing new devices and therapies  Developing educational materials and campaigns  Conducting clinical research  Providing training on how to implement our devices and therapies We disclose payments made to physicians and teaching hospitals  in every country where it is required by law.
","('Access_And_Affordability', 0.42942923307418823)","('Customer_Welfare', 0.07480556517839432)","('Product_Quality_And_Safety', 0.07216299325227737)","('NON-ESG', 0.42942923307418823)","('NON-ESG', 0.07480556517839432)","('NON-ESG', 0.07216299325227737)"
Line 798,"In the United States,  payment disclosures are published on the U.S. Centers for Medicare  and Medicaid Services Open Payments site.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5861585736274719)","('Systemic_Risk_Management', 0.10389165580272675)","('Business_Ethics', 0.04115284979343414)","(['Corporate Governance'], 0.5861585736274719)","('NON-ESG', 0.10389165580272675)","('NON-ESG', 0.04115284979343414)"
Line 799,"As discussed above, in  FY19 we resolved three cases related to alleged improper sales and  marketing practices or interactions with healthcare providers.
","('Business_Ethics', 0.7504814267158508)","('Competitive_Behavior', 0.07349125295877457)","('Selling_Practices_And_Product_Labeling', 0.03245007246732712)","(['Business Ethics'], 0.7504814267158508)","('NON-ESG', 0.07349125295877457)","('NON-ESG', 0.03245007246732712)"
Line 800,"Countering corruption The Medtronic board of directors oversees our anti-bribery and   anti-corruption program.
","('Business_Ethics', 0.9760105609893799)","('Management_Of_Legal_And_Regulatory_Framework', 0.002356152515858412)","('Competitive_Behavior', 0.002045387402176857)","(['Business Ethics'], 0.9760105609893799)","('NON-ESG', 0.002356152515858412)","('NON-ESG', 0.002045387402176857)"
Line 801,"The program is strengthened by feedback  from regulators, third-party auditing, and benchmarks of other  companies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7359259724617004)","('Business_Ethics', 0.08861906826496124)","('Competitive_Behavior', 0.06792643666267395)","(['Corporate Governance'], 0.7359259724617004)","('NON-ESG', 0.08861906826496124)","('NON-ESG', 0.06792643666267395)"
Line 802,"We have 217 (full-time equivalent) employees with  expertise in anti-corruption enforcement, including former U.S.  Department of Justice prosecutors.
","('Business_Ethics', 0.959527850151062)","('Management_Of_Legal_And_Regulatory_Framework', 0.005570301786065102)","('Competitive_Behavior', 0.003041177289560437)","(['Business Ethics'], 0.959527850151062)","('NON-ESG', 0.005570301786065102)","('NON-ESG', 0.003041177289560437)"
Line 803,"potential off-label use promotion.
","('Selling_Practices_And_Product_Labeling', 0.4973618984222412)","('Customer_Welfare', 0.16340018808841705)","('Competitive_Behavior', 0.08210241794586182)","('NON-ESG', 0.4973618984222412)","('NON-ESG', 0.16340018808841705)","('NON-ESG', 0.08210241794586182)"
Line 804,"In our internal review, we found four  incidents of noncompliance with our policies concerning marketing  communications and no incidents concerning our policies for   product and service information and labeling.
","('Selling_Practices_And_Product_Labeling', 0.9225305318832397)","('Customer_Welfare', 0.010484570637345314)","('Product_Quality_And_Safety', 0.009628448635339737)","(['Marketing Practices'], 0.9225305318832397)","('NON-ESG', 0.010484570637345314)","('NON-ESG', 0.009628448635339737)"
Line 805,"In FY19, we settled three matters related to alleged improper  marketing or sales practices by entities acquired by Medtronic   (legacy ev3/Covidien) totaling $50.9 million.
","('Business_Ethics', 0.8325117230415344)","('Competitive_Behavior', 0.0581090934574604)","('Selling_Practices_And_Product_Labeling', 0.01416558027267456)","(['Business Ethics'], 0.8325117230415344)","('NON-ESG', 0.0581090934574604)","('NON-ESG', 0.01416558027267456)"
Line 806,"The settlements that the  Medtronic entities agreed to all concerned matters that took place  either largely or entirely prior to Medtronic acquiring the businesses  in which the activities took place.
","('Management_Of_Legal_And_Regulatory_Framework', 0.629657506942749)","('Competitive_Behavior', 0.06628062576055527)","('Business_Ethics', 0.0637131929397583)","(['Corporate Governance'], 0.629657506942749)","('NON-ESG', 0.06628062576055527)","('NON-ESG', 0.0637131929397583)"
Line 807,"Medtronic has made significant  investments in ensuring that it fulfills its obligations to all of its  stakeholders and to do business the right way.
","('Business_Model_Resilience', 0.2392696738243103)","('Management_Of_Legal_And_Regulatory_Framework', 0.22137250006198883)","('Human_Rights_And_Community_Relations', 0.08940920978784561)","('NON-ESG', 0.2392696738243103)","('NON-ESG', 0.22137250006198883)","('NON-ESG', 0.08940920978784561)"
Line 808,"Responsible Marketing to Customers and Patients FY17 FY18 FYFines or Settlements Related   to Improper Marketing or Sales   of Products*0 1†3** Marketing and Sales Employees  T raining Product Promotion14.899 15.566 21.
","('Selling_Practices_And_Product_Labeling', 0.6907931566238403)","('Customer_Welfare', 0.06399749964475632)","('Product_Quality_And_Safety', 0.05721283704042435)","(['Marketing Practices'], 0.6907931566238403)","('NON-ESG', 0.06399749964475632)","('NON-ESG', 0.05721283704042435)"
Line 809,"* Fines noted represent the fiscal year the fine was paid.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5111978650093079)","('Business_Ethics', 0.35890626907348633)","('Director_Removal', 0.01281673926860094)","(['Corporate Governance'], 0.5111978650093079)","('NON-ESG', 0.35890626907348633)","('NON-ESG', 0.01281673926860094)"
Line 810,"† Settlement was related to alleged improper marketing and sales of our Infuse™ product.
","('Selling_Practices_And_Product_Labeling', 0.4832267761230469)","('Customer_Welfare', 0.1428840309381485)","('Product_Quality_And_Safety', 0.10515088587999344)","('NON-ESG', 0.4832267761230469)","('NON-ESG', 0.1428840309381485)","('NON-ESG', 0.10515088587999344)"
Line 811,"** In two cases, Medtronic did not admit wrongdoing.
","('Business_Ethics', 0.9418931603431702)","('Competitive_Behavior', 0.00846846867352724)","('Management_Of_Legal_And_Regulatory_Framework', 0.006689297966659069)","(['Business Ethics'], 0.9418931603431702)","('NON-ESG', 0.00846846867352724)","('NON-ESG', 0.006689297966659069)"
Line 812,"The third settlement was a misdemeanor for  alleged off-label promotion between 2005 and 2009, by the legacy ev3 entity.
","('Competitive_Behavior', 0.2759701609611511)","('Selling_Practices_And_Product_Labeling', 0.2616933286190033)","('Customer_Welfare', 0.11708514392375946)","('NON-ESG', 0.2759701609611511)","('NON-ESG', 0.2616933286190033)","('NON-ESG', 0.11708514392375946)"
Line 813,"Medtronic paid   $17.9 million in fines and penalties on behalf of that entity, which was acquired first by Covidien   and then by Medtronic.
","('Management_Of_Legal_And_Regulatory_Framework', 0.36769887804985046)","('Business_Ethics', 0.3655470311641693)","('Competitive_Behavior', 0.0740995779633522)","('NON-ESG', 0.36769887804985046)","('NON-ESG', 0.3655470311641693)","('NON-ESG', 0.0740995779633522)"
Line 814,"83Owner (DRO) at Medtronic responsible for holding our distributors  accountable to our anti-corruption requirements.
","('Business_Ethics', 0.9696341753005981)","('Management_Of_Legal_And_Regulatory_Framework', 0.006147903390228748)","('Competitive_Behavior', 0.0026749318931251764)","(['Business Ethics'], 0.9696341753005981)","('NON-ESG', 0.006147903390228748)","('NON-ESG', 0.0026749318931251764)"
Line 815,"The DROs meet  with distributors to discuss and certify understanding of ethical  requirements.
","('Business_Ethics', 0.8342878222465515)","('Product_Quality_And_Safety', 0.032953087240457535)","('Competitive_Behavior', 0.02017861045897007)","(['Business Ethics'], 0.8342878222465515)","('NON-ESG', 0.032953087240457535)","('NON-ESG', 0.02017861045897007)"
Line 816,"Distributors must assign a lead team member to  manage ethical responsibilities within their organization and set a  performance goal related to the initiative.
","('Business_Ethics', 0.8035087585449219)","('Human_Rights_And_Community_Relations', 0.03546344116330147)","('Competitive_Behavior', 0.02109912596642971)","(['Business Ethics'], 0.8035087585449219)","('NON-ESG', 0.03546344116330147)","('NON-ESG', 0.02109912596642971)"
Line 817,"In FY19, we expanded our  onsite monitoring program to reach more than 11% of our third-party  distributors, compared to 2.5% the previous year .
","('Supply_Chain_Management', 0.22069211304187775)","('Systemic_Risk_Management', 0.13671346008777618)","('Competitive_Behavior', 0.10458540171384811)","('NON-ESG', 0.22069211304187775)","('NON-ESG', 0.13671346008777618)","('NON-ESG', 0.10458540171384811)"
Line 818,"We are expanding our direct sales infrastructure in specific markets  to reduce our reliance on third-party distributors, decrease risk, and  improve customer service.
","('Competitive_Behavior', 0.22963972389698029)","('Customer_Welfare', 0.2174542397260666)","('Product_Design_And_Lifecycle_Management', 0.19317626953125)","('NON-ESG', 0.22963972389698029)","('NON-ESG', 0.2174542397260666)","('NON-ESG', 0.19317626953125)"
Line 819,"In FY19, Medtronic was not subject to any fines, settlements, or  monetary losses related to noncompliance with anti-corruption laws.
","('Business_Ethics', 0.9632644653320312)","('Management_Of_Legal_And_Regulatory_Framework', 0.008177665062248707)","('Systemic_Risk_Management', 0.003079406451433897)","(['Business Ethics'], 0.9632644653320312)","('NON-ESG', 0.008177665062248707)","('NON-ESG', 0.003079406451433897)"
Line 820,"Our 2019 Form 10-K on file with the U.S. Securities and Exchange  Commission includes a description of risk factors impacting our  global business operations, including risks relating to corruption and  anti-competitive behavior .
","('Business_Ethics', 0.9610521197319031)","('Competitive_Behavior', 0.006192509550601244)","('Systemic_Risk_Management', 0.004830390680581331)","(['Business Ethics'], 0.9610521197319031)","('NON-ESG', 0.006192509550601244)","('NON-ESG', 0.004830390680581331)"
Line 821,"Countering Corruption  FY17 FY18 FYEmployees Supporting Anti- Corruption Efforts (Full- Time  Employee Equivalents)220 217 Third-Party Distributors Receiving  Anti-Corruption T raining93% 96% 95% Third-Party Distributors Receiving  Onsite Monitoring2.5% 2.5% 11.2%We partner with third-party  entities to distribute our  products to customers.
","('Business_Ethics', 0.9690635800361633)","('Data_Security', 0.003013515379279852)","('Competitive_Behavior', 0.0025470368564128876)","(['Business Ethics'], 0.9690635800361633)","('NON-ESG', 0.003013515379279852)","('NON-ESG', 0.0025470368564128876)"
Line 822,"We  hold third parties to the same  standards to which we hold  ourselves and require them  to implement their own anti- corruption programs.
","('Business_Ethics', 0.9576481580734253)","('Management_Of_Legal_And_Regulatory_Framework', 0.009298043325543404)","('Competitive_Behavior', 0.004740509670227766)","(['Business Ethics'], 0.9576481580734253)","('NON-ESG', 0.009298043325543404)","('NON-ESG', 0.004740509670227766)"
Line 823,"T o ensure  that distributors adhere to our  ethical standards, we:  Deliver annual anti-corruption  training that covers our  Distributor Code   of Conduct  Support and monitor  compliance   Conduct onsite monitoring   of distributors   Assess corruption potential  prior to renewing or   entering contracts In FY19, we launched an initiative  to increase compliance with our  Distributor Code of Conduct.
","('Business_Ethics', 0.9747874140739441)","('Management_Of_Legal_And_Regulatory_Framework', 0.0027723144739866257)","('Product_Quality_And_Safety', 0.0026375893503427505)","(['Business Ethics'], 0.9747874140739441)","('NON-ESG', 0.0027723144739866257)","('NON-ESG', 0.0026375893503427505)"
Line 824,"We established a commercial  Distributor Relationship Corruption is a risk in our  industry.
","('Business_Ethics', 0.8689368963241577)","('Competitive_Behavior', 0.033225782215595245)","('Systemic_Risk_Management', 0.028179669752717018)","(['Business Ethics'], 0.8689368963241577)","('NON-ESG', 0.033225782215595245)","('NON-ESG', 0.028179669752717018)"
Line 825,"Our Code of Conduct  prohibits personnel from  exchanging gifts, bribes, or  facilitation payments.
","('Business_Ethics', 0.9714120030403137)","('Management_Of_Legal_And_Regulatory_Framework', 0.002872478449717164)","('Labor_Practices', 0.0021814724896103144)","(['Business Ethics'], 0.9714120030403137)","('NON-ESG', 0.002872478449717164)","('NON-ESG', 0.0021814724896103144)"
Line 826,"Through  our policies, guidelines, and  training programs, we clearly  communicate our ethical  standards to Medtronic  employees.
","('Business_Ethics', 0.9295542240142822)","('Product_Quality_And_Safety', 0.009253264404833317)","('Management_Of_Legal_And_Regulatory_Framework', 0.0074948580004274845)","(['Business Ethics'], 0.9295542240142822)","('NON-ESG', 0.009253264404833317)","('NON-ESG', 0.0074948580004274845)"
Line 827,"An employee can  raise an ethical concern through  our Voice Y our Concern Line,  among other channels.
","('Business_Ethics', 0.8071369528770447)","('Human_Rights_And_Community_Relations', 0.04447416588664055)","('Management_Of_Legal_And_Regulatory_Framework', 0.018045121803879738)","(['Business Ethics'], 0.8071369528770447)","('NON-ESG', 0.04447416588664055)","('NON-ESG', 0.018045121803879738)"
Line 828,"We implement anti-corruption  training to make internal and  external stakeholders aware of  regulations and to explain how  ethically challenging scenarios  should be addressed.
","('Business_Ethics', 0.9692793488502502)","('Management_Of_Legal_And_Regulatory_Framework', 0.005980880465358496)","('Competitive_Behavior', 0.0029150000773370266)","(['Business Ethics'], 0.9692793488502502)","('NON-ESG', 0.005980880465358496)","('NON-ESG', 0.0029150000773370266)"
Line 829,"Anti- corruption is covered in our  required Code of Conduct  training cycle.
","('Business_Ethics', 0.9733636975288391)","('Management_Of_Legal_And_Regulatory_Framework', 0.0027324468828737736)","('Data_Security', 0.002222870709374547)","(['Business Ethics'], 0.9733636975288391)","('NON-ESG', 0.0027324468828737736)","('NON-ESG', 0.002222870709374547)"
Line 830,"Our process  ensures that new hires receive  anti-corruption training upon  joining the company and that  customer-facing employees  receive the training every   two years.
","('Business_Ethics', 0.9617821574211121)","('Product_Quality_And_Safety', 0.004029422532767057)","('Employee_Health_And_Safety', 0.002809074940159917)","(['Business Ethics'], 0.9617821574211121)","('NON-ESG', 0.004029422532767057)","('NON-ESG', 0.002809074940159917)"
Line 831,"84Protecting information is critically important for Medtronic, our  customers, and most importantly, the patients who use our products.
","('Product_Design_And_Lifecycle_Management', 0.8392058610916138)","('Selling_Practices_And_Product_Labeling', 0.03940713778138161)","('Customer_Welfare', 0.029698271304368973)","(['Product Stewardship'], 0.8392058610916138)","('NON-ESG', 0.03940713778138161)","('NON-ESG', 0.029698271304368973)"
Line 832,"We have designed our security and privacy programs to safeguard  data in a rapidly evolving environment.
","('Data_Security', 0.9535305500030518)","('Customer_Privacy', 0.010791847482323647)","('Systemic_Risk_Management', 0.0029076156206429005)","(['Information Security/Cybersecurity & System Availability'], 0.9535305500030518)","('NON-ESG', 0.010791847482323647)","('NON-ESG', 0.0029076156206429005)"
Line 833,"We are in a time of rapid adoption of connected data devices and  powerful data analysis.
","('Data_Security', 0.6441836357116699)","('Customer_Privacy', 0.07155544310808182)","('Energy_Management', 0.04437979683279991)","(['Information Security/Cybersecurity & System Availability'], 0.6441836357116699)","('NON-ESG', 0.07155544310808182)","('NON-ESG', 0.04437979683279991)"
Line 834,"Big data is contributing to innovative products  and faster research, and it is critical to our business to protect   this information.
","('Product_Design_And_Lifecycle_Management', 0.32571402192115784)","('Customer_Privacy', 0.177460715174675)","('Data_Security', 0.17270654439926147)","('NON-ESG', 0.32571402192115784)","('NON-ESG', 0.177460715174675)","('NON-ESG', 0.17270654439926147)"
Line 835,"Our cybersecurity program is constantly adapting and improving in  response to technology developments and the threat landscape.
","('Data_Security', 0.8445627689361572)","('Systemic_Risk_Management', 0.04012908786535263)","('Business_Model_Resilience', 0.02079331874847412)","(['Information Security/Cybersecurity & System Availability'], 0.8445627689361572)","('NON-ESG', 0.04012908786535263)","('NON-ESG', 0.02079331874847412)"
Line 836,"Our  program is designed to reflect ISO 27001 and the National Institute  of Standards and T echnology standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.36118146777153015)","('Product_Quality_And_Safety', 0.2988564670085907)","('Product_Design_And_Lifecycle_Management', 0.03469366207718849)","('NON-ESG', 0.36118146777153015)","('NON-ESG', 0.2988564670085907)","('NON-ESG', 0.03469366207718849)"
Line 837,"T o advance data security  practices, we collaborate with third-party organizations such as the Health Information Sharing and Analysis Center and AdvaMed.
","('Data_Security', 0.9554136395454407)","('Customer_Privacy', 0.008929910138249397)","('Systemic_Risk_Management', 0.002953004790470004)","(['Information Security/Cybersecurity & System Availability'], 0.9554136395454407)","('NON-ESG', 0.008929910138249397)","('NON-ESG', 0.002953004790470004)"
Line 838,"We also contribute to global product and cybersecurity standards in  collaboration with the U.S. Food and Drug Administration (FDA) and  other regulatory advocacy groups.
","('Management_Of_Legal_And_Regulatory_Framework', 0.386565238237381)","('Product_Quality_And_Safety', 0.14932386577129364)","('Business_Ethics', 0.14159291982650757)","('NON-ESG', 0.386565238237381)","('NON-ESG', 0.14932386577129364)","('NON-ESG', 0.14159291982650757)"
Line 839,"Medtronic employees and contractors play a crucial role in  safeguarding data.
","('Data_Security', 0.8249231576919556)","('Customer_Privacy', 0.07004456222057343)","('Business_Ethics', 0.015829071402549744)","(['Information Security/Cybersecurity & System Availability'], 0.8249231576919556)","('NON-ESG', 0.07004456222057343)","('NON-ESG', 0.015829071402549744)"
Line 840,"We train all employees and contingent workers  on data privacy and security, so they understand their role in  identifying, protecting, and preserving particular types of data.
","('Data_Security', 0.9043161869049072)","('Customer_Privacy', 0.04184583202004433)","('Waste_And_Hazardous_Materials_Management', 0.0060607134364545345)","(['Information Security/Cybersecurity & System Availability'], 0.9043161869049072)","('NON-ESG', 0.04184583202004433)","('NON-ESG', 0.0060607134364545345)"
Line 841,"In  FY19, we expanded our trainings to raise employee awareness of  privacy and security obligations.
","('Data_Security', 0.9365031719207764)","('Customer_Privacy', 0.018415190279483795)","('Director_Removal', 0.0042624156922101974)","(['Information Security/Cybersecurity & System Availability'], 0.9365031719207764)","('NON-ESG', 0.018415190279483795)","('NON-ESG', 0.0042624156922101974)"
Line 842,"We provided E.U. General Data  Protection Regulation training for global corporate employees and  noncorporate E.U. employees.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5157418251037598)","('Business_Ethics', 0.12042558193206787)","('Labor_Practices', 0.08480661362409592)","(['Corporate Governance'], 0.5157418251037598)","('NON-ESG', 0.12042558193206787)","('NON-ESG', 0.08480661362409592)"
Line 843,"We also delivered Privacy by Design  training to the vast majority of E.U. employees and employees in key  global functions, such as Legal and IT .
","('Data_Security', 0.8995112180709839)","('Customer_Privacy', 0.03218763694167137)","('Business_Ethics', 0.010796630755066872)","(['Information Security/Cybersecurity & System Availability'], 0.8995112180709839)","('NON-ESG', 0.03218763694167137)","('NON-ESG', 0.010796630755066872)"
Line 844,"U.S. employees additionally  completed training on U.S. privacy laws.
","('Customer_Privacy', 0.48256322741508484)","('Data_Security', 0.33814066648483276)","('Management_Of_Legal_And_Regulatory_Framework', 0.01865147054195404)","('NON-ESG', 0.48256322741508484)","('NON-ESG', 0.33814066648483276)","('NON-ESG', 0.01865147054195404)"
Line 845,"When we acquire a company, we conduct privacy and security   due diligence, implement policies and procedures, and deliver  employee training.
","('Data_Security', 0.9453537464141846)","('Customer_Privacy', 0.012321608141064644)","('Business_Ethics', 0.0037825254257768393)","(['Information Security/Cybersecurity & System Availability'], 0.9453537464141846)","('NON-ESG', 0.012321608141064644)","('NON-ESG', 0.0037825254257768393)"
Line 846,"Vendors must also adhere to our data security and privacy  standards, and we review privacy and security risks as part of our  vendor assessment process.
","('Data_Security', 0.9610523581504822)","('Customer_Privacy', 0.0058860331773757935)","('Systemic_Risk_Management', 0.002858881838619709)","(['Information Security/Cybersecurity & System Availability'], 0.9610523581504822)","('NON-ESG', 0.0058860331773757935)","('NON-ESG', 0.002858881838619709)"
Line 847,"Contingent workers must complete  annual privacy and security training.
","('Data_Security', 0.9482982158660889)","('Customer_Privacy', 0.007590488530695438)","('Business_Ethics', 0.003899747272953391)","(['Information Security/Cybersecurity & System Availability'], 0.9482982158660889)","('NON-ESG', 0.007590488530695438)","('NON-ESG', 0.003899747272953391)"
Line 848,"D ATA SECURITY   & PRIVACY Adding   Business Value   By investing in data security and privacy measures, we build  investor confidence, retain customer trust, respect patients,  and ensure compliance with new regulations.
","('Data_Security', 0.9571766257286072)","('Customer_Privacy', 0.006908210925757885)","('Business_Ethics', 0.00414307089522481)","(['Information Security/Cybersecurity & System Availability'], 0.9571766257286072)","('NON-ESG', 0.006908210925757885)","('NON-ESG', 0.00414307089522481)"
Line 849,"Medtronic adheres to state,  federal, and (where applicable)  international breach notification  requirements.
","('Data_Security', 0.8231706619262695)","('Business_Ethics', 0.03299887478351593)","('Systemic_Risk_Management', 0.02586960233747959)","(['Information Security/Cybersecurity & System Availability'], 0.8231706619262695)","('NON-ESG', 0.03299887478351593)","('NON-ESG', 0.02586960233747959)"
Line 850,"As an example,  in accordance with HIPAA- related data breach notification  requirements, Medtronic self- reports incidents involving  loss or inappropriate access  to patient information to the  Office for Civil Rights of the  U.S. Department of Health and  Human Services.
","('Data_Security', 0.8970047235488892)","('Customer_Privacy', 0.03821990266442299)","('Business_Ethics', 0.008540336973965168)","(['Information Security/Cybersecurity & System Availability'], 0.8970047235488892)","('NON-ESG', 0.03821990266442299)","('NON-ESG', 0.008540336973965168)"
Line 851,"Looking ahead, we are focused  on reducing data security and  privacy risk by:  Improving processes and  technology for threat  detection and response  Improving technology and  processes for identity and  access management  Raising the security IQ of  employees  Continuing to improve our  data security and privacy  guidelines and trainingOur product security efforts  align with regulatory standards,  protect patients, and ensure  the highest levels of product  usability.
","('Data_Security', 0.9631772041320801)","('Customer_Privacy', 0.0052132210694253445)","('Business_Ethics', 0.0029678852297365665)","(['Information Security/Cybersecurity & System Availability'], 0.9631772041320801)","('NON-ESG', 0.0052132210694253445)","('NON-ESG', 0.0029678852297365665)"
Line 852,"Our robust security  program is managed by the  Medtronic Global Security  Office and embedded in the full  product life cycle by subject- matter experts within each  business unit.
","('Data_Security', 0.9117145538330078)","('Systemic_Risk_Management', 0.0100160613656044)","('Business_Model_Resilience', 0.008061873726546764)","(['Information Security/Cybersecurity & System Availability'], 0.9117145538330078)","('NON-ESG', 0.0100160613656044)","('NON-ESG', 0.008061873726546764)"
Line 853,"Our security  approach and risk management  are informed by internal and  external medical device security  experts, current security  practices, as well as rigorous  development processes and  vulnerability testing.
","('Data_Security', 0.9542797803878784)","('Systemic_Risk_Management', 0.005638646427541971)","('Business_Ethics', 0.00412514666095376)","(['Information Security/Cybersecurity & System Availability'], 0.9542797803878784)","('NON-ESG', 0.005638646427541971)","('NON-ESG', 0.00412514666095376)"
Line 854,"We encourage physicians,  patients, and other interested  parties to submit questions  or concerns about medical  device security matters to  Medtronic.com/security.
","('Data_Security', 0.9557244777679443)","('Customer_Privacy', 0.004984251223504543)","('Director_Removal', 0.0038344429340213537)","(['Information Security/Cybersecurity & System Availability'], 0.9557244777679443)","('NON-ESG', 0.004984251223504543)","('NON-ESG', 0.0038344429340213537)"
Line 855,"Our  global security team tracks,  investigates, and responds to  these inquiries.
","('Data_Security', 0.26460495591163635)","('Critical_Incident_Risk_Management', 0.20865735411643982)","('Business_Ethics', 0.16117636859416962)","('NON-ESG', 0.26460495591163635)","('NON-ESG', 0.20865735411643982)","('NON-ESG', 0.16117636859416962)"
Line 856,"8586Our suppliers are critical to our Mission.
","('Supply_Chain_Management', 0.9335039258003235)","('Product_Design_And_Lifecycle_Management', 0.010137651115655899)","('Water_And_Wastewater_Management', 0.004537886939942837)","(['Supply Chain Management'], 0.9335039258003235)","('NON-ESG', 0.010137651115655899)","('NON-ESG', 0.004537886939942837)"
Line 857,"They enable us to create  and deliver products and services that improve the lives of millions  of people every year .
","('Product_Design_And_Lifecycle_Management', 0.9493750929832458)","('Product_Quality_And_Safety', 0.0058864108286798)","('Customer_Welfare', 0.005691640079021454)","(['Product Stewardship'], 0.9493750929832458)","('NON-ESG', 0.0058864108286798)","('NON-ESG', 0.005691640079021454)"
Line 858,"It is important to us that the companies in  our supply chain share our values — including our focus on quality,  responsible business practices, and sustainability.
","('Supply_Chain_Management', 0.9306023716926575)","('Product_Design_And_Lifecycle_Management', 0.015833323821425438)","('Employee_Health_And_Safety', 0.004600344225764275)","(['Supply Chain Management'], 0.9306023716926575)","('NON-ESG', 0.015833323821425438)","('NON-ESG', 0.004600344225764275)"
Line 859,"T ogether we can  make a lasting, positive difference to patients, and to the communities  and environment in which we operate.OUR GLOBAL SUPPL Y CHAIN We value the skills and experience of every supplier we work with.
","('Supply_Chain_Management', 0.8503773808479309)","('Human_Rights_And_Community_Relations', 0.0223477054387331)","('Product_Design_And_Lifecycle_Management', 0.014508185908198357)","(['Supply Chain Management'], 0.8503773808479309)","('NON-ESG', 0.0223477054387331)","('NON-ESG', 0.014508185908198357)"
Line 860,"More than 48,000 companies across 135 countries contribute their  talent and ideas to our supply chain every day.
","('Supply_Chain_Management', 0.9403432011604309)","('Labor_Practices', 0.0060041737742722034)","('Waste_And_Hazardous_Materials_Management', 0.005383700598031282)","(['Supply Chain Management'], 0.9403432011604309)","('NON-ESG', 0.0060041737742722034)","('NON-ESG', 0.005383700598031282)"
Line 861,"They play a crucial  role in maintaining our reputation for world-class quality, and in  retaining the trust of our many stakeholders.
","('Business_Model_Resilience', 0.2089805006980896)","('Business_Ethics', 0.1796543449163437)","('Competitive_Behavior', 0.06743624061346054)","('NON-ESG', 0.2089805006980896)","('NON-ESG', 0.1796543449163437)","('NON-ESG', 0.06743624061346054)"
Line 862,"In FY19, we spent more than $11.5 billion with our suppliers globally.
","('Supply_Chain_Management', 0.9008768796920776)","('Product_Design_And_Lifecycle_Management', 0.016430214047431946)","('GHG_Emissions', 0.008092047646641731)","(['Supply Chain Management'], 0.9008768796920776)","('NON-ESG', 0.016430214047431946)","('NON-ESG', 0.008092047646641731)"
Line 863,"Supply Chain Spend ($ Millions)  FY17 FY18 FYAustralia $73.7 $100.9 $80.Canada $149.0 $132.1 $118.China $281.9 $343.1 $378.France $185.6 $178.3 $152.Germany $220.0 $261.1 $253.Ireland $205.9 $251.5 $230.Israel $21.1 $86.5 $52.Japan $164.9 $182.7 $169.Mexico $151.9 $146.1 $170.Netherlands $184.9 $221.5 $256.Singapore $126.9 $114.2 $108.Switzerland $191.1 $178.8 $130.United States $8,498.7 $7,935.6 $7,932.T otal for Locations Listed $10,455.6 $10,132.9 $10,033.T otal Spend $11,927.5 $11,670.7 $11,560.4SUPPL Y CHAIN  RESPONSIBILITY Adding   Business Value   Our $11.5 billion supply chain is central to our ability to provide  high-quality, life-improving products and services.
","('Supply_Chain_Management', 0.8838575482368469)","('Systemic_Risk_Management', 0.01953069120645523)","('Business_Model_Resilience', 0.007995479740202427)","(['Supply Chain Management'], 0.8838575482368469)","('NON-ESG', 0.01953069120645523)","('NON-ESG', 0.007995479740202427)"
Line 864,"Supply Chain Spend ($ Millions)  FY17 FY18 FYAustralia $73.7 $100.9 $80.Canada $149.0 $132.1 $118.China $281.9 $343.1 $378.France $185.6 $178.3 $152.Germany $220.0 $261.1 $253.Ireland $205.9 $251.5 $230.Israel $21.1 $86.5 $52.Japan $164.9 $182.7 $169.Mexico $151.9 $146.1 $170.Netherlands $184.9 $221.5 $256.Singapore $126.9 $114.2 $108.Switzerland $191.1 $178.8 $130.United States $8,498.7 $7,935.6 $7,932.T otal for Locations Listed $10,455.6 $10,132.9 $10,033.T otal Spend $11,927.5 $11,670.7 $11,560.4SUPPL Y CHAIN  RESPONSIBILITY Adding   Business Value   Our $11.5 billion supply chain is central to our ability to provide  high-quality, life-improving products and services.
","('Supply_Chain_Management', 0.4777888059616089)","('Product_Design_And_Lifecycle_Management', 0.37529924511909485)","('Waste_And_Hazardous_Materials_Management', 0.013074618764221668)","('NON-ESG', 0.4777888059616089)","('NON-ESG', 0.37529924511909485)","('NON-ESG', 0.013074618764221668)"
Line 865,"Our supply  chain management systems are instrumental in minimizing  disruptions and quality failures.87internal website, Inside Medtronic, features diverse suppliers   that bring exceptional value and positive impact to Medtronic   and our customers.
","('Supply_Chain_Management', 0.9481750726699829)","('Product_Design_And_Lifecycle_Management', 0.004586285911500454)","('Labor_Practices', 0.004221427720040083)","(['Supply Chain Management'], 0.9481750726699829)","('NON-ESG', 0.004586285911500454)","('NON-ESG', 0.004221427720040083)"
Line 866,"Extending the value of diversity through our supply chain   We are working with our larger suppliers to support and enable  them to engage with diverse companies in their own supply  chains.
","('Supply_Chain_Management', 0.8977753520011902)","('Labor_Practices', 0.015693282708525658)","('Employee_Engagement_Inclusion_And_Diversity', 0.010093155317008495)","(['Supply Chain Management'], 0.8977753520011902)","('NON-ESG', 0.015693282708525658)","('NON-ESG', 0.010093155317008495)"
Line 867,"Building on an earlier pilot program, in FY19 we worked  with selected suppliers to review their engagement with diverse  suppliers, including their level of spend.
","('Supply_Chain_Management', 0.9363188743591309)","('Product_Design_And_Lifecycle_Management', 0.0062575326301157475)","('Labor_Practices', 0.004956287331879139)","(['Supply Chain Management'], 0.9363188743591309)","('NON-ESG', 0.0062575326301157475)","('NON-ESG', 0.004956287331879139)"
Line 868,"We have extended this  program to include our top 50 suppliers.
","('Supply_Chain_Management', 0.9260260462760925)","('Product_Design_And_Lifecycle_Management', 0.007124593947082758)","('GHG_Emissions', 0.005871140398085117)","(['Supply Chain Management'], 0.9260260462760925)","('NON-ESG', 0.007124593947082758)","('NON-ESG', 0.005871140398085117)"
Line 869,"Recognizing diversity at the heart of our world-class   supply chain   At our annual Global Supplier Conference, our Supplier Excellence  Awards recognize a select group of suppliers for their role in  bringing exceptional value to the Medtronic supply chain.
","('Supply_Chain_Management', 0.9442300796508789)","('Labor_Practices', 0.007449072320014238)","('Product_Design_And_Lifecycle_Management', 0.004135175608098507)","(['Supply Chain Management'], 0.9442300796508789)","('NON-ESG', 0.007449072320014238)","('NON-ESG', 0.004135175608098507)"
Line 870,"In FY19,  nearly half of these awards went to diverse or small companies,  demonstrating the importance of these suppliers to our business.
","('Supply_Chain_Management', 0.9353917241096497)","('Product_Design_And_Lifecycle_Management', 0.00678835017606616)","('Labor_Practices', 0.005089840851724148)","(['Supply Chain Management'], 0.9353917241096497)","('NON-ESG', 0.00678835017606616)","('NON-ESG', 0.005089840851724148)"
Line 871,"Hosting our annual procurement fair   We co-hosted the fair with Disability:IN, National Association  of Women Business Owners, the National Veteran Business  Development Center , the North Central Minority Supplier  Development Council, Quorum, and the Women’s Business  Development Center .
","('Employee_Engagement_Inclusion_And_Diversity', 0.7557558417320251)","('Supply_Chain_Management', 0.03257334232330322)","('Labor_Practices', 0.02796199545264244)","(['Human Capital Development'], 0.7557558417320251)","('NON-ESG', 0.03257334232330322)","('NON-ESG', 0.02796199545264244)"
Line 872,"More than 250 attendees met for a day of  networking and supplier development programming.SUPPLIER DIVERSITY A key strength of our supply chain is its diversity.
","('Supply_Chain_Management', 0.793053388595581)","('Employee_Engagement_Inclusion_And_Diversity', 0.03994269296526909)","('Labor_Practices', 0.03175731375813484)","(['Supply Chain Management'], 0.793053388595581)","('NON-ESG', 0.03994269296526909)","('NON-ESG', 0.03175731375813484)"
Line 873,"Working with  businesses owned by women, ethnically diverse groups, disabled  people, LGBTQ+ individuals, and veterans keeps us agile and  innovative.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9742384552955627)","('Human_Rights_And_Community_Relations', 0.0024730709847062826)","('Employee_Health_And_Safety', 0.0017119202530011535)","(['Human Capital Development'], 0.9742384552955627)","('NON-ESG', 0.0024730709847062826)","('NON-ESG', 0.0017119202530011535)"
Line 874,"We proactively seek to maintain this diversity through  our Supplier Diversity program.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9638447761535645)","('Employee_Health_And_Safety', 0.0031673386693000793)","('Labor_Practices', 0.002407558262348175)","(['Human Capital Development'], 0.9638447761535645)","('NON-ESG', 0.0031673386693000793)","('NON-ESG', 0.002407558262348175)"
Line 875,"Our Supplier Diversity team, Supplier  Diversity Steering Committee, and executive management team  oversee this program, setting strategy and goals each year .
","('Employee_Engagement_Inclusion_And_Diversity', 0.8896406888961792)","('Supply_Chain_Management', 0.014442192390561104)","('Labor_Practices', 0.013653657399117947)","(['Human Capital Development'], 0.8896406888961792)","('NON-ESG', 0.014442192390561104)","('NON-ESG', 0.013653657399117947)"
Line 876,"Our Supplier Diversity Policy recognizes and supports  10 diverse supplier types, including:   Small businesses  Businesses certifiably owned by women, ethnically diverse  groups, disabled people, LGBTQ+ individuals, or veterans  Disadvantaged businesses and those located in historically  underutilized business zones We are committed to extending the shared value that diverse  suppliers bring to our business, shareholders, and communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9704486727714539)","('Human_Rights_And_Community_Relations', 0.002275585662573576)","('Employee_Health_And_Safety', 0.0020938583184033632)","(['Human Capital Development'], 0.9704486727714539)","('NON-ESG', 0.002275585662573576)","('NON-ESG', 0.0020938583184033632)"
Line 877,"Our FY19 supplier diversity highlights include:  Showcasing exceptional suppliers  T o celebrate our diverse suppliers, in FY19 we created  the Medtronic Supplier Showcase.
","('Supply_Chain_Management', 0.734741747379303)","('Employee_Engagement_Inclusion_And_Diversity', 0.05578157678246498)","('Labor_Practices', 0.036374904215335846)","(['Supply Chain Management'], 0.734741747379303)","('NON-ESG', 0.05578157678246498)","('NON-ESG', 0.036374904215335846)"
Line 878,"This regular series of  communications — shared with our employees through our CASE STUDY WORKING WITH DIVERSE SUPPLIERS   THA T SHARE OUR VALUES  PKG Packaging is a minority-owned, local company based in the  U.S. city of Oxnard, California.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5738484859466553)","('Supply_Chain_Management', 0.06912190467119217)","('Product_Design_And_Lifecycle_Management', 0.04751256853342056)","(['Human Capital Development'], 0.5738484859466553)","('NON-ESG', 0.06912190467119217)","('NON-ESG', 0.04751256853342056)"
Line 879,"It specializes in providing innovative  and sustainable packaging for businesses across the country,  including Medtronic.
","('Product_Design_And_Lifecycle_Management', 0.9550905227661133)","('Energy_Management', 0.004474760498851538)","('Selling_Practices_And_Product_Labeling', 0.003443139372393489)","(['Product Stewardship'], 0.9550905227661133)","('NON-ESG', 0.004474760498851538)","('NON-ESG', 0.003443139372393489)"
Line 880,"Since 1998, PKG Packaging has provided  Medtronic with packaging solutions for insulin pumps used by  diabetes patients.
","('Product_Design_And_Lifecycle_Management', 0.7349994778633118)","('Customer_Welfare', 0.05754470452666283)","('Selling_Practices_And_Product_Labeling', 0.033547502011060715)","(['Product Stewardship'], 0.7349994778633118)","('NON-ESG', 0.05754470452666283)","('NON-ESG', 0.033547502011060715)"
Line 881,"PKG Packaging is the type of partner we often seek out to help  improve our supply chain — not only because they are a diverse  supplier , but also because they value their employees as much as  they value their business.
","('Supply_Chain_Management', 0.9360467791557312)","('Product_Design_And_Lifecycle_Management', 0.011940162628889084)","('Waste_And_Hazardous_Materials_Management', 0.003913756925612688)","(['Supply Chain Management'], 0.9360467791557312)","('NON-ESG', 0.011940162628889084)","('NON-ESG', 0.003913756925612688)"
Line 882,"The 20-person team at PKG Packaging welcomes local college  students who need flexible work schedules as they develop skills  and experience for the future.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5210683941841125)","('Employee_Health_And_Safety', 0.1314474642276764)","('Labor_Practices', 0.06702421605587006)","(['Human Capital Development'], 0.5210683941841125)","('NON-ESG', 0.1314474642276764)","('NON-ESG', 0.06702421605587006)"
Line 883,"The company is also committed to  creating opportunities for minority groups and actively seeks to  build its employee population from within the local community.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9684269428253174)","('Human_Rights_And_Community_Relations', 0.004847454372793436)","('Access_And_Affordability', 0.002169625135138631)","(['Human Capital Development'], 0.9684269428253174)","('NON-ESG', 0.004847454372793436)","('NON-ESG', 0.002169625135138631)"
Line 884,"These are the kind of values that Medtronic looks for in a supplier .
","('Supply_Chain_Management', 0.8357663750648499)","('Product_Design_And_Lifecycle_Management', 0.034593697637319565)","('Business_Model_Resilience', 0.015241876244544983)","(['Supply Chain Management'], 0.8357663750648499)","('NON-ESG', 0.034593697637319565)","('NON-ESG', 0.015241876244544983)"
Line 885,"As a mission-driven company, we aim to make the world a  healthier place.
","('Employee_Health_And_Safety', 0.2168598473072052)","('Product_Design_And_Lifecycle_Management', 0.14559662342071533)","('Customer_Welfare', 0.0848432257771492)","('NON-ESG', 0.2168598473072052)","('NON-ESG', 0.14559662342071533)","('NON-ESG', 0.0848432257771492)"
Line 886,"It’s an idea embedded in our business, activated  by our employees, and extended by our partners — including  PKG Packaging.
","('Product_Design_And_Lifecycle_Management', 0.9335832595825195)","('Selling_Practices_And_Product_Labeling', 0.008399075828492641)","('Waste_And_Hazardous_Materials_Management', 0.006837389897555113)","(['Product Stewardship'], 0.9335832595825195)","('NON-ESG', 0.008399075828492641)","('NON-ESG', 0.006837389897555113)"
Line 887,"In FY19, we directed about 24% of our U.S. supplier spend to small and diverse companies.
","('Supply_Chain_Management', 0.9204410314559937)","('Product_Design_And_Lifecycle_Management', 0.01058814488351345)","('Labor_Practices', 0.007122356910258532)","(['Supply Chain Management'], 0.9204410314559937)","('NON-ESG', 0.01058814488351345)","('NON-ESG', 0.007122356910258532)"
Line 888,"U.S. Diverse Supply Chain Spend by Category ($ Million)*†  FY17 FY18** FY19†† $ U.S. Spend % U.S. Spend $ U.S. Spend % U.S. Spend $ U.S. Spend % U.S. Spend Small Business $1,554 24% $1,341 22% $1,144 17% Veteran-Owned Business $67 1.1% $69 1.1% $133 1.9% Minority-Owned Business Enterprise $208 3.0% $270 4.4% $245 3.7% Women-Owned Business Enterprise $139 2.2% $122 2.0% $177 2.6%    *This table includes U.S. addressable spend, which totaled approximately $6.7 billion in FY19.
","('Supply_Chain_Management', 0.9041341543197632)","('Systemic_Risk_Management', 0.009945802390575409)","('Product_Design_And_Lifecycle_Management', 0.009416721761226654)","(['Supply Chain Management'], 0.9041341543197632)","('NON-ESG', 0.009945802390575409)","('NON-ESG', 0.009416721761226654)"
Line 889,"Non-addressable spend includes employee-related benefits, health insurance, taxes, and royalties.
","('Employee_Health_And_Safety', 0.39881327748298645)","('Labor_Practices', 0.16279911994934082)","('Employee_Engagement_Inclusion_And_Diversity', 0.08726819604635239)","('NON-ESG', 0.39881327748298645)","('NON-ESG', 0.16279911994934082)","('NON-ESG', 0.08726819604635239)"
Line 890,"†Due to overlap between different categories of small and diverse suppliers, figures in this table do not add up to the total annual figures for spend with small and diverse companies.
","('Supply_Chain_Management', 0.8351528644561768)","('Product_Design_And_Lifecycle_Management', 0.019431529566645622)","('Customer_Welfare', 0.018919499590992928)","(['Supply Chain Management'], 0.8351528644561768)","('NON-ESG', 0.019431529566645622)","('NON-ESG', 0.018919499590992928)"
Line 891,"**The decrease in small and diverse supplier spend from FY17 to FY18 is primarily due to the Fortis divesture that occurred in FY17.
","('Supply_Chain_Management', 0.9414424300193787)","('Systemic_Risk_Management', 0.007060669828206301)","('Business_Model_Resilience', 0.006633812095969915)","(['Supply Chain Management'], 0.9414424300193787)","('NON-ESG', 0.007060669828206301)","('NON-ESG', 0.006633812095969915)"
Line 892,"OUR SUPPLIER DIVERSITY ECONOMIC IMPACT14   In FY19, we undertook a detailed assessment of our impact with diverse suppliers in the U.S. and Puerto Rico.
","('Supply_Chain_Management', 0.7029158473014832)","('Employee_Engagement_Inclusion_And_Diversity', 0.08332808315753937)","('Labor_Practices', 0.03058026172220707)","(['Supply Chain Management'], 0.7029158473014832)","('NON-ESG', 0.08332808315753937)","('NON-ESG', 0.03058026172220707)"
Line 893,"The data we analyzed was   from FY18:              T o support the local economies in which we operate, we aim to use local suppliers where possible.
","('Supply_Chain_Management', 0.8828964829444885)","('GHG_Emissions', 0.010299798101186752)","('Product_Design_And_Lifecycle_Management', 0.008688412606716156)","(['Supply Chain Management'], 0.8828964829444885)","('NON-ESG', 0.010299798101186752)","('NON-ESG', 0.008688412606716156)"
Line 894,"For example, our analysis of FY18 data  also showed that our U.S. corporate office in Minneapolis spent $771 million with suppliers within the state of Minnesota.
","('Supply_Chain_Management', 0.8962686657905579)","('Labor_Practices', 0.010360503569245338)","('GHG_Emissions', 0.009290492162108421)","(['Supply Chain Management'], 0.8962686657905579)","('NON-ESG', 0.010360503569245338)","('NON-ESG', 0.009290492162108421)"
Line 895,"Of this total spend,  43% was with small and diverse suppliers.15  14  Data coverage: FY18 data for the United States and Puerto Rico.
","('Supply_Chain_Management', 0.9073356986045837)","('Product_Design_And_Lifecycle_Management', 0.01517246663570404)","('Customer_Welfare', 0.007875347509980202)","(['Supply Chain Management'], 0.9073356986045837)","('NON-ESG', 0.01517246663570404)","('NON-ESG', 0.007875347509980202)"
Line 896,"15  Also includes ZIP codes from Wisconsin.purchases from   small and diverse  businesses$1.BILLION+  economic   production activity$3.BILLION+ jobs supported in the U.S.  at small and diverse suppliers, lower-tier suppliers, and community businesses17,500+ wages and benefits  earned through  supported jobs$1.BILLION+  U.S. federal, state,  and local taxes  generated$MILLION 90T raining and collaboration We provide comprehensive,  responsible supply management  training to employees in  procurement and sourcing roles.
","('Supply_Chain_Management', 0.8791958689689636)","('Labor_Practices', 0.022961510345339775)","('Product_Design_And_Lifecycle_Management', 0.015686100348830223)","(['Supply Chain Management'], 0.8791958689689636)","('NON-ESG', 0.022961510345339775)","('NON-ESG', 0.015686100348830223)"
Line 897,"15  Also includes ZIP codes from Wisconsin.purchases from   small and diverse  businesses$1.BILLION+  economic   production activity$3.BILLION+ jobs supported in the U.S.  at small and diverse suppliers, lower-tier suppliers, and community businesses17,500+ wages and benefits  earned through  supported jobs$1.BILLION+  U.S. federal, state,  and local taxes  generated$MILLION 90T raining and collaboration We provide comprehensive,  responsible supply management  training to employees in  procurement and sourcing roles.
","('Competitive_Behavior', 0.2870981991291046)","('Management_Of_Legal_And_Regulatory_Framework', 0.0826430469751358)","('Business_Ethics', 0.07303354889154434)","('NON-ESG', 0.2870981991291046)","('NON-ESG', 0.0826430469751358)","('NON-ESG', 0.07303354889154434)"
Line 898,"The training focuses on labor  and human rights issues —  including human trafficking   and slavery.
","('Human_Rights_And_Community_Relations', 0.47751668095588684)","('Labor_Practices', 0.37619292736053467)","('Employee_Engagement_Inclusion_And_Diversity', 0.021318800747394562)","('NON-ESG', 0.47751668095588684)","('NON-ESG', 0.37619292736053467)","('NON-ESG', 0.021318800747394562)"
Line 899,"We also participate in the  Sustainable Purchasing  Leadership Council and the  Conference Board to share  knowledge with our peers.
","('Product_Design_And_Lifecycle_Management', 0.5068097114562988)","('Business_Model_Resilience', 0.10307899862527847)","('Supply_Chain_Management', 0.0775727778673172)","(['Product Stewardship'], 0.5068097114562988)","('NON-ESG', 0.10307899862527847)","('NON-ESG', 0.0775727778673172)"
Line 900,"Monitoring compliance  and performance FY19 marked the beginning of  a three-year process to expand  our Global Supplier Standards  Compliance Program.
","('Supply_Chain_Management', 0.22393256425857544)","('Product_Quality_And_Safety', 0.1912042796611786)","('Management_Of_Legal_And_Regulatory_Framework', 0.18624982237815857)","('NON-ESG', 0.22393256425857544)","('NON-ESG', 0.1912042796611786)","('NON-ESG', 0.18624982237815857)"
Line 901,"Our  primary aim is to ensure that  our top-spend suppliers fully  understand and meet our  requirements.EMBEDDING SUST AINABILITY AND RESPONSIBILITY   IN OUR SUPPL Y CHAIN  Through our Responsible Supply Management Program, we work with our suppliers to:  Uphold human rights and labor standards in our supply chain  Reduce our environmental impact globally and locally  Enhance our reputation  Medtronic codes, policies, and standards relevant to our supply chain  Global Supplier Standards describe the minimum social, ethical, and environmental requirements  and expectations of our suppliers.
","('Supply_Chain_Management', 0.8436236381530762)","('Labor_Practices', 0.06247331202030182)","('Employee_Health_And_Safety', 0.008732786402106285)","(['Supply Chain Management'], 0.8436236381530762)","('NON-ESG', 0.06247331202030182)","('NON-ESG', 0.008732786402106285)"
Line 902,"Our  primary aim is to ensure that  our top-spend suppliers fully  understand and meet our  requirements.EMBEDDING SUST AINABILITY AND RESPONSIBILITY   IN OUR SUPPL Y CHAIN  Through our Responsible Supply Management Program, we work with our suppliers to:  Uphold human rights and labor standards in our supply chain  Reduce our environmental impact globally and locally  Enhance our reputation  Medtronic codes, policies, and standards relevant to our supply chain  Global Supplier Standards describe the minimum social, ethical, and environmental requirements  and expectations of our suppliers.
","('Supply_Chain_Management', 0.7074341177940369)","('Human_Rights_And_Community_Relations', 0.03979096934199333)","('Labor_Practices', 0.03784988075494766)","(['Supply Chain Management'], 0.7074341177940369)","('NON-ESG', 0.03979096934199333)","('NON-ESG', 0.03784988075494766)"
Line 903,"Supplier selection and management processes, supplier  agreements, and purchase order terms and conditions all include reference to the Standards.
","('Supply_Chain_Management', 0.9290695786476135)","('Labor_Practices', 0.010338605381548405)","('Selling_Practices_And_Product_Labeling', 0.004206561017781496)","(['Supply Chain Management'], 0.9290695786476135)","('NON-ESG', 0.010338605381548405)","('NON-ESG', 0.004206561017781496)"
Line 904,"Global Human Rights and Labor Standards Policy applies to all Medtronic locations, all Medtronic  personnel, and any third-party labor agencies providing employees on our behalf.
","('Labor_Practices', 0.974010705947876)","('Director_Removal', 0.0025151814334094524)","('Business_Ethics', 0.0021182484924793243)","(['Labor Practice Indicators'], 0.974010705947876)","('NON-ESG', 0.0025151814334094524)","('NON-ESG', 0.0021182484924793243)"
Line 905,"We strive to:  Ensure that our suppliers adhere to the minimum standards that are outlined within this policy   Conduct our business in a manner that demonstrates a respect for internationally recognized  human rights and the dignity of all people  Global Anti-Human T rafficking and Forced Labor Policy outlines our commitment to a work  environment free from human trafficking, slavery, unlawful child labor , and forced labor of any kind.
","('Labor_Practices', 0.9530438184738159)","('Human_Rights_And_Community_Relations', 0.008166330866515636)","('Employee_Health_And_Safety', 0.005184473469853401)","(['Labor Practice Indicators'], 0.9530438184738159)","('NON-ESG', 0.008166330866515636)","('NON-ESG', 0.005184473469853401)"
Line 906,"The policy applies to all Medtronic locations and personnel and any third-party labor agencies  providing services to Medtronic.
","('Labor_Practices', 0.9760385155677795)","('Director_Removal', 0.002224783878773451)","('Supply_Chain_Management', 0.0020983421709388494)","(['Labor Practice Indicators'], 0.9760385155677795)","('NON-ESG', 0.002224783878773451)","('NON-ESG', 0.0020983421709388494)"
Line 907,"We strive to ensure that our suppliers adhere to the minimum  standards that are outlined within this policy.
","('Labor_Practices', 0.35416075587272644)","('Product_Quality_And_Safety', 0.15880802273750305)","('Management_Of_Legal_And_Regulatory_Framework', 0.14889518916606903)","('NON-ESG', 0.35416075587272644)","('NON-ESG', 0.15880802273750305)","('NON-ESG', 0.14889518916606903)"
Line 908,"Code of Conduct includes employees, officers, directors, and anyone conducting business on  behalf of Medtronic, such as contractors, consultants, and distributors.potential environmental, social,  and governance (ESG) risks.
","('Human_Rights_And_Community_Relations', 0.2679067552089691)","('Management_Of_Legal_And_Regulatory_Framework', 0.2000589817762375)","('Business_Ethics', 0.1868486851453781)","('NON-ESG', 0.2679067552089691)","('NON-ESG', 0.2000589817762375)","('NON-ESG', 0.1868486851453781)"
Line 909,"This included certain suppliers  located in high-risk countries for  human rights and environmental  compliance, or where vulnerable  workers are likely to be  employed.
","('Human_Rights_And_Community_Relations', 0.3711678385734558)","('Employee_Health_And_Safety', 0.25068169832229614)","('Labor_Practices', 0.21153810620307922)","('NON-ESG', 0.3711678385734558)","('NON-ESG', 0.25068169832229614)","('NON-ESG', 0.21153810620307922)"
Line 910,"We are taking the  learnings from these initial 150  self-assessments to build the  capacity of our suppliers for  future assessments and guide  our audit process.
","('Supply_Chain_Management', 0.8682959675788879)","('Systemic_Risk_Management', 0.01590115949511528)","('Management_Of_Legal_And_Regulatory_Framework', 0.011452595703303814)","(['Supply Chain Management'], 0.8682959675788879)","('NON-ESG', 0.01590115949511528)","('NON-ESG', 0.011452595703303814)"
Line 911,"As we continue to extend  our monitoring and auditing  process, we know there is more  work to do to monitor and  mitigate less visible risks.
","('Systemic_Risk_Management', 0.8786398768424988)","('Business_Ethics', 0.01732523739337921)","('Physical_Impacts_Of_Climate_Change', 0.013406763784587383)","(['Risk & Crisis Management'], 0.8786398768424988)","('NON-ESG', 0.01732523739337921)","('NON-ESG', 0.013406763784587383)"
Line 912,"We  are determined to work with our  suppliers to fully understand  and improve their social and  environmental performance —  ultimately contributing to a more  sustainable supply chain.
","('Supply_Chain_Management', 0.944111168384552)","('Product_Design_And_Lifecycle_Management', 0.008293168619275093)","('Physical_Impacts_Of_Climate_Change', 0.004291176330298185)","(['Supply Chain Management'], 0.944111168384552)","('NON-ESG', 0.008293168619275093)","('NON-ESG', 0.004291176330298185)"
Line 913,"During this first year , we  focused on building the  capacity of our suppliers  to answer our requests for  information comprehensively  and consistently.
","('Supply_Chain_Management', 0.856276273727417)","('GHG_Emissions', 0.01427797507494688)","('Selling_Practices_And_Product_Labeling', 0.012603063136339188)","(['Supply Chain Management'], 0.856276273727417)","('NON-ESG', 0.01427797507494688)","('NON-ESG', 0.012603063136339188)"
Line 914,"In year two, we will focus on  self-assessment activities  with top-spend direct  material suppliers and  contract manufacturers.
","('Supply_Chain_Management', 0.9109045267105103)","('Product_Design_And_Lifecycle_Management', 0.016546979546546936)","('Labor_Practices', 0.006430680863559246)","(['Supply Chain Management'], 0.9109045267105103)","('NON-ESG', 0.016546979546546936)","('NON-ESG', 0.006430680863559246)"
Line 915,"We  will conduct onsite audits with  those suppliers considered  to be at the highest risk of  noncompliance.
","('Business_Ethics', 0.2987925410270691)","('Supply_Chain_Management', 0.16164293885231018)","('Management_Of_Legal_And_Regulatory_Framework', 0.16065369546413422)","('NON-ESG', 0.2987925410270691)","('NON-ESG', 0.16164293885231018)","('NON-ESG', 0.16065369546413422)"
Line 916,"In year three, we plan to  extend the coverage of the  program to more suppliers.
","('Supply_Chain_Management', 0.6917329430580139)","('Management_Of_Legal_And_Regulatory_Framework', 0.04208504036068916)","('Energy_Management', 0.03447727859020233)","(['Supply Chain Management'], 0.6917329430580139)","('NON-ESG', 0.04208504036068916)","('NON-ESG', 0.03447727859020233)"
Line 917,"We launched our new  monitoring process by  sending self-assessment  questionnaires to suppliers  deemed to have inherent or  Thirty-five percent published  sustainability reports  T en percent had  sustainability-related goals  published online  T wenty-nine percent had  information relating to  sustainability on their website In FY19, our Responsible  Supply Management  Program director was  named in the 2018 Assent  Compliance list of T op 100  CSR Influence Leaders.
","('Supply_Chain_Management', 0.9309965968132019)","('Product_Design_And_Lifecycle_Management', 0.00930082518607378)","('Business_Model_Resilience', 0.005864983424544334)","(['Supply Chain Management'], 0.9309965968132019)","('NON-ESG', 0.00930082518607378)","('NON-ESG', 0.005864983424544334)"
Line 918,"The list recognizes people  who use their influence  to help others establish  or improve corporate  social responsibility  programs, contributing to  improvements throughout  global supply chains.We have a clearly defined  process to address  noncompliance:  We issue compliance  improvement requests to  ensure that corrective action   is taken.
","('Supply_Chain_Management', 0.5432148575782776)","('Human_Rights_And_Community_Relations', 0.17115402221679688)","('Business_Model_Resilience', 0.0539483018219471)","(['Supply Chain Management'], 0.5432148575782776)","('NON-ESG', 0.17115402221679688)","('NON-ESG', 0.0539483018219471)"
Line 919,"We ask category managers to  incorporate these requests  into suppliers’ continuous  improvement plans.
","('Supply_Chain_Management', 0.8790350556373596)","('Energy_Management', 0.011926583014428616)","('Product_Design_And_Lifecycle_Management', 0.009348796680569649)","(['Supply Chain Management'], 0.8790350556373596)","('NON-ESG', 0.011926583014428616)","('NON-ESG', 0.009348796680569649)"
Line 920,"If issues persist, ultimately  a review of the business  relationship will occur .
","('Systemic_Risk_Management', 0.5220396518707275)","('Business_Model_Resilience', 0.2208067774772644)","('Business_Ethics', 0.038752056658267975)","(['Risk & Crisis Management'], 0.5220396518707275)","('NON-ESG', 0.2208067774772644)","('NON-ESG', 0.038752056658267975)"
Line 921,"In FY19, we trained 55 category  managers on this process.
","('Competitive_Behavior', 0.2050534337759018)","('Business_Model_Resilience', 0.18188686668872833)","('Employee_Engagement_Inclusion_And_Diversity', 0.17900513112545013)","('NON-ESG', 0.2050534337759018)","('NON-ESG', 0.18188686668872833)","('NON-ESG', 0.17900513112545013)"
Line 922,"We encourage our suppliers   to report publicly on their   social and environmental goals  and performance.
","('Supply_Chain_Management', 0.7125391960144043)","('Human_Rights_And_Community_Relations', 0.07456520944833755)","('GHG_Emissions', 0.027650179341435432)","(['Supply Chain Management'], 0.7125391960144043)","('NON-ESG', 0.07456520944833755)","('NON-ESG', 0.027650179341435432)"
Line 923,"Of the   202 suppliers assessed in  our FY19 review of supplier  sustainability reporting:16   16  Our 202 top suppliers by spend.92 Require suppliers to comply  with the law and uphold  responsible sourcing practices  Reference conflict   minerals requirements   in supplier agreements   and purchase orders  Follow the Organisation for  Economic Co-operation  and Development (OECD)  guidance on conflict minerals  — including surveying  suppliers to collect data   on the smelters in their   supply chains We report the results of our  supplier survey to the U.S.  Securities and Exchange  Commission annually.
","('Supply_Chain_Management', 0.947216272354126)","('Labor_Practices', 0.005792834796011448)","('Water_And_Wastewater_Management', 0.0035197697579860687)","(['Supply Chain Management'], 0.947216272354126)","('NON-ESG', 0.005792834796011448)","('NON-ESG', 0.0035197697579860687)"
Line 924,"Of the   202 suppliers assessed in  our FY19 review of supplier  sustainability reporting:16   16  Our 202 top suppliers by spend.92 Require suppliers to comply  with the law and uphold  responsible sourcing practices  Reference conflict   minerals requirements   in supplier agreements   and purchase orders  Follow the Organisation for  Economic Co-operation  and Development (OECD)  guidance on conflict minerals  — including surveying  suppliers to collect data   on the smelters in their   supply chains We report the results of our  supplier survey to the U.S.  Securities and Exchange  Commission annually.
","('Supply_Chain_Management', 0.8541484475135803)","('Product_Design_And_Lifecycle_Management', 0.02086208574473858)","('Labor_Practices', 0.01954321563243866)","(['Supply Chain Management'], 0.8541484475135803)","('NON-ESG', 0.02086208574473858)","('NON-ESG', 0.01954321563243866)"
Line 925,"Our FY19  results show a steady decrease in  the number of “red flag” smelters  in our supply chain across the last  three years.
","('Supply_Chain_Management', 0.9291890263557434)","('Labor_Practices', 0.007729161065071821)","('Waste_And_Hazardous_Materials_Management', 0.006331148557364941)","(['Supply Chain Management'], 0.9291890263557434)","('NON-ESG', 0.007729161065071821)","('NON-ESG', 0.006331148557364941)"
Line 926,"We will continue to  assess and work with suppliers to  further reduce the risk of conflict  minerals in our supply chain.
","('Supply_Chain_Management', 0.9394259452819824)","('Waste_And_Hazardous_Materials_Management', 0.005402242299169302)","('Labor_Practices', 0.0052870833314955235)","(['Supply Chain Management'], 0.9394259452819824)","('NON-ESG', 0.005402242299169302)","('NON-ESG', 0.0052870833314955235)"
Line 927,"Read  our full FY19 Conflict Minerals  Report and our Conflict  Minerals Policy.Materials of concern and  conflict minerals Materials of concern include  those that have the potential —  if not managed correctly —   to negatively impact people or  the environment.
","('Supply_Chain_Management', 0.46073177456855774)","('Waste_And_Hazardous_Materials_Management', 0.07734797149896622)","('Human_Rights_And_Community_Relations', 0.06858234852552414)","('NON-ESG', 0.46073177456855774)","('NON-ESG', 0.07734797149896622)","('NON-ESG', 0.06858234852552414)"
Line 928,"We require   our suppliers to responsibly  manage and disclose any  such materials used in our  manufacturing processes,   final products, or packaging.
","('Product_Design_And_Lifecycle_Management', 0.9427039623260498)","('Supply_Chain_Management', 0.007962754927575588)","('Selling_Practices_And_Product_Labeling', 0.007863923907279968)","(['Product Stewardship'], 0.9427039623260498)","('NON-ESG', 0.007962754927575588)","('NON-ESG', 0.007863923907279968)"
Line 929,"Read more about our approach  to product stewardship.
","('Product_Design_And_Lifecycle_Management', 0.9457753300666809)","('Product_Quality_And_Safety', 0.008018981665372849)","('Customer_Welfare', 0.006178193259984255)","(['Product Stewardship'], 0.9457753300666809)","('NON-ESG', 0.008018981665372849)","('NON-ESG', 0.006178193259984255)"
Line 930,"Some of our products contain  tin, tungsten, tantalum, or gold.
","('Product_Design_And_Lifecycle_Management', 0.6145749092102051)","('Waste_And_Hazardous_Materials_Management', 0.06184288114309311)","('Supply_Chain_Management', 0.054433275014162064)","(['Product Stewardship'], 0.6145749092102051)","('NON-ESG', 0.06184288114309311)","('NON-ESG', 0.054433275014162064)"
Line 931,"In the Democratic Republic  of Congo and neighboring  countries, the mining and  processing of these metals   have been linked to the funding  of armed conflict.
","('Critical_Incident_Risk_Management', 0.18279485404491425)","('Supply_Chain_Management', 0.16298626363277435)","('Human_Rights_And_Community_Relations', 0.15527905523777008)","('NON-ESG', 0.18279485404491425)","('NON-ESG', 0.16298626363277435)","('NON-ESG', 0.15527905523777008)"
Line 932,"T o prevent the  use of conflict minerals in our  products, we continue to:  Support the U.S. Dodd- Frank Act, which requires  companies to disclose   the use of any such   conflict mineralsMedtronic is a member of the  Responsible Minerals Initiative.
","('Supply_Chain_Management', 0.18587243556976318)","('Product_Design_And_Lifecycle_Management', 0.16077107191085815)","('Selling_Practices_And_Product_Labeling', 0.08546935766935349)","('NON-ESG', 0.18587243556976318)","('NON-ESG', 0.16077107191085815)","('NON-ESG', 0.08546935766935349)"
Line 933,"SUPPLIER QUALITY  MANAGEMENT Our ability to improve lives  depends upon the quality of  our products.
","('Product_Design_And_Lifecycle_Management', 0.9486088752746582)","('Product_Quality_And_Safety', 0.009479070082306862)","('Supply_Chain_Management', 0.006318168714642525)","(['Product Stewardship'], 0.9486088752746582)","('NON-ESG', 0.009479070082306862)","('NON-ESG', 0.006318168714642525)"
Line 934,"We share this  responsibility for quality with  our suppliers, communicating  our expectations through our  Supplier Quality Excellence  Manual.
","('Supply_Chain_Management', 0.749263346195221)","('Product_Design_And_Lifecycle_Management', 0.06888459622859955)","('Product_Quality_And_Safety', 0.027918297797441483)","(['Supply Chain Management'], 0.749263346195221)","('NON-ESG', 0.06888459622859955)","('NON-ESG', 0.027918297797441483)"
Line 935,"We support suppliers to meet  our standards through:  Regular quality audits based  on product and supplier risk  Continuous improvement  programs, facilitated onsite  at supplier manufacturing  locations  Collaboration with suppliers to  improve the design, reliability,  and manufacturability of  components and products  Support of supplier business  continuity management  planning initiatives — building their capability to proactively  identify and mitigate global  operational risks  In FY19, we updated our existing  supplier quality protocols, tools,  and training materials to make  them easier to use and more  accessible.
","('Supply_Chain_Management', 0.8486232161521912)","('Product_Design_And_Lifecycle_Management', 0.05067121237516403)","('Product_Quality_And_Safety', 0.014513703994452953)","(['Supply Chain Management'], 0.8486232161521912)","('NON-ESG', 0.05067121237516403)","('NON-ESG', 0.014513703994452953)"
Line 936,"We support suppliers to meet  our standards through:  Regular quality audits based  on product and supplier risk  Continuous improvement  programs, facilitated onsite  at supplier manufacturing  locations  Collaboration with suppliers to  improve the design, reliability,  and manufacturability of  components and products  Support of supplier business  continuity management  planning initiatives — building their capability to proactively  identify and mitigate global  operational risks  In FY19, we updated our existing  supplier quality protocols, tools,  and training materials to make  them easier to use and more  accessible.
","('Supply_Chain_Management', 0.8938801884651184)","('Product_Design_And_Lifecycle_Management', 0.02999875508248806)","('Waste_And_Hazardous_Materials_Management', 0.007012031506747007)","(['Supply Chain Management'], 0.8938801884651184)","('NON-ESG', 0.02999875508248806)","('NON-ESG', 0.007012031506747007)"
Line 937,"We also included  new guidance on regulatory  requirements, such as the  recent E.U. Medical Device  Regulation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9735368490219116)","('Energy_Management', 0.0020082539413124323)","('Director_Removal', 0.0019206446595489979)","(['Corporate Governance'], 0.9735368490219116)","('NON-ESG', 0.0020082539413124323)","('NON-ESG', 0.0019206446595489979)"
Line 938,"Currently, four Medtronic  supplier sites participate  in the U.S. Food and Drug  Administration (FDA) Case for  Quality program.
","('Supply_Chain_Management', 0.8321537971496582)","('Customer_Welfare', 0.029574401676654816)","('Product_Design_And_Lifecycle_Management', 0.019859611988067627)","(['Supply Chain Management'], 0.8321537971496582)","('NON-ESG', 0.029574401676654816)","('NON-ESG', 0.019859611988067627)"
Line 939,"Additionally,  Medtronic subscribes to  MedAccred — an industry- managed supply chain  oversight program.
","('Supply_Chain_Management', 0.9518706798553467)","('Labor_Practices', 0.004846685100346804)","('Physical_Impacts_Of_Climate_Change', 0.003634615335613489)","(['Supply Chain Management'], 0.9518706798553467)","('NON-ESG', 0.004846685100346804)","('NON-ESG', 0.003634615335613489)"
Line 940,"This  third-party accreditation  focuses on improving process  repeatability while reducing  nonconformances.
","('Product_Design_And_Lifecycle_Management', 0.33678627014160156)","('Supply_Chain_Management', 0.09821881353855133)","('Competitive_Behavior', 0.09146848320960999)","('NON-ESG', 0.33678627014160156)","('NON-ESG', 0.09821881353855133)","('NON-ESG', 0.09146848320960999)"
Line 941,"We have  shared details of the program  with suppliers and encourage  them to pursue accreditation.
","('Supply_Chain_Management', 0.6643736958503723)","('Management_Of_Legal_And_Regulatory_Framework', 0.06738228350877762)","('Product_Design_And_Lifecycle_Management', 0.026399943977594376)","(['Supply Chain Management'], 0.6643736958503723)","('NON-ESG', 0.06738228350877762)","('NON-ESG', 0.026399943977594376)"
Line 942,"93As we continue to deliver innovative new treatments and therapies,  our commitment to quality must remain constant.
","('Access_And_Affordability', 0.2519567608833313)","('Customer_Welfare', 0.1643587052822113)","('Product_Quality_And_Safety', 0.10412105172872543)","('NON-ESG', 0.2519567608833313)","('NON-ESG', 0.1643587052822113)","('NON-ESG', 0.10412105172872543)"
Line 943,"Our customers,  patients, partners, and investors trust us to deliver products that are  safe, effective, and reliable.
","('Product_Design_And_Lifecycle_Management', 0.3761141002178192)","('Product_Quality_And_Safety', 0.20667128264904022)","('Customer_Welfare', 0.11387205123901367)","('NON-ESG', 0.3761141002178192)","('NON-ESG', 0.20667128264904022)","('NON-ESG', 0.11387205123901367)"
Line 944,"Our global quality strategy guides us to  take a rigorous approach to safety and reliability at each stage of the  product life cycle.ENSURING QUALITY ACROSS   OUR VALUE CHAIN We monitor quality at each stage in our value chain — design,  manufacturing, pre-clinical and clinical trials, and post-market  surveillance.
","('Product_Quality_And_Safety', 0.8421044945716858)","('Product_Design_And_Lifecycle_Management', 0.049234725534915924)","('Customer_Welfare', 0.013471859507262707)","(['Product Quality & Recall Management'], 0.8421044945716858)","('NON-ESG', 0.049234725534915924)","('NON-ESG', 0.013471859507262707)"
Line 945,"Through our “Quality Begins with Me” culture, all  Medtronic employees share this responsibility.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3306049406528473)","('Employee_Health_And_Safety', 0.21892406046390533)","('Human_Rights_And_Community_Relations', 0.07446330785751343)","('NON-ESG', 0.3306049406528473)","('NON-ESG', 0.21892406046390533)","('NON-ESG', 0.07446330785751343)"
Line 946,"We share four fundamental expectations through ongoing  communications and training, so that every Medtronic employee  knows quality is nonnegotiable:  Put the patient first  Be courageous  Strive to prevent issues before they arise  Hold each other accountable In FY19, we developed a “Quality Begins With Me 2.0” assessment  model that we will pilot at three sites in FY20.
","('Business_Ethics', 0.24088327586650848)","('Product_Quality_And_Safety', 0.20218412578105927)","('Employee_Health_And_Safety', 0.08837467432022095)","('NON-ESG', 0.24088327586650848)","('NON-ESG', 0.20218412578105927)","('NON-ESG', 0.08837467432022095)"
Line 947,"Compared to the  previous version, this model helps us delve deeper into the data  to understand the underlying causes of scores and evaluate  improvement year-over-year .
","('Systemic_Risk_Management', 0.2648221552371979)","('Competitive_Behavior', 0.19906367361545563)","('Management_Of_Legal_And_Regulatory_Framework', 0.08766424655914307)","('NON-ESG', 0.2648221552371979)","('NON-ESG', 0.19906367361545563)","('NON-ESG', 0.08766424655914307)"
Line 948,"It also adds the flexibility to tailor  assessments to the specific needs and challenges of the site or  functions being assessed.
","('Business_Model_Resilience', 0.29188022017478943)","('Product_Design_And_Lifecycle_Management', 0.1277766227722168)","('Access_And_Affordability', 0.06018147990107536)","('NON-ESG', 0.29188022017478943)","('NON-ESG', 0.1277766227722168)","('NON-ESG', 0.06018147990107536)"
Line 949,"PRODUCT QUALITY Adding   Business Value   The lifesaving and health-improving aspects of our products  mean that quality is critical to our patient and physician  customers, reputation, and ongoing business success.
","('Product_Design_And_Lifecycle_Management', 0.937289834022522)","('Product_Quality_And_Safety', 0.014444250613451004)","('Selling_Practices_And_Product_Labeling', 0.00797751173377037)","(['Product Stewardship'], 0.937289834022522)","('NON-ESG', 0.014444250613451004)","('NON-ESG', 0.00797751173377037)"
Line 950,"We  uphold our high-quality standards with comprehensive quality  management systems, a through approach to research and  clinical trials, and rigorous post-market surveillance.ACROSS FOUR GLOBAL  BUSINESS UNITS50IN FY19,WE CONDUCTED QUALITY  CUL TURE  ASSESSMENTS AND HOSTED ACROSS MEDTRONIC156QUALITY  DAY EVENTS94Also, in FY19:  We conducted 50 quality culture assessments across four global  business units and established a baseline Quality Culture Index.
","('Business_Ethics', 0.34798890352249146)","('Product_Quality_And_Safety', 0.24878932535648346)","('Systemic_Risk_Management', 0.06275461614131927)","('NON-ESG', 0.34798890352249146)","('NON-ESG', 0.24878932535648346)","('NON-ESG', 0.06275461614131927)"
Line 951,"The Medtronic Quality Culture Playbook was adopted by  AdvaMed as a guidance document for the medical device  industry to promote quality culture.
","('Product_Quality_And_Safety', 0.2957558333873749)","('Supply_Chain_Management', 0.13408882915973663)","('Systemic_Risk_Management', 0.09080837666988373)","('NON-ESG', 0.2957558333873749)","('NON-ESG', 0.13408882915973663)","('NON-ESG', 0.09080837666988373)"
Line 952,"We hosted 156 Quality Day events across Medtronic.
","('Product_Design_And_Lifecycle_Management', 0.13573116064071655)","('Business_Model_Resilience', 0.10733584314584732)","('Management_Of_Legal_And_Regulatory_Framework', 0.08527911454439163)","('NON-ESG', 0.13573116064071655)","('NON-ESG', 0.10733584314584732)","('NON-ESG', 0.08527911454439163)"
Line 953,"Our quality management systems are aligned to ISO 13485.
","('Product_Quality_And_Safety', 0.4453519284725189)","('Business_Ethics', 0.12192348390817642)","('Management_Of_Legal_And_Regulatory_Framework', 0.08997882902622223)","('NON-ESG', 0.4453519284725189)","('NON-ESG', 0.12192348390817642)","('NON-ESG', 0.08997882902622223)"
Line 954,"Putting safety first  Safety is our first and foremost priority, and we will never put  innovation or profits over the well-being of the people who  use our products.
","('Product_Quality_And_Safety', 0.7381733059883118)","('Employee_Health_And_Safety', 0.12068487703800201)","('Product_Design_And_Lifecycle_Management', 0.024561680853366852)","(['Product Quality & Recall Management'], 0.7381733059883118)","('NON-ESG', 0.12068487703800201)","('NON-ESG', 0.024561680853366852)"
Line 955,"We want to bring new, potentially lifesaving  therapies to patients as soon as possible, but we will not offer   a device or therapy to patients until we have confirmed safety   and efficacy.17  In the context of the medical condition at issue and on the basis of the product meeting   all appropriate regulatory requirements applicable in that market.
","('Product_Quality_And_Safety', 0.7950429320335388)","('Selling_Practices_And_Product_Labeling', 0.05554540455341339)","('Customer_Welfare', 0.026740949600934982)","(['Product Quality & Recall Management'], 0.7950429320335388)","('NON-ESG', 0.05554540455341339)","('NON-ESG', 0.026740949600934982)"
Line 956,"Participate in knowledge-sharing events to extend best practices  across the company — including the Medtronic Predictive  Engineering Summit in FY T rain executive leaders responsible for product portfolio decisions  on DRM  Inform leaders of DRM applications specific to their business or  functional areas  Require all new product development projects to set DRM targets  and execute the best practices defined by DRM Manufacturing quality  We embed quality in our manufacturing processes using a set of  standardized approaches: Medtronic Operating System (MOS), First- Time Quality (FTQ) methodology, and Supplier Optimization and Risk  Reduction (SOAR) strategies.
","('Product_Design_And_Lifecycle_Management', 0.8740347623825073)","('Product_Quality_And_Safety', 0.040776174515485764)","('Customer_Welfare', 0.012651867233216763)","(['Product Stewardship'], 0.8740347623825073)","('NON-ESG', 0.040776174515485764)","('NON-ESG', 0.012651867233216763)"
Line 957,"Participate in knowledge-sharing events to extend best practices  across the company — including the Medtronic Predictive  Engineering Summit in FY T rain executive leaders responsible for product portfolio decisions  on DRM  Inform leaders of DRM applications specific to their business or  functional areas  Require all new product development projects to set DRM targets  and execute the best practices defined by DRM Manufacturing quality  We embed quality in our manufacturing processes using a set of  standardized approaches: Medtronic Operating System (MOS), First- Time Quality (FTQ) methodology, and Supplier Optimization and Risk  Reduction (SOAR) strategies.
","('Supply_Chain_Management', 0.9534057378768921)","('Systemic_Risk_Management', 0.00392467575147748)","('Product_Design_And_Lifecycle_Management', 0.0036822303663939238)","(['Supply Chain Management'], 0.9534057378768921)","('NON-ESG', 0.00392467575147748)","('NON-ESG', 0.0036822303663939238)"
Line 958,"Manufacturing Quality Systems Description Medtronic Operating  System (MOS)MOS improves manufacturing and supplier quality  by building continuous improvement principles into  production through Lean Six Sigma.
","('Supply_Chain_Management', 0.846502959728241)","('Product_Design_And_Lifecycle_Management', 0.042463600635528564)","('Business_Model_Resilience', 0.010417223908007145)","(['Supply Chain Management'], 0.846502959728241)","('NON-ESG', 0.042463600635528564)","('NON-ESG', 0.010417223908007145)"
Line 959,"We develop our  leaders to apply MOS within their teams.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2953275442123413)","('Business_Model_Resilience', 0.20338013768196106)","('Human_Rights_And_Community_Relations', 0.0635133758187294)","('NON-ESG', 0.2953275442123413)","('NON-ESG', 0.20338013768196106)","('NON-ESG', 0.0635133758187294)"
Line 960,"First- Time Quality  (FTQ) methodologyA part of MOS, FTQ teaches employees to see the  potential for error , develop strong controls, and identify  where improvements can have the biggest impact.
","('Systemic_Risk_Management', 0.3812352418899536)","('Business_Ethics', 0.22630855441093445)","('Competitive_Behavior', 0.05026882886886597)","('NON-ESG', 0.3812352418899536)","('NON-ESG', 0.22630855441093445)","('NON-ESG', 0.05026882886886597)"
Line 961,"Supplier Optimization  and Risk Reduction  (SOAR)Through the SOAR program, we partner with  strategic suppliers to ensure that risks are identified  and mitigated, and that products and processes are  designed correctly.
","('Supply_Chain_Management', 0.8741340041160583)","('Product_Design_And_Lifecycle_Management', 0.04932546988129616)","('Business_Model_Resilience', 0.0067171393893659115)","(['Supply Chain Management'], 0.8741340041160583)","('NON-ESG', 0.04932546988129616)","('NON-ESG', 0.0067171393893659115)"
Line 962,"Read more about our approach to  supplier quality management.New product development  requires collaboration across  several Medtronic functions,  including Research and  Development, Operations,  Quality, and Marketing.
","('Product_Design_And_Lifecycle_Management', 0.9379569888114929)","('Product_Quality_And_Safety', 0.010794387198984623)","('Supply_Chain_Management', 0.010137535631656647)","(['Product Stewardship'], 0.9379569888114929)","('NON-ESG', 0.010794387198984623)","('NON-ESG', 0.010137535631656647)"
Line 963,"T o  embed DRM practices across  the company, we:  Conduct annual assessments  of our product development  locations and execute  improvement plans based on  the results  Provide Green Belt, Black  Belt, and Master Black Belt  training and certification to  increase the skills within the  organization to make those  improvements  Provide customized training  for project development  teams to enhance their  planning and execution of  DRM activitiesPRODUCT   DESIGN AND  DEVELOPMENT Design, reliability,  manufacturability The Medtronic Design,  Reliability, Manufacturability  (DRM) methodology is our set  of best practices for ensuring  product quality, safety, and  reliability throughout product  design and development.
","('Product_Design_And_Lifecycle_Management', 0.3527604341506958)","('Product_Quality_And_Safety', 0.2744717597961426)","('Access_And_Affordability', 0.053496960550546646)","('NON-ESG', 0.3527604341506958)","('NON-ESG', 0.2744717597961426)","('NON-ESG', 0.053496960550546646)"
Line 964,"T o  embed DRM practices across  the company, we:  Conduct annual assessments  of our product development  locations and execute  improvement plans based on  the results  Provide Green Belt, Black  Belt, and Master Black Belt  training and certification to  increase the skills within the  organization to make those  improvements  Provide customized training  for project development  teams to enhance their  planning and execution of  DRM activitiesPRODUCT   DESIGN AND  DEVELOPMENT Design, reliability,  manufacturability The Medtronic Design,  Reliability, Manufacturability  (DRM) methodology is our set  of best practices for ensuring  product quality, safety, and  reliability throughout product  design and development.
","('Product_Design_And_Lifecycle_Management', 0.5707769989967346)","('Product_Quality_And_Safety', 0.29616647958755493)","('Employee_Health_And_Safety', 0.018806545063853264)","(['Product Stewardship'], 0.5707769989967346)","('NON-ESG', 0.29616647958755493)","('NON-ESG', 0.018806545063853264)"
Line 965,"Our engineers use DRM to carry  out predictive engineering:  simulating product use,  predicting and measuring  performance, and identifying  areas for improvement.
","('Product_Design_And_Lifecycle_Management', 0.9527842402458191)","('Product_Quality_And_Safety', 0.007914829067885876)","('Selling_Practices_And_Product_Labeling', 0.005252358503639698)","(['Product Stewardship'], 0.9527842402458191)","('NON-ESG', 0.007914829067885876)","('NON-ESG', 0.005252358503639698)"
Line 966,"This  process yields higher-quality  designs and reduces time to  market — enabling patients  in need to access products  as safely and efficiently as  possible.
","('Product_Design_And_Lifecycle_Management', 0.9510555863380432)","('Product_Quality_And_Safety', 0.008624901063740253)","('Customer_Welfare', 0.006318199913948774)","(['Product Stewardship'], 0.9510555863380432)","('NON-ESG', 0.008624901063740253)","('NON-ESG', 0.006318199913948774)"
Line 967,"We continually improve  our predictive capabilities by  refining our design practices  and measuring predictive  engineering outcomes for every  new product.96 Sharing learnings from external inspections with all sites across the  enterprise to implement preventive process improvements  Facilitating improvements at 51 of our facilities through compliance  assessments and audits  We value external review and assessment of our quality and  compliance by regulatory agencies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.37132376432418823)","('Product_Quality_And_Safety', 0.24414968490600586)","('Business_Ethics', 0.21091225743293762)","('NON-ESG', 0.37132376432418823)","('NON-ESG', 0.24414968490600586)","('NON-ESG', 0.21091225743293762)"
Line 968,"These assessments confirm  regulatory priorities and highlight areas where we can strengthen  our approach.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9732624292373657)","('Director_Removal', 0.0019045204389840364)","('Ecological_Impacts', 0.0018936429405584931)","(['Corporate Governance'], 0.9732624292373657)","('NON-ESG', 0.0019045204389840364)","('NON-ESG', 0.0018936429405584931)"
Line 969,"We implement changes to policies, procedures, and  processes when needed, sharing our learnings across our facilities  through our Inspection Knowledge Management process.
","('Management_Of_Legal_And_Regulatory_Framework', 0.861379861831665)","('Human_Rights_And_Community_Relations', 0.027890732511878014)","('Business_Ethics', 0.012973204255104065)","(['Corporate Governance'], 0.861379861831665)","('NON-ESG', 0.027890732511878014)","('NON-ESG', 0.012973204255104065)"
Line 970,"Our goal is to maintain an average of 0.5 or fewer findings per external  regulatory inspection and 1.0 or fewer findings per U.S. Food and Drug  Administration (FDA) inspection.
","('Management_Of_Legal_And_Regulatory_Framework', 0.864876925945282)","('Business_Ethics', 0.03380020707845688)","('Product_Quality_And_Safety', 0.01817031018435955)","(['Corporate Governance'], 0.864876925945282)","('NON-ESG', 0.03380020707845688)","('NON-ESG', 0.01817031018435955)"
Line 971,"We met both goals this year , with an  average of 0.17 findings per regulatory inspection and 0.23 findings  per FDA inspection (a 44% improvement from FY18).
","('Management_Of_Legal_And_Regulatory_Framework', 0.8644022345542908)","('Business_Ethics', 0.042067669332027435)","('Product_Quality_And_Safety', 0.015493798069655895)","(['Corporate Governance'], 0.8644022345542908)","('NON-ESG', 0.042067669332027435)","('NON-ESG', 0.015493798069655895)"
Line 972,"Maintaining Quality Facilities FY17 FY18 FYExternal Regulatory Inspections at  Medtronic Sites Globally284 253 External Regulatory Inspections  Globally That Resulted in No  Findings93% 93% 94% Average Findings per External  Regulatory Inspection0.18 0.19 0.Average Findings per FDA  Inspection0.73 0.41 0.MCARE Assessments and  Supported Improvements40 45 51When applied to high-risk processes, our FTQ methodology achieves   a 30% to 80% reduction in nonconformances, including those related  to product specifications.
","('Business_Ethics', 0.29474425315856934)","('Management_Of_Legal_And_Regulatory_Framework', 0.27568909525871277)","('Product_Quality_And_Safety', 0.24256952106952667)","('NON-ESG', 0.29474425315856934)","('NON-ESG', 0.27568909525871277)","('NON-ESG', 0.24256952106952667)"
Line 973,"Maintaining Quality Facilities FY17 FY18 FYExternal Regulatory Inspections at  Medtronic Sites Globally284 253 External Regulatory Inspections  Globally That Resulted in No  Findings93% 93% 94% Average Findings per External  Regulatory Inspection0.18 0.19 0.Average Findings per FDA  Inspection0.73 0.41 0.MCARE Assessments and  Supported Improvements40 45 51When applied to high-risk processes, our FTQ methodology achieves   a 30% to 80% reduction in nonconformances, including those related  to product specifications.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4533320665359497)","('Business_Ethics', 0.07052871584892273)","('Ecological_Impacts', 0.045888952910900116)","('NON-ESG', 0.4533320665359497)","('NON-ESG', 0.07052871584892273)","('NON-ESG', 0.045888952910900116)"
Line 974,"The methodology can help individual  manufacturing sites achieve between $200,000 and $300,000 in   cost savings.18   In FY19, we extended deployment of FTQ to 100% of our  manufacturing sites and launched our enterprise-wide scorecard   to formally track program benefits.
","('Energy_Management', 0.3867262005805969)","('Product_Design_And_Lifecycle_Management', 0.22369155287742615)","('Supply_Chain_Management', 0.11476371437311172)","('NON-ESG', 0.3867262005805969)","('NON-ESG', 0.22369155287742615)","('NON-ESG', 0.11476371437311172)"
Line 975,"We also launched an FTQ   center of excellence in Puerto Rico to support consistent utilization   of the methodology by DRM practitioners.
","('Access_And_Affordability', 0.36363112926483154)","('Management_Of_Legal_And_Regulatory_Framework', 0.18319761753082275)","('Employee_Engagement_Inclusion_And_Diversity', 0.0593712143599987)","('NON-ESG', 0.36363112926483154)","('NON-ESG', 0.18319761753082275)","('NON-ESG', 0.0593712143599987)"
Line 976,"QUALITY AND COMPLIANCE   A T OUR F ACILITIES The Medtronic Corporatewide Assessment for Regulatory Excellence  (MCARE) is our global compliance oversight program for assessing  quality management systems at our facilities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.652759313583374)","('Business_Ethics', 0.2361914962530136)","('Product_Quality_And_Safety', 0.014872243627905846)","(['Corporate Governance'], 0.652759313583374)","('NON-ESG', 0.2361914962530136)","('NON-ESG', 0.014872243627905846)"
Line 977,"Its focus is threefold:  maintain a consistently high level of quality, comply with regulations,  and prepare for new regulatory requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.965755820274353)","('Competitive_Behavior', 0.002537438878789544)","('Product_Quality_And_Safety', 0.0024909102357923985)","(['Corporate Governance'], 0.965755820274353)","('NON-ESG', 0.002537438878789544)","('NON-ESG', 0.0024909102357923985)"
Line 978,"Through MCARE,   we engage with site leadership at manufacturing, design, and  distribution centers.
","('Product_Design_And_Lifecycle_Management', 0.6424846053123474)","('Supply_Chain_Management', 0.11530633270740509)","('Customer_Welfare', 0.04820125922560692)","(['Product Stewardship'], 0.6424846053123474)","('NON-ESG', 0.11530633270740509)","('NON-ESG', 0.04820125922560692)"
Line 979,"In FY19, the Corporate Quality MCARE team continued its oversight  of quality system compliance, including:   Participating in steering committees and oversight of warning   letter resolution activities   Reviewing remediation actions to ensure robust work   and documentation 18  Based on case studies where sites have executed FTQ methodology at a given work step or work  steps.
","('Business_Ethics', 0.7453817129135132)","('Management_Of_Legal_And_Regulatory_Framework', 0.12332486361265182)","('Product_Quality_And_Safety', 0.026585325598716736)","(['Business Ethics'], 0.7453817129135132)","('NON-ESG', 0.12332486361265182)","('NON-ESG', 0.026585325598716736)"
Line 980,"This figure increases when FTQ is used more often.Approval from the Institutional  Animal Care and Use  Committee is required before  we carry out any such activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3391413390636444)","('Access_And_Affordability', 0.23073482513427734)","('Ecological_Impacts', 0.07431825995445251)","('NON-ESG', 0.3391413390636444)","('NON-ESG', 0.23073482513427734)","('NON-ESG', 0.07431825995445251)"
Line 981,"We comply with all relevant  standards and requirements   for animal-related research   and testing.
","('Product_Quality_And_Safety', 0.4924774169921875)","('Management_Of_Legal_And_Regulatory_Framework', 0.2145213782787323)","('Business_Ethics', 0.06481953710317612)","('NON-ESG', 0.4924774169921875)","('NON-ESG', 0.2145213782787323)","('NON-ESG', 0.06481953710317612)"
Line 982,"This includes those  set by the Association for  Assessment and Accreditation  of Laboratory Animal Care,   the FDA, and the U.S.  Department of Agriculture’s  Animal Welfare Act.
","('Product_Quality_And_Safety', 0.16604463756084442)","('Access_And_Affordability', 0.11355473846197128)","('Ecological_Impacts', 0.10160215198993683)","('NON-ESG', 0.16604463756084442)","('NON-ESG', 0.11355473846197128)","('NON-ESG', 0.10160215198993683)"
Line 983,"We are committed to treating  all animals used in the research  process respectfully and  humanely, by taking every  feasible measure to safeguard  their welfare.
","('Ecological_Impacts', 0.3266027271747589)","('Waste_And_Hazardous_Materials_Management', 0.10549009591341019)","('Selling_Practices_And_Product_Labeling', 0.06341675668954849)","('NON-ESG', 0.3266027271747589)","('NON-ESG', 0.10549009591341019)","('NON-ESG', 0.06341675668954849)"
Line 984,"We work with  scientists, veterinary surgeons,  and other experts to refine trials  to minimize distress or harm.
","('Product_Quality_And_Safety', 0.1546400934457779)","('Business_Ethics', 0.14806827902793884)","('Employee_Health_And_Safety', 0.1110459715127945)","('NON-ESG', 0.1546400934457779)","('NON-ESG', 0.14806827902793884)","('NON-ESG', 0.1110459715127945)"
Line 985,"Seeking alternatives The International Organization  for Standardization (ISO) is  developing a standard on testing  of human skin cell–based PRE-CLINICAL  RESEARCH Pre-clinical research gives  us vital insight into how our  products will function in practice.
","('Product_Design_And_Lifecycle_Management', 0.4584631621837616)","('Customer_Welfare', 0.1876334398984909)","('Product_Quality_And_Safety', 0.1453193724155426)","('NON-ESG', 0.4584631621837616)","('NON-ESG', 0.1876334398984909)","('NON-ESG', 0.1453193724155426)"
Line 986,"The pre-clinical stage can  include animal-related research,  as well as non-animal human  cadaver and modeling work.
","('Access_And_Affordability', 0.2364455610513687)","('Customer_Welfare', 0.12031523138284683)","('GHG_Emissions', 0.08215002715587616)","('NON-ESG', 0.2364455610513687)","('NON-ESG', 0.12031523138284683)","('NON-ESG', 0.08215002715587616)"
Line 987,"Animal-related research Regulatory requirements for  medical products sometimes  necessitate animal research  and testing.
","('Selling_Practices_And_Product_Labeling', 0.260903000831604)","('Customer_Welfare', 0.1612764447927475)","('Product_Quality_And_Safety', 0.11800704151391983)","('NON-ESG', 0.260903000831604)","('NON-ESG', 0.1612764447927475)","('NON-ESG', 0.11800704151391983)"
Line 988,"We use animals in  research activities only when no  acceptable alternatives exist,   as described in our Policy  Regarding the Use of Animals.
","('Customer_Welfare', 0.16905097663402557)","('Selling_Practices_And_Product_Labeling', 0.15371975302696228)","('Ecological_Impacts', 0.13763871788978577)","('NON-ESG', 0.16905097663402557)","('NON-ESG', 0.15371975302696228)","('NON-ESG', 0.13763871788978577)"
Line 989,"This policy applies to:  Research that contributes  significantly to patient welfare   Work specifically mandated  by regulatory agencies to  ensure patient safety   or efficacyirritation.
","('Product_Quality_And_Safety', 0.6893941164016724)","('Employee_Health_And_Safety', 0.11119751632213593)","('Access_And_Affordability', 0.03194870427250862)","(['Product Quality & Recall Management'], 0.6893941164016724)","('NON-ESG', 0.11119751632213593)","('NON-ESG', 0.03194870427250862)"
Line 990,"T o inform this work,  we submit research findings on  alternatives to animal testing for  skin irritation.
","('Employee_Health_And_Safety', 0.7698895931243896)","('Product_Quality_And_Safety', 0.05580293387174606)","('Employee_Engagement_Inclusion_And_Diversity', 0.023413244634866714)","(['Operational Eco-Efficiency'], 0.7698895931243896)","('NON-ESG', 0.05580293387174606)","('NON-ESG', 0.023413244634866714)"
Line 991,"We continue to  invest in our corporate research  group’s fundamental modeling  work, with the goal of reducing  the number of animals used in  future research.
","('GHG_Emissions', 0.20761319994926453)","('Ecological_Impacts', 0.13818250596523285)","('Customer_Welfare', 0.12208933383226395)","('NON-ESG', 0.20761319994926453)","('NON-ESG', 0.13818250596523285)","('NON-ESG', 0.12208933383226395)"
Line 992,"CLINICAL TRIALS Clinical trials are a key  component in establishing the  effectiveness and safety of our  products, and a critical part  of quality control.
","('Product_Quality_And_Safety', 0.8840399384498596)","('Selling_Practices_And_Product_Labeling', 0.019847439602017403)","('Product_Design_And_Lifecycle_Management', 0.01654953695833683)","(['Product Quality & Recall Management'], 0.8840399384498596)","('NON-ESG', 0.019847439602017403)","('NON-ESG', 0.01654953695833683)"
Line 993,"More than  2,000 clinical employees work  to ensure that our clinical trials  are undertaken ethically and  effectively.
","('Competitive_Behavior', 0.35439324378967285)","('Business_Ethics', 0.2524413764476776)","('Management_Of_Legal_And_Regulatory_Framework', 0.08386398106813431)","('NON-ESG', 0.35439324378967285)","('NON-ESG', 0.2524413764476776)","('NON-ESG', 0.08386398106813431)"
Line 994,"We are committed to following  our Code of Conduct and  Global Business Conduct  Standards Policy when  conducting clinical trials, and  to adhering to all relevant laws  and regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9075239896774292)","('Business_Ethics', 0.029542820528149605)","('Product_Quality_And_Safety', 0.010384575463831425)","(['Corporate Governance'], 0.9075239896774292)","('NON-ESG', 0.029542820528149605)","('NON-ESG', 0.010384575463831425)"
Line 995,"This ensures  that we take a consistent and rigorous approach to protecting  patient safety and safeguarding  patient data.
","('Employee_Health_And_Safety', 0.5994592308998108)","('Product_Quality_And_Safety', 0.24416276812553406)","('Access_And_Affordability', 0.015256236307322979)","(['Operational Eco-Efficiency'], 0.5994592308998108)","('NON-ESG', 0.24416276812553406)","('NON-ESG', 0.015256236307322979)"
Line 996,"It also helps to  deliver accurate findings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5090892910957336)","('Business_Ethics', 0.25286799669265747)","('Competitive_Behavior', 0.04690760001540184)","(['Corporate Governance'], 0.5090892910957336)","('NON-ESG', 0.25286799669265747)","('NON-ESG', 0.04690760001540184)"
Line 997,"We revise our internal guidelines  and procedures to meet new  and emerging regulatory  requirements, including recent  updates to take account of:  The General Data Protection  Regulation, effective   May  The E.U. Medical Device  Regulation, effective   May Medtronic is a member of  the working group shaping  the next revision of the ISO  14155:2011 standard for clinical  research.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9691048860549927)","('Competitive_Behavior', 0.0028936800081282854)","('Product_Quality_And_Safety', 0.0022323084995150566)","(['Corporate Governance'], 0.9691048860549927)","('NON-ESG', 0.0028936800081282854)","('NON-ESG', 0.0022323084995150566)"
Line 998,"We are preparing for  implementation of the revised  standard in time for its expected  launch in 2020.98PRODUCT USE AND  PERFORMANCE Post-market surveillance Once a product is launched, we  track its use and collect data  on patient outcomes to obtain  vital feedback for future product  designs and to measure and  improve patient safety.
","('Product_Quality_And_Safety', 0.7001295685768127)","('Product_Design_And_Lifecycle_Management', 0.1088646799325943)","('Selling_Practices_And_Product_Labeling', 0.055573731660842896)","(['Product Quality & Recall Management'], 0.7001295685768127)","('NON-ESG', 0.1088646799325943)","('NON-ESG', 0.055573731660842896)"
Line 999,"We:  Collect data through our  Post-Approval Clinical  Surveillance process, in  partnership with hospitals,  health systems, physicians,  clinics, governments, and  third parties  Fund in-depth, post-market  clinical studies to further  understand the efficacy  of specific therapies and  product lines  Collect and analyze customer  feedback and information  through our global complaint  handling systemCollaboration, engagement, and data sharing Sharing knowledge and data about clinical trials contributes to safety, quality, and efficiency — accelerating  medical discovery and enabling patients to benefit more quickly.
","('Selling_Practices_And_Product_Labeling', 0.3376542925834656)","('Customer_Welfare', 0.1915930062532425)","('Product_Quality_And_Safety', 0.08045139163732529)","('NON-ESG', 0.3376542925834656)","('NON-ESG', 0.1915930062532425)","('NON-ESG', 0.08045139163732529)"
Line 1000,"We:  Collect data through our  Post-Approval Clinical  Surveillance process, in  partnership with hospitals,  health systems, physicians,  clinics, governments, and  third parties  Fund in-depth, post-market  clinical studies to further  understand the efficacy  of specific therapies and  product lines  Collect and analyze customer  feedback and information  through our global complaint  handling systemCollaboration, engagement, and data sharing Sharing knowledge and data about clinical trials contributes to safety, quality, and efficiency — accelerating  medical discovery and enabling patients to benefit more quickly.
","('Product_Quality_And_Safety', 0.7604352235794067)","('Employee_Health_And_Safety', 0.09954172372817993)","('Product_Design_And_Lifecycle_Management', 0.0198519229888916)","(['Product Quality & Recall Management'], 0.7604352235794067)","('NON-ESG', 0.09954172372817993)","('NON-ESG', 0.0198519229888916)"
Line 1001,"The U.S. Clinical T rials Registry is a national database detailing the purpose, eligibility requirements,  locations, and status of more than 310,000 clinical trials.19 Medtronic and other companies operating in the  United States are required to disclose information to the database about applicable trials.
","('Competitive_Behavior', 0.21697528660297394)","('Management_Of_Legal_And_Regulatory_Framework', 0.12195919454097748)","('Access_And_Affordability', 0.11517086625099182)","('NON-ESG', 0.21697528660297394)","('NON-ESG', 0.12195919454097748)","('NON-ESG', 0.11517086625099182)"
Line 1002,"We also:  Collaborate with external researchers, institutions, and physicians to advance our clinical trials practice  Publish findings in peer-reviewed scientific and medical journals  Work with several organizations to advance the development of clinical standards — see table below Clinical Standard Development and Education Engagements Organization FYClinical T rials T ransformation  Initiative (CTTI)Medtronic is an active member of CTTI, in roles including expert meeting participants, project  team leaders, and executive committee members.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3952119052410126)","('Product_Quality_And_Safety', 0.11604728549718857)","('Access_And_Affordability', 0.10251957178115845)","('NON-ESG', 0.3952119052410126)","('NON-ESG', 0.11604728549718857)","('NON-ESG', 0.10251957178115845)"
Line 1003,"We also:  Collaborate with external researchers, institutions, and physicians to advance our clinical trials practice  Publish findings in peer-reviewed scientific and medical journals  Work with several organizations to advance the development of clinical standards — see table below Clinical Standard Development and Education Engagements Organization FYClinical T rials T ransformation  Initiative (CTTI)Medtronic is an active member of CTTI, in roles including expert meeting participants, project  team leaders, and executive committee members.
","('Director_Removal', 0.5731150507926941)","('Management_Of_Legal_And_Regulatory_Framework', 0.0631139725446701)","('Labor_Practices', 0.04127969220280647)","(['Anti-Crime Policy & Measures'], 0.5731150507926941)","('NON-ESG', 0.0631139725446701)","('NON-ESG', 0.04127969220280647)"
Line 1004,"Association for the  Advancement of Medical  Instrumentation (AAMI)Medtronic is involved in the AAMI’s domestic and international standards work.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5074475407600403)","('Product_Quality_And_Safety', 0.2094683051109314)","('Business_Ethics', 0.05534273386001587)","(['Corporate Governance'], 0.5074475407600403)","('NON-ESG', 0.2094683051109314)","('NON-ESG', 0.05534273386001587)"
Line 1005,"Our  employees participate in more than 100 AAMI committees and working groups and hold 11  leadership positions, including co-chair of the Standards Board.
","('Director_Removal', 0.5278677940368652)","('Employee_Engagement_Inclusion_And_Diversity', 0.09425454586744308)","('Management_Of_Legal_And_Regulatory_Framework', 0.07737308740615845)","(['Anti-Crime Policy & Measures'], 0.5278677940368652)","('NON-ESG', 0.09425454586744308)","('NON-ESG', 0.07737308740615845)"
Line 1006,"International Medical Device  Regulators Forum (IMDRF)Medtronic maintains an active presence in the IMDRF .
","('Management_Of_Legal_And_Regulatory_Framework', 0.34281712770462036)","('Competitive_Behavior', 0.2840491831302643)","('Product_Quality_And_Safety', 0.06258580088615417)","('NON-ESG', 0.34281712770462036)","('NON-ESG', 0.2840491831302643)","('NON-ESG', 0.06258580088615417)"
Line 1007,"Our subject matter experts attend  biannual IMDRF meetings and serve as industry representatives on IMDRF initiatives.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6793809533119202)","('Business_Model_Resilience', 0.03556715324521065)","('Supply_Chain_Management', 0.025497153401374817)","(['Corporate Governance'], 0.6793809533119202)","('NON-ESG', 0.03556715324521065)","('NON-ESG', 0.025497153401374817)"
Line 1008,"Medtronic has supported and participated in IMDRF pilot programs, including the Medical  Device Single Audit program.
","('Access_And_Affordability', 0.5132930278778076)","('Management_Of_Legal_And_Regulatory_Framework', 0.10699985921382904)","('Product_Quality_And_Safety', 0.06345521658658981)","(['Health Outcome Contribution'], 0.5132930278778076)","('NON-ESG', 0.10699985921382904)","('NON-ESG', 0.06345521658658981)"
Line 1009,"Medical Device Innovation  Consortium (MDIC)The chief medical and scientific officer of Medtronic serves on the board of directors of  MDIC, a public-private partnership that aims to advance regulatory science in the medical  device industry.
","('Competitive_Behavior', 0.1674453467130661)","('Customer_Welfare', 0.14480073750019073)","('Product_Design_And_Lifecycle_Management', 0.0975508838891983)","('NON-ESG', 0.1674453467130661)","('NON-ESG', 0.14480073750019073)","('NON-ESG', 0.0975508838891983)"
Line 1010,"Medtronic has been involved both with the MDIC Computational Modeling  and Simulation project and with multiple aspects of the National Evaluation System for  health T echnology (NEST).
","('Access_And_Affordability', 0.37793731689453125)","('Ecological_Impacts', 0.06486883014440536)","('Systemic_Risk_Management', 0.059290509670972824)","('NON-ESG', 0.37793731689453125)","('NON-ESG', 0.06486883014440536)","('NON-ESG', 0.059290509670972824)"
Line 1011,"19 Correct as of 15 August 2019.99FDA Actions and Recalls FY17 FY18 FYFDA Class I Recalls 5 3 Open FDA Warning Letters for  Product-Related Regulatory  Actions2 1 3* Open FDA Warning Letters  Resolved During the Y ear1 1 *  One additional warning letter was received for HeartWare, prior to the Medtronic acquisition of  HeartWare International.
","('Product_Quality_And_Safety', 0.3119983375072479)","('Management_Of_Legal_And_Regulatory_Framework', 0.20473165810108185)","('Selling_Practices_And_Product_Labeling', 0.1151699423789978)","('NON-ESG', 0.3119983375072479)","('NON-ESG', 0.20473165810108185)","('NON-ESG', 0.1151699423789978)"
Line 1012,"This is not included in the figure for FY19.
","('Systemic_Risk_Management', 0.2023010104894638)","('Management_Of_Legal_And_Regulatory_Framework', 0.1740090698003769)","('Physical_Impacts_Of_Climate_Change', 0.16719429194927216)","('NON-ESG', 0.2023010104894638)","('NON-ESG', 0.1740090698003769)","('NON-ESG', 0.16719429194927216)"
Line 1013,"FY19 FDA Class I Recalls and Safety Communication Product List   for Medtronic Devices  Devices FDA Class I Recalls 1.
","('Product_Quality_And_Safety', 0.8631107807159424)","('Selling_Practices_And_Product_Labeling', 0.025289330631494522)","('Competitive_Behavior', 0.012154372408986092)","(['Product Quality & Recall Management'], 0.8631107807159424)","('NON-ESG', 0.025289330631494522)","('NON-ESG', 0.012154372408986092)"
Line 1014,"Puritan Bennett™ 980 (PB980)   ventilator series 2.
","('Energy_Management', 0.2717207074165344)","('Critical_Incident_Risk_Management', 0.22582094371318817)","('Air_Quality', 0.08881358057260513)","('NON-ESG', 0.2717207074165344)","('NON-ESG', 0.22582094371318817)","('NON-ESG', 0.08881358057260513)"
Line 1015,"Synergy Cranial Software/StealthStation  S7 cranial software 3.
","('Employee_Health_And_Safety', 0.22466467320919037)","('Business_Ethics', 0.14567425847053528)","('Ecological_Impacts', 0.0764932632446289)","('NON-ESG', 0.22466467320919037)","('NON-ESG', 0.14567425847053528)","('NON-ESG', 0.0764932632446289)"
Line 1016,"Adapta, Versa, Sensia, Relia, Attesta,  Sphera, Vitatron A, E, G, and Q series 4.
","('Competitive_Behavior', 0.3580947816371918)","('Management_Of_Legal_And_Regulatory_Framework', 0.15752489864826202)","('Business_Ethics', 0.10089846700429916)","('NON-ESG', 0.3580947816371918)","('NON-ESG', 0.15752489864826202)","('NON-ESG', 0.10089846700429916)"
Line 1017,"HeartWare HVAD FDA Safety Communication  for Human Medical Products  Database*1.
","('Product_Quality_And_Safety', 0.9016914963722229)","('Selling_Practices_And_Product_Labeling', 0.016767313703894615)","('Customer_Welfare', 0.008677537553012371)","(['Product Quality & Recall Management'], 0.9016914963722229)","('NON-ESG', 0.016767313703894615)","('NON-ESG', 0.008677537553012371)"
Line 1018,"Cardiac implantable electronic device  (CIED) 2.
","('Employee_Health_And_Safety', 0.2208460122346878)","('Product_Design_And_Lifecycle_Management', 0.11098068952560425)","('Access_And_Affordability', 0.08581206202507019)","('NON-ESG', 0.2208460122346878)","('NON-ESG', 0.11098068952560425)","('NON-ESG', 0.08581206202507019)"
Line 1019,"Cardiac implantable cardioverter  defibrillators (ICDs) or cardiac  resynchronization therapy defibrillators  (CRT -Ds) *  The FDA issues Safety Communications to provide the public with new safety information about a  product.
","('Product_Quality_And_Safety', 0.8414938449859619)","('Selling_Practices_And_Product_Labeling', 0.047214679419994354)","('Employee_Health_And_Safety', 0.010816964320838451)","(['Product Quality & Recall Management'], 0.8414938449859619)","('NON-ESG', 0.047214679419994354)","('NON-ESG', 0.010816964320838451)"
Line 1020,"This includes some actions that have been classified as recalls by the FDA.
","('Product_Quality_And_Safety', 0.2541409730911255)","('Management_Of_Legal_And_Regulatory_Framework', 0.08652453869581223)","('Selling_Practices_And_Product_Labeling', 0.07943364977836609)","('NON-ESG', 0.2541409730911255)","('NON-ESG', 0.08652453869581223)","('NON-ESG', 0.07943364977836609)"
Line 1021,"Work with global regulators and industry stakeholders to improve  our post-market surveillance  Develop and standardize models to measure and improve patient  safety and clinical outcomes Product-related regulatory actions We take regulatory and field safety issues very seriously.
","('Product_Quality_And_Safety', 0.912662148475647)","('Selling_Practices_And_Product_Labeling', 0.01030581071972847)","('Employee_Health_And_Safety', 0.009213398210704327)","(['Product Quality & Recall Management'], 0.912662148475647)","('NON-ESG', 0.01030581071972847)","('NON-ESG', 0.009213398210704327)"
Line 1022,"When we  are alerted to an issue with one of our products, we assess the  issue quickly and take corrective action where appropriate, including  initiating voluntary product recalls.
","('Product_Quality_And_Safety', 0.49283567070961)","('Selling_Practices_And_Product_Labeling', 0.2662792205810547)","('Product_Design_And_Lifecycle_Management', 0.06083047389984131)","('NON-ESG', 0.49283567070961)","('NON-ESG', 0.2662792205810547)","('NON-ESG', 0.06083047389984131)"
Line 1023,"We work to understand and   resolve the root cause of problems and have systems in place to  prevent recurrence.
","('Systemic_Risk_Management', 0.5070176720619202)","('Critical_Incident_Risk_Management', 0.07657453417778015)","('Business_Ethics', 0.07023224979639053)","(['Risk & Crisis Management'], 0.5070176720619202)","('NON-ESG', 0.07657453417778015)","('NON-ESG', 0.07023224979639053)"
Line 1024,"In FY19, four Medtronic products were subject to Class I recalls.
","('Product_Design_And_Lifecycle_Management', 0.5600320100784302)","('Product_Quality_And_Safety', 0.22736002504825592)","('Selling_Practices_And_Product_Labeling', 0.03926202282309532)","(['Product Stewardship'], 0.5600320100784302)","('NON-ESG', 0.22736002504825592)","('NON-ESG', 0.03926202282309532)"
Line 1025,"More  detail on the nature of these recalls can be found on the FDA List of  Device Recalls website.
","('Product_Quality_And_Safety', 0.22610929608345032)","('Systemic_Risk_Management', 0.13980834186077118)","('Critical_Incident_Risk_Management', 0.07707519084215164)","('NON-ESG', 0.22610929608345032)","('NON-ESG', 0.13980834186077118)","('NON-ESG', 0.07707519084215164)"
Line 1026,"Learn more about the Medtronic commitment to global corporate  citizenship at www.medtronic.com/citizenship.ABOUT THIS REPORT101This report was prepared in accordance with the Global Reporting  Initiative Standards Core guidelines — an internationally recognized  framework for sustainability reporting.
","('Human_Rights_And_Community_Relations', 0.28071996569633484)","('Employee_Engagement_Inclusion_And_Diversity', 0.15367387235164642)","('Business_Model_Resilience', 0.10351575165987015)","('NON-ESG', 0.28071996569633484)","('NON-ESG', 0.15367387235164642)","('NON-ESG', 0.10351575165987015)"
Line 1027,"The content is also informed  by the reporting requirements of the Sustainability Accounting  Standards Board for Medical Equipment and Supplies and the   RobecoSAM annual survey used to determine the Dow Jones  Sustainability Indices.
","('Product_Quality_And_Safety', 0.18015268445014954)","('Supply_Chain_Management', 0.1346214860677719)","('Management_Of_Legal_And_Regulatory_Framework', 0.08365756273269653)","('NON-ESG', 0.18015268445014954)","('NON-ESG', 0.1346214860677719)","('NON-ESG', 0.08365756273269653)"
Line 1028,"For more information, see our   2019 ESG Disclosure Index.
","('Systemic_Risk_Management', 0.3823295533657074)","('Business_Model_Resilience', 0.3111226558685303)","('Physical_Impacts_Of_Climate_Change', 0.0329207219183445)","('NON-ESG', 0.3823295533657074)","('NON-ESG', 0.3111226558685303)","('NON-ESG', 0.0329207219183445)"
Line 1029,"Scope and data Unless otherwise stated, all performance reporting covers our fiscal  year 2019 (FY19) from April 28, 2018, through April 26, 2019.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2634090781211853)","('Business_Model_Resilience', 0.2066432386636734)","('Systemic_Risk_Management', 0.09540016204118729)","('NON-ESG', 0.2634090781211853)","('NON-ESG', 0.2066432386636734)","('NON-ESG', 0.09540016204118729)"
Line 1030,"This report includes data from Medtronic PLC and all its consolidated  subsidiaries.
","('Systemic_Risk_Management', 0.3025481104850769)","('Business_Model_Resilience', 0.11913834512233734)","('Director_Removal', 0.08619964122772217)","('NON-ESG', 0.3025481104850769)","('NON-ESG', 0.11913834512233734)","('NON-ESG', 0.08619964122772217)"
Line 1031,"Environmental, health, and safety data are from our  manufacturing and research and development facilities.
","('Employee_Health_And_Safety', 0.6758308410644531)","('Product_Quality_And_Safety', 0.18561382591724396)","('Product_Design_And_Lifecycle_Management', 0.020146287977695465)","(['Operational Eco-Efficiency'], 0.6758308410644531)","('NON-ESG', 0.18561382591724396)","('NON-ESG', 0.020146287977695465)"
Line 1032,"All reported data are best estimates.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1862509846687317)","('Systemic_Risk_Management', 0.12693600356578827)","('Access_And_Affordability', 0.08804959058761597)","('NON-ESG', 0.1862509846687317)","('NON-ESG', 0.12693600356578827)","('NON-ESG', 0.08804959058761597)"
Line 1033,"Medtronic subsidiaries   whose impact on overall data is less than 10% have been omitted.
","('Systemic_Risk_Management', 0.599193811416626)","('Business_Model_Resilience', 0.16078531742095947)","('Supply_Chain_Management', 0.03955710679292679)","(['Risk & Crisis Management'], 0.599193811416626)","('NON-ESG', 0.16078531742095947)","('NON-ESG', 0.03955710679292679)"
Line 1034,"All financial information is reported in U.S. dollars.Forward-looking statements Any forward-looking statements are subject to risks and  uncertainties, including those found in our periodic reports on file  with the U.S. Securities and Exchange Commission.
","('Systemic_Risk_Management', 0.9203516840934753)","('Business_Model_Resilience', 0.011443860828876495)","('Business_Ethics', 0.008705553598701954)","(['Risk & Crisis Management'], 0.9203516840934753)","('NON-ESG', 0.011443860828876495)","('NON-ESG', 0.008705553598701954)"
Line 1035,"Actual results  may differ materially from anticipated results.
","('Competitive_Behavior', 0.31018584966659546)","('Management_Of_Legal_And_Regulatory_Framework', 0.13230739533901215)","('Business_Model_Resilience', 0.10175710171461105)","('NON-ESG', 0.31018584966659546)","('NON-ESG', 0.13230739533901215)","('NON-ESG', 0.10175710171461105)"
Line 1036,"We welcome your views as a valued stakeholder .
","('Human_Rights_And_Community_Relations', 0.3915615975856781)","('Business_Model_Resilience', 0.11277938634157181)","('Director_Removal', 0.07792971283197403)","('NON-ESG', 0.3915615975856781)","('NON-ESG', 0.11277938634157181)","('NON-ESG', 0.07792971283197403)"
Line 1037,"T o provide   feedback or request further information, please email  integratedreport@medtronic.com.
","('Management_Of_Legal_And_Regulatory_Framework', 0.14498095214366913)","('Access_And_Affordability', 0.10084271430969238)","('Product_Quality_And_Safety', 0.07817927747964859)","('NON-ESG', 0.14498095214366913)","('NON-ESG', 0.10084271430969238)","('NON-ESG', 0.07817927747964859)"
Line 1038,"ABOUT THIS REPORT $ $ Medtronic PLC GAAP to Non-GAAP Reconciliations (Unaudited) (in Millions)* FY19 FY18 FYNet Cash Provided by Operating Activities $7,007 $4,684 $6,Additions to Property, Plant, and Equipment (1,134) (1,068) (1,254) Free Cash Flow†$5,873 $3,616 $5,* Investors should consider these non-GAAP measures in addition to, and not as a substitute for , financial performance measures prepared in accordance with U.S. GAAP .
","('Systemic_Risk_Management', 0.4839446246623993)","('Management_Of_Legal_And_Regulatory_Framework', 0.28895434737205505)","('Business_Ethics', 0.040748659521341324)","('NON-ESG', 0.4839446246623993)","('NON-ESG', 0.28895434737205505)","('NON-ESG', 0.040748659521341324)"
Line 1039,"†  Free cash flow represents operating cash flows less property, plant, and equipment additions.
","('Systemic_Risk_Management', 0.5854781866073608)","('Competitive_Behavior', 0.08356306701898575)","('Management_Of_Legal_And_Regulatory_Framework', 0.053732942789793015)","(['Risk & Crisis Management'], 0.5854781866073608)","('NON-ESG', 0.08356306701898575)","('NON-ESG', 0.053732942789793015)"
Line 1040,"Medtronic PLC Worldwide Revenue: Geographic* (Unaudited) (in Millions) Fiscal Y ear Comparable Constant Currency FY19 FY18 Growth Current Impact†Revised FY18**Growth U.S. $16,194 $15,875 2.0% — $15,465 4.7% Non-U.S. Developed $9,631 $9,627 — (205) $9,516 3.4% Emerging Markets $4,732 $4,451 6.3% (250) $4,422 12.7% T otal $30,557 $29,953 2.0% (455) $29,403 5.5%    *   U.S. includes the United States and U.S. territories.
","('Systemic_Risk_Management', 0.5085609555244446)","('Business_Model_Resilience', 0.13808822631835938)","('Competitive_Behavior', 0.079266257584095)","(['Risk & Crisis Management'], 0.5085609555244446)","('NON-ESG', 0.13808822631835938)","('NON-ESG', 0.079266257584095)"
Line 1041,"Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries of Western  Europe.
","('Competitive_Behavior', 0.6694265604019165)","('Business_Model_Resilience', 0.07608500123023987)","('Systemic_Risk_Management', 0.06626177579164505)","(['Business Ethics'], 0.6694265604019165)","('NON-ESG', 0.07608500123023987)","('NON-ESG', 0.06626177579164505)"
Line 1042,"Emerging Markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S.  developed markets, as previously defined.
","('Competitive_Behavior', 0.3180278241634369)","('Business_Model_Resilience', 0.2505907118320465)","('Systemic_Risk_Management', 0.23671706020832062)","('NON-ESG', 0.3180278241634369)","('NON-ESG', 0.2505907118320465)","('NON-ESG', 0.23671706020832062)"
Line 1043,"† The currency impact to revenue measures the change in revenue between current and prior year periods using constant exchange rates.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8717475533485413)","('Systemic_Risk_Management', 0.033245526254177094)","('Competitive_Behavior', 0.013154529966413975)","(['Corporate Governance'], 0.8717475533485413)","('NON-ESG', 0.033245526254177094)","('NON-ESG', 0.013154529966413975)"
Line 1044,"**  Revised revenue excludes revenue related to the divested Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses for the first quarter of   FY18.
","('Access_And_Affordability', 0.2527877688407898)","('Customer_Welfare', 0.17460379004478455)","('Product_Quality_And_Safety', 0.10316977649927139)","('NON-ESG', 0.2527877688407898)","('NON-ESG', 0.17460379004478455)","('NON-ESG', 0.10316977649927139)"
Line 1045,"NON-GAAP   AND OTHER   FINANCIAL MEASURES 103Pump therapy is not recommended for  people whose vision or hearing does not allow  recognition of pump signals and alarms.
","('Employee_Health_And_Safety', 0.3404655456542969)","('Employee_Engagement_Inclusion_And_Diversity', 0.19546933472156525)","('Access_And_Affordability', 0.07667514681816101)","('NON-ESG', 0.3404655456542969)","('NON-ESG', 0.19546933472156525)","('NON-ESG', 0.07667514681816101)"
Line 1046,"Pump  therapy is not recommended for people who  are unwilling or unable to maintain contact  with their healthcare professional.
","('Employee_Health_And_Safety', 0.6493677496910095)","('Access_And_Affordability', 0.06302299350500107)","('Labor_Practices', 0.03788282722234726)","(['Operational Eco-Efficiency'], 0.6493677496910095)","('NON-ESG', 0.06302299350500107)","('NON-ESG', 0.03788282722234726)"
Line 1047,"The safety  of the MiniMed™ 670G system has not been  studied in pregnant women.
","('Product_Quality_And_Safety', 0.39782610535621643)","('Customer_Welfare', 0.10529711097478867)","('Employee_Health_And_Safety', 0.08670344948768616)","('NON-ESG', 0.39782610535621643)","('NON-ESG', 0.10529711097478867)","('NON-ESG', 0.08670344948768616)"
Line 1048,"For complete  details of the system, including product  and important safety information such as  indications, contraindications, warnings  and precautions associated with system  and its components, please consult http:/ / www.medtronicdiabetes.com/important- safety-information#minimed-670g and  the appropriate user guide at http:/ /www.
","('Product_Quality_And_Safety', 0.8624005317687988)","('Selling_Practices_And_Product_Labeling', 0.03324604406952858)","('Employee_Health_And_Safety', 0.01795816794037819)","(['Product Quality & Recall Management'], 0.8624005317687988)","('NON-ESG', 0.03324604406952858)","('NON-ESG', 0.01795816794037819)"
Line 1049,"medtronicdiabetes.com/download-library.IMPORT ANT SAFETY INFORMA TION:  MINIMED™ 670G SYSTEM  The Medtronic MiniMed™ 670G system is  intended for continuous delivery of basal insulin  (at user selectable rates) and administration of  insulin boluses (in user selectable amounts) for  the management of type 1 diabetes mellitus  in persons, seven years of age and older ,  requiring insulin as well as for the continuous  monitoring and trending of glucose levels in  the fluid under the skin.
","('Customer_Welfare', 0.34204763174057007)","('Access_And_Affordability', 0.12286733090877533)","('Selling_Practices_And_Product_Labeling', 0.10458598285913467)","('NON-ESG', 0.34204763174057007)","('NON-ESG', 0.12286733090877533)","('NON-ESG', 0.10458598285913467)"
Line 1050,"The MiniMed™ 670G  system includes SmartGuard™ technology,  which can be programmed to automatically  adjust delivery of basal insulin based on  Continuous Glucose Monitor sensor glucose  values and can suspend delivery of insulin  when the sensor glucose value falls below or  is predicted to fall below predefined threshold  values.
","('Customer_Welfare', 0.3945288360118866)","('Energy_Management', 0.21048612892627716)","('Selling_Practices_And_Product_Labeling', 0.051668185740709305)","('NON-ESG', 0.3945288360118866)","('NON-ESG', 0.21048612892627716)","('NON-ESG', 0.051668185740709305)"
Line 1051,"The system requires a prescription.
","('Selling_Practices_And_Product_Labeling', 0.20339323580265045)","('Customer_Privacy', 0.16044671833515167)","('Access_And_Affordability', 0.06632604449987411)","('NON-ESG', 0.20339323580265045)","('NON-ESG', 0.16044671833515167)","('NON-ESG', 0.06632604449987411)"
Line 1052,"The Guardian™ Sensor (3) glucose values are  not intended to be used directly for making  therapy adjustments, but rather to provide  an indication of when a fingerstick may be required.
","('Customer_Welfare', 0.49478355050086975)","('Competitive_Behavior', 0.06340356916189194)","('Energy_Management', 0.05765747278928757)","('NON-ESG', 0.49478355050086975)","('NON-ESG', 0.06340356916189194)","('NON-ESG', 0.05765747278928757)"
Line 1053,"A confirmatory finger stick test via  the CONTOUR®NEXT LINK 2.4 blood glucose  meter is required prior to making adjustments  to diabetes therapy.
","('Access_And_Affordability', 0.24995596706867218)","('Customer_Welfare', 0.24391432106494904)","('Energy_Management', 0.06790750473737717)","('NON-ESG', 0.24995596706867218)","('NON-ESG', 0.24391432106494904)","('NON-ESG', 0.06790750473737717)"
Line 1054,"All therapy adjustments  should be based on measurements obtained  using the CONTOUR®NEXT LINK 2.4 blood  glucose meter and not on values provided  by the Guardian™ Sensor (3).
","('Customer_Welfare', 0.25850608944892883)","('Energy_Management', 0.16858458518981934)","('Access_And_Affordability', 0.09685627371072769)","('NON-ESG', 0.25850608944892883)","('NON-ESG', 0.16858458518981934)","('NON-ESG', 0.09685627371072769)"
Line 1055,"Always check  the pump display to ensure the glucose  result shown agrees with the glucose results  shown on the CONTOUR®NEXT LINK 2.4  blood glucose meter .
","('Energy_Management', 0.3328787386417389)","('Customer_Welfare', 0.19321495294570923)","('Water_And_Wastewater_Management', 0.08377647399902344)","('NON-ESG', 0.3328787386417389)","('NON-ESG', 0.19321495294570923)","('NON-ESG', 0.08377647399902344)"
Line 1056,"Do not calibrate your  CGM device or calculate a bolus using a blood  glucose meter result taken from an Alternative  Site (palm) or from a control solution test.
","('Customer_Welfare', 0.22232522070407867)","('Energy_Management', 0.15298905968666077)","('Access_And_Affordability', 0.10037001967430115)","('NON-ESG', 0.22232522070407867)","('NON-ESG', 0.15298905968666077)","('NON-ESG', 0.10037001967430115)"
Line 1057,"It  is not recommended to calibrate your CGM  device when sensor or blood glucose values  are changing rapidly, e.g., following a meal or  physical exercise.
","('Customer_Welfare', 0.2611745297908783)","('Energy_Management', 0.10262878239154816)","('Access_And_Affordability', 0.09751971065998077)","('NON-ESG', 0.2611745297908783)","('NON-ESG', 0.10262878239154816)","('NON-ESG', 0.09751971065998077)"
Line 1058,"If a control solution test is  out of range, please note that the result may be  transmitted to your pump when in the “ Always”  send mode.WARNING: Medtronic performed an  evaluation of the MiniMed™ 670G system and  determined that it may not be safe for use  in children under the age of 7 because of the  way that the system is designed and the daily  insulin requirements.
","('Access_And_Affordability', 0.6166231632232666)","('Product_Quality_And_Safety', 0.09065952897071838)","('Customer_Welfare', 0.05748376250267029)","(['Health Outcome Contribution'], 0.6166231632232666)","('NON-ESG', 0.09065952897071838)","('NON-ESG', 0.05748376250267029)"
Line 1059,"Therefore this device  should not be used in anyone under the age  of 7 years old.
","('Access_And_Affordability', 0.7216032147407532)","('Employee_Engagement_Inclusion_And_Diversity', 0.04015131667256355)","('Product_Quality_And_Safety', 0.03231024742126465)","(['Health Outcome Contribution'], 0.7216032147407532)","('NON-ESG', 0.04015131667256355)","('NON-ESG', 0.03231024742126465)"
Line 1060,"This device should also not be  used in patients who require less than a total  daily insulin dose of 8 units per day because  the device requires a minimum of 8 units per  day to operate safely.
","('Customer_Welfare', 0.2873789370059967)","('Access_And_Affordability', 0.22177843749523163)","('Selling_Practices_And_Product_Labeling', 0.14865471422672272)","('NON-ESG', 0.2873789370059967)","('NON-ESG', 0.22177843749523163)","('NON-ESG', 0.14865471422672272)"
Line 1061,UC202003288a EN,"('Management_Of_Legal_And_Regulatory_Framework', 0.7486751079559326)","('GHG_Emissions', 0.03678494319319725)","('Competitive_Behavior', 0.026714468374848366)","(['Corporate Governance'], 0.7486751079559326)","('NON-ESG', 0.03678494319319725)","('NON-ESG', 0.026714468374848366)"
